identifier_id,identifier_type,official_symbol,aliases,organism_official,score_1,score_2,hit,unique_id_x,entry_id,experimental_method,matthews_coefficient,percent_solvent_content,crystallization_method,ph,crystal_growth_procedure,temp_k,deposition_date,release_date,number_of_non_hydrogen_atoms,total_polymer_instances,total_polymer_residues,number_of_water_molecules,disulfide_bond_count,molecular_weight,number_of_distinct_protein_entities,refinement_resolution,structure_determination_methodology,average_b_factor,r_free,r_work,structure_title,sequence,entity_polymer_type,polymer_entity_sequence_length,entity_macromolecule_type,total_polymer_entity_instances,molecular_weight_entity,macromolecule_name,ec_number,ec_provenance_source,source_organism,taxonomy_id,total_polymer_residues_assembly,total_polymer_instances_assembly,oligomeric_count,oligomeric_state,stoichiometry,ligand_id,ligand_formula,ligand_mw,ligand_name,inchi,unique_id_y
147111,ENTREZ_GENE,notum,hNOTUM,Homo sapiens,0.3242088962445864,3.389869e-10,YES,146,4UZ1,X-RAY DIFFRACTION,1.9,34.0,Desconocido,4.6,"1.5 M AMMONIUM SULPHATE, 0.1 M SODIUM ACETATE PH 4.6",289.6514371309434,2014-09-04,2015-02-25,3212,1,383,287.0,7,44.17,1,1.4,experimental,18.766,0.18045,0.14387,STRUCTURE OF THE WNT DEACYLASE NOTUM - CRYSTAL FORM III - 1.4A,ETGSAQQLNEDLRLHLLLNTSVTCNDGSPAGYYLKESRGSRRWLLFLEGGWYCFNRENCDSRYDTMRRLMSSRDWPRTRTGTGILSSQPEENPYWWNANMVFIPYCSSDVWSGASSKSEKNEYAFMGALIIQEVVRELLGRGLSGAKVLLLAGSSAGGTGVLLNVDRVAEQLEKLGYPAIQVRGLADSGWFLDNKQYRHTDCVDTITCAPTEAIRRGIRYWNGVVPERCRRQFQEGEEWNCFFGYKVYPTLRSPVFVVQWLFDEAQLTVDNVHLTGQPVQEGLRLYIQNLGRELRHTLKDVPASFAPACLSHEIIIRSHWTDVQVKGTSLPRALHCWDRSLHDSHKASKTPLKGCPVHLVDSCPWPHCNPSCPTGTKHHHHHH,Protein,383,polypeptide(L),1,43.567,notum,3.1.1.1,PDB Primary Data,Homo sapiens,9606,383,1,1,Monomer,A1,NAG,C8 H15 N O6,221.208,2-acetamido-2-deoxy-beta-D-glucopyranose,"InChI=1S/C8H15NO6/c1-3(11)9-5-7(13)6(12)4(2-10)15-8(5)14/h4-8,10,12-14H,2H2,1H3,(H,9,11)/t4-,5-,6-,7-,8-/m1/s1",
147111,ENTREZ_GENE,notum,hNOTUM,Homo sapiens,0.3242088962445864,3.389869e-10,YES,146,4UZ5,X-RAY DIFFRACTION,2.5,52.0,Desconocido,6.0,"10 %W/V PEG4000, 0.01 M CACL2, 0.05 M NACACOD PH 6.0, 0.20 M KCL, 1 MM HEPARIN HEXAMER",289.6514371309434,2014-09-04,2015-02-25,2901,1,383,84.0,7,43.82,1,2.1,experimental,43.492,0.2371,0.18746,STRUCTURE OF THE WNT DEACYLASE NOTUM - CRYSTAL FORM IV - 2.1A,ETGSAQQLNEDLRLHLLLNTSVTCNDGSPAGYYLKESRGSRRWLLFLEGGWYCFNRENCDSRYDTMRRLMSSRDWPRTRTGTGILSSQPEENPYWWNANMVFIPYCSSDVWSGASSKSEKNEYAFMGALIIQEVVRELLGRGLSGAKVLLLAGSSAGGTGVLLNVDRVAEQLEKLGYPAIQVRGLADSGWFLDNKQYRHTDCVDTITCAPTEAIRRGIRYWNGVVPERCRRQFQEGEEWNCFFGYKVYPTLRSPVFVVQWLFDEAQLTVDNVHLTGQPVQEGLRLYIQNLGRELRHTLKDVPASFAPACLSHEIIIRSHWTDVQVKGTSLPRALHCWDRSLHDSHKASKTPLKGCPVHLVDSCPWPHCNPSCPTGTKHHHHHH,Protein,383,polypeptide(L),1,43.567,notum,3.1.1.1,PDB Primary Data,Homo sapiens,9606,383,1,1,Monomer,A1,NAG,C8 H15 N O6,221.208,2-acetamido-2-deoxy-beta-D-glucopyranose,"InChI=1S/C8H15NO6/c1-3(11)9-5-7(13)6(12)4(2-10)15-8(5)14/h4-8,10,12-14H,2H2,1H3,(H,9,11)/t4-,5-,6-,7-,8-/m1/s1",
50450,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,1.0,1.308357e-10,YES,1046,7QXZ,X-RAY DIFFRACTION,3.8,67.66,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NAH2PO4, PH 5.5, 2 M NACL; RESERVOIR SOLUTION: 3.0-3.2M NACL",293.15,2022-01-27,2022-04-13,4278,1,480,568.0,3,52.89,1,1.8,experimental,27.27,0.2173,0.1815,X-ray structure of furin in complex with the dichlorophenylpyridine-based inhibitor 5,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHH,Protein,480,polypeptide(L),1,52.112,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,480,1,1,Monomer,A1,CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
50450,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,1.0,1.308357e-10,YES,1046,8B4V,X-RAY DIFFRACTION,3.75,67.16,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NAH2PO4, PH 5.5, 2 M NACL; RESERVOIR SOLUTION: 3.0-3.2M NACL",293.15,2022-09-21,2023-10-04,4300,1,480,508.0,4,52.95,1,1.6,experimental,26.89,0.1658,0.1535,X-ray structure of furin (PCSK3) in complex with benzamidine,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHH,Protein,480,polypeptide(L),1,52.112,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,480,1,1,Monomer,A1,BEN,C7 H8 N2,120.152,BENZAMIDINE,"InChI=1S/C7H8N2/c8-7(9)6-4-2-1-3-5-6/h1-5H,(H3,8,9)",
50450,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,1.0,1.308357e-10,YES,1046,8B4W,X-RAY DIFFRACTION,3.75,67.17,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NAH2PO4, PH 5.5, 2 M NACL; RESERVOIR SOLUTION: 3.0-3.2M NACL",293.15,2022-09-21,2023-10-04,4403,1,480,497.0,4,53.21,1,1.6,experimental,27.18,0.179,0.1659,X-ray structure of furin (PCSK3) in complex with 1H-isoindol-3-amine,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHH,Protein,480,polypeptide(L),1,52.112,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,480,1,1,Monomer,A1,F05,C8 H8 N2,132.163,1H-isoindol-3-amine,"InChI=1S/C8H8N2/c9-8-7-4-2-1-3-6(7)5-10-8/h1-4H,5H2,(H2,9,10)",
50450,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,1.0,1.308357e-10,YES,1046,8B4X,X-RAY DIFFRACTION,3.75,67.24,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NAH2PO4, PH 5.5, 2 M NACL; RESERVOIR SOLUTION: 3.0-3.2M NACL",293.15,2022-09-21,2023-10-04,4276,2,485,462.0,4,53.27,2,1.6,experimental,28.95,0.1695,0.158,X-ray structure of furin (PCSK3) in complex with Guanidinomethyl-Phac-R-Tle-K-6-(aminomethyl)-3-amino-isoindol,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHH,Protein,480,polypeptide(L),1,52.112,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,485,2,2,Hetero 2-mer,"A1, B1",CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
50450,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,1.0,1.308357e-10,YES,1046,8OYH,X-RAY DIFFRACTION,3.76,67.27,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NAH2PO4, PH 5.5, 2 M NACL; RESERVOIR SOLUTION: 3.0-3.2M NACL",293.15,2023-05-04,2024-03-13,4092,2,485,340.0,4,53.27,2,1.8,experimental,36.56,0.188,0.1735,X-ray structure of furin (PCSK3) in complex with Guanidinomethyl-Phac-Can-Tle-Can-6-(aminomethyl)-3-amino-isoindol,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHH,Protein,480,polypeptide(L),1,52.112,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,485,2,2,Hetero 2-mer,"A1, B1",CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
50450,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,1.0,1.308357e-10,YES,1046,4Z2A,X-RAY DIFFRACTION,2.36,47.94,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"Well 13% PEG 8K, 0.110M K-dihydrogen phosphate, 0.1M HEPES pH 7.5, 350 uL protein with 350uL well drops, MRC sitting drop",277.0,2015-03-29,2016-05-04,4016,1,465,408.0,4,50.92,1,1.89,experimental,16.9953,0.1834,0.1479,Crystal structure of unglycosylated apo human furin @1.89A,YQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKDLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQDWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTA,Protein,465,polypeptide(L),1,50.506,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,465,1,1,Monomer,A1,EDO,C2 H6 O2,62.068,"1,2-ETHANEDIOL","InChI=1S/C2H6O2/c3-1-2-4/h3-4H,1-2H2",
50450,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,1.0,1.308357e-10,YES,1046,7O1U,X-RAY DIFFRACTION,3.74,67.12,"VAPOR DIFFUSION, SITTING DROP",5.5,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NAH2PO4, PH 5.5, 2 M NACL; RESERVOIR SOLUTION: 3.0-3.2M NACL",293.15,2021-03-30,2021-09-01,4375,1,480,519.0,4,53.19,1,1.7,experimental,26.23,0.1666,0.155,X-ray structure of furin in complex with the guanylhydrazone-based inhibitor 1 (BEV241),DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHH,Protein,480,polypeptide(L),1,52.112,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,480,1,1,Monomer,A1,Desconocido,Na,22.99,SODIUM ION,InChI=1S/Na/q+1,
50450,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,1.0,1.308357e-10,YES,1046,7O1W,X-RAY DIFFRACTION,3.74,67.1,"VAPOR DIFFUSION, SITTING DROP",5.5,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NAH2PO4, PH 5.5, 2 M NACL; RESERVOIR SOLUTION: 3.0-3.2M NACL",293.15,2021-03-30,2021-09-01,4335,1,480,424.0,4,53.69,1,1.8,experimental,29.36,0.1791,0.16,X-ray structure of furin in complex with the guanylhydrazone-based inhibitor 2 (mi307) soaked at 1 M NaCl,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHH,Protein,480,polypeptide(L),1,52.112,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,480,1,1,Monomer,A1,CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
50450,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,1.0,1.308357e-10,YES,1046,7O1Y,X-RAY DIFFRACTION,3.72,66.95,"VAPOR DIFFUSION, SITTING DROP",5.5,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NAH2PO4, PH 5.5, 2 M NACL; RESERVOIR SOLUTION: 3.0-3.2M NACL",293.15,2021-03-30,2021-09-01,4321,1,480,475.0,4,53.91,1,1.7,experimental,29.48,0.177,0.1622,X-ray structure of furin in complex with the guanylhydrazone-based inhibitor 2 (mi307) soaked at 0.25 M NaCl,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHH,Protein,480,polypeptide(L),1,52.112,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,480,1,1,Monomer,A1,CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
50450,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,1.0,1.308357e-10,YES,1046,7O20,X-RAY DIFFRACTION,3.67,66.48,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NAH2PO4, PH 5.5, 2 M NACL; RESERVOIR SOLUTION: 3.0-3.2M NACL",293.15,2021-03-30,2021-09-01,4190,1,480,376.0,4,53.54,1,1.8,experimental,33.26,0.1761,0.1624,X-ray structure of furin in complex with the guanylhydrazone-based inhibitor 3 (mi300),DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHH,Protein,480,polypeptide(L),1,52.112,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,480,1,1,Monomer,A1,CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
50450,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,1.0,1.308357e-10,YES,1046,7O22,X-RAY DIFFRACTION,3.69,66.7,"VAPOR DIFFUSION, SITTING DROP",5.5,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NAH2PO4, PH 5.5, 2 M NACL; RESERVOIR SOLUTION: 3.0-3.2M NACL",293.15,2021-03-30,2021-09-01,4130,1,480,427.0,4,53.15,1,1.8,experimental,33.5,0.1825,0.169,X-ray structure of furin in complex with the guanylhydrazone-based inhibitor 4 (mi359),DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHH,Protein,480,polypeptide(L),1,52.112,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,480,1,1,Monomer,A1,CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
50450,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,1.0,1.308357e-10,YES,1046,7QY0,X-RAY DIFFRACTION,3.72,66.91,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NAH2PO4, PH 5.5, 2 M NACL; RESERVOIR SOLUTION: 3.0-3.2M NACL",293.15,2022-01-27,2022-04-20,4378,1,480,476.0,4,53.68,1,1.54,experimental,26.16,0.1725,0.1493,X-ray structure of furin in complex with the dichlorophenylpyridine-based inhibitor 1,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHH,Protein,480,polypeptide(L),1,52.112,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,480,1,1,Monomer,A1,I0T,C32 H42 Cl2 N6 O3,629.62,"N-[[1-[[2-[3,5-bis(chloranyl)phenyl]-6-[6-[4-(2-methoxyethyl)piperazin-4-ium-1-yl]pyridin-3-yl]oxy-pyridin-4-yl]methyl]piperidin-1-ium-4-yl]methyl]ethanamide","InChI=1S/C32H40Cl2N6O3/c1-23(41)35-20-24-5-7-39(8-6-24)22-25-15-30(26-17-27(33)19-28(34)18-26)37-32(16-25)43-29-3-4-31(36-21-29)40-11-9-38(10-12-40)13-14-42-2/h3-4,15-19,21,24H,5-14,20,22H2,1-2H3,(H,35,41)/p+2",
50450,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,1.0,1.308357e-10,YES,1046,7QY1,X-RAY DIFFRACTION,2.568825997777984,50.34669344500458,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NAH2PO4, PH 5.5, 2 M NACL; RESERVOIR SOLUTION: 3.0-3.2M NACL",293.15,2022-01-27,2022-04-20,4387,1,480,483.0,4,53.77,1,1.45,experimental,25.78,0.1754,0.1502,X-ray structure of furin in complex with the dichlorophenylpyridine-based inhibitor 4,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHH,Protein,480,polypeptide(L),1,52.112,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,480,1,1,Monomer,A1,I0W,C32 H39 Cl2 N6 O4,642.596,"3-[4-[5-[4-[[4-(acetamidomethyl)piperidin-1-ium-1-yl]methyl]-6-[3,5-bis(chloranyl)phenyl]pyridin-2-yl]oxypyridin-2-yl]piperazin-1-ium-1-yl]propanoate","InChI=1S/C32H38Cl2N6O4/c1-22(41)35-19-23-4-7-39(8-5-23)21-24-14-29(25-16-26(33)18-27(34)17-25)37-31(15-24)44-28-2-3-30(36-20-28)40-12-10-38(11-13-40)9-6-32(42)43/h2-3,14-18,20,23H,4-13,19,21H2,1H3,(H,35,41)(H,42,43)/p+1",
50450,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,1.0,1.308357e-10,YES,1046,7QY2,X-RAY DIFFRACTION,3.71,66.87,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NAH2PO4, PH 5.5, 2 M NACL; RESERVOIR SOLUTION: 3.0-3.2M NACL",293.15,2022-01-27,2022-04-20,4373,1,480,471.0,4,53.72,1,1.55,experimental,27.19,0.1877,0.1645,X-ray structure of furin in complex with the dichlorophenylpyridine-based inhibitor 2,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHH,Protein,480,polypeptide(L),1,52.112,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,480,1,1,Monomer,A1,I0Q,C33 H42 Cl2 N7 O4,671.637,"(2R)-4-[4-[5-[4-[[4-(acetamidomethyl)piperidin-1-ium-1-yl]methyl]-6-[3,5-bis(chloranyl)phenyl]pyridin-2-yl]oxypyrimidin-2-yl]piperazin-1-ium-1-yl]-2-methyl-butanoate","InChI=1S/C33H41Cl2N7O4/c1-22(32(44)45)3-6-40-9-11-42(12-10-40)33-37-19-29(20-38-33)46-31-14-25(13-30(39-31)26-15-27(34)17-28(35)16-26)21-41-7-4-24(5-8-41)18-36-23(2)43/h13-17,19-20,22,24H,3-12,18,21H2,1-2H3,(H,36,43)(H,44,45)/p+1/t22-/m1/s1",
50450,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,1.0,1.308357e-10,YES,1046,7LCU,X-RAY DIFFRACTION,2.25,45.43,VAPOR DIFFUSION,7.5,"PEG8000, potassium dihydrogen phosphate",277.0,2021-01-11,2022-01-12,4057,1,490,352.0,5,54.37,1,1.24,experimental,14.5,0.1944,0.1764,"X-ray structure of Furin bound to BOS-318, a small molecule inhibitor",DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKDLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQDWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTAGENLYFQGDYKDDDDKGHHHHHH,Protein,490,polypeptide(L),1,53.512,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,490,1,1,Monomer,A1,CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
50450,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,1.0,1.308357e-10,YES,1046,6HLB,X-RAY DIFFRACTION,3.77,67.33,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NaH2PO4, PH 5.5-6.0, 2 M NaCL, 3% DMSO; RESERVOIR SOLUTION: 3-4M NaCL",293.15,2018-09-11,2019-02-06,4028,2,491,338.0,3,54.39,2,2.0,experimental,39.57218347825871,0.1874,0.1686,X-ray structure of furin in complex with the cyclic peptide c[succinyl-Phe-2-Nal-(Arg)4-Lys]-Arg-4-Amba,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHHHH,Protein,482,polypeptide(L),1,52.389,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,491,2,2,Hetero 2-mer,"A1, B1",CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
50450,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,1.0,1.308357e-10,YES,1046,6HLD,X-RAY DIFFRACTION,3.78,67.46,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NaH2PO4, PH 5.5-6.0, 2 M NaCL, 3% DMSO; RESERVOIR SOLUTION: 3-4M NaCL",293.15,2018-09-11,2019-02-06,4067,2,489,343.0,3,54.06,2,2.1,experimental,39.57218347825871,0.1959,0.17,X-ray structure of furin in complex with the cyclic peptide c[succinyl-Phe-2-Nal-(Arg)3-Lys]-Lys-4-Amba,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHHHH,Protein,482,polypeptide(L),1,52.389,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,489,2,2,Hetero 2-mer,"A1, B1",CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
50450,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,1.0,1.308357e-10,YES,1046,6HLE,X-RAY DIFFRACTION,3.84,68.01,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NaH2PO4, PH 5.5-6.0, 2 M NaCL, 3% DMSO; RESERVOIR SOLUTION: 3-4M NaCL",293.15,2018-09-11,2019-02-06,4127,2,488,390.0,3,53.91,2,1.994,experimental,39.57218347825871,0.1908,0.1667,X-ray structure of furin in complex with the P6-P2-cyclized peptide H-Lys-Arg-Arg-Tle-Lys-4-Amba,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHHHH,Protein,482,polypeptide(L),1,52.389,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,488,2,2,Hetero 2-mer,"A1, B1",CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
50450,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,1.0,1.308357e-10,YES,1046,6HZA,X-RAY DIFFRACTION,3.64,66.19,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NaH2PO4, PH 5.5-6.0, 2 M NaCL, 3% DMSO; RESERVOIR SOLUTION: 3-4M NaCL",293.15,2018-10-23,2019-02-06,4150,2,487,416.0,3,53.73,2,1.9,experimental,39.57218347825871,0.1859,0.1661,X-ray structure of furin in complex with the cyclic peptide c[glutaryl-Arg-Arg-Lys]-Arg-4-Amba,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHHHH,Protein,482,polypeptide(L),1,52.389,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,487,2,2,Hetero 2-mer,"A1, B1",CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
50450,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,1.0,1.308357e-10,YES,1046,6HZB,X-RAY DIFFRACTION,3.66,66.41,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NaH2PO4, PH 5.5-6.0, 2 M NaCL, 3% DMSO; RESERVOIR SOLUTION: 3-4M NaCL",293.15,2018-10-23,2019-02-06,4150,2,487,418.0,3,53.7,2,1.9,experimental,39.57218347825871,0.1824,0.1646,X-ray structure of furin in complex with the cyclic inhibitor c[glutaryl-Arg-Arg-Lys]-Lys-4-Amba,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHHHH,Protein,482,polypeptide(L),1,52.389,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,487,2,2,Hetero 2-mer,"A1, B1",CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
50450,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,1.0,1.308357e-10,YES,1046,6HZD,X-RAY DIFFRACTION,3.64,66.22,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NaH2PO4, PH 5.5-6.0, 2 M NaCL, 3% DMSO; RESERVOIR SOLUTION: 3-4M NaCL",293.15,2018-10-23,2019-02-06,4163,2,488,418.0,3,53.89,2,1.9,experimental,39.57218347825871,0.1827,0.1641,X-ray structure of furin in complex with the cyclic inhibitor c[glutaryl-Arg-Arg-Arg-Lys]-Arg-4-Amba,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHHHH,Protein,482,polypeptide(L),1,52.389,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,488,2,2,Hetero 2-mer,"A1, B1",CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
50450,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,1.0,1.308357e-10,YES,1046,6YD2,X-RAY DIFFRACTION,3.7,66.74,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100MM MES, 200MM K/NAH2PO4, PH 5.5-6.0, 2 M NACL; RESERVOIR SOLUTION: 3-4M NACL",293.15,2020-03-20,2021-02-17,4179,2,487,444.0,3,53.58,2,1.8,experimental,32.05,0.1771,0.1575,X-ray structure of furin in complex with the canavanine-based inhibitor 4-aminomethyl-phenylacetyl-canavanine-Tle-Arg-Amba,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHHHH,Protein,482,polypeptide(L),1,52.389,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,487,2,2,Hetero 2-mer,"A1, B1",CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
50450,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,1.0,1.308357e-10,YES,1046,6YD3,X-RAY DIFFRACTION,3.72,66.96,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100MM MES, 200MM K/NAH2PO4, PH 5.5-6.0, 2 M NACL; RESERVOIR SOLUTION: 3-4M NACL",293.15,2020-03-20,2021-02-17,4159,2,485,418.0,3,53.34,2,2.0,experimental,32.04,0.1854,0.1595,X-ray structure of furin in complex with the canavanine derived inhibitor 4-guanidinomethyl-phenylacetyl-Canavanine-Tle-Arg-Amba,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHH,Protein,480,polypeptide(L),1,52.112,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,485,2,2,Hetero 2-mer,"A1, B1",CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
50450,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,1.0,1.308357e-10,YES,1046,6YD4,X-RAY DIFFRACTION,3.73,67.06,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100MM MES, 200MM K/NAH2PO4, PH 5.5-6.0, 2 M NACL; RESERVOIR SOLUTION: 3-4M NACL",291.15,2020-03-20,2021-02-17,4237,2,485,477.0,3,53.37,2,1.7,experimental,31.24,0.1694,0.1532,X-ray structure of furin in complex with the canavanine-based inhibitor 4-guanidinomethyl-phenylacetyl-Canavanine-Tle-Canavanine-Amba,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHH,Protein,480,polypeptide(L),1,52.112,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,485,2,2,Hetero 2-mer,"A1, B1",CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
50450,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,1.0,1.308357e-10,YES,1046,6YD7,X-RAY DIFFRACTION,3.74,67.08,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100MM MES, 200MM K/NAH2PO4, PH 5.5-6.0, 2 M NACL; RESERVOIR SOLUTION: 3-4M NACL",291.15,2020-03-20,2021-02-17,4211,2,485,465.0,3,53.37,2,1.8,experimental,29.7,0.1709,0.1538,X-ray structure of furin in complex with the canavanine-based inhibitor 4-guanidinomethyl-phenylacetyl-Arg-Tle-Canavanine-Amba,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHH,Protein,480,polypeptide(L),1,52.112,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,485,2,2,Hetero 2-mer,"A1, B1",CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
50450,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,1.0,1.308357e-10,YES,1046,7QXY,X-RAY DIFFRACTION,2.568825997777984,50.34669344500458,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NAH2PO4, PH 5.5, 2 M NACL; RESERVOIR SOLUTION: 3.0-3.2M NACL",293.15,2022-01-27,2022-04-20,4386,1,480,661.0,2,53.0,1,1.478,experimental,24.97,0.1823,0.1705,X-ray structure of furin in complex with the dichlorophenylpyridine-based inhibitor 3,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHH,Protein,480,polypeptide(L),1,52.112,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,480,1,1,Monomer,A1,CL,Cl,35.453,CHLORIDE ION,InChI=1S/ClH/h1H/p-1,
50450,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,1.0,1.308357e-10,YES,1046,4RYD,X-RAY DIFFRACTION,2.86,56.93,"VAPOR DIFFUSION, SITTING DROP",8.5,"50mM Tris, 2.8M sodium formate, 15mM Cymal-7, pH 8.5, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293.0,2014-12-15,2015-05-27,23768,12,2922,2034.0,18,320.52,2,2.15,experimental,39.57218347825871,0.2186,0.1862,X-ray structure of human furin in complex with the competitive inhibitor para-guanidinomethyl-Phac-R-Tle-R-Amba,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHHHH,Protein,482,polypeptide(L),6,52.389,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,487,2,2,Hetero 2-mer,"A1, B1",FMT,C H2 O2,46.025,FORMIC ACID,"InChI=1S/CH2O2/c2-1-3/h1H,(H,2,3)",
50450,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,1.0,1.308357e-10,YES,1046,5JXH,X-RAY DIFFRACTION,3.67,66.49,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"crystallization solution: 100 mM MES, 200 mM K/NaH2PO4, pH 5.5-6.0, 3-4 M NaCl, 3% DMSO; reservoir solution: 3-4 M NaCl",293.15,2016-05-13,2016-10-05,4261,2,487,534.0,3,53.39,2,2.0,experimental,39.57218347825871,0.1853,0.1566,Structure the proprotein convertase furin in complex with meta-guanidinomethyl-Phac-RVR-Amba at 2.0 Angstrom resolution.,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHHHH,Protein,482,polypeptide(L),1,52.389,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,487,2,2,Hetero 2-mer,"A1, B1",CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
50450,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,1.0,1.308357e-10,YES,1046,5JXG,X-RAY DIFFRACTION,3.73,67.05,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"crystallization solution: 100 mM MES, 200 mM K/NaH2PO4, pH 5.5-6.0, 3-4 M NaCl, 3% DMSO; reservoir solution: 3-4 M NaCl",293.15,2016-05-13,2016-10-05,4360,1,482,645.0,3,52.73,1,1.8,experimental,39.57218347825871,0.1733,0.154,Structure of the unliganded form of the proprotein convertase furin.,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHHHH,Protein,482,polypeptide(L),1,52.389,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,482,1,1,Monomer,A1,CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
50450,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,1.0,1.308357e-10,YES,1046,5JXI,X-RAY DIFFRACTION,3.76,67.3,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"crystallization solution: 100 mM MES, 200 mM K/NaH2PO4, pH 5.5-6.0, 3-4 M NaCl, 3% DMSO; reservoir solution: 3-4 M NaCl",293.15,2016-05-13,2016-10-05,4164,1,482,521.0,3,52.63,1,2.0,experimental,39.57218347825871,0.1851,0.1576,Structure of the unliganded form of the proprotein convertase furin in presence of EDTA.,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHHHH,Protein,482,polypeptide(L),1,52.389,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,482,1,1,Monomer,A1,CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
50450,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,1.0,1.308357e-10,YES,1046,5MIM,X-RAY DIFFRACTION,3.75,67.2,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100 MM MES, 200 MM K/NAH2PO4, PH 5.5-6.0, 3-4 M NACL, 3% DMSO; RESERVOIR SOLUTION: 3-4 M NACL",293.15,2016-11-28,2017-05-10,4275,1,482,486.0,3,53.81,1,1.9,experimental,39.57218347825871,0.1838,0.1647,"Xray structure of human furin bound with the 2,5-dideoxystreptamine derived small molecule inhibitor 1n",DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHHHH,Protein,482,polypeptide(L),1,52.389,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,482,1,1,Monomer,A1,CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
50450,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,1.0,1.308357e-10,YES,1046,5JXJ,X-RAY DIFFRACTION,3.69,66.65,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"crystallization solution: 100 mM MES, 200 mM K/NaH2PO4, pH 5.5-6.0, 3-4 M NaCl, 3% DMSO; reservoir solution: 3-4 M NaCl",293.15,2016-05-13,2016-10-05,4185,2,487,461.0,3,53.35,2,2.0,experimental,39.57218347825871,0.1889,0.1668,Structure of the proprotein convertase furin complexed to meta-guanidinomethyl-Phac-RVR-Amba in presence of EDTA,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHHHH,Protein,482,polypeptide(L),1,52.389,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,487,2,2,Hetero 2-mer,"A1, B1",CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
50450,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,1.0,1.308357e-10,YES,1046,6EQV,X-RAY DIFFRACTION,3.67,66.45,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NaH2PO4, PH 5.5-6.0, 3-4M NaCl, 3% DMSO; RESERVOIR SOLUTION: 3-4 M NaCl",293.15,2017-10-16,2018-02-28,4212,2,487,510.0,3,53.3,2,1.895,experimental,39.57218347825871,0.1821,0.1637,X-ray structure of the proprotein convertase furin bound with the competitive inhibitor Phac-Cit-Val-Arg-Amba,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHHHH,Protein,482,polypeptide(L),1,52.389,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,487,2,2,Hetero 2-mer,"A1, B1",CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
50450,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,1.0,1.308357e-10,YES,1046,6EQW,X-RAY DIFFRACTION,3.66,66.42,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NaH2PO4, PH 5.5-6.0, 3-4 M NaCL, 3% DMSO; RESERVOIR SOLUTION: 3-4M NaCL",293.15,2017-10-16,2018-02-28,4183,2,487,486.0,3,53.36,2,1.994,experimental,39.57218347825871,0.1842,0.1619,X-ray structure of the proprotein convertase furin bound with the competitive inhibitor 4-aminomethyl-phenylacetyl-Arg-Val-Arg-Amba,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHHHH,Protein,482,polypeptide(L),1,52.389,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,487,2,2,Hetero 2-mer,"A1, B1",CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
50450,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,1.0,1.308357e-10,YES,1046,6EQX,X-RAY DIFFRACTION,3.66,66.36,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"100mM MES, 200mM K/NaH2PO4, PH 5.5-6.0, 3-4 M NaCL, 3% DMSO; RESERVOIR SOLUTION: 3-4M NaCL",293.15,2017-10-16,2018-02-28,4186,2,488,471.0,3,53.51,2,1.994,experimental,39.57218347825871,0.1837,0.162,X-ray structure of the proprotein convertase furin bound with the competitive inhibitor Arg-Arg-Arg-Val-Arg-Amba,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHHHH,Protein,482,polypeptide(L),1,52.389,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,488,2,2,Hetero 2-mer,"A1, B1",CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
41930,ENTREZ_GENE,mdm2,ACTFSHDMXhdm2,Homo sapiens,1.0,2.26e-14,YES,1136,4UD7,X-RAY DIFFRACTION,2.8,56.0,Desconocido,4.0,0.1 M SODIUM CITRATE PH 4.0 AND 15 % PEG8000,289.6514371309434,2014-12-08,2016-01-13,4008,8,520,262.0,0,58.68,2,1.6,experimental,23.018,0.17838,0.13846,Structure of the stapled peptide YS-02 bound to MDM2,GPLGSSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDAAQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSEN,Protein,114,polypeptide(L),4,12.831,mdm2,6.3.2,PDB Primary Data,Homo sapiens,9606,130,2,2,Hetero 2-mer,"A1, B1",Desconocido,Desconocido,246.2971348233669,Desconocido,Desconocido,
13870,ENTREZ_GENE,crebbp,CBPKAT3ARSTSRSTS1,Homo sapiens,0.9824842370876162,3.49e-14,YES,1284,6YIK,X-RAY DIFFRACTION,3.42,64.06,"VAPOR DIFFUSION, SITTING DROP",7.5,"21% PEG3350
15% ethylene glycol
0.25M sodium formate",277.0,2020-04-01,2020-04-15,3453,3,357,385.0,0,44.74,1,1.7,experimental,32.625,0.184,0.156,Crystal structure of the CREBBP bromodomain in complex with a tetrahydroquinoxaline ligand,SMRKKIFKPEELRQALMPTLEALYRQDPESLPFRQPVDPQLLGIPDYFDIVKNPMDLSTIKRKLDTGQYQEPWQYVDDVWLMFNNAWLYNRKTSRVYKFCSKLAEVFEQEIDPVMQSLG,Protein,119,polypeptide(L),3,14.223,crebbp,2.3.1.48,PDB Primary Data,Homo sapiens,9606,119,1,1,Monomer,A1,OSQ,C22 H24 F2 N4 O2,414.448,"(3~{R})-~{N}-[3-(3,4-dihydro-2~{H}-quinolin-1-yl)-2,2-bis(fluoranyl)propyl]-3-methyl-2-oxidanylidene-3,4-dihydro-1~{H}-quinoxaline-5-carboxamide","InChI=1S/C22H24F2N4O2/c1-14-20(29)27-17-9-4-8-16(19(17)26-14)21(30)25-12-22(23,24)13-28-11-5-7-15-6-2-3-10-18(15)28/h2-4,6,8-10,14,26H,5,7,11-13H2,1H3,(H,25,30)(H,27,29)/t14-/m1/s1",
13870,ENTREZ_GENE,crebbp,CBPKAT3ARSTSRSTS1,Homo sapiens,0.9824842370876162,3.49e-14,YES,1284,6SXX,X-RAY DIFFRACTION,2.18,43.67,"VAPOR DIFFUSION, HANGING DROP",6.982430939226492,"25% PEG3350, 0.2 M Potassium thiocyanate, 5% EtGly",277.0,2019-09-26,2020-07-29,1940,2,238,81.0,0,28.95,1,2.01,experimental,52.99,0.2533,0.1955,Crystal structure of the bromodomain of human CREBBP in complex with ACA007,SMRKKIFKPEELRQALMPTLEALYRQDPESLPFRQPVDPQLLGIPDYFDIVKNPMDLSTIKRKLDTGQYQEPWQYVDDVWLMFNNAWLYNRKTSRVYKFCSKLAEVFEQEIDPVMQSLG,Protein,119,polypeptide(L),2,14.223,crebbp,2.3.1.48,PDB Primary Data,Homo sapiens,9606,119,1,1,Monomer,A1,EDO,C2 H6 O2,62.068,"1,2-ETHANEDIOL","InChI=1S/C2H6O2/c3-1-2-4/h3-4H,1-2H2",
13870,ENTREZ_GENE,crebbp,CBPKAT3ARSTSRSTS1,Homo sapiens,0.9824842370876162,3.49e-14,YES,1284,6YIL,X-RAY DIFFRACTION,2.2,44.01,"VAPOR DIFFUSION, SITTING DROP",7.5,"20% PEG3350
10% ethylene glycol
0.2M sodium acetate",277.0,2020-04-01,2020-04-15,1160,1,119,154.0,0,14.64,1,1.22,experimental,12.75,0.1511,0.1321,Crystal structure of the CREBBP bromodomain in complex with a tetrahydroquinoxaline ligand,SMRKKIFKPEELRQALMPTLEALYRQDPESLPFRQPVDPQLLGIPDYFDIVKNPMDLSTIKRKLDTGQYQEPWQYVDDVWLMFNNAWLYNRKTSRVYKFCSKLAEVFEQEIDPVMQSLG,Protein,119,polypeptide(L),1,14.223,crebbp,2.3.1.48,PDB Primary Data,Homo sapiens,9606,119,1,1,Monomer,A1,OSQ,C22 H24 F2 N4 O2,414.448,"(3~{R})-~{N}-[3-(3,4-dihydro-2~{H}-quinolin-1-yl)-2,2-bis(fluoranyl)propyl]-3-methyl-2-oxidanylidene-3,4-dihydro-1~{H}-quinoxaline-5-carboxamide","InChI=1S/C22H24F2N4O2/c1-14-20(29)27-17-9-4-8-16(19(17)26-14)21(30)25-12-22(23,24)13-28-11-5-7-15-6-2-3-10-18(15)28/h2-4,6,8-10,14,26H,5,7,11-13H2,1H3,(H,25,30)(H,27,29)/t14-/m1/s1",
13870,ENTREZ_GENE,crebbp,CBPKAT3ARSTSRSTS1,Homo sapiens,0.9824842370876162,3.49e-14,YES,1284,6YIM,X-RAY DIFFRACTION,2.2,44.12,"VAPOR DIFFUSION, SITTING DROP",7.5,"20% PEG3350
10% ethylene glycol
0.2M sodium fluoride",277.0,2020-04-01,2020-04-15,1174,1,119,163.0,0,14.65,1,1.23,experimental,12.85,0.167,0.1397,Crystal structure of the CREBBP bromodomain in complex with a benzo-diazepine ligand,SMRKKIFKPEELRQALMPTLEALYRQDPESLPFRQPVDPQLLGIPDYFDIVKNPMDLSTIKRKLDTGQYQEPWQYVDDVWLMFNNAWLYNRKTSRVYKFCSKLAEVFEQEIDPVMQSLG,Protein,119,polypeptide(L),1,14.223,crebbp,2.3.1.48,PDB Primary Data,Homo sapiens,9606,119,1,1,Monomer,A1,OS8,C24 H30 N4 O3,422.52,"(4~{R})-~{N}-[3-(7-methoxy-3,4-dihydro-2~{H}-quinolin-1-yl)propyl]-4-methyl-2-oxidanylidene-1,3,4,5-tetrahydro-1,5-benzodiazepine-6-carboxamide","InChI=1S/C24H30N4O3/c1-16-14-22(29)27-20-8-3-7-19(23(20)26-16)24(30)25-11-5-13-28-12-4-6-17-9-10-18(31-2)15-21(17)28/h3,7-10,15-16,26H,4-6,11-14H2,1-2H3,(H,25,30)(H,27,29)/t16-/m1/s1",
13870,ENTREZ_GENE,crebbp,CBPKAT3ARSTSRSTS1,Homo sapiens,0.9824842370876162,3.49e-14,YES,1284,6YIJ,X-RAY DIFFRACTION,2.95,58.37,"VAPOR DIFFUSION, SITTING DROP",8.3,"20% ethylene glycol
21% PEG6K
0.1M tris pH 8.3
0.125M lithium chloride",277.0,2020-04-01,2020-04-15,7177,7,833,224.0,0,102.4,1,2.2,experimental,44.856,0.2693,0.2022,Crystal structure of the CREBBP bromodomain in complex with a benzo-diazepine ligand,SMRKKIFKPEELRQALMPTLEALYRQDPESLPFRQPVDPQLLGIPDYFDIVKNPMDLSTIKRKLDTGQYQEPWQYVDDVWLMFNNAWLYNRKTSRVYKFCSKLAEVFEQEIDPVMQSLG,Protein,119,polypeptide(L),7,14.223,crebbp,2.3.1.48,PDB Primary Data,Homo sapiens,9606,119,1,1,Monomer,A1,OSN,C25 H31 N3 O2,405.533,"(4~{R})-6-[(~{E})-5-(7-methoxy-3,4-dihydro-2~{H}-quinolin-1-yl)pent-1-enyl]-4-methyl-1,3,4,5-tetrahydro-1,5-benzodiazepin-2-one","InChI=1S/C25H31N3O2/c1-18-16-24(29)27-22-11-6-9-20(25(22)26-18)8-4-3-5-14-28-15-7-10-19-12-13-21(30-2)17-23(19)28/h4,6,8-9,11-13,17-18,26H,3,5,7,10,14-16H2,1-2H3,(H,27,29)/b8-4+/t18-/m1/s1",
56339,ENTREZ_GENE,mettl3,IME4M6AMTA70Spo8hMETTL3,Homo sapiens,1.0,2.512401e-10,YES,1966,5IL1,X-RAY DIFFRACTION,2.58,52.33,"VAPOR DIFFUSION, HANGING DROP",5.7,"PEG 8000, sodium citrate",291.0,2016-03-04,2016-05-25,4336,2,512,337.0,0,59.81,2,1.71,experimental,39.57218347825871,0.2069,0.1798,Crystal structure of SAM-bound METTL3-METTL14 complex,FPPQWICCDIRYLDVSILGKFAVVMADPPWDIHMELPYGTLTDDEMRRLNIPVLQDDGFLFLWVTGRAMELGRECLNLWGYERVDEIIWVKTNQLQRIIRTGRTGHWLNHGKEHCLVGVKGNPQGFNQGLDCDVIVAEVRSTSHKPDEIYGMIERLSPGTRKIELFGRPHNVQPNWITLGNQLDGIHLLDPDVVARFKQRYPDGIISKPKNL,Protein,212,polypeptide(L),1,24.427,mettl3,2.1.1.62,PDB Primary Data,Homo sapiens,9606,512,2,2,Hetero 2-mer,"A1, B1",SAM,C15 H22 N6 O5 S,398.437,S-ADENOSYLMETHIONINE,"InChI=1S/C15H22N6O5S/c1-27(3-2-7(16)15(24)25)4-8-10(22)11(23)14(26-8)21-6-20-9-12(17)18-5-19-13(9)21/h5-8,10-11,14,22-23H,2-4,16H2,1H3,(H2-,17,18,19,24,25)/t7-,8+,10+,11+,14+,27-/m0/s1",
56339,ENTREZ_GENE,mettl3,IME4M6AMTA70Spo8hMETTL3,Homo sapiens,1.0,2.512401e-10,YES,1966,5IL0,X-RAY DIFFRACTION,2.55,51.69,"VAPOR DIFFUSION, HANGING DROP",5.7,"PEG 8000, sodium citrate",291.0,2016-03-04,2016-05-25,4347,2,512,331.0,0,59.43,2,1.882,experimental,39.57218347825871,0.205,0.1747,Crystal structural of the METTL3-METTL14 complex for N6-adenosine methylation,FPPQWICCDIRYLDVSILGKFAVVMADPPWDIHMELPYGTLTDDEMRRLNIPVLQDDGFLFLWVTGRAMELGRECLNLWGYERVDEIIWVKTNQLQRIIRTGRTGHWLNHGKEHCLVGVKGNPQGFNQGLDCDVIVAEVRSTSHKPDEIYGMIERLSPGTRKIELFGRPHNVQPNWITLGNQLDGIHLLDPDVVARFKQRYPDGIISKPKNL,Protein,212,polypeptide(L),1,24.427,mettl3,2.1.1.62,PDB Primary Data,Homo sapiens,9606,512,2,2,Hetero 2-mer,"A1, B1",EDO,C2 H6 O2,62.068,"1,2-ETHANEDIOL","InChI=1S/C2H6O2/c3-1-2-4/h3-4H,1-2H2",
56339,ENTREZ_GENE,mettl3,IME4M6AMTA70Spo8hMETTL3,Homo sapiens,1.0,2.512401e-10,YES,1966,5IL2,X-RAY DIFFRACTION,2.66,53.7,"VAPOR DIFFUSION, HANGING DROP",5.7,"PEG 8000, sodium citrate",291.0,2016-03-04,2016-05-25,4393,2,512,376.0,1,59.85,2,1.606,experimental,39.57218347825871,0.1992,0.1848,Crystal structure of SAH-bound METTL3-METTL14 complex,FPPQWICCDIRYLDVSILGKFAVVMADPPWDIHMELPYGTLTDDEMRRLNIPVLQDDGFLFLWVTGRAMELGRECLNLWGYERVDEIIWVKTNQLQRIIRTGRTGHWLNHGKEHCLVGVKGNPQGFNQGLDCDVIVAEVRSTSHKPDEIYGMIERLSPGTRKIELFGRPHNVQPNWITLGNQLDGIHLLDPDVVARFKQRYPDGIISKPKNL,Protein,212,polypeptide(L),1,24.427,mettl3,2.1.1.62,PDB Primary Data,Homo sapiens,9606,512,2,2,Hetero 2-mer,"A1, B1",EDO,C2 H6 O2,62.068,"1,2-ETHANEDIOL","InChI=1S/C2H6O2/c3-1-2-4/h3-4H,1-2H2",
563390,ENTREZ_GENE,mettl3,IME4M6AMTA70Spo8hMETTL3,Homo sapiens,0.6157353650378212,4e-16,YES,2090,5IL1,X-RAY DIFFRACTION,2.58,52.33,"VAPOR DIFFUSION, HANGING DROP",5.7,"PEG 8000, sodium citrate",291.0,2016-03-04,2016-05-25,4336,2,512,337.0,0,59.81,2,1.71,experimental,39.57218347825871,0.2069,0.1798,Crystal structure of SAM-bound METTL3-METTL14 complex,FPPQWICCDIRYLDVSILGKFAVVMADPPWDIHMELPYGTLTDDEMRRLNIPVLQDDGFLFLWVTGRAMELGRECLNLWGYERVDEIIWVKTNQLQRIIRTGRTGHWLNHGKEHCLVGVKGNPQGFNQGLDCDVIVAEVRSTSHKPDEIYGMIERLSPGTRKIELFGRPHNVQPNWITLGNQLDGIHLLDPDVVARFKQRYPDGIISKPKNL,Protein,212,polypeptide(L),1,24.427,mettl3,2.1.1.62,PDB Primary Data,Homo sapiens,9606,512,2,2,Hetero 2-mer,"A1, B1",SAM,C15 H22 N6 O5 S,398.437,S-ADENOSYLMETHIONINE,"InChI=1S/C15H22N6O5S/c1-27(3-2-7(16)15(24)25)4-8-10(22)11(23)14(26-8)21-6-20-9-12(17)18-5-19-13(9)21/h5-8,10-11,14,22-23H,2-4,16H2,1H3,(H2-,17,18,19,24,25)/t7-,8+,10+,11+,14+,27-/m0/s1",
563390,ENTREZ_GENE,mettl3,IME4M6AMTA70Spo8hMETTL3,Homo sapiens,0.6157353650378212,4e-16,YES,2090,5IL0,X-RAY DIFFRACTION,2.55,51.69,"VAPOR DIFFUSION, HANGING DROP",5.7,"PEG 8000, sodium citrate",291.0,2016-03-04,2016-05-25,4347,2,512,331.0,0,59.43,2,1.882,experimental,39.57218347825871,0.205,0.1747,Crystal structural of the METTL3-METTL14 complex for N6-adenosine methylation,FPPQWICCDIRYLDVSILGKFAVVMADPPWDIHMELPYGTLTDDEMRRLNIPVLQDDGFLFLWVTGRAMELGRECLNLWGYERVDEIIWVKTNQLQRIIRTGRTGHWLNHGKEHCLVGVKGNPQGFNQGLDCDVIVAEVRSTSHKPDEIYGMIERLSPGTRKIELFGRPHNVQPNWITLGNQLDGIHLLDPDVVARFKQRYPDGIISKPKNL,Protein,212,polypeptide(L),1,24.427,mettl3,2.1.1.62,PDB Primary Data,Homo sapiens,9606,512,2,2,Hetero 2-mer,"A1, B1",EDO,C2 H6 O2,62.068,"1,2-ETHANEDIOL","InChI=1S/C2H6O2/c3-1-2-4/h3-4H,1-2H2",
563390,ENTREZ_GENE,mettl3,IME4M6AMTA70Spo8hMETTL3,Homo sapiens,0.6157353650378212,4e-16,YES,2090,5IL2,X-RAY DIFFRACTION,2.66,53.7,"VAPOR DIFFUSION, HANGING DROP",5.7,"PEG 8000, sodium citrate",291.0,2016-03-04,2016-05-25,4393,2,512,376.0,1,59.85,2,1.606,experimental,39.57218347825871,0.1992,0.1848,Crystal structure of SAH-bound METTL3-METTL14 complex,FPPQWICCDIRYLDVSILGKFAVVMADPPWDIHMELPYGTLTDDEMRRLNIPVLQDDGFLFLWVTGRAMELGRECLNLWGYERVDEIIWVKTNQLQRIIRTGRTGHWLNHGKEHCLVGVKGNPQGFNQGLDCDVIVAEVRSTSHKPDEIYGMIERLSPGTRKIELFGRPHNVQPNWITLGNQLDGIHLLDPDVVARFKQRYPDGIISKPKNL,Protein,212,polypeptide(L),1,24.427,mettl3,2.1.1.62,PDB Primary Data,Homo sapiens,9606,512,2,2,Hetero 2-mer,"A1, B1",EDO,C2 H6 O2,62.068,"1,2-ETHANEDIOL","InChI=1S/C2H6O2/c3-1-2-4/h3-4H,1-2H2",
6730,ENTREZ_GENE,braf,BRAF1BrafBRAF1NS7RAFB1,Homo sapiens,0.6157568960776733,1.55e-13,YES,2168,5VR3,X-RAY DIFFRACTION,2.58,52.44,"VAPOR DIFFUSION, HANGING DROP",6.5,"0.1 M Bis-Tris pH 6.5, 2.0 M ammonium sulphate",293.15,2017-05-10,2018-02-14,510,1,88,13.0,0,9.64,1,2.102,experimental,39.57218347825871,0.2244,0.2095,Crystal structure of the BRS domain of BRAF,GAMDPGGGGSSAADPAIPEEVWNIKQMIKLTQEHIEALLDKFGGEHNPPSIYLEAYEEYTSKLDALQQREQQLLESLGNGTDFSVSSS,Protein,88,polypeptide(L),1,9.544,braf,2.7.11.1,PDB Primary Data,Homo sapiens,9606,88,1,1,Monomer,A1,SO4,O4 S,96.063,SULFATE ION,"InChI=1S/H2O4S/c1-5(2,3)4/h(H2,1,2,3,4)/p-2",
1387,ENTREZ_GENE,crebbp,CBPKAT3ARSTSRSTS1,Homo sapiens,0.7131014900813358,3.432902e-10,YES,2553,6YIK,X-RAY DIFFRACTION,3.42,64.06,"VAPOR DIFFUSION, SITTING DROP",7.5,"21% PEG3350
15% ethylene glycol
0.25M sodium formate",277.0,2020-04-01,2020-04-15,3453,3,357,385.0,0,44.74,1,1.7,experimental,32.625,0.184,0.156,Crystal structure of the CREBBP bromodomain in complex with a tetrahydroquinoxaline ligand,SMRKKIFKPEELRQALMPTLEALYRQDPESLPFRQPVDPQLLGIPDYFDIVKNPMDLSTIKRKLDTGQYQEPWQYVDDVWLMFNNAWLYNRKTSRVYKFCSKLAEVFEQEIDPVMQSLG,Protein,119,polypeptide(L),3,14.223,crebbp,2.3.1.48,PDB Primary Data,Homo sapiens,9606,119,1,1,Monomer,A1,OSQ,C22 H24 F2 N4 O2,414.448,"(3~{R})-~{N}-[3-(3,4-dihydro-2~{H}-quinolin-1-yl)-2,2-bis(fluoranyl)propyl]-3-methyl-2-oxidanylidene-3,4-dihydro-1~{H}-quinoxaline-5-carboxamide","InChI=1S/C22H24F2N4O2/c1-14-20(29)27-17-9-4-8-16(19(17)26-14)21(30)25-12-22(23,24)13-28-11-5-7-15-6-2-3-10-18(15)28/h2-4,6,8-10,14,26H,5,7,11-13H2,1H3,(H,25,30)(H,27,29)/t14-/m1/s1",
1387,ENTREZ_GENE,crebbp,CBPKAT3ARSTSRSTS1,Homo sapiens,0.7131014900813358,3.432902e-10,YES,2553,6SXX,X-RAY DIFFRACTION,2.18,43.67,"VAPOR DIFFUSION, HANGING DROP",6.982430939226492,"25% PEG3350, 0.2 M Potassium thiocyanate, 5% EtGly",277.0,2019-09-26,2020-07-29,1940,2,238,81.0,0,28.95,1,2.01,experimental,52.99,0.2533,0.1955,Crystal structure of the bromodomain of human CREBBP in complex with ACA007,SMRKKIFKPEELRQALMPTLEALYRQDPESLPFRQPVDPQLLGIPDYFDIVKNPMDLSTIKRKLDTGQYQEPWQYVDDVWLMFNNAWLYNRKTSRVYKFCSKLAEVFEQEIDPVMQSLG,Protein,119,polypeptide(L),2,14.223,crebbp,2.3.1.48,PDB Primary Data,Homo sapiens,9606,119,1,1,Monomer,A1,EDO,C2 H6 O2,62.068,"1,2-ETHANEDIOL","InChI=1S/C2H6O2/c3-1-2-4/h3-4H,1-2H2",
1387,ENTREZ_GENE,crebbp,CBPKAT3ARSTSRSTS1,Homo sapiens,0.7131014900813358,3.432902e-10,YES,2553,6YIL,X-RAY DIFFRACTION,2.2,44.01,"VAPOR DIFFUSION, SITTING DROP",7.5,"20% PEG3350
10% ethylene glycol
0.2M sodium acetate",277.0,2020-04-01,2020-04-15,1160,1,119,154.0,0,14.64,1,1.22,experimental,12.75,0.1511,0.1321,Crystal structure of the CREBBP bromodomain in complex with a tetrahydroquinoxaline ligand,SMRKKIFKPEELRQALMPTLEALYRQDPESLPFRQPVDPQLLGIPDYFDIVKNPMDLSTIKRKLDTGQYQEPWQYVDDVWLMFNNAWLYNRKTSRVYKFCSKLAEVFEQEIDPVMQSLG,Protein,119,polypeptide(L),1,14.223,crebbp,2.3.1.48,PDB Primary Data,Homo sapiens,9606,119,1,1,Monomer,A1,OSQ,C22 H24 F2 N4 O2,414.448,"(3~{R})-~{N}-[3-(3,4-dihydro-2~{H}-quinolin-1-yl)-2,2-bis(fluoranyl)propyl]-3-methyl-2-oxidanylidene-3,4-dihydro-1~{H}-quinoxaline-5-carboxamide","InChI=1S/C22H24F2N4O2/c1-14-20(29)27-17-9-4-8-16(19(17)26-14)21(30)25-12-22(23,24)13-28-11-5-7-15-6-2-3-10-18(15)28/h2-4,6,8-10,14,26H,5,7,11-13H2,1H3,(H,25,30)(H,27,29)/t14-/m1/s1",
1387,ENTREZ_GENE,crebbp,CBPKAT3ARSTSRSTS1,Homo sapiens,0.7131014900813358,3.432902e-10,YES,2553,6YIM,X-RAY DIFFRACTION,2.2,44.12,"VAPOR DIFFUSION, SITTING DROP",7.5,"20% PEG3350
10% ethylene glycol
0.2M sodium fluoride",277.0,2020-04-01,2020-04-15,1174,1,119,163.0,0,14.65,1,1.23,experimental,12.85,0.167,0.1397,Crystal structure of the CREBBP bromodomain in complex with a benzo-diazepine ligand,SMRKKIFKPEELRQALMPTLEALYRQDPESLPFRQPVDPQLLGIPDYFDIVKNPMDLSTIKRKLDTGQYQEPWQYVDDVWLMFNNAWLYNRKTSRVYKFCSKLAEVFEQEIDPVMQSLG,Protein,119,polypeptide(L),1,14.223,crebbp,2.3.1.48,PDB Primary Data,Homo sapiens,9606,119,1,1,Monomer,A1,OS8,C24 H30 N4 O3,422.52,"(4~{R})-~{N}-[3-(7-methoxy-3,4-dihydro-2~{H}-quinolin-1-yl)propyl]-4-methyl-2-oxidanylidene-1,3,4,5-tetrahydro-1,5-benzodiazepine-6-carboxamide","InChI=1S/C24H30N4O3/c1-16-14-22(29)27-20-8-3-7-19(23(20)26-16)24(30)25-11-5-13-28-12-4-6-17-9-10-18(31-2)15-21(17)28/h3,7-10,15-16,26H,4-6,11-14H2,1-2H3,(H,25,30)(H,27,29)/t16-/m1/s1",
1387,ENTREZ_GENE,crebbp,CBPKAT3ARSTSRSTS1,Homo sapiens,0.7131014900813358,3.432902e-10,YES,2553,6YIJ,X-RAY DIFFRACTION,2.95,58.37,"VAPOR DIFFUSION, SITTING DROP",8.3,"20% ethylene glycol
21% PEG6K
0.1M tris pH 8.3
0.125M lithium chloride",277.0,2020-04-01,2020-04-15,7177,7,833,224.0,0,102.4,1,2.2,experimental,44.856,0.2693,0.2022,Crystal structure of the CREBBP bromodomain in complex with a benzo-diazepine ligand,SMRKKIFKPEELRQALMPTLEALYRQDPESLPFRQPVDPQLLGIPDYFDIVKNPMDLSTIKRKLDTGQYQEPWQYVDDVWLMFNNAWLYNRKTSRVYKFCSKLAEVFEQEIDPVMQSLG,Protein,119,polypeptide(L),7,14.223,crebbp,2.3.1.48,PDB Primary Data,Homo sapiens,9606,119,1,1,Monomer,A1,OSN,C25 H31 N3 O2,405.533,"(4~{R})-6-[(~{E})-5-(7-methoxy-3,4-dihydro-2~{H}-quinolin-1-yl)pent-1-enyl]-4-methyl-1,3,4,5-tetrahydro-1,5-benzodiazepin-2-one","InChI=1S/C25H31N3O2/c1-18-16-24(29)27-22-11-6-9-20(25(22)26-18)8-4-3-5-14-28-15-7-10-19-12-13-21(30-2)17-23(19)28/h4,6,8-9,11-13,17-18,26H,3,5,7,10,14-16H2,1-2H3,(H,27,29)/b8-4+/t18-/m1/s1",
1471110,ENTREZ_GENE,notum,hNOTUM,Homo sapiens,0.6202892752366174,9.66269e-11,YES,3231,4UZ1,X-RAY DIFFRACTION,1.9,34.0,Desconocido,4.6,"1.5 M AMMONIUM SULPHATE, 0.1 M SODIUM ACETATE PH 4.6",289.6514371309434,2014-09-04,2015-02-25,3212,1,383,287.0,7,44.17,1,1.4,experimental,18.766,0.18045,0.14387,STRUCTURE OF THE WNT DEACYLASE NOTUM - CRYSTAL FORM III - 1.4A,ETGSAQQLNEDLRLHLLLNTSVTCNDGSPAGYYLKESRGSRRWLLFLEGGWYCFNRENCDSRYDTMRRLMSSRDWPRTRTGTGILSSQPEENPYWWNANMVFIPYCSSDVWSGASSKSEKNEYAFMGALIIQEVVRELLGRGLSGAKVLLLAGSSAGGTGVLLNVDRVAEQLEKLGYPAIQVRGLADSGWFLDNKQYRHTDCVDTITCAPTEAIRRGIRYWNGVVPERCRRQFQEGEEWNCFFGYKVYPTLRSPVFVVQWLFDEAQLTVDNVHLTGQPVQEGLRLYIQNLGRELRHTLKDVPASFAPACLSHEIIIRSHWTDVQVKGTSLPRALHCWDRSLHDSHKASKTPLKGCPVHLVDSCPWPHCNPSCPTGTKHHHHHH,Protein,383,polypeptide(L),1,43.567,notum,3.1.1.1,PDB Primary Data,Homo sapiens,9606,383,1,1,Monomer,A1,NAG,C8 H15 N O6,221.208,2-acetamido-2-deoxy-beta-D-glucopyranose,"InChI=1S/C8H15NO6/c1-3(11)9-5-7(13)6(12)4(2-10)15-8(5)14/h4-8,10,12-14H,2H2,1H3,(H,9,11)/t4-,5-,6-,7-,8-/m1/s1",
1471110,ENTREZ_GENE,notum,hNOTUM,Homo sapiens,0.6202892752366174,9.66269e-11,YES,3231,4UZ5,X-RAY DIFFRACTION,2.5,52.0,Desconocido,6.0,"10 %W/V PEG4000, 0.01 M CACL2, 0.05 M NACACOD PH 6.0, 0.20 M KCL, 1 MM HEPARIN HEXAMER",289.6514371309434,2014-09-04,2015-02-25,2901,1,383,84.0,7,43.82,1,2.1,experimental,43.492,0.2371,0.18746,STRUCTURE OF THE WNT DEACYLASE NOTUM - CRYSTAL FORM IV - 2.1A,ETGSAQQLNEDLRLHLLLNTSVTCNDGSPAGYYLKESRGSRRWLLFLEGGWYCFNRENCDSRYDTMRRLMSSRDWPRTRTGTGILSSQPEENPYWWNANMVFIPYCSSDVWSGASSKSEKNEYAFMGALIIQEVVRELLGRGLSGAKVLLLAGSSAGGTGVLLNVDRVAEQLEKLGYPAIQVRGLADSGWFLDNKQYRHTDCVDTITCAPTEAIRRGIRYWNGVVPERCRRQFQEGEEWNCFFGYKVYPTLRSPVFVVQWLFDEAQLTVDNVHLTGQPVQEGLRLYIQNLGRELRHTLKDVPASFAPACLSHEIIIRSHWTDVQVKGTSLPRALHCWDRSLHDSHKASKTPLKGCPVHLVDSCPWPHCNPSCPTGTKHHHHHH,Protein,383,polypeptide(L),1,43.567,notum,3.1.1.1,PDB Primary Data,Homo sapiens,9606,383,1,1,Monomer,A1,NAG,C8 H15 N O6,221.208,2-acetamido-2-deoxy-beta-D-glucopyranose,"InChI=1S/C8H15NO6/c1-3(11)9-5-7(13)6(12)4(2-10)15-8(5)14/h4-8,10,12-14H,2H2,1H3,(H,9,11)/t4-,5-,6-,7-,8-/m1/s1",
57710,ENTREZ_GENE,ptpn2,PTN2PTPTTCPTPTCELLPTPTCPTP,Homo sapiens,0.6328764545122484,4.48589e-11,NO,4504,8U0H,X-RAY DIFFRACTION,2.41,49.06,"VAPOR DIFFUSION, HANGING DROP",6.9,"0.49M Sodium phosphate monobasic monohydrate, 0.91M Potassium phosphate dibasic",296.0,2023-08-29,2024-09-04,5135,2,648,385.0,0,78.03,1,1.93,experimental,38.32,0.1917,0.1726,Crystal structure of PTPN2 with a PROTAC,MAMPTTIEREFEELDTQRRWQPLYLEIRNESHDYPHRVAKFPENRNRNRYRDVSPYDHSRVKLQNAENDYINASLVDIEEAQRSYILTQGPLPNTCCHFWLMVWQQKTKAVVMLNRIVEKESVKCAQYWPTDDQEMLFKETGFSVKLLSEDVKSYYTVHLLQLENINSGETRTISHFHYTTWPDFGVPESPASFLNFLFKVRESGSLNPDHGPAVIHCSAGIGRSGTFSLVDTCLVLMEKGDDINIKQVLLNMRKYRMGLIQTPDQLRFSYMAIIEGAKCIKGDSSIQKRWKELSKEDLSPAFDHSPNKIMTEKYNHHHHHHHH,Protein,324,polypeptide(L),2,37.966,ptpn2,3.1.3.48,PDB Primary Data,Homo sapiens,9606,324,1,1,Monomer,A1,UB0,C46 H49 Cl N6 O12 S2,977.497,"(5P)-3-(carboxymethoxy)-4-chloro-5-(3-{[(4S)-1-({3-[2-(4-{3-[(3R)-2,6-dioxopiperidin-3-yl]-2-oxo-2,3-dihydro-1,3-benzoxazol-6-yl}piperidin-1-yl)acetamido]phenyl}methanesulfonyl)-2,2-dimethylpiperidin-4-yl]amino}phenyl)thiophene-2-carboxylic acid","InChI=1S/C46H49ClN6O12S2/c1-46(2)22-32(48-31-8-4-6-29(20-31)41-39(47)40(64-24-38(56)57)42(66-41)44(59)60)15-18-52(46)67(62,63)25-26-5-3-7-30(19-26)49-37(55)23-51-16-13-27(14-17-51)28-9-10-33-35(21-28)65-45(61)53(33)34-11-12-36(54)50-43(34)58/h3-10,19-21,27,32,34,48H,11-18,22-25H2,1-2H3,(H,49,55)(H,56,57)(H,59,60)(H,50,54,58)/t32-,34+/m0/s1",
4193,ENTREZ_GENE,mdm2,ACTFSHDMXhdm2,Homo sapiens,0.6544083517950884,1.14856e-11,YES,12259,4UD7,X-RAY DIFFRACTION,2.8,56.0,Desconocido,4.0,0.1 M SODIUM CITRATE PH 4.0 AND 15 % PEG8000,289.6514371309434,2014-12-08,2016-01-13,4008,8,520,262.0,0,58.68,2,1.6,experimental,23.018,0.17838,0.13846,Structure of the stapled peptide YS-02 bound to MDM2,GPLGSSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDAAQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSEN,Protein,114,polypeptide(L),4,12.831,mdm2,6.3.2,PDB Primary Data,Homo sapiens,9606,130,2,2,Hetero 2-mer,"A1, B1",Desconocido,Desconocido,246.2971348233669,Desconocido,Desconocido,
25340,ENTREZ_GENE,fyn,SLKSYNp59FYN,Homo sapiens,0.6041238467317691,4.48589e-11,NO,13767,6EDF,X-RAY DIFFRACTION,2.0,37.6,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"20% PEG3350, 0.2 M magnesium acetate",291.0,2018-08-09,2018-08-29,693,1,79,61.0,0,8.94,1,1.4,experimental,12.097,0.1721,0.1434,Fragment of a tyrosine-protein kinase,GGVTLFVALYDYEARTEDDISVHKGEKVQILNSSEGDWWEVRSLTTGETGYVPSNYVAPVDGSAAMGPVLRLRAFYNGG,Protein,79,polypeptide(L),1,8.591,fyn,2.7.10.2,PDB Primary Data,Homo sapiens,9606,79,1,1,Monomer,A1,GOL,C3 H8 O3,92.094,GLYCEROL,"InChI=1S/C3H8O3/c4-1-3(6)2-5/h3-6H,1-2H2",
673,ENTREZ_GENE,braf,BRAF1BrafBRAF1NS7RAFB1,Homo sapiens,0.5702154123375144,0.0,NO,14420,5VR3,X-RAY DIFFRACTION,2.58,52.44,"VAPOR DIFFUSION, HANGING DROP",6.5,"0.1 M Bis-Tris pH 6.5, 2.0 M ammonium sulphate",293.15,2017-05-10,2018-02-14,510,1,88,13.0,0,9.64,1,2.102,experimental,39.57218347825871,0.2244,0.2095,Crystal structure of the BRS domain of BRAF,GAMDPGGGGSSAADPAIPEEVWNIKQMIKLTQEHIEALLDKFGGEHNPPSIYLEAYEEYTSKLDALQQREQQLLESLGNGTDFSVSSS,Protein,88,polypeptide(L),1,9.544,braf,2.7.11.1,PDB Primary Data,Homo sapiens,9606,88,1,1,Monomer,A1,SO4,O4 S,96.063,SULFATE ION,"InChI=1S/H2O4S/c1-5(2,3)4/h(H2,1,2,3,4)/p-2",
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.6164795196939467,8.523e-13,YES,16897,7QXZ,X-RAY DIFFRACTION,3.8,67.66,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NAH2PO4, PH 5.5, 2 M NACL; RESERVOIR SOLUTION: 3.0-3.2M NACL",293.15,2022-01-27,2022-04-13,4278,1,480,568.0,3,52.89,1,1.8,experimental,27.27,0.2173,0.1815,X-ray structure of furin in complex with the dichlorophenylpyridine-based inhibitor 5,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHH,Protein,480,polypeptide(L),1,52.112,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,480,1,1,Monomer,A1,CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.6164795196939467,8.523e-13,YES,16897,8B4V,X-RAY DIFFRACTION,3.75,67.16,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NAH2PO4, PH 5.5, 2 M NACL; RESERVOIR SOLUTION: 3.0-3.2M NACL",293.15,2022-09-21,2023-10-04,4300,1,480,508.0,4,52.95,1,1.6,experimental,26.89,0.1658,0.1535,X-ray structure of furin (PCSK3) in complex with benzamidine,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHH,Protein,480,polypeptide(L),1,52.112,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,480,1,1,Monomer,A1,BEN,C7 H8 N2,120.152,BENZAMIDINE,"InChI=1S/C7H8N2/c8-7(9)6-4-2-1-3-5-6/h1-5H,(H3,8,9)",
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.6164795196939467,8.523e-13,YES,16897,8B4W,X-RAY DIFFRACTION,3.75,67.17,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NAH2PO4, PH 5.5, 2 M NACL; RESERVOIR SOLUTION: 3.0-3.2M NACL",293.15,2022-09-21,2023-10-04,4403,1,480,497.0,4,53.21,1,1.6,experimental,27.18,0.179,0.1659,X-ray structure of furin (PCSK3) in complex with 1H-isoindol-3-amine,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHH,Protein,480,polypeptide(L),1,52.112,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,480,1,1,Monomer,A1,F05,C8 H8 N2,132.163,1H-isoindol-3-amine,"InChI=1S/C8H8N2/c9-8-7-4-2-1-3-6(7)5-10-8/h1-4H,5H2,(H2,9,10)",
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.6164795196939467,8.523e-13,YES,16897,8B4X,X-RAY DIFFRACTION,3.75,67.24,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NAH2PO4, PH 5.5, 2 M NACL; RESERVOIR SOLUTION: 3.0-3.2M NACL",293.15,2022-09-21,2023-10-04,4276,2,485,462.0,4,53.27,2,1.6,experimental,28.95,0.1695,0.158,X-ray structure of furin (PCSK3) in complex with Guanidinomethyl-Phac-R-Tle-K-6-(aminomethyl)-3-amino-isoindol,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHH,Protein,480,polypeptide(L),1,52.112,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,485,2,2,Hetero 2-mer,"A1, B1",CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.6164795196939467,8.523e-13,YES,16897,8OYH,X-RAY DIFFRACTION,3.76,67.27,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NAH2PO4, PH 5.5, 2 M NACL; RESERVOIR SOLUTION: 3.0-3.2M NACL",293.15,2023-05-04,2024-03-13,4092,2,485,340.0,4,53.27,2,1.8,experimental,36.56,0.188,0.1735,X-ray structure of furin (PCSK3) in complex with Guanidinomethyl-Phac-Can-Tle-Can-6-(aminomethyl)-3-amino-isoindol,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHH,Protein,480,polypeptide(L),1,52.112,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,485,2,2,Hetero 2-mer,"A1, B1",CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.6164795196939467,8.523e-13,YES,16897,4Z2A,X-RAY DIFFRACTION,2.36,47.94,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"Well 13% PEG 8K, 0.110M K-dihydrogen phosphate, 0.1M HEPES pH 7.5, 350 uL protein with 350uL well drops, MRC sitting drop",277.0,2015-03-29,2016-05-04,4016,1,465,408.0,4,50.92,1,1.89,experimental,16.9953,0.1834,0.1479,Crystal structure of unglycosylated apo human furin @1.89A,YQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKDLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQDWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTA,Protein,465,polypeptide(L),1,50.506,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,465,1,1,Monomer,A1,EDO,C2 H6 O2,62.068,"1,2-ETHANEDIOL","InChI=1S/C2H6O2/c3-1-2-4/h3-4H,1-2H2",
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.6164795196939467,8.523e-13,YES,16897,7O1U,X-RAY DIFFRACTION,3.74,67.12,"VAPOR DIFFUSION, SITTING DROP",5.5,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NAH2PO4, PH 5.5, 2 M NACL; RESERVOIR SOLUTION: 3.0-3.2M NACL",293.15,2021-03-30,2021-09-01,4375,1,480,519.0,4,53.19,1,1.7,experimental,26.23,0.1666,0.155,X-ray structure of furin in complex with the guanylhydrazone-based inhibitor 1 (BEV241),DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHH,Protein,480,polypeptide(L),1,52.112,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,480,1,1,Monomer,A1,Desconocido,Na,22.99,SODIUM ION,InChI=1S/Na/q+1,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.6164795196939467,8.523e-13,YES,16897,7O1W,X-RAY DIFFRACTION,3.74,67.1,"VAPOR DIFFUSION, SITTING DROP",5.5,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NAH2PO4, PH 5.5, 2 M NACL; RESERVOIR SOLUTION: 3.0-3.2M NACL",293.15,2021-03-30,2021-09-01,4335,1,480,424.0,4,53.69,1,1.8,experimental,29.36,0.1791,0.16,X-ray structure of furin in complex with the guanylhydrazone-based inhibitor 2 (mi307) soaked at 1 M NaCl,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHH,Protein,480,polypeptide(L),1,52.112,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,480,1,1,Monomer,A1,CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.6164795196939467,8.523e-13,YES,16897,7O1Y,X-RAY DIFFRACTION,3.72,66.95,"VAPOR DIFFUSION, SITTING DROP",5.5,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NAH2PO4, PH 5.5, 2 M NACL; RESERVOIR SOLUTION: 3.0-3.2M NACL",293.15,2021-03-30,2021-09-01,4321,1,480,475.0,4,53.91,1,1.7,experimental,29.48,0.177,0.1622,X-ray structure of furin in complex with the guanylhydrazone-based inhibitor 2 (mi307) soaked at 0.25 M NaCl,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHH,Protein,480,polypeptide(L),1,52.112,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,480,1,1,Monomer,A1,CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.6164795196939467,8.523e-13,YES,16897,7O20,X-RAY DIFFRACTION,3.67,66.48,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NAH2PO4, PH 5.5, 2 M NACL; RESERVOIR SOLUTION: 3.0-3.2M NACL",293.15,2021-03-30,2021-09-01,4190,1,480,376.0,4,53.54,1,1.8,experimental,33.26,0.1761,0.1624,X-ray structure of furin in complex with the guanylhydrazone-based inhibitor 3 (mi300),DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHH,Protein,480,polypeptide(L),1,52.112,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,480,1,1,Monomer,A1,CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.6164795196939467,8.523e-13,YES,16897,7O22,X-RAY DIFFRACTION,3.69,66.7,"VAPOR DIFFUSION, SITTING DROP",5.5,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NAH2PO4, PH 5.5, 2 M NACL; RESERVOIR SOLUTION: 3.0-3.2M NACL",293.15,2021-03-30,2021-09-01,4130,1,480,427.0,4,53.15,1,1.8,experimental,33.5,0.1825,0.169,X-ray structure of furin in complex with the guanylhydrazone-based inhibitor 4 (mi359),DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHH,Protein,480,polypeptide(L),1,52.112,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,480,1,1,Monomer,A1,CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.6164795196939467,8.523e-13,YES,16897,7QY0,X-RAY DIFFRACTION,3.72,66.91,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NAH2PO4, PH 5.5, 2 M NACL; RESERVOIR SOLUTION: 3.0-3.2M NACL",293.15,2022-01-27,2022-04-20,4378,1,480,476.0,4,53.68,1,1.54,experimental,26.16,0.1725,0.1493,X-ray structure of furin in complex with the dichlorophenylpyridine-based inhibitor 1,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHH,Protein,480,polypeptide(L),1,52.112,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,480,1,1,Monomer,A1,I0T,C32 H42 Cl2 N6 O3,629.62,"N-[[1-[[2-[3,5-bis(chloranyl)phenyl]-6-[6-[4-(2-methoxyethyl)piperazin-4-ium-1-yl]pyridin-3-yl]oxy-pyridin-4-yl]methyl]piperidin-1-ium-4-yl]methyl]ethanamide","InChI=1S/C32H40Cl2N6O3/c1-23(41)35-20-24-5-7-39(8-6-24)22-25-15-30(26-17-27(33)19-28(34)18-26)37-32(16-25)43-29-3-4-31(36-21-29)40-11-9-38(10-12-40)13-14-42-2/h3-4,15-19,21,24H,5-14,20,22H2,1-2H3,(H,35,41)/p+2",
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.6164795196939467,8.523e-13,YES,16897,7QY1,X-RAY DIFFRACTION,2.568825997777984,50.34669344500458,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NAH2PO4, PH 5.5, 2 M NACL; RESERVOIR SOLUTION: 3.0-3.2M NACL",293.15,2022-01-27,2022-04-20,4387,1,480,483.0,4,53.77,1,1.45,experimental,25.78,0.1754,0.1502,X-ray structure of furin in complex with the dichlorophenylpyridine-based inhibitor 4,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHH,Protein,480,polypeptide(L),1,52.112,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,480,1,1,Monomer,A1,I0W,C32 H39 Cl2 N6 O4,642.596,"3-[4-[5-[4-[[4-(acetamidomethyl)piperidin-1-ium-1-yl]methyl]-6-[3,5-bis(chloranyl)phenyl]pyridin-2-yl]oxypyridin-2-yl]piperazin-1-ium-1-yl]propanoate","InChI=1S/C32H38Cl2N6O4/c1-22(41)35-19-23-4-7-39(8-5-23)21-24-14-29(25-16-26(33)18-27(34)17-25)37-31(15-24)44-28-2-3-30(36-20-28)40-12-10-38(11-13-40)9-6-32(42)43/h2-3,14-18,20,23H,4-13,19,21H2,1H3,(H,35,41)(H,42,43)/p+1",
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.6164795196939467,8.523e-13,YES,16897,7QY2,X-RAY DIFFRACTION,3.71,66.87,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NAH2PO4, PH 5.5, 2 M NACL; RESERVOIR SOLUTION: 3.0-3.2M NACL",293.15,2022-01-27,2022-04-20,4373,1,480,471.0,4,53.72,1,1.55,experimental,27.19,0.1877,0.1645,X-ray structure of furin in complex with the dichlorophenylpyridine-based inhibitor 2,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHH,Protein,480,polypeptide(L),1,52.112,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,480,1,1,Monomer,A1,I0Q,C33 H42 Cl2 N7 O4,671.637,"(2R)-4-[4-[5-[4-[[4-(acetamidomethyl)piperidin-1-ium-1-yl]methyl]-6-[3,5-bis(chloranyl)phenyl]pyridin-2-yl]oxypyrimidin-2-yl]piperazin-1-ium-1-yl]-2-methyl-butanoate","InChI=1S/C33H41Cl2N7O4/c1-22(32(44)45)3-6-40-9-11-42(12-10-40)33-37-19-29(20-38-33)46-31-14-25(13-30(39-31)26-15-27(34)17-28(35)16-26)21-41-7-4-24(5-8-41)18-36-23(2)43/h13-17,19-20,22,24H,3-12,18,21H2,1-2H3,(H,36,43)(H,44,45)/p+1/t22-/m1/s1",
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.6164795196939467,8.523e-13,YES,16897,7LCU,X-RAY DIFFRACTION,2.25,45.43,VAPOR DIFFUSION,7.5,"PEG8000, potassium dihydrogen phosphate",277.0,2021-01-11,2022-01-12,4057,1,490,352.0,5,54.37,1,1.24,experimental,14.5,0.1944,0.1764,"X-ray structure of Furin bound to BOS-318, a small molecule inhibitor",DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKDLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQDWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTAGENLYFQGDYKDDDDKGHHHHHH,Protein,490,polypeptide(L),1,53.512,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,490,1,1,Monomer,A1,CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.6164795196939467,8.523e-13,YES,16897,6HLB,X-RAY DIFFRACTION,3.77,67.33,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NaH2PO4, PH 5.5-6.0, 2 M NaCL, 3% DMSO; RESERVOIR SOLUTION: 3-4M NaCL",293.15,2018-09-11,2019-02-06,4028,2,491,338.0,3,54.39,2,2.0,experimental,39.57218347825871,0.1874,0.1686,X-ray structure of furin in complex with the cyclic peptide c[succinyl-Phe-2-Nal-(Arg)4-Lys]-Arg-4-Amba,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHHHH,Protein,482,polypeptide(L),1,52.389,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,491,2,2,Hetero 2-mer,"A1, B1",CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.6164795196939467,8.523e-13,YES,16897,6HLD,X-RAY DIFFRACTION,3.78,67.46,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NaH2PO4, PH 5.5-6.0, 2 M NaCL, 3% DMSO; RESERVOIR SOLUTION: 3-4M NaCL",293.15,2018-09-11,2019-02-06,4067,2,489,343.0,3,54.06,2,2.1,experimental,39.57218347825871,0.1959,0.17,X-ray structure of furin in complex with the cyclic peptide c[succinyl-Phe-2-Nal-(Arg)3-Lys]-Lys-4-Amba,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHHHH,Protein,482,polypeptide(L),1,52.389,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,489,2,2,Hetero 2-mer,"A1, B1",CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.6164795196939467,8.523e-13,YES,16897,6HLE,X-RAY DIFFRACTION,3.84,68.01,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NaH2PO4, PH 5.5-6.0, 2 M NaCL, 3% DMSO; RESERVOIR SOLUTION: 3-4M NaCL",293.15,2018-09-11,2019-02-06,4127,2,488,390.0,3,53.91,2,1.994,experimental,39.57218347825871,0.1908,0.1667,X-ray structure of furin in complex with the P6-P2-cyclized peptide H-Lys-Arg-Arg-Tle-Lys-4-Amba,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHHHH,Protein,482,polypeptide(L),1,52.389,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,488,2,2,Hetero 2-mer,"A1, B1",CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.6164795196939467,8.523e-13,YES,16897,6HZA,X-RAY DIFFRACTION,3.64,66.19,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NaH2PO4, PH 5.5-6.0, 2 M NaCL, 3% DMSO; RESERVOIR SOLUTION: 3-4M NaCL",293.15,2018-10-23,2019-02-06,4150,2,487,416.0,3,53.73,2,1.9,experimental,39.57218347825871,0.1859,0.1661,X-ray structure of furin in complex with the cyclic peptide c[glutaryl-Arg-Arg-Lys]-Arg-4-Amba,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHHHH,Protein,482,polypeptide(L),1,52.389,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,487,2,2,Hetero 2-mer,"A1, B1",CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.6164795196939467,8.523e-13,YES,16897,6HZB,X-RAY DIFFRACTION,3.66,66.41,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NaH2PO4, PH 5.5-6.0, 2 M NaCL, 3% DMSO; RESERVOIR SOLUTION: 3-4M NaCL",293.15,2018-10-23,2019-02-06,4150,2,487,418.0,3,53.7,2,1.9,experimental,39.57218347825871,0.1824,0.1646,X-ray structure of furin in complex with the cyclic inhibitor c[glutaryl-Arg-Arg-Lys]-Lys-4-Amba,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHHHH,Protein,482,polypeptide(L),1,52.389,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,487,2,2,Hetero 2-mer,"A1, B1",CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.6164795196939467,8.523e-13,YES,16897,6HZD,X-RAY DIFFRACTION,3.64,66.22,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NaH2PO4, PH 5.5-6.0, 2 M NaCL, 3% DMSO; RESERVOIR SOLUTION: 3-4M NaCL",293.15,2018-10-23,2019-02-06,4163,2,488,418.0,3,53.89,2,1.9,experimental,39.57218347825871,0.1827,0.1641,X-ray structure of furin in complex with the cyclic inhibitor c[glutaryl-Arg-Arg-Arg-Lys]-Arg-4-Amba,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHHHH,Protein,482,polypeptide(L),1,52.389,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,488,2,2,Hetero 2-mer,"A1, B1",CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.6164795196939467,8.523e-13,YES,16897,6YD2,X-RAY DIFFRACTION,3.7,66.74,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100MM MES, 200MM K/NAH2PO4, PH 5.5-6.0, 2 M NACL; RESERVOIR SOLUTION: 3-4M NACL",293.15,2020-03-20,2021-02-17,4179,2,487,444.0,3,53.58,2,1.8,experimental,32.05,0.1771,0.1575,X-ray structure of furin in complex with the canavanine-based inhibitor 4-aminomethyl-phenylacetyl-canavanine-Tle-Arg-Amba,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHHHH,Protein,482,polypeptide(L),1,52.389,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,487,2,2,Hetero 2-mer,"A1, B1",CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.6164795196939467,8.523e-13,YES,16897,6YD3,X-RAY DIFFRACTION,3.72,66.96,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100MM MES, 200MM K/NAH2PO4, PH 5.5-6.0, 2 M NACL; RESERVOIR SOLUTION: 3-4M NACL",293.15,2020-03-20,2021-02-17,4159,2,485,418.0,3,53.34,2,2.0,experimental,32.04,0.1854,0.1595,X-ray structure of furin in complex with the canavanine derived inhibitor 4-guanidinomethyl-phenylacetyl-Canavanine-Tle-Arg-Amba,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHH,Protein,480,polypeptide(L),1,52.112,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,485,2,2,Hetero 2-mer,"A1, B1",CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.6164795196939467,8.523e-13,YES,16897,6YD4,X-RAY DIFFRACTION,3.73,67.06,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100MM MES, 200MM K/NAH2PO4, PH 5.5-6.0, 2 M NACL; RESERVOIR SOLUTION: 3-4M NACL",291.15,2020-03-20,2021-02-17,4237,2,485,477.0,3,53.37,2,1.7,experimental,31.24,0.1694,0.1532,X-ray structure of furin in complex with the canavanine-based inhibitor 4-guanidinomethyl-phenylacetyl-Canavanine-Tle-Canavanine-Amba,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHH,Protein,480,polypeptide(L),1,52.112,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,485,2,2,Hetero 2-mer,"A1, B1",CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.6164795196939467,8.523e-13,YES,16897,6YD7,X-RAY DIFFRACTION,3.74,67.08,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100MM MES, 200MM K/NAH2PO4, PH 5.5-6.0, 2 M NACL; RESERVOIR SOLUTION: 3-4M NACL",291.15,2020-03-20,2021-02-17,4211,2,485,465.0,3,53.37,2,1.8,experimental,29.7,0.1709,0.1538,X-ray structure of furin in complex with the canavanine-based inhibitor 4-guanidinomethyl-phenylacetyl-Arg-Tle-Canavanine-Amba,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHH,Protein,480,polypeptide(L),1,52.112,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,485,2,2,Hetero 2-mer,"A1, B1",CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.6164795196939467,8.523e-13,YES,16897,7QXY,X-RAY DIFFRACTION,2.568825997777984,50.34669344500458,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NAH2PO4, PH 5.5, 2 M NACL; RESERVOIR SOLUTION: 3.0-3.2M NACL",293.15,2022-01-27,2022-04-20,4386,1,480,661.0,2,53.0,1,1.478,experimental,24.97,0.1823,0.1705,X-ray structure of furin in complex with the dichlorophenylpyridine-based inhibitor 3,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHH,Protein,480,polypeptide(L),1,52.112,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,480,1,1,Monomer,A1,CL,Cl,35.453,CHLORIDE ION,InChI=1S/ClH/h1H/p-1,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.6164795196939467,8.523e-13,YES,16897,4RYD,X-RAY DIFFRACTION,2.86,56.93,"VAPOR DIFFUSION, SITTING DROP",8.5,"50mM Tris, 2.8M sodium formate, 15mM Cymal-7, pH 8.5, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293.0,2014-12-15,2015-05-27,23768,12,2922,2034.0,18,320.52,2,2.15,experimental,39.57218347825871,0.2186,0.1862,X-ray structure of human furin in complex with the competitive inhibitor para-guanidinomethyl-Phac-R-Tle-R-Amba,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHHHH,Protein,482,polypeptide(L),6,52.389,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,487,2,2,Hetero 2-mer,"A1, B1",FMT,C H2 O2,46.025,FORMIC ACID,"InChI=1S/CH2O2/c2-1-3/h1H,(H,2,3)",
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.6164795196939467,8.523e-13,YES,16897,5JXH,X-RAY DIFFRACTION,3.67,66.49,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"crystallization solution: 100 mM MES, 200 mM K/NaH2PO4, pH 5.5-6.0, 3-4 M NaCl, 3% DMSO; reservoir solution: 3-4 M NaCl",293.15,2016-05-13,2016-10-05,4261,2,487,534.0,3,53.39,2,2.0,experimental,39.57218347825871,0.1853,0.1566,Structure the proprotein convertase furin in complex with meta-guanidinomethyl-Phac-RVR-Amba at 2.0 Angstrom resolution.,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHHHH,Protein,482,polypeptide(L),1,52.389,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,487,2,2,Hetero 2-mer,"A1, B1",CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.6164795196939467,8.523e-13,YES,16897,5JXG,X-RAY DIFFRACTION,3.73,67.05,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"crystallization solution: 100 mM MES, 200 mM K/NaH2PO4, pH 5.5-6.0, 3-4 M NaCl, 3% DMSO; reservoir solution: 3-4 M NaCl",293.15,2016-05-13,2016-10-05,4360,1,482,645.0,3,52.73,1,1.8,experimental,39.57218347825871,0.1733,0.154,Structure of the unliganded form of the proprotein convertase furin.,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHHHH,Protein,482,polypeptide(L),1,52.389,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,482,1,1,Monomer,A1,CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.6164795196939467,8.523e-13,YES,16897,5JXI,X-RAY DIFFRACTION,3.76,67.3,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"crystallization solution: 100 mM MES, 200 mM K/NaH2PO4, pH 5.5-6.0, 3-4 M NaCl, 3% DMSO; reservoir solution: 3-4 M NaCl",293.15,2016-05-13,2016-10-05,4164,1,482,521.0,3,52.63,1,2.0,experimental,39.57218347825871,0.1851,0.1576,Structure of the unliganded form of the proprotein convertase furin in presence of EDTA.,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHHHH,Protein,482,polypeptide(L),1,52.389,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,482,1,1,Monomer,A1,CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.6164795196939467,8.523e-13,YES,16897,5MIM,X-RAY DIFFRACTION,3.75,67.2,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100 MM MES, 200 MM K/NAH2PO4, PH 5.5-6.0, 3-4 M NACL, 3% DMSO; RESERVOIR SOLUTION: 3-4 M NACL",293.15,2016-11-28,2017-05-10,4275,1,482,486.0,3,53.81,1,1.9,experimental,39.57218347825871,0.1838,0.1647,"Xray structure of human furin bound with the 2,5-dideoxystreptamine derived small molecule inhibitor 1n",DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHHHH,Protein,482,polypeptide(L),1,52.389,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,482,1,1,Monomer,A1,CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.6164795196939467,8.523e-13,YES,16897,5JXJ,X-RAY DIFFRACTION,3.69,66.65,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"crystallization solution: 100 mM MES, 200 mM K/NaH2PO4, pH 5.5-6.0, 3-4 M NaCl, 3% DMSO; reservoir solution: 3-4 M NaCl",293.15,2016-05-13,2016-10-05,4185,2,487,461.0,3,53.35,2,2.0,experimental,39.57218347825871,0.1889,0.1668,Structure of the proprotein convertase furin complexed to meta-guanidinomethyl-Phac-RVR-Amba in presence of EDTA,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHHHH,Protein,482,polypeptide(L),1,52.389,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,487,2,2,Hetero 2-mer,"A1, B1",CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.6164795196939467,8.523e-13,YES,16897,6EQV,X-RAY DIFFRACTION,3.67,66.45,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NaH2PO4, PH 5.5-6.0, 3-4M NaCl, 3% DMSO; RESERVOIR SOLUTION: 3-4 M NaCl",293.15,2017-10-16,2018-02-28,4212,2,487,510.0,3,53.3,2,1.895,experimental,39.57218347825871,0.1821,0.1637,X-ray structure of the proprotein convertase furin bound with the competitive inhibitor Phac-Cit-Val-Arg-Amba,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHHHH,Protein,482,polypeptide(L),1,52.389,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,487,2,2,Hetero 2-mer,"A1, B1",CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.6164795196939467,8.523e-13,YES,16897,6EQW,X-RAY DIFFRACTION,3.66,66.42,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NaH2PO4, PH 5.5-6.0, 3-4 M NaCL, 3% DMSO; RESERVOIR SOLUTION: 3-4M NaCL",293.15,2017-10-16,2018-02-28,4183,2,487,486.0,3,53.36,2,1.994,experimental,39.57218347825871,0.1842,0.1619,X-ray structure of the proprotein convertase furin bound with the competitive inhibitor 4-aminomethyl-phenylacetyl-Arg-Val-Arg-Amba,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHHHH,Protein,482,polypeptide(L),1,52.389,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,487,2,2,Hetero 2-mer,"A1, B1",CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.6164795196939467,8.523e-13,YES,16897,6EQX,X-RAY DIFFRACTION,3.66,66.36,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"100mM MES, 200mM K/NaH2PO4, PH 5.5-6.0, 3-4 M NaCL, 3% DMSO; RESERVOIR SOLUTION: 3-4M NaCL",293.15,2017-10-16,2018-02-28,4186,2,488,471.0,3,53.51,2,1.994,experimental,39.57218347825871,0.1837,0.162,X-ray structure of the proprotein convertase furin bound with the competitive inhibitor Arg-Arg-Arg-Val-Arg-Amba,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHHHH,Protein,482,polypeptide(L),1,52.389,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,488,2,2,Hetero 2-mer,"A1, B1",CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
2534,ENTREZ_GENE,fyn,SLKSYNp59FYN,Homo sapiens,0.6229227310047164,2.36336e-11,NO,19127,6EDF,X-RAY DIFFRACTION,2.0,37.6,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"20% PEG3350, 0.2 M magnesium acetate",291.0,2018-08-09,2018-08-29,693,1,79,61.0,0,8.94,1,1.4,experimental,12.097,0.1721,0.1434,Fragment of a tyrosine-protein kinase,GGVTLFVALYDYEARTEDDISVHKGEKVQILNSSEGDWWEVRSLTTGETGYVPSNYVAPVDGSAAMGPVLRLRAFYNGG,Protein,79,polypeptide(L),1,8.591,fyn,2.7.10.2,PDB Primary Data,Homo sapiens,9606,79,1,1,Monomer,A1,GOL,C3 H8 O3,92.094,GLYCEROL,"InChI=1S/C3H8O3/c4-1-3(6)2-5/h3-6H,1-2H2",
5771,ENTREZ_GENE,ptpn2,PTN2PTPTTCPTPTCELLPTPTCPTP,Homo sapiens,0.7961177486839865,3.45504e-11,NO,19522,8U0H,X-RAY DIFFRACTION,2.41,49.06,"VAPOR DIFFUSION, HANGING DROP",6.9,"0.49M Sodium phosphate monobasic monohydrate, 0.91M Potassium phosphate dibasic",296.0,2023-08-29,2024-09-04,5135,2,648,385.0,0,78.03,1,1.93,experimental,38.32,0.1917,0.1726,Crystal structure of PTPN2 with a PROTAC,MAMPTTIEREFEELDTQRRWQPLYLEIRNESHDYPHRVAKFPENRNRNRYRDVSPYDHSRVKLQNAENDYINASLVDIEEAQRSYILTQGPLPNTCCHFWLMVWQQKTKAVVMLNRIVEKESVKCAQYWPTDDQEMLFKETGFSVKLLSEDVKSYYTVHLLQLENINSGETRTISHFHYTTWPDFGVPESPASFLNFLFKVRESGSLNPDHGPAVIHCSAGIGRSGTFSLVDTCLVLMEKGDDINIKQVLLNMRKYRMGLIQTPDQLRFSYMAIIEGAKCIKGDSSIQKRWKELSKEDLSPAFDHSPNKIMTEKYNHHHHHHHH,Protein,324,polypeptide(L),2,37.966,ptpn2,3.1.3.48,PDB Primary Data,Homo sapiens,9606,324,1,1,Monomer,A1,UB0,C46 H49 Cl N6 O12 S2,977.497,"(5P)-3-(carboxymethoxy)-4-chloro-5-(3-{[(4S)-1-({3-[2-(4-{3-[(3R)-2,6-dioxopiperidin-3-yl]-2-oxo-2,3-dihydro-1,3-benzoxazol-6-yl}piperidin-1-yl)acetamido]phenyl}methanesulfonyl)-2,2-dimethylpiperidin-4-yl]amino}phenyl)thiophene-2-carboxylic acid","InChI=1S/C46H49ClN6O12S2/c1-46(2)22-32(48-31-8-4-6-29(20-31)41-39(47)40(64-24-38(56)57)42(66-41)44(59)60)15-18-52(46)67(62,63)25-26-5-3-7-30(19-26)49-37(55)23-51-16-13-27(14-17-51)28-9-10-33-35(21-28)65-45(61)53(33)34-11-12-36(54)50-43(34)58/h3-10,19-21,27,32,34,48H,11-18,22-25H2,1-2H3,(H,49,55)(H,56,57)(H,59,60)(H,50,54,58)/t32-,34+/m0/s1",
4193,ENTREZ_GENE,mdm2,ACTFSHDMXhdm2,Homo sapiens,0.6929793995583658,9.06273e-11,NO,23635,4UD7,X-RAY DIFFRACTION,2.8,56.0,Desconocido,4.0,0.1 M SODIUM CITRATE PH 4.0 AND 15 % PEG8000,289.6514371309434,2014-12-08,2016-01-13,4008,8,520,262.0,0,58.68,2,1.6,experimental,23.018,0.17838,0.13846,Structure of the stapled peptide YS-02 bound to MDM2,GPLGSSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDAAQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSEN,Protein,114,polypeptide(L),4,12.831,mdm2,6.3.2,PDB Primary Data,Homo sapiens,9606,130,2,2,Hetero 2-mer,"A1, B1",Desconocido,Desconocido,246.2971348233669,Desconocido,Desconocido,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.4652937024375994,2.88487e-11,YES,25860,7QXZ,X-RAY DIFFRACTION,3.8,67.66,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NAH2PO4, PH 5.5, 2 M NACL; RESERVOIR SOLUTION: 3.0-3.2M NACL",293.15,2022-01-27,2022-04-13,4278,1,480,568.0,3,52.89,1,1.8,experimental,27.27,0.2173,0.1815,X-ray structure of furin in complex with the dichlorophenylpyridine-based inhibitor 5,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHH,Protein,480,polypeptide(L),1,52.112,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,480,1,1,Monomer,A1,CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.4652937024375994,2.88487e-11,YES,25860,8B4V,X-RAY DIFFRACTION,3.75,67.16,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NAH2PO4, PH 5.5, 2 M NACL; RESERVOIR SOLUTION: 3.0-3.2M NACL",293.15,2022-09-21,2023-10-04,4300,1,480,508.0,4,52.95,1,1.6,experimental,26.89,0.1658,0.1535,X-ray structure of furin (PCSK3) in complex with benzamidine,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHH,Protein,480,polypeptide(L),1,52.112,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,480,1,1,Monomer,A1,BEN,C7 H8 N2,120.152,BENZAMIDINE,"InChI=1S/C7H8N2/c8-7(9)6-4-2-1-3-5-6/h1-5H,(H3,8,9)",
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.4652937024375994,2.88487e-11,YES,25860,8B4W,X-RAY DIFFRACTION,3.75,67.17,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NAH2PO4, PH 5.5, 2 M NACL; RESERVOIR SOLUTION: 3.0-3.2M NACL",293.15,2022-09-21,2023-10-04,4403,1,480,497.0,4,53.21,1,1.6,experimental,27.18,0.179,0.1659,X-ray structure of furin (PCSK3) in complex with 1H-isoindol-3-amine,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHH,Protein,480,polypeptide(L),1,52.112,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,480,1,1,Monomer,A1,F05,C8 H8 N2,132.163,1H-isoindol-3-amine,"InChI=1S/C8H8N2/c9-8-7-4-2-1-3-6(7)5-10-8/h1-4H,5H2,(H2,9,10)",
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.4652937024375994,2.88487e-11,YES,25860,8B4X,X-RAY DIFFRACTION,3.75,67.24,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NAH2PO4, PH 5.5, 2 M NACL; RESERVOIR SOLUTION: 3.0-3.2M NACL",293.15,2022-09-21,2023-10-04,4276,2,485,462.0,4,53.27,2,1.6,experimental,28.95,0.1695,0.158,X-ray structure of furin (PCSK3) in complex with Guanidinomethyl-Phac-R-Tle-K-6-(aminomethyl)-3-amino-isoindol,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHH,Protein,480,polypeptide(L),1,52.112,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,485,2,2,Hetero 2-mer,"A1, B1",CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.4652937024375994,2.88487e-11,YES,25860,8OYH,X-RAY DIFFRACTION,3.76,67.27,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NAH2PO4, PH 5.5, 2 M NACL; RESERVOIR SOLUTION: 3.0-3.2M NACL",293.15,2023-05-04,2024-03-13,4092,2,485,340.0,4,53.27,2,1.8,experimental,36.56,0.188,0.1735,X-ray structure of furin (PCSK3) in complex with Guanidinomethyl-Phac-Can-Tle-Can-6-(aminomethyl)-3-amino-isoindol,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHH,Protein,480,polypeptide(L),1,52.112,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,485,2,2,Hetero 2-mer,"A1, B1",CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.4652937024375994,2.88487e-11,YES,25860,4Z2A,X-RAY DIFFRACTION,2.36,47.94,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"Well 13% PEG 8K, 0.110M K-dihydrogen phosphate, 0.1M HEPES pH 7.5, 350 uL protein with 350uL well drops, MRC sitting drop",277.0,2015-03-29,2016-05-04,4016,1,465,408.0,4,50.92,1,1.89,experimental,16.9953,0.1834,0.1479,Crystal structure of unglycosylated apo human furin @1.89A,YQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKDLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQDWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTA,Protein,465,polypeptide(L),1,50.506,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,465,1,1,Monomer,A1,EDO,C2 H6 O2,62.068,"1,2-ETHANEDIOL","InChI=1S/C2H6O2/c3-1-2-4/h3-4H,1-2H2",
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.4652937024375994,2.88487e-11,YES,25860,7O1U,X-RAY DIFFRACTION,3.74,67.12,"VAPOR DIFFUSION, SITTING DROP",5.5,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NAH2PO4, PH 5.5, 2 M NACL; RESERVOIR SOLUTION: 3.0-3.2M NACL",293.15,2021-03-30,2021-09-01,4375,1,480,519.0,4,53.19,1,1.7,experimental,26.23,0.1666,0.155,X-ray structure of furin in complex with the guanylhydrazone-based inhibitor 1 (BEV241),DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHH,Protein,480,polypeptide(L),1,52.112,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,480,1,1,Monomer,A1,Desconocido,Na,22.99,SODIUM ION,InChI=1S/Na/q+1,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.4652937024375994,2.88487e-11,YES,25860,7O1W,X-RAY DIFFRACTION,3.74,67.1,"VAPOR DIFFUSION, SITTING DROP",5.5,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NAH2PO4, PH 5.5, 2 M NACL; RESERVOIR SOLUTION: 3.0-3.2M NACL",293.15,2021-03-30,2021-09-01,4335,1,480,424.0,4,53.69,1,1.8,experimental,29.36,0.1791,0.16,X-ray structure of furin in complex with the guanylhydrazone-based inhibitor 2 (mi307) soaked at 1 M NaCl,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHH,Protein,480,polypeptide(L),1,52.112,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,480,1,1,Monomer,A1,CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.4652937024375994,2.88487e-11,YES,25860,7O1Y,X-RAY DIFFRACTION,3.72,66.95,"VAPOR DIFFUSION, SITTING DROP",5.5,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NAH2PO4, PH 5.5, 2 M NACL; RESERVOIR SOLUTION: 3.0-3.2M NACL",293.15,2021-03-30,2021-09-01,4321,1,480,475.0,4,53.91,1,1.7,experimental,29.48,0.177,0.1622,X-ray structure of furin in complex with the guanylhydrazone-based inhibitor 2 (mi307) soaked at 0.25 M NaCl,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHH,Protein,480,polypeptide(L),1,52.112,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,480,1,1,Monomer,A1,CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.4652937024375994,2.88487e-11,YES,25860,7O20,X-RAY DIFFRACTION,3.67,66.48,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NAH2PO4, PH 5.5, 2 M NACL; RESERVOIR SOLUTION: 3.0-3.2M NACL",293.15,2021-03-30,2021-09-01,4190,1,480,376.0,4,53.54,1,1.8,experimental,33.26,0.1761,0.1624,X-ray structure of furin in complex with the guanylhydrazone-based inhibitor 3 (mi300),DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHH,Protein,480,polypeptide(L),1,52.112,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,480,1,1,Monomer,A1,CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.4652937024375994,2.88487e-11,YES,25860,7O22,X-RAY DIFFRACTION,3.69,66.7,"VAPOR DIFFUSION, SITTING DROP",5.5,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NAH2PO4, PH 5.5, 2 M NACL; RESERVOIR SOLUTION: 3.0-3.2M NACL",293.15,2021-03-30,2021-09-01,4130,1,480,427.0,4,53.15,1,1.8,experimental,33.5,0.1825,0.169,X-ray structure of furin in complex with the guanylhydrazone-based inhibitor 4 (mi359),DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHH,Protein,480,polypeptide(L),1,52.112,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,480,1,1,Monomer,A1,CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.4652937024375994,2.88487e-11,YES,25860,7QY0,X-RAY DIFFRACTION,3.72,66.91,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NAH2PO4, PH 5.5, 2 M NACL; RESERVOIR SOLUTION: 3.0-3.2M NACL",293.15,2022-01-27,2022-04-20,4378,1,480,476.0,4,53.68,1,1.54,experimental,26.16,0.1725,0.1493,X-ray structure of furin in complex with the dichlorophenylpyridine-based inhibitor 1,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHH,Protein,480,polypeptide(L),1,52.112,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,480,1,1,Monomer,A1,I0T,C32 H42 Cl2 N6 O3,629.62,"N-[[1-[[2-[3,5-bis(chloranyl)phenyl]-6-[6-[4-(2-methoxyethyl)piperazin-4-ium-1-yl]pyridin-3-yl]oxy-pyridin-4-yl]methyl]piperidin-1-ium-4-yl]methyl]ethanamide","InChI=1S/C32H40Cl2N6O3/c1-23(41)35-20-24-5-7-39(8-6-24)22-25-15-30(26-17-27(33)19-28(34)18-26)37-32(16-25)43-29-3-4-31(36-21-29)40-11-9-38(10-12-40)13-14-42-2/h3-4,15-19,21,24H,5-14,20,22H2,1-2H3,(H,35,41)/p+2",
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.4652937024375994,2.88487e-11,YES,25860,7QY1,X-RAY DIFFRACTION,2.568825997777984,50.34669344500458,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NAH2PO4, PH 5.5, 2 M NACL; RESERVOIR SOLUTION: 3.0-3.2M NACL",293.15,2022-01-27,2022-04-20,4387,1,480,483.0,4,53.77,1,1.45,experimental,25.78,0.1754,0.1502,X-ray structure of furin in complex with the dichlorophenylpyridine-based inhibitor 4,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHH,Protein,480,polypeptide(L),1,52.112,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,480,1,1,Monomer,A1,I0W,C32 H39 Cl2 N6 O4,642.596,"3-[4-[5-[4-[[4-(acetamidomethyl)piperidin-1-ium-1-yl]methyl]-6-[3,5-bis(chloranyl)phenyl]pyridin-2-yl]oxypyridin-2-yl]piperazin-1-ium-1-yl]propanoate","InChI=1S/C32H38Cl2N6O4/c1-22(41)35-19-23-4-7-39(8-5-23)21-24-14-29(25-16-26(33)18-27(34)17-25)37-31(15-24)44-28-2-3-30(36-20-28)40-12-10-38(11-13-40)9-6-32(42)43/h2-3,14-18,20,23H,4-13,19,21H2,1H3,(H,35,41)(H,42,43)/p+1",
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.4652937024375994,2.88487e-11,YES,25860,7QY2,X-RAY DIFFRACTION,3.71,66.87,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NAH2PO4, PH 5.5, 2 M NACL; RESERVOIR SOLUTION: 3.0-3.2M NACL",293.15,2022-01-27,2022-04-20,4373,1,480,471.0,4,53.72,1,1.55,experimental,27.19,0.1877,0.1645,X-ray structure of furin in complex with the dichlorophenylpyridine-based inhibitor 2,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHH,Protein,480,polypeptide(L),1,52.112,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,480,1,1,Monomer,A1,I0Q,C33 H42 Cl2 N7 O4,671.637,"(2R)-4-[4-[5-[4-[[4-(acetamidomethyl)piperidin-1-ium-1-yl]methyl]-6-[3,5-bis(chloranyl)phenyl]pyridin-2-yl]oxypyrimidin-2-yl]piperazin-1-ium-1-yl]-2-methyl-butanoate","InChI=1S/C33H41Cl2N7O4/c1-22(32(44)45)3-6-40-9-11-42(12-10-40)33-37-19-29(20-38-33)46-31-14-25(13-30(39-31)26-15-27(34)17-28(35)16-26)21-41-7-4-24(5-8-41)18-36-23(2)43/h13-17,19-20,22,24H,3-12,18,21H2,1-2H3,(H,36,43)(H,44,45)/p+1/t22-/m1/s1",
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.4652937024375994,2.88487e-11,YES,25860,7LCU,X-RAY DIFFRACTION,2.25,45.43,VAPOR DIFFUSION,7.5,"PEG8000, potassium dihydrogen phosphate",277.0,2021-01-11,2022-01-12,4057,1,490,352.0,5,54.37,1,1.24,experimental,14.5,0.1944,0.1764,"X-ray structure of Furin bound to BOS-318, a small molecule inhibitor",DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKDLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQDWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTAGENLYFQGDYKDDDDKGHHHHHH,Protein,490,polypeptide(L),1,53.512,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,490,1,1,Monomer,A1,CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.4652937024375994,2.88487e-11,YES,25860,6HLB,X-RAY DIFFRACTION,3.77,67.33,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NaH2PO4, PH 5.5-6.0, 2 M NaCL, 3% DMSO; RESERVOIR SOLUTION: 3-4M NaCL",293.15,2018-09-11,2019-02-06,4028,2,491,338.0,3,54.39,2,2.0,experimental,39.57218347825871,0.1874,0.1686,X-ray structure of furin in complex with the cyclic peptide c[succinyl-Phe-2-Nal-(Arg)4-Lys]-Arg-4-Amba,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHHHH,Protein,482,polypeptide(L),1,52.389,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,491,2,2,Hetero 2-mer,"A1, B1",CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.4652937024375994,2.88487e-11,YES,25860,6HLD,X-RAY DIFFRACTION,3.78,67.46,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NaH2PO4, PH 5.5-6.0, 2 M NaCL, 3% DMSO; RESERVOIR SOLUTION: 3-4M NaCL",293.15,2018-09-11,2019-02-06,4067,2,489,343.0,3,54.06,2,2.1,experimental,39.57218347825871,0.1959,0.17,X-ray structure of furin in complex with the cyclic peptide c[succinyl-Phe-2-Nal-(Arg)3-Lys]-Lys-4-Amba,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHHHH,Protein,482,polypeptide(L),1,52.389,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,489,2,2,Hetero 2-mer,"A1, B1",CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.4652937024375994,2.88487e-11,YES,25860,6HLE,X-RAY DIFFRACTION,3.84,68.01,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NaH2PO4, PH 5.5-6.0, 2 M NaCL, 3% DMSO; RESERVOIR SOLUTION: 3-4M NaCL",293.15,2018-09-11,2019-02-06,4127,2,488,390.0,3,53.91,2,1.994,experimental,39.57218347825871,0.1908,0.1667,X-ray structure of furin in complex with the P6-P2-cyclized peptide H-Lys-Arg-Arg-Tle-Lys-4-Amba,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHHHH,Protein,482,polypeptide(L),1,52.389,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,488,2,2,Hetero 2-mer,"A1, B1",CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.4652937024375994,2.88487e-11,YES,25860,6HZA,X-RAY DIFFRACTION,3.64,66.19,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NaH2PO4, PH 5.5-6.0, 2 M NaCL, 3% DMSO; RESERVOIR SOLUTION: 3-4M NaCL",293.15,2018-10-23,2019-02-06,4150,2,487,416.0,3,53.73,2,1.9,experimental,39.57218347825871,0.1859,0.1661,X-ray structure of furin in complex with the cyclic peptide c[glutaryl-Arg-Arg-Lys]-Arg-4-Amba,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHHHH,Protein,482,polypeptide(L),1,52.389,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,487,2,2,Hetero 2-mer,"A1, B1",CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.4652937024375994,2.88487e-11,YES,25860,6HZB,X-RAY DIFFRACTION,3.66,66.41,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NaH2PO4, PH 5.5-6.0, 2 M NaCL, 3% DMSO; RESERVOIR SOLUTION: 3-4M NaCL",293.15,2018-10-23,2019-02-06,4150,2,487,418.0,3,53.7,2,1.9,experimental,39.57218347825871,0.1824,0.1646,X-ray structure of furin in complex with the cyclic inhibitor c[glutaryl-Arg-Arg-Lys]-Lys-4-Amba,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHHHH,Protein,482,polypeptide(L),1,52.389,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,487,2,2,Hetero 2-mer,"A1, B1",CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.4652937024375994,2.88487e-11,YES,25860,6HZD,X-RAY DIFFRACTION,3.64,66.22,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NaH2PO4, PH 5.5-6.0, 2 M NaCL, 3% DMSO; RESERVOIR SOLUTION: 3-4M NaCL",293.15,2018-10-23,2019-02-06,4163,2,488,418.0,3,53.89,2,1.9,experimental,39.57218347825871,0.1827,0.1641,X-ray structure of furin in complex with the cyclic inhibitor c[glutaryl-Arg-Arg-Arg-Lys]-Arg-4-Amba,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHHHH,Protein,482,polypeptide(L),1,52.389,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,488,2,2,Hetero 2-mer,"A1, B1",CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.4652937024375994,2.88487e-11,YES,25860,6YD2,X-RAY DIFFRACTION,3.7,66.74,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100MM MES, 200MM K/NAH2PO4, PH 5.5-6.0, 2 M NACL; RESERVOIR SOLUTION: 3-4M NACL",293.15,2020-03-20,2021-02-17,4179,2,487,444.0,3,53.58,2,1.8,experimental,32.05,0.1771,0.1575,X-ray structure of furin in complex with the canavanine-based inhibitor 4-aminomethyl-phenylacetyl-canavanine-Tle-Arg-Amba,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHHHH,Protein,482,polypeptide(L),1,52.389,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,487,2,2,Hetero 2-mer,"A1, B1",CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.4652937024375994,2.88487e-11,YES,25860,6YD3,X-RAY DIFFRACTION,3.72,66.96,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100MM MES, 200MM K/NAH2PO4, PH 5.5-6.0, 2 M NACL; RESERVOIR SOLUTION: 3-4M NACL",293.15,2020-03-20,2021-02-17,4159,2,485,418.0,3,53.34,2,2.0,experimental,32.04,0.1854,0.1595,X-ray structure of furin in complex with the canavanine derived inhibitor 4-guanidinomethyl-phenylacetyl-Canavanine-Tle-Arg-Amba,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHH,Protein,480,polypeptide(L),1,52.112,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,485,2,2,Hetero 2-mer,"A1, B1",CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.4652937024375994,2.88487e-11,YES,25860,6YD4,X-RAY DIFFRACTION,3.73,67.06,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100MM MES, 200MM K/NAH2PO4, PH 5.5-6.0, 2 M NACL; RESERVOIR SOLUTION: 3-4M NACL",291.15,2020-03-20,2021-02-17,4237,2,485,477.0,3,53.37,2,1.7,experimental,31.24,0.1694,0.1532,X-ray structure of furin in complex with the canavanine-based inhibitor 4-guanidinomethyl-phenylacetyl-Canavanine-Tle-Canavanine-Amba,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHH,Protein,480,polypeptide(L),1,52.112,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,485,2,2,Hetero 2-mer,"A1, B1",CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.4652937024375994,2.88487e-11,YES,25860,6YD7,X-RAY DIFFRACTION,3.74,67.08,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100MM MES, 200MM K/NAH2PO4, PH 5.5-6.0, 2 M NACL; RESERVOIR SOLUTION: 3-4M NACL",291.15,2020-03-20,2021-02-17,4211,2,485,465.0,3,53.37,2,1.8,experimental,29.7,0.1709,0.1538,X-ray structure of furin in complex with the canavanine-based inhibitor 4-guanidinomethyl-phenylacetyl-Arg-Tle-Canavanine-Amba,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHH,Protein,480,polypeptide(L),1,52.112,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,485,2,2,Hetero 2-mer,"A1, B1",CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.4652937024375994,2.88487e-11,YES,25860,7QXY,X-RAY DIFFRACTION,2.568825997777984,50.34669344500458,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NAH2PO4, PH 5.5, 2 M NACL; RESERVOIR SOLUTION: 3.0-3.2M NACL",293.15,2022-01-27,2022-04-20,4386,1,480,661.0,2,53.0,1,1.478,experimental,24.97,0.1823,0.1705,X-ray structure of furin in complex with the dichlorophenylpyridine-based inhibitor 3,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHH,Protein,480,polypeptide(L),1,52.112,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,480,1,1,Monomer,A1,CL,Cl,35.453,CHLORIDE ION,InChI=1S/ClH/h1H/p-1,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.4652937024375994,2.88487e-11,YES,25860,4RYD,X-RAY DIFFRACTION,2.86,56.93,"VAPOR DIFFUSION, SITTING DROP",8.5,"50mM Tris, 2.8M sodium formate, 15mM Cymal-7, pH 8.5, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293.0,2014-12-15,2015-05-27,23768,12,2922,2034.0,18,320.52,2,2.15,experimental,39.57218347825871,0.2186,0.1862,X-ray structure of human furin in complex with the competitive inhibitor para-guanidinomethyl-Phac-R-Tle-R-Amba,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHHHH,Protein,482,polypeptide(L),6,52.389,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,487,2,2,Hetero 2-mer,"A1, B1",FMT,C H2 O2,46.025,FORMIC ACID,"InChI=1S/CH2O2/c2-1-3/h1H,(H,2,3)",
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.4652937024375994,2.88487e-11,YES,25860,5JXH,X-RAY DIFFRACTION,3.67,66.49,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"crystallization solution: 100 mM MES, 200 mM K/NaH2PO4, pH 5.5-6.0, 3-4 M NaCl, 3% DMSO; reservoir solution: 3-4 M NaCl",293.15,2016-05-13,2016-10-05,4261,2,487,534.0,3,53.39,2,2.0,experimental,39.57218347825871,0.1853,0.1566,Structure the proprotein convertase furin in complex with meta-guanidinomethyl-Phac-RVR-Amba at 2.0 Angstrom resolution.,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHHHH,Protein,482,polypeptide(L),1,52.389,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,487,2,2,Hetero 2-mer,"A1, B1",CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.4652937024375994,2.88487e-11,YES,25860,5JXG,X-RAY DIFFRACTION,3.73,67.05,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"crystallization solution: 100 mM MES, 200 mM K/NaH2PO4, pH 5.5-6.0, 3-4 M NaCl, 3% DMSO; reservoir solution: 3-4 M NaCl",293.15,2016-05-13,2016-10-05,4360,1,482,645.0,3,52.73,1,1.8,experimental,39.57218347825871,0.1733,0.154,Structure of the unliganded form of the proprotein convertase furin.,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHHHH,Protein,482,polypeptide(L),1,52.389,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,482,1,1,Monomer,A1,CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.4652937024375994,2.88487e-11,YES,25860,5JXI,X-RAY DIFFRACTION,3.76,67.3,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"crystallization solution: 100 mM MES, 200 mM K/NaH2PO4, pH 5.5-6.0, 3-4 M NaCl, 3% DMSO; reservoir solution: 3-4 M NaCl",293.15,2016-05-13,2016-10-05,4164,1,482,521.0,3,52.63,1,2.0,experimental,39.57218347825871,0.1851,0.1576,Structure of the unliganded form of the proprotein convertase furin in presence of EDTA.,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHHHH,Protein,482,polypeptide(L),1,52.389,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,482,1,1,Monomer,A1,CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.4652937024375994,2.88487e-11,YES,25860,5MIM,X-RAY DIFFRACTION,3.75,67.2,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100 MM MES, 200 MM K/NAH2PO4, PH 5.5-6.0, 3-4 M NACL, 3% DMSO; RESERVOIR SOLUTION: 3-4 M NACL",293.15,2016-11-28,2017-05-10,4275,1,482,486.0,3,53.81,1,1.9,experimental,39.57218347825871,0.1838,0.1647,"Xray structure of human furin bound with the 2,5-dideoxystreptamine derived small molecule inhibitor 1n",DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHHHH,Protein,482,polypeptide(L),1,52.389,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,482,1,1,Monomer,A1,CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.4652937024375994,2.88487e-11,YES,25860,5JXJ,X-RAY DIFFRACTION,3.69,66.65,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"crystallization solution: 100 mM MES, 200 mM K/NaH2PO4, pH 5.5-6.0, 3-4 M NaCl, 3% DMSO; reservoir solution: 3-4 M NaCl",293.15,2016-05-13,2016-10-05,4185,2,487,461.0,3,53.35,2,2.0,experimental,39.57218347825871,0.1889,0.1668,Structure of the proprotein convertase furin complexed to meta-guanidinomethyl-Phac-RVR-Amba in presence of EDTA,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHHHH,Protein,482,polypeptide(L),1,52.389,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,487,2,2,Hetero 2-mer,"A1, B1",CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.4652937024375994,2.88487e-11,YES,25860,6EQV,X-RAY DIFFRACTION,3.67,66.45,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NaH2PO4, PH 5.5-6.0, 3-4M NaCl, 3% DMSO; RESERVOIR SOLUTION: 3-4 M NaCl",293.15,2017-10-16,2018-02-28,4212,2,487,510.0,3,53.3,2,1.895,experimental,39.57218347825871,0.1821,0.1637,X-ray structure of the proprotein convertase furin bound with the competitive inhibitor Phac-Cit-Val-Arg-Amba,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHHHH,Protein,482,polypeptide(L),1,52.389,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,487,2,2,Hetero 2-mer,"A1, B1",CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.4652937024375994,2.88487e-11,YES,25860,6EQW,X-RAY DIFFRACTION,3.66,66.42,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NaH2PO4, PH 5.5-6.0, 3-4 M NaCL, 3% DMSO; RESERVOIR SOLUTION: 3-4M NaCL",293.15,2017-10-16,2018-02-28,4183,2,487,486.0,3,53.36,2,1.994,experimental,39.57218347825871,0.1842,0.1619,X-ray structure of the proprotein convertase furin bound with the competitive inhibitor 4-aminomethyl-phenylacetyl-Arg-Val-Arg-Amba,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHHHH,Protein,482,polypeptide(L),1,52.389,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,487,2,2,Hetero 2-mer,"A1, B1",CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.4652937024375994,2.88487e-11,YES,25860,6EQX,X-RAY DIFFRACTION,3.66,66.36,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"100mM MES, 200mM K/NaH2PO4, PH 5.5-6.0, 3-4 M NaCL, 3% DMSO; RESERVOIR SOLUTION: 3-4M NaCL",293.15,2017-10-16,2018-02-28,4186,2,488,471.0,3,53.51,2,1.994,experimental,39.57218347825871,0.1837,0.162,X-ray structure of the proprotein convertase furin bound with the competitive inhibitor Arg-Arg-Arg-Val-Arg-Amba,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHHHH,Protein,482,polypeptide(L),1,52.389,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,488,2,2,Hetero 2-mer,"A1, B1",CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
5771,ENTREZ_GENE,ptpn2,PTN2PTPTTCPTPTCELLPTPTCPTP,Homo sapiens,0.6013876898089777,0.0,YES,27846,8U0H,X-RAY DIFFRACTION,2.41,49.06,"VAPOR DIFFUSION, HANGING DROP",6.9,"0.49M Sodium phosphate monobasic monohydrate, 0.91M Potassium phosphate dibasic",296.0,2023-08-29,2024-09-04,5135,2,648,385.0,0,78.03,1,1.93,experimental,38.32,0.1917,0.1726,Crystal structure of PTPN2 with a PROTAC,MAMPTTIEREFEELDTQRRWQPLYLEIRNESHDYPHRVAKFPENRNRNRYRDVSPYDHSRVKLQNAENDYINASLVDIEEAQRSYILTQGPLPNTCCHFWLMVWQQKTKAVVMLNRIVEKESVKCAQYWPTDDQEMLFKETGFSVKLLSEDVKSYYTVHLLQLENINSGETRTISHFHYTTWPDFGVPESPASFLNFLFKVRESGSLNPDHGPAVIHCSAGIGRSGTFSLVDTCLVLMEKGDDINIKQVLLNMRKYRMGLIQTPDQLRFSYMAIIEGAKCIKGDSSIQKRWKELSKEDLSPAFDHSPNKIMTEKYNHHHHHHHH,Protein,324,polypeptide(L),2,37.966,ptpn2,3.1.3.48,PDB Primary Data,Homo sapiens,9606,324,1,1,Monomer,A1,UB0,C46 H49 Cl N6 O12 S2,977.497,"(5P)-3-(carboxymethoxy)-4-chloro-5-(3-{[(4S)-1-({3-[2-(4-{3-[(3R)-2,6-dioxopiperidin-3-yl]-2-oxo-2,3-dihydro-1,3-benzoxazol-6-yl}piperidin-1-yl)acetamido]phenyl}methanesulfonyl)-2,2-dimethylpiperidin-4-yl]amino}phenyl)thiophene-2-carboxylic acid","InChI=1S/C46H49ClN6O12S2/c1-46(2)22-32(48-31-8-4-6-29(20-31)41-39(47)40(64-24-38(56)57)42(66-41)44(59)60)15-18-52(46)67(62,63)25-26-5-3-7-30(19-26)49-37(55)23-51-16-13-27(14-17-51)28-9-10-33-35(21-28)65-45(61)53(33)34-11-12-36(54)50-43(34)58/h3-10,19-21,27,32,34,48H,11-18,22-25H2,1-2H3,(H,49,55)(H,56,57)(H,59,60)(H,50,54,58)/t32-,34+/m0/s1",
56339,ENTREZ_GENE,mettl3,IME4M6AMTA70Spo8hMETTL3,Homo sapiens,0.5279449317932859,3.49e-14,YES,29307,5IL1,X-RAY DIFFRACTION,2.58,52.33,"VAPOR DIFFUSION, HANGING DROP",5.7,"PEG 8000, sodium citrate",291.0,2016-03-04,2016-05-25,4336,2,512,337.0,0,59.81,2,1.71,experimental,39.57218347825871,0.2069,0.1798,Crystal structure of SAM-bound METTL3-METTL14 complex,FPPQWICCDIRYLDVSILGKFAVVMADPPWDIHMELPYGTLTDDEMRRLNIPVLQDDGFLFLWVTGRAMELGRECLNLWGYERVDEIIWVKTNQLQRIIRTGRTGHWLNHGKEHCLVGVKGNPQGFNQGLDCDVIVAEVRSTSHKPDEIYGMIERLSPGTRKIELFGRPHNVQPNWITLGNQLDGIHLLDPDVVARFKQRYPDGIISKPKNL,Protein,212,polypeptide(L),1,24.427,mettl3,2.1.1.62,PDB Primary Data,Homo sapiens,9606,512,2,2,Hetero 2-mer,"A1, B1",SAM,C15 H22 N6 O5 S,398.437,S-ADENOSYLMETHIONINE,"InChI=1S/C15H22N6O5S/c1-27(3-2-7(16)15(24)25)4-8-10(22)11(23)14(26-8)21-6-20-9-12(17)18-5-19-13(9)21/h5-8,10-11,14,22-23H,2-4,16H2,1H3,(H2-,17,18,19,24,25)/t7-,8+,10+,11+,14+,27-/m0/s1",
56339,ENTREZ_GENE,mettl3,IME4M6AMTA70Spo8hMETTL3,Homo sapiens,0.5279449317932859,3.49e-14,YES,29307,5IL0,X-RAY DIFFRACTION,2.55,51.69,"VAPOR DIFFUSION, HANGING DROP",5.7,"PEG 8000, sodium citrate",291.0,2016-03-04,2016-05-25,4347,2,512,331.0,0,59.43,2,1.882,experimental,39.57218347825871,0.205,0.1747,Crystal structural of the METTL3-METTL14 complex for N6-adenosine methylation,FPPQWICCDIRYLDVSILGKFAVVMADPPWDIHMELPYGTLTDDEMRRLNIPVLQDDGFLFLWVTGRAMELGRECLNLWGYERVDEIIWVKTNQLQRIIRTGRTGHWLNHGKEHCLVGVKGNPQGFNQGLDCDVIVAEVRSTSHKPDEIYGMIERLSPGTRKIELFGRPHNVQPNWITLGNQLDGIHLLDPDVVARFKQRYPDGIISKPKNL,Protein,212,polypeptide(L),1,24.427,mettl3,2.1.1.62,PDB Primary Data,Homo sapiens,9606,512,2,2,Hetero 2-mer,"A1, B1",EDO,C2 H6 O2,62.068,"1,2-ETHANEDIOL","InChI=1S/C2H6O2/c3-1-2-4/h3-4H,1-2H2",
56339,ENTREZ_GENE,mettl3,IME4M6AMTA70Spo8hMETTL3,Homo sapiens,0.5279449317932859,3.49e-14,YES,29307,5IL2,X-RAY DIFFRACTION,2.66,53.7,"VAPOR DIFFUSION, HANGING DROP",5.7,"PEG 8000, sodium citrate",291.0,2016-03-04,2016-05-25,4393,2,512,376.0,1,59.85,2,1.606,experimental,39.57218347825871,0.1992,0.1848,Crystal structure of SAH-bound METTL3-METTL14 complex,FPPQWICCDIRYLDVSILGKFAVVMADPPWDIHMELPYGTLTDDEMRRLNIPVLQDDGFLFLWVTGRAMELGRECLNLWGYERVDEIIWVKTNQLQRIIRTGRTGHWLNHGKEHCLVGVKGNPQGFNQGLDCDVIVAEVRSTSHKPDEIYGMIERLSPGTRKIELFGRPHNVQPNWITLGNQLDGIHLLDPDVVARFKQRYPDGIISKPKNL,Protein,212,polypeptide(L),1,24.427,mettl3,2.1.1.62,PDB Primary Data,Homo sapiens,9606,512,2,2,Hetero 2-mer,"A1, B1",EDO,C2 H6 O2,62.068,"1,2-ETHANEDIOL","InChI=1S/C2H6O2/c3-1-2-4/h3-4H,1-2H2",
2534,ENTREZ_GENE,fyn,SLKSYNp59FYN,Homo sapiens,1.0,7.83293e-11,YES,30163,6EDF,X-RAY DIFFRACTION,2.0,37.6,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"20% PEG3350, 0.2 M magnesium acetate",291.0,2018-08-09,2018-08-29,693,1,79,61.0,0,8.94,1,1.4,experimental,12.097,0.1721,0.1434,Fragment of a tyrosine-protein kinase,GGVTLFVALYDYEARTEDDISVHKGEKVQILNSSEGDWWEVRSLTTGETGYVPSNYVAPVDGSAAMGPVLRLRAFYNGG,Protein,79,polypeptide(L),1,8.591,fyn,2.7.10.2,PDB Primary Data,Homo sapiens,9606,79,1,1,Monomer,A1,GOL,C3 H8 O3,92.094,GLYCEROL,"InChI=1S/C3H8O3/c4-1-3(6)2-5/h3-6H,1-2H2",
673,ENTREZ_GENE,braf,BRAF1BrafBRAF1NS7RAFB1,Homo sapiens,0.6955726513493959,8.43543e-11,NO,31653,5VR3,X-RAY DIFFRACTION,2.58,52.44,"VAPOR DIFFUSION, HANGING DROP",6.5,"0.1 M Bis-Tris pH 6.5, 2.0 M ammonium sulphate",293.15,2017-05-10,2018-02-14,510,1,88,13.0,0,9.64,1,2.102,experimental,39.57218347825871,0.2244,0.2095,Crystal structure of the BRS domain of BRAF,GAMDPGGGGSSAADPAIPEEVWNIKQMIKLTQEHIEALLDKFGGEHNPPSIYLEAYEEYTSKLDALQQREQQLLESLGNGTDFSVSSS,Protein,88,polypeptide(L),1,9.544,braf,2.7.11.1,PDB Primary Data,Homo sapiens,9606,88,1,1,Monomer,A1,SO4,O4 S,96.063,SULFATE ION,"InChI=1S/H2O4S/c1-5(2,3)4/h(H2,1,2,3,4)/p-2",
1387,ENTREZ_GENE,crebbp,CBPKAT3ARSTSRSTS1,Homo sapiens,0.7015441804552652,9.0567e-11,NO,31690,6YIK,X-RAY DIFFRACTION,3.42,64.06,"VAPOR DIFFUSION, SITTING DROP",7.5,"21% PEG3350
15% ethylene glycol
0.25M sodium formate",277.0,2020-04-01,2020-04-15,3453,3,357,385.0,0,44.74,1,1.7,experimental,32.625,0.184,0.156,Crystal structure of the CREBBP bromodomain in complex with a tetrahydroquinoxaline ligand,SMRKKIFKPEELRQALMPTLEALYRQDPESLPFRQPVDPQLLGIPDYFDIVKNPMDLSTIKRKLDTGQYQEPWQYVDDVWLMFNNAWLYNRKTSRVYKFCSKLAEVFEQEIDPVMQSLG,Protein,119,polypeptide(L),3,14.223,crebbp,2.3.1.48,PDB Primary Data,Homo sapiens,9606,119,1,1,Monomer,A1,OSQ,C22 H24 F2 N4 O2,414.448,"(3~{R})-~{N}-[3-(3,4-dihydro-2~{H}-quinolin-1-yl)-2,2-bis(fluoranyl)propyl]-3-methyl-2-oxidanylidene-3,4-dihydro-1~{H}-quinoxaline-5-carboxamide","InChI=1S/C22H24F2N4O2/c1-14-20(29)27-17-9-4-8-16(19(17)26-14)21(30)25-12-22(23,24)13-28-11-5-7-15-6-2-3-10-18(15)28/h2-4,6,8-10,14,26H,5,7,11-13H2,1H3,(H,25,30)(H,27,29)/t14-/m1/s1",
1387,ENTREZ_GENE,crebbp,CBPKAT3ARSTSRSTS1,Homo sapiens,0.7015441804552652,9.0567e-11,NO,31690,6SXX,X-RAY DIFFRACTION,2.18,43.67,"VAPOR DIFFUSION, HANGING DROP",6.982430939226492,"25% PEG3350, 0.2 M Potassium thiocyanate, 5% EtGly",277.0,2019-09-26,2020-07-29,1940,2,238,81.0,0,28.95,1,2.01,experimental,52.99,0.2533,0.1955,Crystal structure of the bromodomain of human CREBBP in complex with ACA007,SMRKKIFKPEELRQALMPTLEALYRQDPESLPFRQPVDPQLLGIPDYFDIVKNPMDLSTIKRKLDTGQYQEPWQYVDDVWLMFNNAWLYNRKTSRVYKFCSKLAEVFEQEIDPVMQSLG,Protein,119,polypeptide(L),2,14.223,crebbp,2.3.1.48,PDB Primary Data,Homo sapiens,9606,119,1,1,Monomer,A1,EDO,C2 H6 O2,62.068,"1,2-ETHANEDIOL","InChI=1S/C2H6O2/c3-1-2-4/h3-4H,1-2H2",
1387,ENTREZ_GENE,crebbp,CBPKAT3ARSTSRSTS1,Homo sapiens,0.7015441804552652,9.0567e-11,NO,31690,6YIL,X-RAY DIFFRACTION,2.2,44.01,"VAPOR DIFFUSION, SITTING DROP",7.5,"20% PEG3350
10% ethylene glycol
0.2M sodium acetate",277.0,2020-04-01,2020-04-15,1160,1,119,154.0,0,14.64,1,1.22,experimental,12.75,0.1511,0.1321,Crystal structure of the CREBBP bromodomain in complex with a tetrahydroquinoxaline ligand,SMRKKIFKPEELRQALMPTLEALYRQDPESLPFRQPVDPQLLGIPDYFDIVKNPMDLSTIKRKLDTGQYQEPWQYVDDVWLMFNNAWLYNRKTSRVYKFCSKLAEVFEQEIDPVMQSLG,Protein,119,polypeptide(L),1,14.223,crebbp,2.3.1.48,PDB Primary Data,Homo sapiens,9606,119,1,1,Monomer,A1,OSQ,C22 H24 F2 N4 O2,414.448,"(3~{R})-~{N}-[3-(3,4-dihydro-2~{H}-quinolin-1-yl)-2,2-bis(fluoranyl)propyl]-3-methyl-2-oxidanylidene-3,4-dihydro-1~{H}-quinoxaline-5-carboxamide","InChI=1S/C22H24F2N4O2/c1-14-20(29)27-17-9-4-8-16(19(17)26-14)21(30)25-12-22(23,24)13-28-11-5-7-15-6-2-3-10-18(15)28/h2-4,6,8-10,14,26H,5,7,11-13H2,1H3,(H,25,30)(H,27,29)/t14-/m1/s1",
1387,ENTREZ_GENE,crebbp,CBPKAT3ARSTSRSTS1,Homo sapiens,0.7015441804552652,9.0567e-11,NO,31690,6YIM,X-RAY DIFFRACTION,2.2,44.12,"VAPOR DIFFUSION, SITTING DROP",7.5,"20% PEG3350
10% ethylene glycol
0.2M sodium fluoride",277.0,2020-04-01,2020-04-15,1174,1,119,163.0,0,14.65,1,1.23,experimental,12.85,0.167,0.1397,Crystal structure of the CREBBP bromodomain in complex with a benzo-diazepine ligand,SMRKKIFKPEELRQALMPTLEALYRQDPESLPFRQPVDPQLLGIPDYFDIVKNPMDLSTIKRKLDTGQYQEPWQYVDDVWLMFNNAWLYNRKTSRVYKFCSKLAEVFEQEIDPVMQSLG,Protein,119,polypeptide(L),1,14.223,crebbp,2.3.1.48,PDB Primary Data,Homo sapiens,9606,119,1,1,Monomer,A1,OS8,C24 H30 N4 O3,422.52,"(4~{R})-~{N}-[3-(7-methoxy-3,4-dihydro-2~{H}-quinolin-1-yl)propyl]-4-methyl-2-oxidanylidene-1,3,4,5-tetrahydro-1,5-benzodiazepine-6-carboxamide","InChI=1S/C24H30N4O3/c1-16-14-22(29)27-20-8-3-7-19(23(20)26-16)24(30)25-11-5-13-28-12-4-6-17-9-10-18(31-2)15-21(17)28/h3,7-10,15-16,26H,4-6,11-14H2,1-2H3,(H,25,30)(H,27,29)/t16-/m1/s1",
1387,ENTREZ_GENE,crebbp,CBPKAT3ARSTSRSTS1,Homo sapiens,0.7015441804552652,9.0567e-11,NO,31690,6YIJ,X-RAY DIFFRACTION,2.95,58.37,"VAPOR DIFFUSION, SITTING DROP",8.3,"20% ethylene glycol
21% PEG6K
0.1M tris pH 8.3
0.125M lithium chloride",277.0,2020-04-01,2020-04-15,7177,7,833,224.0,0,102.4,1,2.2,experimental,44.856,0.2693,0.2022,Crystal structure of the CREBBP bromodomain in complex with a benzo-diazepine ligand,SMRKKIFKPEELRQALMPTLEALYRQDPESLPFRQPVDPQLLGIPDYFDIVKNPMDLSTIKRKLDTGQYQEPWQYVDDVWLMFNNAWLYNRKTSRVYKFCSKLAEVFEQEIDPVMQSLG,Protein,119,polypeptide(L),7,14.223,crebbp,2.3.1.48,PDB Primary Data,Homo sapiens,9606,119,1,1,Monomer,A1,OSN,C25 H31 N3 O2,405.533,"(4~{R})-6-[(~{E})-5-(7-methoxy-3,4-dihydro-2~{H}-quinolin-1-yl)pent-1-enyl]-4-methyl-1,3,4,5-tetrahydro-1,5-benzodiazepin-2-one","InChI=1S/C25H31N3O2/c1-18-16-24(29)27-22-11-6-9-20(25(22)26-18)8-4-3-5-14-28-15-7-10-19-12-13-21(30-2)17-23(19)28/h4,6,8-9,11-13,17-18,26H,3,5,7,10,14-16H2,1-2H3,(H,27,29)/b8-4+/t18-/m1/s1",
13870,ENTREZ_GENE,crebbp,CBPKAT3ARSTSRSTS1,Homo sapiens,0.5689361255979865,2.9143e-12,NO,36193,6YIK,X-RAY DIFFRACTION,3.42,64.06,"VAPOR DIFFUSION, SITTING DROP",7.5,"21% PEG3350
15% ethylene glycol
0.25M sodium formate",277.0,2020-04-01,2020-04-15,3453,3,357,385.0,0,44.74,1,1.7,experimental,32.625,0.184,0.156,Crystal structure of the CREBBP bromodomain in complex with a tetrahydroquinoxaline ligand,SMRKKIFKPEELRQALMPTLEALYRQDPESLPFRQPVDPQLLGIPDYFDIVKNPMDLSTIKRKLDTGQYQEPWQYVDDVWLMFNNAWLYNRKTSRVYKFCSKLAEVFEQEIDPVMQSLG,Protein,119,polypeptide(L),3,14.223,crebbp,2.3.1.48,PDB Primary Data,Homo sapiens,9606,119,1,1,Monomer,A1,OSQ,C22 H24 F2 N4 O2,414.448,"(3~{R})-~{N}-[3-(3,4-dihydro-2~{H}-quinolin-1-yl)-2,2-bis(fluoranyl)propyl]-3-methyl-2-oxidanylidene-3,4-dihydro-1~{H}-quinoxaline-5-carboxamide","InChI=1S/C22H24F2N4O2/c1-14-20(29)27-17-9-4-8-16(19(17)26-14)21(30)25-12-22(23,24)13-28-11-5-7-15-6-2-3-10-18(15)28/h2-4,6,8-10,14,26H,5,7,11-13H2,1H3,(H,25,30)(H,27,29)/t14-/m1/s1",
13870,ENTREZ_GENE,crebbp,CBPKAT3ARSTSRSTS1,Homo sapiens,0.5689361255979865,2.9143e-12,NO,36193,6SXX,X-RAY DIFFRACTION,2.18,43.67,"VAPOR DIFFUSION, HANGING DROP",6.982430939226492,"25% PEG3350, 0.2 M Potassium thiocyanate, 5% EtGly",277.0,2019-09-26,2020-07-29,1940,2,238,81.0,0,28.95,1,2.01,experimental,52.99,0.2533,0.1955,Crystal structure of the bromodomain of human CREBBP in complex with ACA007,SMRKKIFKPEELRQALMPTLEALYRQDPESLPFRQPVDPQLLGIPDYFDIVKNPMDLSTIKRKLDTGQYQEPWQYVDDVWLMFNNAWLYNRKTSRVYKFCSKLAEVFEQEIDPVMQSLG,Protein,119,polypeptide(L),2,14.223,crebbp,2.3.1.48,PDB Primary Data,Homo sapiens,9606,119,1,1,Monomer,A1,EDO,C2 H6 O2,62.068,"1,2-ETHANEDIOL","InChI=1S/C2H6O2/c3-1-2-4/h3-4H,1-2H2",
13870,ENTREZ_GENE,crebbp,CBPKAT3ARSTSRSTS1,Homo sapiens,0.5689361255979865,2.9143e-12,NO,36193,6YIL,X-RAY DIFFRACTION,2.2,44.01,"VAPOR DIFFUSION, SITTING DROP",7.5,"20% PEG3350
10% ethylene glycol
0.2M sodium acetate",277.0,2020-04-01,2020-04-15,1160,1,119,154.0,0,14.64,1,1.22,experimental,12.75,0.1511,0.1321,Crystal structure of the CREBBP bromodomain in complex with a tetrahydroquinoxaline ligand,SMRKKIFKPEELRQALMPTLEALYRQDPESLPFRQPVDPQLLGIPDYFDIVKNPMDLSTIKRKLDTGQYQEPWQYVDDVWLMFNNAWLYNRKTSRVYKFCSKLAEVFEQEIDPVMQSLG,Protein,119,polypeptide(L),1,14.223,crebbp,2.3.1.48,PDB Primary Data,Homo sapiens,9606,119,1,1,Monomer,A1,OSQ,C22 H24 F2 N4 O2,414.448,"(3~{R})-~{N}-[3-(3,4-dihydro-2~{H}-quinolin-1-yl)-2,2-bis(fluoranyl)propyl]-3-methyl-2-oxidanylidene-3,4-dihydro-1~{H}-quinoxaline-5-carboxamide","InChI=1S/C22H24F2N4O2/c1-14-20(29)27-17-9-4-8-16(19(17)26-14)21(30)25-12-22(23,24)13-28-11-5-7-15-6-2-3-10-18(15)28/h2-4,6,8-10,14,26H,5,7,11-13H2,1H3,(H,25,30)(H,27,29)/t14-/m1/s1",
13870,ENTREZ_GENE,crebbp,CBPKAT3ARSTSRSTS1,Homo sapiens,0.5689361255979865,2.9143e-12,NO,36193,6YIM,X-RAY DIFFRACTION,2.2,44.12,"VAPOR DIFFUSION, SITTING DROP",7.5,"20% PEG3350
10% ethylene glycol
0.2M sodium fluoride",277.0,2020-04-01,2020-04-15,1174,1,119,163.0,0,14.65,1,1.23,experimental,12.85,0.167,0.1397,Crystal structure of the CREBBP bromodomain in complex with a benzo-diazepine ligand,SMRKKIFKPEELRQALMPTLEALYRQDPESLPFRQPVDPQLLGIPDYFDIVKNPMDLSTIKRKLDTGQYQEPWQYVDDVWLMFNNAWLYNRKTSRVYKFCSKLAEVFEQEIDPVMQSLG,Protein,119,polypeptide(L),1,14.223,crebbp,2.3.1.48,PDB Primary Data,Homo sapiens,9606,119,1,1,Monomer,A1,OS8,C24 H30 N4 O3,422.52,"(4~{R})-~{N}-[3-(7-methoxy-3,4-dihydro-2~{H}-quinolin-1-yl)propyl]-4-methyl-2-oxidanylidene-1,3,4,5-tetrahydro-1,5-benzodiazepine-6-carboxamide","InChI=1S/C24H30N4O3/c1-16-14-22(29)27-20-8-3-7-19(23(20)26-16)24(30)25-11-5-13-28-12-4-6-17-9-10-18(31-2)15-21(17)28/h3,7-10,15-16,26H,4-6,11-14H2,1-2H3,(H,25,30)(H,27,29)/t16-/m1/s1",
13870,ENTREZ_GENE,crebbp,CBPKAT3ARSTSRSTS1,Homo sapiens,0.5689361255979865,2.9143e-12,NO,36193,6YIJ,X-RAY DIFFRACTION,2.95,58.37,"VAPOR DIFFUSION, SITTING DROP",8.3,"20% ethylene glycol
21% PEG6K
0.1M tris pH 8.3
0.125M lithium chloride",277.0,2020-04-01,2020-04-15,7177,7,833,224.0,0,102.4,1,2.2,experimental,44.856,0.2693,0.2022,Crystal structure of the CREBBP bromodomain in complex with a benzo-diazepine ligand,SMRKKIFKPEELRQALMPTLEALYRQDPESLPFRQPVDPQLLGIPDYFDIVKNPMDLSTIKRKLDTGQYQEPWQYVDDVWLMFNNAWLYNRKTSRVYKFCSKLAEVFEQEIDPVMQSLG,Protein,119,polypeptide(L),7,14.223,crebbp,2.3.1.48,PDB Primary Data,Homo sapiens,9606,119,1,1,Monomer,A1,OSN,C25 H31 N3 O2,405.533,"(4~{R})-6-[(~{E})-5-(7-methoxy-3,4-dihydro-2~{H}-quinolin-1-yl)pent-1-enyl]-4-methyl-1,3,4,5-tetrahydro-1,5-benzodiazepin-2-one","InChI=1S/C25H31N3O2/c1-18-16-24(29)27-22-11-6-9-20(25(22)26-18)8-4-3-5-14-28-15-7-10-19-12-13-21(30-2)17-23(19)28/h4,6,8-9,11-13,17-18,26H,3,5,7,10,14-16H2,1-2H3,(H,27,29)/b8-4+/t18-/m1/s1",
563390,ENTREZ_GENE,mettl3,IME4M6AMTA70Spo8hMETTL3,Homo sapiens,0.5346906256329504,3.9e-15,NO,36268,5IL1,X-RAY DIFFRACTION,2.58,52.33,"VAPOR DIFFUSION, HANGING DROP",5.7,"PEG 8000, sodium citrate",291.0,2016-03-04,2016-05-25,4336,2,512,337.0,0,59.81,2,1.71,experimental,39.57218347825871,0.2069,0.1798,Crystal structure of SAM-bound METTL3-METTL14 complex,FPPQWICCDIRYLDVSILGKFAVVMADPPWDIHMELPYGTLTDDEMRRLNIPVLQDDGFLFLWVTGRAMELGRECLNLWGYERVDEIIWVKTNQLQRIIRTGRTGHWLNHGKEHCLVGVKGNPQGFNQGLDCDVIVAEVRSTSHKPDEIYGMIERLSPGTRKIELFGRPHNVQPNWITLGNQLDGIHLLDPDVVARFKQRYPDGIISKPKNL,Protein,212,polypeptide(L),1,24.427,mettl3,2.1.1.62,PDB Primary Data,Homo sapiens,9606,512,2,2,Hetero 2-mer,"A1, B1",SAM,C15 H22 N6 O5 S,398.437,S-ADENOSYLMETHIONINE,"InChI=1S/C15H22N6O5S/c1-27(3-2-7(16)15(24)25)4-8-10(22)11(23)14(26-8)21-6-20-9-12(17)18-5-19-13(9)21/h5-8,10-11,14,22-23H,2-4,16H2,1H3,(H2-,17,18,19,24,25)/t7-,8+,10+,11+,14+,27-/m0/s1",
563390,ENTREZ_GENE,mettl3,IME4M6AMTA70Spo8hMETTL3,Homo sapiens,0.5346906256329504,3.9e-15,NO,36268,5IL0,X-RAY DIFFRACTION,2.55,51.69,"VAPOR DIFFUSION, HANGING DROP",5.7,"PEG 8000, sodium citrate",291.0,2016-03-04,2016-05-25,4347,2,512,331.0,0,59.43,2,1.882,experimental,39.57218347825871,0.205,0.1747,Crystal structural of the METTL3-METTL14 complex for N6-adenosine methylation,FPPQWICCDIRYLDVSILGKFAVVMADPPWDIHMELPYGTLTDDEMRRLNIPVLQDDGFLFLWVTGRAMELGRECLNLWGYERVDEIIWVKTNQLQRIIRTGRTGHWLNHGKEHCLVGVKGNPQGFNQGLDCDVIVAEVRSTSHKPDEIYGMIERLSPGTRKIELFGRPHNVQPNWITLGNQLDGIHLLDPDVVARFKQRYPDGIISKPKNL,Protein,212,polypeptide(L),1,24.427,mettl3,2.1.1.62,PDB Primary Data,Homo sapiens,9606,512,2,2,Hetero 2-mer,"A1, B1",EDO,C2 H6 O2,62.068,"1,2-ETHANEDIOL","InChI=1S/C2H6O2/c3-1-2-4/h3-4H,1-2H2",
563390,ENTREZ_GENE,mettl3,IME4M6AMTA70Spo8hMETTL3,Homo sapiens,0.5346906256329504,3.9e-15,NO,36268,5IL2,X-RAY DIFFRACTION,2.66,53.7,"VAPOR DIFFUSION, HANGING DROP",5.7,"PEG 8000, sodium citrate",291.0,2016-03-04,2016-05-25,4393,2,512,376.0,1,59.85,2,1.606,experimental,39.57218347825871,0.1992,0.1848,Crystal structure of SAH-bound METTL3-METTL14 complex,FPPQWICCDIRYLDVSILGKFAVVMADPPWDIHMELPYGTLTDDEMRRLNIPVLQDDGFLFLWVTGRAMELGRECLNLWGYERVDEIIWVKTNQLQRIIRTGRTGHWLNHGKEHCLVGVKGNPQGFNQGLDCDVIVAEVRSTSHKPDEIYGMIERLSPGTRKIELFGRPHNVQPNWITLGNQLDGIHLLDPDVVARFKQRYPDGIISKPKNL,Protein,212,polypeptide(L),1,24.427,mettl3,2.1.1.62,PDB Primary Data,Homo sapiens,9606,512,2,2,Hetero 2-mer,"A1, B1",EDO,C2 H6 O2,62.068,"1,2-ETHANEDIOL","InChI=1S/C2H6O2/c3-1-2-4/h3-4H,1-2H2",
50450,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.8073984892450549,2.32223e-11,YES,38177,7QXZ,X-RAY DIFFRACTION,3.8,67.66,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NAH2PO4, PH 5.5, 2 M NACL; RESERVOIR SOLUTION: 3.0-3.2M NACL",293.15,2022-01-27,2022-04-13,4278,1,480,568.0,3,52.89,1,1.8,experimental,27.27,0.2173,0.1815,X-ray structure of furin in complex with the dichlorophenylpyridine-based inhibitor 5,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHH,Protein,480,polypeptide(L),1,52.112,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,480,1,1,Monomer,A1,CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
50450,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.8073984892450549,2.32223e-11,YES,38177,8B4V,X-RAY DIFFRACTION,3.75,67.16,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NAH2PO4, PH 5.5, 2 M NACL; RESERVOIR SOLUTION: 3.0-3.2M NACL",293.15,2022-09-21,2023-10-04,4300,1,480,508.0,4,52.95,1,1.6,experimental,26.89,0.1658,0.1535,X-ray structure of furin (PCSK3) in complex with benzamidine,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHH,Protein,480,polypeptide(L),1,52.112,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,480,1,1,Monomer,A1,BEN,C7 H8 N2,120.152,BENZAMIDINE,"InChI=1S/C7H8N2/c8-7(9)6-4-2-1-3-5-6/h1-5H,(H3,8,9)",
50450,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.8073984892450549,2.32223e-11,YES,38177,8B4W,X-RAY DIFFRACTION,3.75,67.17,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NAH2PO4, PH 5.5, 2 M NACL; RESERVOIR SOLUTION: 3.0-3.2M NACL",293.15,2022-09-21,2023-10-04,4403,1,480,497.0,4,53.21,1,1.6,experimental,27.18,0.179,0.1659,X-ray structure of furin (PCSK3) in complex with 1H-isoindol-3-amine,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHH,Protein,480,polypeptide(L),1,52.112,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,480,1,1,Monomer,A1,F05,C8 H8 N2,132.163,1H-isoindol-3-amine,"InChI=1S/C8H8N2/c9-8-7-4-2-1-3-6(7)5-10-8/h1-4H,5H2,(H2,9,10)",
50450,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.8073984892450549,2.32223e-11,YES,38177,8B4X,X-RAY DIFFRACTION,3.75,67.24,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NAH2PO4, PH 5.5, 2 M NACL; RESERVOIR SOLUTION: 3.0-3.2M NACL",293.15,2022-09-21,2023-10-04,4276,2,485,462.0,4,53.27,2,1.6,experimental,28.95,0.1695,0.158,X-ray structure of furin (PCSK3) in complex with Guanidinomethyl-Phac-R-Tle-K-6-(aminomethyl)-3-amino-isoindol,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHH,Protein,480,polypeptide(L),1,52.112,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,485,2,2,Hetero 2-mer,"A1, B1",CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
50450,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.8073984892450549,2.32223e-11,YES,38177,8OYH,X-RAY DIFFRACTION,3.76,67.27,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NAH2PO4, PH 5.5, 2 M NACL; RESERVOIR SOLUTION: 3.0-3.2M NACL",293.15,2023-05-04,2024-03-13,4092,2,485,340.0,4,53.27,2,1.8,experimental,36.56,0.188,0.1735,X-ray structure of furin (PCSK3) in complex with Guanidinomethyl-Phac-Can-Tle-Can-6-(aminomethyl)-3-amino-isoindol,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHH,Protein,480,polypeptide(L),1,52.112,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,485,2,2,Hetero 2-mer,"A1, B1",CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
50450,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.8073984892450549,2.32223e-11,YES,38177,4Z2A,X-RAY DIFFRACTION,2.36,47.94,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"Well 13% PEG 8K, 0.110M K-dihydrogen phosphate, 0.1M HEPES pH 7.5, 350 uL protein with 350uL well drops, MRC sitting drop",277.0,2015-03-29,2016-05-04,4016,1,465,408.0,4,50.92,1,1.89,experimental,16.9953,0.1834,0.1479,Crystal structure of unglycosylated apo human furin @1.89A,YQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKDLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQDWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTA,Protein,465,polypeptide(L),1,50.506,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,465,1,1,Monomer,A1,EDO,C2 H6 O2,62.068,"1,2-ETHANEDIOL","InChI=1S/C2H6O2/c3-1-2-4/h3-4H,1-2H2",
50450,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.8073984892450549,2.32223e-11,YES,38177,7O1U,X-RAY DIFFRACTION,3.74,67.12,"VAPOR DIFFUSION, SITTING DROP",5.5,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NAH2PO4, PH 5.5, 2 M NACL; RESERVOIR SOLUTION: 3.0-3.2M NACL",293.15,2021-03-30,2021-09-01,4375,1,480,519.0,4,53.19,1,1.7,experimental,26.23,0.1666,0.155,X-ray structure of furin in complex with the guanylhydrazone-based inhibitor 1 (BEV241),DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHH,Protein,480,polypeptide(L),1,52.112,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,480,1,1,Monomer,A1,Desconocido,Na,22.99,SODIUM ION,InChI=1S/Na/q+1,
50450,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.8073984892450549,2.32223e-11,YES,38177,7O1W,X-RAY DIFFRACTION,3.74,67.1,"VAPOR DIFFUSION, SITTING DROP",5.5,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NAH2PO4, PH 5.5, 2 M NACL; RESERVOIR SOLUTION: 3.0-3.2M NACL",293.15,2021-03-30,2021-09-01,4335,1,480,424.0,4,53.69,1,1.8,experimental,29.36,0.1791,0.16,X-ray structure of furin in complex with the guanylhydrazone-based inhibitor 2 (mi307) soaked at 1 M NaCl,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHH,Protein,480,polypeptide(L),1,52.112,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,480,1,1,Monomer,A1,CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
50450,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.8073984892450549,2.32223e-11,YES,38177,7O1Y,X-RAY DIFFRACTION,3.72,66.95,"VAPOR DIFFUSION, SITTING DROP",5.5,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NAH2PO4, PH 5.5, 2 M NACL; RESERVOIR SOLUTION: 3.0-3.2M NACL",293.15,2021-03-30,2021-09-01,4321,1,480,475.0,4,53.91,1,1.7,experimental,29.48,0.177,0.1622,X-ray structure of furin in complex with the guanylhydrazone-based inhibitor 2 (mi307) soaked at 0.25 M NaCl,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHH,Protein,480,polypeptide(L),1,52.112,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,480,1,1,Monomer,A1,CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
50450,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.8073984892450549,2.32223e-11,YES,38177,7O20,X-RAY DIFFRACTION,3.67,66.48,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NAH2PO4, PH 5.5, 2 M NACL; RESERVOIR SOLUTION: 3.0-3.2M NACL",293.15,2021-03-30,2021-09-01,4190,1,480,376.0,4,53.54,1,1.8,experimental,33.26,0.1761,0.1624,X-ray structure of furin in complex with the guanylhydrazone-based inhibitor 3 (mi300),DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHH,Protein,480,polypeptide(L),1,52.112,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,480,1,1,Monomer,A1,CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
50450,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.8073984892450549,2.32223e-11,YES,38177,7O22,X-RAY DIFFRACTION,3.69,66.7,"VAPOR DIFFUSION, SITTING DROP",5.5,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NAH2PO4, PH 5.5, 2 M NACL; RESERVOIR SOLUTION: 3.0-3.2M NACL",293.15,2021-03-30,2021-09-01,4130,1,480,427.0,4,53.15,1,1.8,experimental,33.5,0.1825,0.169,X-ray structure of furin in complex with the guanylhydrazone-based inhibitor 4 (mi359),DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHH,Protein,480,polypeptide(L),1,52.112,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,480,1,1,Monomer,A1,CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
50450,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.8073984892450549,2.32223e-11,YES,38177,7QY0,X-RAY DIFFRACTION,3.72,66.91,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NAH2PO4, PH 5.5, 2 M NACL; RESERVOIR SOLUTION: 3.0-3.2M NACL",293.15,2022-01-27,2022-04-20,4378,1,480,476.0,4,53.68,1,1.54,experimental,26.16,0.1725,0.1493,X-ray structure of furin in complex with the dichlorophenylpyridine-based inhibitor 1,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHH,Protein,480,polypeptide(L),1,52.112,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,480,1,1,Monomer,A1,I0T,C32 H42 Cl2 N6 O3,629.62,"N-[[1-[[2-[3,5-bis(chloranyl)phenyl]-6-[6-[4-(2-methoxyethyl)piperazin-4-ium-1-yl]pyridin-3-yl]oxy-pyridin-4-yl]methyl]piperidin-1-ium-4-yl]methyl]ethanamide","InChI=1S/C32H40Cl2N6O3/c1-23(41)35-20-24-5-7-39(8-6-24)22-25-15-30(26-17-27(33)19-28(34)18-26)37-32(16-25)43-29-3-4-31(36-21-29)40-11-9-38(10-12-40)13-14-42-2/h3-4,15-19,21,24H,5-14,20,22H2,1-2H3,(H,35,41)/p+2",
50450,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.8073984892450549,2.32223e-11,YES,38177,7QY1,X-RAY DIFFRACTION,2.568825997777984,50.34669344500458,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NAH2PO4, PH 5.5, 2 M NACL; RESERVOIR SOLUTION: 3.0-3.2M NACL",293.15,2022-01-27,2022-04-20,4387,1,480,483.0,4,53.77,1,1.45,experimental,25.78,0.1754,0.1502,X-ray structure of furin in complex with the dichlorophenylpyridine-based inhibitor 4,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHH,Protein,480,polypeptide(L),1,52.112,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,480,1,1,Monomer,A1,I0W,C32 H39 Cl2 N6 O4,642.596,"3-[4-[5-[4-[[4-(acetamidomethyl)piperidin-1-ium-1-yl]methyl]-6-[3,5-bis(chloranyl)phenyl]pyridin-2-yl]oxypyridin-2-yl]piperazin-1-ium-1-yl]propanoate","InChI=1S/C32H38Cl2N6O4/c1-22(41)35-19-23-4-7-39(8-5-23)21-24-14-29(25-16-26(33)18-27(34)17-25)37-31(15-24)44-28-2-3-30(36-20-28)40-12-10-38(11-13-40)9-6-32(42)43/h2-3,14-18,20,23H,4-13,19,21H2,1H3,(H,35,41)(H,42,43)/p+1",
50450,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.8073984892450549,2.32223e-11,YES,38177,7QY2,X-RAY DIFFRACTION,3.71,66.87,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NAH2PO4, PH 5.5, 2 M NACL; RESERVOIR SOLUTION: 3.0-3.2M NACL",293.15,2022-01-27,2022-04-20,4373,1,480,471.0,4,53.72,1,1.55,experimental,27.19,0.1877,0.1645,X-ray structure of furin in complex with the dichlorophenylpyridine-based inhibitor 2,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHH,Protein,480,polypeptide(L),1,52.112,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,480,1,1,Monomer,A1,I0Q,C33 H42 Cl2 N7 O4,671.637,"(2R)-4-[4-[5-[4-[[4-(acetamidomethyl)piperidin-1-ium-1-yl]methyl]-6-[3,5-bis(chloranyl)phenyl]pyridin-2-yl]oxypyrimidin-2-yl]piperazin-1-ium-1-yl]-2-methyl-butanoate","InChI=1S/C33H41Cl2N7O4/c1-22(32(44)45)3-6-40-9-11-42(12-10-40)33-37-19-29(20-38-33)46-31-14-25(13-30(39-31)26-15-27(34)17-28(35)16-26)21-41-7-4-24(5-8-41)18-36-23(2)43/h13-17,19-20,22,24H,3-12,18,21H2,1-2H3,(H,36,43)(H,44,45)/p+1/t22-/m1/s1",
50450,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.8073984892450549,2.32223e-11,YES,38177,7LCU,X-RAY DIFFRACTION,2.25,45.43,VAPOR DIFFUSION,7.5,"PEG8000, potassium dihydrogen phosphate",277.0,2021-01-11,2022-01-12,4057,1,490,352.0,5,54.37,1,1.24,experimental,14.5,0.1944,0.1764,"X-ray structure of Furin bound to BOS-318, a small molecule inhibitor",DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKDLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQDWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTAGENLYFQGDYKDDDDKGHHHHHH,Protein,490,polypeptide(L),1,53.512,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,490,1,1,Monomer,A1,CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
50450,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.8073984892450549,2.32223e-11,YES,38177,6HLB,X-RAY DIFFRACTION,3.77,67.33,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NaH2PO4, PH 5.5-6.0, 2 M NaCL, 3% DMSO; RESERVOIR SOLUTION: 3-4M NaCL",293.15,2018-09-11,2019-02-06,4028,2,491,338.0,3,54.39,2,2.0,experimental,39.57218347825871,0.1874,0.1686,X-ray structure of furin in complex with the cyclic peptide c[succinyl-Phe-2-Nal-(Arg)4-Lys]-Arg-4-Amba,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHHHH,Protein,482,polypeptide(L),1,52.389,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,491,2,2,Hetero 2-mer,"A1, B1",CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
50450,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.8073984892450549,2.32223e-11,YES,38177,6HLD,X-RAY DIFFRACTION,3.78,67.46,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NaH2PO4, PH 5.5-6.0, 2 M NaCL, 3% DMSO; RESERVOIR SOLUTION: 3-4M NaCL",293.15,2018-09-11,2019-02-06,4067,2,489,343.0,3,54.06,2,2.1,experimental,39.57218347825871,0.1959,0.17,X-ray structure of furin in complex with the cyclic peptide c[succinyl-Phe-2-Nal-(Arg)3-Lys]-Lys-4-Amba,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHHHH,Protein,482,polypeptide(L),1,52.389,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,489,2,2,Hetero 2-mer,"A1, B1",CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
50450,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.8073984892450549,2.32223e-11,YES,38177,6HLE,X-RAY DIFFRACTION,3.84,68.01,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NaH2PO4, PH 5.5-6.0, 2 M NaCL, 3% DMSO; RESERVOIR SOLUTION: 3-4M NaCL",293.15,2018-09-11,2019-02-06,4127,2,488,390.0,3,53.91,2,1.994,experimental,39.57218347825871,0.1908,0.1667,X-ray structure of furin in complex with the P6-P2-cyclized peptide H-Lys-Arg-Arg-Tle-Lys-4-Amba,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHHHH,Protein,482,polypeptide(L),1,52.389,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,488,2,2,Hetero 2-mer,"A1, B1",CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
50450,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.8073984892450549,2.32223e-11,YES,38177,6HZA,X-RAY DIFFRACTION,3.64,66.19,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NaH2PO4, PH 5.5-6.0, 2 M NaCL, 3% DMSO; RESERVOIR SOLUTION: 3-4M NaCL",293.15,2018-10-23,2019-02-06,4150,2,487,416.0,3,53.73,2,1.9,experimental,39.57218347825871,0.1859,0.1661,X-ray structure of furin in complex with the cyclic peptide c[glutaryl-Arg-Arg-Lys]-Arg-4-Amba,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHHHH,Protein,482,polypeptide(L),1,52.389,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,487,2,2,Hetero 2-mer,"A1, B1",CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
50450,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.8073984892450549,2.32223e-11,YES,38177,6HZB,X-RAY DIFFRACTION,3.66,66.41,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NaH2PO4, PH 5.5-6.0, 2 M NaCL, 3% DMSO; RESERVOIR SOLUTION: 3-4M NaCL",293.15,2018-10-23,2019-02-06,4150,2,487,418.0,3,53.7,2,1.9,experimental,39.57218347825871,0.1824,0.1646,X-ray structure of furin in complex with the cyclic inhibitor c[glutaryl-Arg-Arg-Lys]-Lys-4-Amba,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHHHH,Protein,482,polypeptide(L),1,52.389,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,487,2,2,Hetero 2-mer,"A1, B1",CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
50450,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.8073984892450549,2.32223e-11,YES,38177,6HZD,X-RAY DIFFRACTION,3.64,66.22,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NaH2PO4, PH 5.5-6.0, 2 M NaCL, 3% DMSO; RESERVOIR SOLUTION: 3-4M NaCL",293.15,2018-10-23,2019-02-06,4163,2,488,418.0,3,53.89,2,1.9,experimental,39.57218347825871,0.1827,0.1641,X-ray structure of furin in complex with the cyclic inhibitor c[glutaryl-Arg-Arg-Arg-Lys]-Arg-4-Amba,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHHHH,Protein,482,polypeptide(L),1,52.389,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,488,2,2,Hetero 2-mer,"A1, B1",CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
50450,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.8073984892450549,2.32223e-11,YES,38177,6YD2,X-RAY DIFFRACTION,3.7,66.74,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100MM MES, 200MM K/NAH2PO4, PH 5.5-6.0, 2 M NACL; RESERVOIR SOLUTION: 3-4M NACL",293.15,2020-03-20,2021-02-17,4179,2,487,444.0,3,53.58,2,1.8,experimental,32.05,0.1771,0.1575,X-ray structure of furin in complex with the canavanine-based inhibitor 4-aminomethyl-phenylacetyl-canavanine-Tle-Arg-Amba,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHHHH,Protein,482,polypeptide(L),1,52.389,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,487,2,2,Hetero 2-mer,"A1, B1",CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
50450,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.8073984892450549,2.32223e-11,YES,38177,6YD3,X-RAY DIFFRACTION,3.72,66.96,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100MM MES, 200MM K/NAH2PO4, PH 5.5-6.0, 2 M NACL; RESERVOIR SOLUTION: 3-4M NACL",293.15,2020-03-20,2021-02-17,4159,2,485,418.0,3,53.34,2,2.0,experimental,32.04,0.1854,0.1595,X-ray structure of furin in complex with the canavanine derived inhibitor 4-guanidinomethyl-phenylacetyl-Canavanine-Tle-Arg-Amba,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHH,Protein,480,polypeptide(L),1,52.112,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,485,2,2,Hetero 2-mer,"A1, B1",CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
50450,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.8073984892450549,2.32223e-11,YES,38177,6YD4,X-RAY DIFFRACTION,3.73,67.06,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100MM MES, 200MM K/NAH2PO4, PH 5.5-6.0, 2 M NACL; RESERVOIR SOLUTION: 3-4M NACL",291.15,2020-03-20,2021-02-17,4237,2,485,477.0,3,53.37,2,1.7,experimental,31.24,0.1694,0.1532,X-ray structure of furin in complex with the canavanine-based inhibitor 4-guanidinomethyl-phenylacetyl-Canavanine-Tle-Canavanine-Amba,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHH,Protein,480,polypeptide(L),1,52.112,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,485,2,2,Hetero 2-mer,"A1, B1",CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
50450,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.8073984892450549,2.32223e-11,YES,38177,6YD7,X-RAY DIFFRACTION,3.74,67.08,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100MM MES, 200MM K/NAH2PO4, PH 5.5-6.0, 2 M NACL; RESERVOIR SOLUTION: 3-4M NACL",291.15,2020-03-20,2021-02-17,4211,2,485,465.0,3,53.37,2,1.8,experimental,29.7,0.1709,0.1538,X-ray structure of furin in complex with the canavanine-based inhibitor 4-guanidinomethyl-phenylacetyl-Arg-Tle-Canavanine-Amba,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHH,Protein,480,polypeptide(L),1,52.112,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,485,2,2,Hetero 2-mer,"A1, B1",CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
50450,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.8073984892450549,2.32223e-11,YES,38177,7QXY,X-RAY DIFFRACTION,2.568825997777984,50.34669344500458,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NAH2PO4, PH 5.5, 2 M NACL; RESERVOIR SOLUTION: 3.0-3.2M NACL",293.15,2022-01-27,2022-04-20,4386,1,480,661.0,2,53.0,1,1.478,experimental,24.97,0.1823,0.1705,X-ray structure of furin in complex with the dichlorophenylpyridine-based inhibitor 3,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHH,Protein,480,polypeptide(L),1,52.112,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,480,1,1,Monomer,A1,CL,Cl,35.453,CHLORIDE ION,InChI=1S/ClH/h1H/p-1,
50450,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.8073984892450549,2.32223e-11,YES,38177,4RYD,X-RAY DIFFRACTION,2.86,56.93,"VAPOR DIFFUSION, SITTING DROP",8.5,"50mM Tris, 2.8M sodium formate, 15mM Cymal-7, pH 8.5, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293.0,2014-12-15,2015-05-27,23768,12,2922,2034.0,18,320.52,2,2.15,experimental,39.57218347825871,0.2186,0.1862,X-ray structure of human furin in complex with the competitive inhibitor para-guanidinomethyl-Phac-R-Tle-R-Amba,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHHHH,Protein,482,polypeptide(L),6,52.389,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,487,2,2,Hetero 2-mer,"A1, B1",FMT,C H2 O2,46.025,FORMIC ACID,"InChI=1S/CH2O2/c2-1-3/h1H,(H,2,3)",
50450,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.8073984892450549,2.32223e-11,YES,38177,5JXH,X-RAY DIFFRACTION,3.67,66.49,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"crystallization solution: 100 mM MES, 200 mM K/NaH2PO4, pH 5.5-6.0, 3-4 M NaCl, 3% DMSO; reservoir solution: 3-4 M NaCl",293.15,2016-05-13,2016-10-05,4261,2,487,534.0,3,53.39,2,2.0,experimental,39.57218347825871,0.1853,0.1566,Structure the proprotein convertase furin in complex with meta-guanidinomethyl-Phac-RVR-Amba at 2.0 Angstrom resolution.,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHHHH,Protein,482,polypeptide(L),1,52.389,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,487,2,2,Hetero 2-mer,"A1, B1",CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
50450,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.8073984892450549,2.32223e-11,YES,38177,5JXG,X-RAY DIFFRACTION,3.73,67.05,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"crystallization solution: 100 mM MES, 200 mM K/NaH2PO4, pH 5.5-6.0, 3-4 M NaCl, 3% DMSO; reservoir solution: 3-4 M NaCl",293.15,2016-05-13,2016-10-05,4360,1,482,645.0,3,52.73,1,1.8,experimental,39.57218347825871,0.1733,0.154,Structure of the unliganded form of the proprotein convertase furin.,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHHHH,Protein,482,polypeptide(L),1,52.389,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,482,1,1,Monomer,A1,CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
50450,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.8073984892450549,2.32223e-11,YES,38177,5JXI,X-RAY DIFFRACTION,3.76,67.3,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"crystallization solution: 100 mM MES, 200 mM K/NaH2PO4, pH 5.5-6.0, 3-4 M NaCl, 3% DMSO; reservoir solution: 3-4 M NaCl",293.15,2016-05-13,2016-10-05,4164,1,482,521.0,3,52.63,1,2.0,experimental,39.57218347825871,0.1851,0.1576,Structure of the unliganded form of the proprotein convertase furin in presence of EDTA.,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHHHH,Protein,482,polypeptide(L),1,52.389,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,482,1,1,Monomer,A1,CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
50450,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.8073984892450549,2.32223e-11,YES,38177,5MIM,X-RAY DIFFRACTION,3.75,67.2,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100 MM MES, 200 MM K/NAH2PO4, PH 5.5-6.0, 3-4 M NACL, 3% DMSO; RESERVOIR SOLUTION: 3-4 M NACL",293.15,2016-11-28,2017-05-10,4275,1,482,486.0,3,53.81,1,1.9,experimental,39.57218347825871,0.1838,0.1647,"Xray structure of human furin bound with the 2,5-dideoxystreptamine derived small molecule inhibitor 1n",DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHHHH,Protein,482,polypeptide(L),1,52.389,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,482,1,1,Monomer,A1,CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
50450,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.8073984892450549,2.32223e-11,YES,38177,5JXJ,X-RAY DIFFRACTION,3.69,66.65,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"crystallization solution: 100 mM MES, 200 mM K/NaH2PO4, pH 5.5-6.0, 3-4 M NaCl, 3% DMSO; reservoir solution: 3-4 M NaCl",293.15,2016-05-13,2016-10-05,4185,2,487,461.0,3,53.35,2,2.0,experimental,39.57218347825871,0.1889,0.1668,Structure of the proprotein convertase furin complexed to meta-guanidinomethyl-Phac-RVR-Amba in presence of EDTA,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHHHH,Protein,482,polypeptide(L),1,52.389,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,487,2,2,Hetero 2-mer,"A1, B1",CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
50450,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.8073984892450549,2.32223e-11,YES,38177,6EQV,X-RAY DIFFRACTION,3.67,66.45,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NaH2PO4, PH 5.5-6.0, 3-4M NaCl, 3% DMSO; RESERVOIR SOLUTION: 3-4 M NaCl",293.15,2017-10-16,2018-02-28,4212,2,487,510.0,3,53.3,2,1.895,experimental,39.57218347825871,0.1821,0.1637,X-ray structure of the proprotein convertase furin bound with the competitive inhibitor Phac-Cit-Val-Arg-Amba,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHHHH,Protein,482,polypeptide(L),1,52.389,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,487,2,2,Hetero 2-mer,"A1, B1",CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
50450,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.8073984892450549,2.32223e-11,YES,38177,6EQW,X-RAY DIFFRACTION,3.66,66.42,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NaH2PO4, PH 5.5-6.0, 3-4 M NaCL, 3% DMSO; RESERVOIR SOLUTION: 3-4M NaCL",293.15,2017-10-16,2018-02-28,4183,2,487,486.0,3,53.36,2,1.994,experimental,39.57218347825871,0.1842,0.1619,X-ray structure of the proprotein convertase furin bound with the competitive inhibitor 4-aminomethyl-phenylacetyl-Arg-Val-Arg-Amba,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHHHH,Protein,482,polypeptide(L),1,52.389,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,487,2,2,Hetero 2-mer,"A1, B1",CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
50450,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.8073984892450549,2.32223e-11,YES,38177,6EQX,X-RAY DIFFRACTION,3.66,66.36,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"100mM MES, 200mM K/NaH2PO4, PH 5.5-6.0, 3-4 M NaCL, 3% DMSO; RESERVOIR SOLUTION: 3-4M NaCL",293.15,2017-10-16,2018-02-28,4186,2,488,471.0,3,53.51,2,1.994,experimental,39.57218347825871,0.1837,0.162,X-ray structure of the proprotein convertase furin bound with the competitive inhibitor Arg-Arg-Arg-Val-Arg-Amba,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHHHH,Protein,482,polypeptide(L),1,52.389,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,488,2,2,Hetero 2-mer,"A1, B1",CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
25340,ENTREZ_GENE,fyn,SLKSYNp59FYN,Homo sapiens,0.7855345757060894,3.5296e-11,YES,39786,6EDF,X-RAY DIFFRACTION,2.0,37.6,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"20% PEG3350, 0.2 M magnesium acetate",291.0,2018-08-09,2018-08-29,693,1,79,61.0,0,8.94,1,1.4,experimental,12.097,0.1721,0.1434,Fragment of a tyrosine-protein kinase,GGVTLFVALYDYEARTEDDISVHKGEKVQILNSSEGDWWEVRSLTTGETGYVPSNYVAPVDGSAAMGPVLRLRAFYNGG,Protein,79,polypeptide(L),1,8.591,fyn,2.7.10.2,PDB Primary Data,Homo sapiens,9606,79,1,1,Monomer,A1,GOL,C3 H8 O3,92.094,GLYCEROL,"InChI=1S/C3H8O3/c4-1-3(6)2-5/h3-6H,1-2H2",
147111,ENTREZ_GENE,notum,hNOTUM,Homo sapiens,0.8043172640641038,2.828e-13,YES,42470,4UZ1,X-RAY DIFFRACTION,1.9,34.0,Desconocido,4.6,"1.5 M AMMONIUM SULPHATE, 0.1 M SODIUM ACETATE PH 4.6",289.6514371309434,2014-09-04,2015-02-25,3212,1,383,287.0,7,44.17,1,1.4,experimental,18.766,0.18045,0.14387,STRUCTURE OF THE WNT DEACYLASE NOTUM - CRYSTAL FORM III - 1.4A,ETGSAQQLNEDLRLHLLLNTSVTCNDGSPAGYYLKESRGSRRWLLFLEGGWYCFNRENCDSRYDTMRRLMSSRDWPRTRTGTGILSSQPEENPYWWNANMVFIPYCSSDVWSGASSKSEKNEYAFMGALIIQEVVRELLGRGLSGAKVLLLAGSSAGGTGVLLNVDRVAEQLEKLGYPAIQVRGLADSGWFLDNKQYRHTDCVDTITCAPTEAIRRGIRYWNGVVPERCRRQFQEGEEWNCFFGYKVYPTLRSPVFVVQWLFDEAQLTVDNVHLTGQPVQEGLRLYIQNLGRELRHTLKDVPASFAPACLSHEIIIRSHWTDVQVKGTSLPRALHCWDRSLHDSHKASKTPLKGCPVHLVDSCPWPHCNPSCPTGTKHHHHHH,Protein,383,polypeptide(L),1,43.567,notum,3.1.1.1,PDB Primary Data,Homo sapiens,9606,383,1,1,Monomer,A1,NAG,C8 H15 N O6,221.208,2-acetamido-2-deoxy-beta-D-glucopyranose,"InChI=1S/C8H15NO6/c1-3(11)9-5-7(13)6(12)4(2-10)15-8(5)14/h4-8,10,12-14H,2H2,1H3,(H,9,11)/t4-,5-,6-,7-,8-/m1/s1",
147111,ENTREZ_GENE,notum,hNOTUM,Homo sapiens,0.8043172640641038,2.828e-13,YES,42470,4UZ5,X-RAY DIFFRACTION,2.5,52.0,Desconocido,6.0,"10 %W/V PEG4000, 0.01 M CACL2, 0.05 M NACACOD PH 6.0, 0.20 M KCL, 1 MM HEPARIN HEXAMER",289.6514371309434,2014-09-04,2015-02-25,2901,1,383,84.0,7,43.82,1,2.1,experimental,43.492,0.2371,0.18746,STRUCTURE OF THE WNT DEACYLASE NOTUM - CRYSTAL FORM IV - 2.1A,ETGSAQQLNEDLRLHLLLNTSVTCNDGSPAGYYLKESRGSRRWLLFLEGGWYCFNRENCDSRYDTMRRLMSSRDWPRTRTGTGILSSQPEENPYWWNANMVFIPYCSSDVWSGASSKSEKNEYAFMGALIIQEVVRELLGRGLSGAKVLLLAGSSAGGTGVLLNVDRVAEQLEKLGYPAIQVRGLADSGWFLDNKQYRHTDCVDTITCAPTEAIRRGIRYWNGVVPERCRRQFQEGEEWNCFFGYKVYPTLRSPVFVVQWLFDEAQLTVDNVHLTGQPVQEGLRLYIQNLGRELRHTLKDVPASFAPACLSHEIIIRSHWTDVQVKGTSLPRALHCWDRSLHDSHKASKTPLKGCPVHLVDSCPWPHCNPSCPTGTKHHHHHH,Protein,383,polypeptide(L),1,43.567,notum,3.1.1.1,PDB Primary Data,Homo sapiens,9606,383,1,1,Monomer,A1,NAG,C8 H15 N O6,221.208,2-acetamido-2-deoxy-beta-D-glucopyranose,"InChI=1S/C8H15NO6/c1-3(11)9-5-7(13)6(12)4(2-10)15-8(5)14/h4-8,10,12-14H,2H2,1H3,(H,9,11)/t4-,5-,6-,7-,8-/m1/s1",
1471110,ENTREZ_GENE,notum,hNOTUM,Homo sapiens,0.7625705784628247,5.93731e-11,NO,43561,4UZ1,X-RAY DIFFRACTION,1.9,34.0,Desconocido,4.6,"1.5 M AMMONIUM SULPHATE, 0.1 M SODIUM ACETATE PH 4.6",289.6514371309434,2014-09-04,2015-02-25,3212,1,383,287.0,7,44.17,1,1.4,experimental,18.766,0.18045,0.14387,STRUCTURE OF THE WNT DEACYLASE NOTUM - CRYSTAL FORM III - 1.4A,ETGSAQQLNEDLRLHLLLNTSVTCNDGSPAGYYLKESRGSRRWLLFLEGGWYCFNRENCDSRYDTMRRLMSSRDWPRTRTGTGILSSQPEENPYWWNANMVFIPYCSSDVWSGASSKSEKNEYAFMGALIIQEVVRELLGRGLSGAKVLLLAGSSAGGTGVLLNVDRVAEQLEKLGYPAIQVRGLADSGWFLDNKQYRHTDCVDTITCAPTEAIRRGIRYWNGVVPERCRRQFQEGEEWNCFFGYKVYPTLRSPVFVVQWLFDEAQLTVDNVHLTGQPVQEGLRLYIQNLGRELRHTLKDVPASFAPACLSHEIIIRSHWTDVQVKGTSLPRALHCWDRSLHDSHKASKTPLKGCPVHLVDSCPWPHCNPSCPTGTKHHHHHH,Protein,383,polypeptide(L),1,43.567,notum,3.1.1.1,PDB Primary Data,Homo sapiens,9606,383,1,1,Monomer,A1,NAG,C8 H15 N O6,221.208,2-acetamido-2-deoxy-beta-D-glucopyranose,"InChI=1S/C8H15NO6/c1-3(11)9-5-7(13)6(12)4(2-10)15-8(5)14/h4-8,10,12-14H,2H2,1H3,(H,9,11)/t4-,5-,6-,7-,8-/m1/s1",
1471110,ENTREZ_GENE,notum,hNOTUM,Homo sapiens,0.7625705784628247,5.93731e-11,NO,43561,4UZ5,X-RAY DIFFRACTION,2.5,52.0,Desconocido,6.0,"10 %W/V PEG4000, 0.01 M CACL2, 0.05 M NACACOD PH 6.0, 0.20 M KCL, 1 MM HEPARIN HEXAMER",289.6514371309434,2014-09-04,2015-02-25,2901,1,383,84.0,7,43.82,1,2.1,experimental,43.492,0.2371,0.18746,STRUCTURE OF THE WNT DEACYLASE NOTUM - CRYSTAL FORM IV - 2.1A,ETGSAQQLNEDLRLHLLLNTSVTCNDGSPAGYYLKESRGSRRWLLFLEGGWYCFNRENCDSRYDTMRRLMSSRDWPRTRTGTGILSSQPEENPYWWNANMVFIPYCSSDVWSGASSKSEKNEYAFMGALIIQEVVRELLGRGLSGAKVLLLAGSSAGGTGVLLNVDRVAEQLEKLGYPAIQVRGLADSGWFLDNKQYRHTDCVDTITCAPTEAIRRGIRYWNGVVPERCRRQFQEGEEWNCFFGYKVYPTLRSPVFVVQWLFDEAQLTVDNVHLTGQPVQEGLRLYIQNLGRELRHTLKDVPASFAPACLSHEIIIRSHWTDVQVKGTSLPRALHCWDRSLHDSHKASKTPLKGCPVHLVDSCPWPHCNPSCPTGTKHHHHHH,Protein,383,polypeptide(L),1,43.567,notum,3.1.1.1,PDB Primary Data,Homo sapiens,9606,383,1,1,Monomer,A1,NAG,C8 H15 N O6,221.208,2-acetamido-2-deoxy-beta-D-glucopyranose,"InChI=1S/C8H15NO6/c1-3(11)9-5-7(13)6(12)4(2-10)15-8(5)14/h4-8,10,12-14H,2H2,1H3,(H,9,11)/t4-,5-,6-,7-,8-/m1/s1",
57710,ENTREZ_GENE,ptpn2,PTN2PTPTTCPTPTCELLPTPTCPTP,Homo sapiens,0.7497074017427185,8.05947e-11,NO,45076,8U0H,X-RAY DIFFRACTION,2.41,49.06,"VAPOR DIFFUSION, HANGING DROP",6.9,"0.49M Sodium phosphate monobasic monohydrate, 0.91M Potassium phosphate dibasic",296.0,2023-08-29,2024-09-04,5135,2,648,385.0,0,78.03,1,1.93,experimental,38.32,0.1917,0.1726,Crystal structure of PTPN2 with a PROTAC,MAMPTTIEREFEELDTQRRWQPLYLEIRNESHDYPHRVAKFPENRNRNRYRDVSPYDHSRVKLQNAENDYINASLVDIEEAQRSYILTQGPLPNTCCHFWLMVWQQKTKAVVMLNRIVEKESVKCAQYWPTDDQEMLFKETGFSVKLLSEDVKSYYTVHLLQLENINSGETRTISHFHYTTWPDFGVPESPASFLNFLFKVRESGSLNPDHGPAVIHCSAGIGRSGTFSLVDTCLVLMEKGDDINIKQVLLNMRKYRMGLIQTPDQLRFSYMAIIEGAKCIKGDSSIQKRWKELSKEDLSPAFDHSPNKIMTEKYNHHHHHHHH,Protein,324,polypeptide(L),2,37.966,ptpn2,3.1.3.48,PDB Primary Data,Homo sapiens,9606,324,1,1,Monomer,A1,UB0,C46 H49 Cl N6 O12 S2,977.497,"(5P)-3-(carboxymethoxy)-4-chloro-5-(3-{[(4S)-1-({3-[2-(4-{3-[(3R)-2,6-dioxopiperidin-3-yl]-2-oxo-2,3-dihydro-1,3-benzoxazol-6-yl}piperidin-1-yl)acetamido]phenyl}methanesulfonyl)-2,2-dimethylpiperidin-4-yl]amino}phenyl)thiophene-2-carboxylic acid","InChI=1S/C46H49ClN6O12S2/c1-46(2)22-32(48-31-8-4-6-29(20-31)41-39(47)40(64-24-38(56)57)42(66-41)44(59)60)15-18-52(46)67(62,63)25-26-5-3-7-30(19-26)49-37(55)23-51-16-13-27(14-17-51)28-9-10-33-35(21-28)65-45(61)53(33)34-11-12-36(54)50-43(34)58/h3-10,19-21,27,32,34,48H,11-18,22-25H2,1-2H3,(H,49,55)(H,56,57)(H,59,60)(H,50,54,58)/t32-,34+/m0/s1",
6730,ENTREZ_GENE,braf,BRAF1BrafBRAF1NS7RAFB1,Homo sapiens,0.6728659786133895,6.13578e-11,NO,45687,5VR3,X-RAY DIFFRACTION,2.58,52.44,"VAPOR DIFFUSION, HANGING DROP",6.5,"0.1 M Bis-Tris pH 6.5, 2.0 M ammonium sulphate",293.15,2017-05-10,2018-02-14,510,1,88,13.0,0,9.64,1,2.102,experimental,39.57218347825871,0.2244,0.2095,Crystal structure of the BRS domain of BRAF,GAMDPGGGGSSAADPAIPEEVWNIKQMIKLTQEHIEALLDKFGGEHNPPSIYLEAYEEYTSKLDALQQREQQLLESLGNGTDFSVSSS,Protein,88,polypeptide(L),1,9.544,braf,2.7.11.1,PDB Primary Data,Homo sapiens,9606,88,1,1,Monomer,A1,SO4,O4 S,96.063,SULFATE ION,"InChI=1S/H2O4S/c1-5(2,3)4/h(H2,1,2,3,4)/p-2",
41930,ENTREZ_GENE,mdm2,ACTFSHDMXhdm2,Homo sapiens,0.621093831128434,4.79941e-11,NO,48071,4UD7,X-RAY DIFFRACTION,2.8,56.0,Desconocido,4.0,0.1 M SODIUM CITRATE PH 4.0 AND 15 % PEG8000,289.6514371309434,2014-12-08,2016-01-13,4008,8,520,262.0,0,58.68,2,1.6,experimental,23.018,0.17838,0.13846,Structure of the stapled peptide YS-02 bound to MDM2,GPLGSSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDAAQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSEN,Protein,114,polypeptide(L),4,12.831,mdm2,6.3.2,PDB Primary Data,Homo sapiens,9606,130,2,2,Hetero 2-mer,"A1, B1",Desconocido,Desconocido,246.2971348233669,Desconocido,Desconocido,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.6457006657664278,1.004957e-10,NO,51814,7QXZ,X-RAY DIFFRACTION,3.8,67.66,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NAH2PO4, PH 5.5, 2 M NACL; RESERVOIR SOLUTION: 3.0-3.2M NACL",293.15,2022-01-27,2022-04-13,4278,1,480,568.0,3,52.89,1,1.8,experimental,27.27,0.2173,0.1815,X-ray structure of furin in complex with the dichlorophenylpyridine-based inhibitor 5,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHH,Protein,480,polypeptide(L),1,52.112,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,480,1,1,Monomer,A1,CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.6457006657664278,1.004957e-10,NO,51814,8B4V,X-RAY DIFFRACTION,3.75,67.16,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NAH2PO4, PH 5.5, 2 M NACL; RESERVOIR SOLUTION: 3.0-3.2M NACL",293.15,2022-09-21,2023-10-04,4300,1,480,508.0,4,52.95,1,1.6,experimental,26.89,0.1658,0.1535,X-ray structure of furin (PCSK3) in complex with benzamidine,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHH,Protein,480,polypeptide(L),1,52.112,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,480,1,1,Monomer,A1,BEN,C7 H8 N2,120.152,BENZAMIDINE,"InChI=1S/C7H8N2/c8-7(9)6-4-2-1-3-5-6/h1-5H,(H3,8,9)",
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.6457006657664278,1.004957e-10,NO,51814,8B4W,X-RAY DIFFRACTION,3.75,67.17,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NAH2PO4, PH 5.5, 2 M NACL; RESERVOIR SOLUTION: 3.0-3.2M NACL",293.15,2022-09-21,2023-10-04,4403,1,480,497.0,4,53.21,1,1.6,experimental,27.18,0.179,0.1659,X-ray structure of furin (PCSK3) in complex with 1H-isoindol-3-amine,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHH,Protein,480,polypeptide(L),1,52.112,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,480,1,1,Monomer,A1,F05,C8 H8 N2,132.163,1H-isoindol-3-amine,"InChI=1S/C8H8N2/c9-8-7-4-2-1-3-6(7)5-10-8/h1-4H,5H2,(H2,9,10)",
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.6457006657664278,1.004957e-10,NO,51814,8B4X,X-RAY DIFFRACTION,3.75,67.24,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NAH2PO4, PH 5.5, 2 M NACL; RESERVOIR SOLUTION: 3.0-3.2M NACL",293.15,2022-09-21,2023-10-04,4276,2,485,462.0,4,53.27,2,1.6,experimental,28.95,0.1695,0.158,X-ray structure of furin (PCSK3) in complex with Guanidinomethyl-Phac-R-Tle-K-6-(aminomethyl)-3-amino-isoindol,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHH,Protein,480,polypeptide(L),1,52.112,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,485,2,2,Hetero 2-mer,"A1, B1",CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.6457006657664278,1.004957e-10,NO,51814,8OYH,X-RAY DIFFRACTION,3.76,67.27,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NAH2PO4, PH 5.5, 2 M NACL; RESERVOIR SOLUTION: 3.0-3.2M NACL",293.15,2023-05-04,2024-03-13,4092,2,485,340.0,4,53.27,2,1.8,experimental,36.56,0.188,0.1735,X-ray structure of furin (PCSK3) in complex with Guanidinomethyl-Phac-Can-Tle-Can-6-(aminomethyl)-3-amino-isoindol,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHH,Protein,480,polypeptide(L),1,52.112,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,485,2,2,Hetero 2-mer,"A1, B1",CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.6457006657664278,1.004957e-10,NO,51814,4Z2A,X-RAY DIFFRACTION,2.36,47.94,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"Well 13% PEG 8K, 0.110M K-dihydrogen phosphate, 0.1M HEPES pH 7.5, 350 uL protein with 350uL well drops, MRC sitting drop",277.0,2015-03-29,2016-05-04,4016,1,465,408.0,4,50.92,1,1.89,experimental,16.9953,0.1834,0.1479,Crystal structure of unglycosylated apo human furin @1.89A,YQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKDLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQDWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTA,Protein,465,polypeptide(L),1,50.506,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,465,1,1,Monomer,A1,EDO,C2 H6 O2,62.068,"1,2-ETHANEDIOL","InChI=1S/C2H6O2/c3-1-2-4/h3-4H,1-2H2",
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.6457006657664278,1.004957e-10,NO,51814,7O1U,X-RAY DIFFRACTION,3.74,67.12,"VAPOR DIFFUSION, SITTING DROP",5.5,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NAH2PO4, PH 5.5, 2 M NACL; RESERVOIR SOLUTION: 3.0-3.2M NACL",293.15,2021-03-30,2021-09-01,4375,1,480,519.0,4,53.19,1,1.7,experimental,26.23,0.1666,0.155,X-ray structure of furin in complex with the guanylhydrazone-based inhibitor 1 (BEV241),DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHH,Protein,480,polypeptide(L),1,52.112,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,480,1,1,Monomer,A1,Desconocido,Na,22.99,SODIUM ION,InChI=1S/Na/q+1,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.6457006657664278,1.004957e-10,NO,51814,7O1W,X-RAY DIFFRACTION,3.74,67.1,"VAPOR DIFFUSION, SITTING DROP",5.5,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NAH2PO4, PH 5.5, 2 M NACL; RESERVOIR SOLUTION: 3.0-3.2M NACL",293.15,2021-03-30,2021-09-01,4335,1,480,424.0,4,53.69,1,1.8,experimental,29.36,0.1791,0.16,X-ray structure of furin in complex with the guanylhydrazone-based inhibitor 2 (mi307) soaked at 1 M NaCl,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHH,Protein,480,polypeptide(L),1,52.112,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,480,1,1,Monomer,A1,CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.6457006657664278,1.004957e-10,NO,51814,7O1Y,X-RAY DIFFRACTION,3.72,66.95,"VAPOR DIFFUSION, SITTING DROP",5.5,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NAH2PO4, PH 5.5, 2 M NACL; RESERVOIR SOLUTION: 3.0-3.2M NACL",293.15,2021-03-30,2021-09-01,4321,1,480,475.0,4,53.91,1,1.7,experimental,29.48,0.177,0.1622,X-ray structure of furin in complex with the guanylhydrazone-based inhibitor 2 (mi307) soaked at 0.25 M NaCl,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHH,Protein,480,polypeptide(L),1,52.112,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,480,1,1,Monomer,A1,CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.6457006657664278,1.004957e-10,NO,51814,7O20,X-RAY DIFFRACTION,3.67,66.48,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NAH2PO4, PH 5.5, 2 M NACL; RESERVOIR SOLUTION: 3.0-3.2M NACL",293.15,2021-03-30,2021-09-01,4190,1,480,376.0,4,53.54,1,1.8,experimental,33.26,0.1761,0.1624,X-ray structure of furin in complex with the guanylhydrazone-based inhibitor 3 (mi300),DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHH,Protein,480,polypeptide(L),1,52.112,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,480,1,1,Monomer,A1,CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.6457006657664278,1.004957e-10,NO,51814,7O22,X-RAY DIFFRACTION,3.69,66.7,"VAPOR DIFFUSION, SITTING DROP",5.5,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NAH2PO4, PH 5.5, 2 M NACL; RESERVOIR SOLUTION: 3.0-3.2M NACL",293.15,2021-03-30,2021-09-01,4130,1,480,427.0,4,53.15,1,1.8,experimental,33.5,0.1825,0.169,X-ray structure of furin in complex with the guanylhydrazone-based inhibitor 4 (mi359),DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHH,Protein,480,polypeptide(L),1,52.112,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,480,1,1,Monomer,A1,CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.6457006657664278,1.004957e-10,NO,51814,7QY0,X-RAY DIFFRACTION,3.72,66.91,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NAH2PO4, PH 5.5, 2 M NACL; RESERVOIR SOLUTION: 3.0-3.2M NACL",293.15,2022-01-27,2022-04-20,4378,1,480,476.0,4,53.68,1,1.54,experimental,26.16,0.1725,0.1493,X-ray structure of furin in complex with the dichlorophenylpyridine-based inhibitor 1,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHH,Protein,480,polypeptide(L),1,52.112,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,480,1,1,Monomer,A1,I0T,C32 H42 Cl2 N6 O3,629.62,"N-[[1-[[2-[3,5-bis(chloranyl)phenyl]-6-[6-[4-(2-methoxyethyl)piperazin-4-ium-1-yl]pyridin-3-yl]oxy-pyridin-4-yl]methyl]piperidin-1-ium-4-yl]methyl]ethanamide","InChI=1S/C32H40Cl2N6O3/c1-23(41)35-20-24-5-7-39(8-6-24)22-25-15-30(26-17-27(33)19-28(34)18-26)37-32(16-25)43-29-3-4-31(36-21-29)40-11-9-38(10-12-40)13-14-42-2/h3-4,15-19,21,24H,5-14,20,22H2,1-2H3,(H,35,41)/p+2",
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.6457006657664278,1.004957e-10,NO,51814,7QY1,X-RAY DIFFRACTION,2.568825997777984,50.34669344500458,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NAH2PO4, PH 5.5, 2 M NACL; RESERVOIR SOLUTION: 3.0-3.2M NACL",293.15,2022-01-27,2022-04-20,4387,1,480,483.0,4,53.77,1,1.45,experimental,25.78,0.1754,0.1502,X-ray structure of furin in complex with the dichlorophenylpyridine-based inhibitor 4,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHH,Protein,480,polypeptide(L),1,52.112,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,480,1,1,Monomer,A1,I0W,C32 H39 Cl2 N6 O4,642.596,"3-[4-[5-[4-[[4-(acetamidomethyl)piperidin-1-ium-1-yl]methyl]-6-[3,5-bis(chloranyl)phenyl]pyridin-2-yl]oxypyridin-2-yl]piperazin-1-ium-1-yl]propanoate","InChI=1S/C32H38Cl2N6O4/c1-22(41)35-19-23-4-7-39(8-5-23)21-24-14-29(25-16-26(33)18-27(34)17-25)37-31(15-24)44-28-2-3-30(36-20-28)40-12-10-38(11-13-40)9-6-32(42)43/h2-3,14-18,20,23H,4-13,19,21H2,1H3,(H,35,41)(H,42,43)/p+1",
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.6457006657664278,1.004957e-10,NO,51814,7QY2,X-RAY DIFFRACTION,3.71,66.87,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NAH2PO4, PH 5.5, 2 M NACL; RESERVOIR SOLUTION: 3.0-3.2M NACL",293.15,2022-01-27,2022-04-20,4373,1,480,471.0,4,53.72,1,1.55,experimental,27.19,0.1877,0.1645,X-ray structure of furin in complex with the dichlorophenylpyridine-based inhibitor 2,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHH,Protein,480,polypeptide(L),1,52.112,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,480,1,1,Monomer,A1,I0Q,C33 H42 Cl2 N7 O4,671.637,"(2R)-4-[4-[5-[4-[[4-(acetamidomethyl)piperidin-1-ium-1-yl]methyl]-6-[3,5-bis(chloranyl)phenyl]pyridin-2-yl]oxypyrimidin-2-yl]piperazin-1-ium-1-yl]-2-methyl-butanoate","InChI=1S/C33H41Cl2N7O4/c1-22(32(44)45)3-6-40-9-11-42(12-10-40)33-37-19-29(20-38-33)46-31-14-25(13-30(39-31)26-15-27(34)17-28(35)16-26)21-41-7-4-24(5-8-41)18-36-23(2)43/h13-17,19-20,22,24H,3-12,18,21H2,1-2H3,(H,36,43)(H,44,45)/p+1/t22-/m1/s1",
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.6457006657664278,1.004957e-10,NO,51814,7LCU,X-RAY DIFFRACTION,2.25,45.43,VAPOR DIFFUSION,7.5,"PEG8000, potassium dihydrogen phosphate",277.0,2021-01-11,2022-01-12,4057,1,490,352.0,5,54.37,1,1.24,experimental,14.5,0.1944,0.1764,"X-ray structure of Furin bound to BOS-318, a small molecule inhibitor",DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKDLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQDWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTAGENLYFQGDYKDDDDKGHHHHHH,Protein,490,polypeptide(L),1,53.512,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,490,1,1,Monomer,A1,CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.6457006657664278,1.004957e-10,NO,51814,6HLB,X-RAY DIFFRACTION,3.77,67.33,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NaH2PO4, PH 5.5-6.0, 2 M NaCL, 3% DMSO; RESERVOIR SOLUTION: 3-4M NaCL",293.15,2018-09-11,2019-02-06,4028,2,491,338.0,3,54.39,2,2.0,experimental,39.57218347825871,0.1874,0.1686,X-ray structure of furin in complex with the cyclic peptide c[succinyl-Phe-2-Nal-(Arg)4-Lys]-Arg-4-Amba,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHHHH,Protein,482,polypeptide(L),1,52.389,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,491,2,2,Hetero 2-mer,"A1, B1",CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.6457006657664278,1.004957e-10,NO,51814,6HLD,X-RAY DIFFRACTION,3.78,67.46,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NaH2PO4, PH 5.5-6.0, 2 M NaCL, 3% DMSO; RESERVOIR SOLUTION: 3-4M NaCL",293.15,2018-09-11,2019-02-06,4067,2,489,343.0,3,54.06,2,2.1,experimental,39.57218347825871,0.1959,0.17,X-ray structure of furin in complex with the cyclic peptide c[succinyl-Phe-2-Nal-(Arg)3-Lys]-Lys-4-Amba,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHHHH,Protein,482,polypeptide(L),1,52.389,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,489,2,2,Hetero 2-mer,"A1, B1",CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.6457006657664278,1.004957e-10,NO,51814,6HLE,X-RAY DIFFRACTION,3.84,68.01,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NaH2PO4, PH 5.5-6.0, 2 M NaCL, 3% DMSO; RESERVOIR SOLUTION: 3-4M NaCL",293.15,2018-09-11,2019-02-06,4127,2,488,390.0,3,53.91,2,1.994,experimental,39.57218347825871,0.1908,0.1667,X-ray structure of furin in complex with the P6-P2-cyclized peptide H-Lys-Arg-Arg-Tle-Lys-4-Amba,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHHHH,Protein,482,polypeptide(L),1,52.389,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,488,2,2,Hetero 2-mer,"A1, B1",CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.6457006657664278,1.004957e-10,NO,51814,6HZA,X-RAY DIFFRACTION,3.64,66.19,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NaH2PO4, PH 5.5-6.0, 2 M NaCL, 3% DMSO; RESERVOIR SOLUTION: 3-4M NaCL",293.15,2018-10-23,2019-02-06,4150,2,487,416.0,3,53.73,2,1.9,experimental,39.57218347825871,0.1859,0.1661,X-ray structure of furin in complex with the cyclic peptide c[glutaryl-Arg-Arg-Lys]-Arg-4-Amba,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHHHH,Protein,482,polypeptide(L),1,52.389,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,487,2,2,Hetero 2-mer,"A1, B1",CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.6457006657664278,1.004957e-10,NO,51814,6HZB,X-RAY DIFFRACTION,3.66,66.41,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NaH2PO4, PH 5.5-6.0, 2 M NaCL, 3% DMSO; RESERVOIR SOLUTION: 3-4M NaCL",293.15,2018-10-23,2019-02-06,4150,2,487,418.0,3,53.7,2,1.9,experimental,39.57218347825871,0.1824,0.1646,X-ray structure of furin in complex with the cyclic inhibitor c[glutaryl-Arg-Arg-Lys]-Lys-4-Amba,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHHHH,Protein,482,polypeptide(L),1,52.389,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,487,2,2,Hetero 2-mer,"A1, B1",CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.6457006657664278,1.004957e-10,NO,51814,6HZD,X-RAY DIFFRACTION,3.64,66.22,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NaH2PO4, PH 5.5-6.0, 2 M NaCL, 3% DMSO; RESERVOIR SOLUTION: 3-4M NaCL",293.15,2018-10-23,2019-02-06,4163,2,488,418.0,3,53.89,2,1.9,experimental,39.57218347825871,0.1827,0.1641,X-ray structure of furin in complex with the cyclic inhibitor c[glutaryl-Arg-Arg-Arg-Lys]-Arg-4-Amba,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHHHH,Protein,482,polypeptide(L),1,52.389,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,488,2,2,Hetero 2-mer,"A1, B1",CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.6457006657664278,1.004957e-10,NO,51814,6YD2,X-RAY DIFFRACTION,3.7,66.74,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100MM MES, 200MM K/NAH2PO4, PH 5.5-6.0, 2 M NACL; RESERVOIR SOLUTION: 3-4M NACL",293.15,2020-03-20,2021-02-17,4179,2,487,444.0,3,53.58,2,1.8,experimental,32.05,0.1771,0.1575,X-ray structure of furin in complex with the canavanine-based inhibitor 4-aminomethyl-phenylacetyl-canavanine-Tle-Arg-Amba,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHHHH,Protein,482,polypeptide(L),1,52.389,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,487,2,2,Hetero 2-mer,"A1, B1",CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.6457006657664278,1.004957e-10,NO,51814,6YD3,X-RAY DIFFRACTION,3.72,66.96,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100MM MES, 200MM K/NAH2PO4, PH 5.5-6.0, 2 M NACL; RESERVOIR SOLUTION: 3-4M NACL",293.15,2020-03-20,2021-02-17,4159,2,485,418.0,3,53.34,2,2.0,experimental,32.04,0.1854,0.1595,X-ray structure of furin in complex with the canavanine derived inhibitor 4-guanidinomethyl-phenylacetyl-Canavanine-Tle-Arg-Amba,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHH,Protein,480,polypeptide(L),1,52.112,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,485,2,2,Hetero 2-mer,"A1, B1",CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.6457006657664278,1.004957e-10,NO,51814,6YD4,X-RAY DIFFRACTION,3.73,67.06,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100MM MES, 200MM K/NAH2PO4, PH 5.5-6.0, 2 M NACL; RESERVOIR SOLUTION: 3-4M NACL",291.15,2020-03-20,2021-02-17,4237,2,485,477.0,3,53.37,2,1.7,experimental,31.24,0.1694,0.1532,X-ray structure of furin in complex with the canavanine-based inhibitor 4-guanidinomethyl-phenylacetyl-Canavanine-Tle-Canavanine-Amba,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHH,Protein,480,polypeptide(L),1,52.112,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,485,2,2,Hetero 2-mer,"A1, B1",CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.6457006657664278,1.004957e-10,NO,51814,6YD7,X-RAY DIFFRACTION,3.74,67.08,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100MM MES, 200MM K/NAH2PO4, PH 5.5-6.0, 2 M NACL; RESERVOIR SOLUTION: 3-4M NACL",291.15,2020-03-20,2021-02-17,4211,2,485,465.0,3,53.37,2,1.8,experimental,29.7,0.1709,0.1538,X-ray structure of furin in complex with the canavanine-based inhibitor 4-guanidinomethyl-phenylacetyl-Arg-Tle-Canavanine-Amba,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHH,Protein,480,polypeptide(L),1,52.112,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,485,2,2,Hetero 2-mer,"A1, B1",CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.6457006657664278,1.004957e-10,NO,51814,7QXY,X-RAY DIFFRACTION,2.568825997777984,50.34669344500458,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NAH2PO4, PH 5.5, 2 M NACL; RESERVOIR SOLUTION: 3.0-3.2M NACL",293.15,2022-01-27,2022-04-20,4386,1,480,661.0,2,53.0,1,1.478,experimental,24.97,0.1823,0.1705,X-ray structure of furin in complex with the dichlorophenylpyridine-based inhibitor 3,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHH,Protein,480,polypeptide(L),1,52.112,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,480,1,1,Monomer,A1,CL,Cl,35.453,CHLORIDE ION,InChI=1S/ClH/h1H/p-1,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.6457006657664278,1.004957e-10,NO,51814,4RYD,X-RAY DIFFRACTION,2.86,56.93,"VAPOR DIFFUSION, SITTING DROP",8.5,"50mM Tris, 2.8M sodium formate, 15mM Cymal-7, pH 8.5, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293.0,2014-12-15,2015-05-27,23768,12,2922,2034.0,18,320.52,2,2.15,experimental,39.57218347825871,0.2186,0.1862,X-ray structure of human furin in complex with the competitive inhibitor para-guanidinomethyl-Phac-R-Tle-R-Amba,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHHHH,Protein,482,polypeptide(L),6,52.389,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,487,2,2,Hetero 2-mer,"A1, B1",FMT,C H2 O2,46.025,FORMIC ACID,"InChI=1S/CH2O2/c2-1-3/h1H,(H,2,3)",
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.6457006657664278,1.004957e-10,NO,51814,5JXH,X-RAY DIFFRACTION,3.67,66.49,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"crystallization solution: 100 mM MES, 200 mM K/NaH2PO4, pH 5.5-6.0, 3-4 M NaCl, 3% DMSO; reservoir solution: 3-4 M NaCl",293.15,2016-05-13,2016-10-05,4261,2,487,534.0,3,53.39,2,2.0,experimental,39.57218347825871,0.1853,0.1566,Structure the proprotein convertase furin in complex with meta-guanidinomethyl-Phac-RVR-Amba at 2.0 Angstrom resolution.,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHHHH,Protein,482,polypeptide(L),1,52.389,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,487,2,2,Hetero 2-mer,"A1, B1",CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.6457006657664278,1.004957e-10,NO,51814,5JXG,X-RAY DIFFRACTION,3.73,67.05,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"crystallization solution: 100 mM MES, 200 mM K/NaH2PO4, pH 5.5-6.0, 3-4 M NaCl, 3% DMSO; reservoir solution: 3-4 M NaCl",293.15,2016-05-13,2016-10-05,4360,1,482,645.0,3,52.73,1,1.8,experimental,39.57218347825871,0.1733,0.154,Structure of the unliganded form of the proprotein convertase furin.,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHHHH,Protein,482,polypeptide(L),1,52.389,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,482,1,1,Monomer,A1,CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.6457006657664278,1.004957e-10,NO,51814,5JXI,X-RAY DIFFRACTION,3.76,67.3,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"crystallization solution: 100 mM MES, 200 mM K/NaH2PO4, pH 5.5-6.0, 3-4 M NaCl, 3% DMSO; reservoir solution: 3-4 M NaCl",293.15,2016-05-13,2016-10-05,4164,1,482,521.0,3,52.63,1,2.0,experimental,39.57218347825871,0.1851,0.1576,Structure of the unliganded form of the proprotein convertase furin in presence of EDTA.,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHHHH,Protein,482,polypeptide(L),1,52.389,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,482,1,1,Monomer,A1,CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.6457006657664278,1.004957e-10,NO,51814,5MIM,X-RAY DIFFRACTION,3.75,67.2,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100 MM MES, 200 MM K/NAH2PO4, PH 5.5-6.0, 3-4 M NACL, 3% DMSO; RESERVOIR SOLUTION: 3-4 M NACL",293.15,2016-11-28,2017-05-10,4275,1,482,486.0,3,53.81,1,1.9,experimental,39.57218347825871,0.1838,0.1647,"Xray structure of human furin bound with the 2,5-dideoxystreptamine derived small molecule inhibitor 1n",DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHHHH,Protein,482,polypeptide(L),1,52.389,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,482,1,1,Monomer,A1,CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.6457006657664278,1.004957e-10,NO,51814,5JXJ,X-RAY DIFFRACTION,3.69,66.65,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"crystallization solution: 100 mM MES, 200 mM K/NaH2PO4, pH 5.5-6.0, 3-4 M NaCl, 3% DMSO; reservoir solution: 3-4 M NaCl",293.15,2016-05-13,2016-10-05,4185,2,487,461.0,3,53.35,2,2.0,experimental,39.57218347825871,0.1889,0.1668,Structure of the proprotein convertase furin complexed to meta-guanidinomethyl-Phac-RVR-Amba in presence of EDTA,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHHHH,Protein,482,polypeptide(L),1,52.389,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,487,2,2,Hetero 2-mer,"A1, B1",CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.6457006657664278,1.004957e-10,NO,51814,6EQV,X-RAY DIFFRACTION,3.67,66.45,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NaH2PO4, PH 5.5-6.0, 3-4M NaCl, 3% DMSO; RESERVOIR SOLUTION: 3-4 M NaCl",293.15,2017-10-16,2018-02-28,4212,2,487,510.0,3,53.3,2,1.895,experimental,39.57218347825871,0.1821,0.1637,X-ray structure of the proprotein convertase furin bound with the competitive inhibitor Phac-Cit-Val-Arg-Amba,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHHHH,Protein,482,polypeptide(L),1,52.389,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,487,2,2,Hetero 2-mer,"A1, B1",CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.6457006657664278,1.004957e-10,NO,51814,6EQW,X-RAY DIFFRACTION,3.66,66.42,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NaH2PO4, PH 5.5-6.0, 3-4 M NaCL, 3% DMSO; RESERVOIR SOLUTION: 3-4M NaCL",293.15,2017-10-16,2018-02-28,4183,2,487,486.0,3,53.36,2,1.994,experimental,39.57218347825871,0.1842,0.1619,X-ray structure of the proprotein convertase furin bound with the competitive inhibitor 4-aminomethyl-phenylacetyl-Arg-Val-Arg-Amba,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHHHH,Protein,482,polypeptide(L),1,52.389,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,487,2,2,Hetero 2-mer,"A1, B1",CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.6457006657664278,1.004957e-10,NO,51814,6EQX,X-RAY DIFFRACTION,3.66,66.36,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"100mM MES, 200mM K/NaH2PO4, PH 5.5-6.0, 3-4 M NaCL, 3% DMSO; RESERVOIR SOLUTION: 3-4M NaCL",293.15,2017-10-16,2018-02-28,4186,2,488,471.0,3,53.51,2,1.994,experimental,39.57218347825871,0.1837,0.162,X-ray structure of the proprotein convertase furin bound with the competitive inhibitor Arg-Arg-Arg-Val-Arg-Amba,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHHHH,Protein,482,polypeptide(L),1,52.389,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,488,2,2,Hetero 2-mer,"A1, B1",CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
56339,ENTREZ_GENE,mettl3,IME4M6AMTA70Spo8hMETTL3,Homo sapiens,1.0,7.337e-13,YES,53325,5IL1,X-RAY DIFFRACTION,2.58,52.33,"VAPOR DIFFUSION, HANGING DROP",5.7,"PEG 8000, sodium citrate",291.0,2016-03-04,2016-05-25,4336,2,512,337.0,0,59.81,2,1.71,experimental,39.57218347825871,0.2069,0.1798,Crystal structure of SAM-bound METTL3-METTL14 complex,FPPQWICCDIRYLDVSILGKFAVVMADPPWDIHMELPYGTLTDDEMRRLNIPVLQDDGFLFLWVTGRAMELGRECLNLWGYERVDEIIWVKTNQLQRIIRTGRTGHWLNHGKEHCLVGVKGNPQGFNQGLDCDVIVAEVRSTSHKPDEIYGMIERLSPGTRKIELFGRPHNVQPNWITLGNQLDGIHLLDPDVVARFKQRYPDGIISKPKNL,Protein,212,polypeptide(L),1,24.427,mettl3,2.1.1.62,PDB Primary Data,Homo sapiens,9606,512,2,2,Hetero 2-mer,"A1, B1",SAM,C15 H22 N6 O5 S,398.437,S-ADENOSYLMETHIONINE,"InChI=1S/C15H22N6O5S/c1-27(3-2-7(16)15(24)25)4-8-10(22)11(23)14(26-8)21-6-20-9-12(17)18-5-19-13(9)21/h5-8,10-11,14,22-23H,2-4,16H2,1H3,(H2-,17,18,19,24,25)/t7-,8+,10+,11+,14+,27-/m0/s1",
56339,ENTREZ_GENE,mettl3,IME4M6AMTA70Spo8hMETTL3,Homo sapiens,1.0,7.337e-13,YES,53325,5IL0,X-RAY DIFFRACTION,2.55,51.69,"VAPOR DIFFUSION, HANGING DROP",5.7,"PEG 8000, sodium citrate",291.0,2016-03-04,2016-05-25,4347,2,512,331.0,0,59.43,2,1.882,experimental,39.57218347825871,0.205,0.1747,Crystal structural of the METTL3-METTL14 complex for N6-adenosine methylation,FPPQWICCDIRYLDVSILGKFAVVMADPPWDIHMELPYGTLTDDEMRRLNIPVLQDDGFLFLWVTGRAMELGRECLNLWGYERVDEIIWVKTNQLQRIIRTGRTGHWLNHGKEHCLVGVKGNPQGFNQGLDCDVIVAEVRSTSHKPDEIYGMIERLSPGTRKIELFGRPHNVQPNWITLGNQLDGIHLLDPDVVARFKQRYPDGIISKPKNL,Protein,212,polypeptide(L),1,24.427,mettl3,2.1.1.62,PDB Primary Data,Homo sapiens,9606,512,2,2,Hetero 2-mer,"A1, B1",EDO,C2 H6 O2,62.068,"1,2-ETHANEDIOL","InChI=1S/C2H6O2/c3-1-2-4/h3-4H,1-2H2",
56339,ENTREZ_GENE,mettl3,IME4M6AMTA70Spo8hMETTL3,Homo sapiens,1.0,7.337e-13,YES,53325,5IL2,X-RAY DIFFRACTION,2.66,53.7,"VAPOR DIFFUSION, HANGING DROP",5.7,"PEG 8000, sodium citrate",291.0,2016-03-04,2016-05-25,4393,2,512,376.0,1,59.85,2,1.606,experimental,39.57218347825871,0.1992,0.1848,Crystal structure of SAH-bound METTL3-METTL14 complex,FPPQWICCDIRYLDVSILGKFAVVMADPPWDIHMELPYGTLTDDEMRRLNIPVLQDDGFLFLWVTGRAMELGRECLNLWGYERVDEIIWVKTNQLQRIIRTGRTGHWLNHGKEHCLVGVKGNPQGFNQGLDCDVIVAEVRSTSHKPDEIYGMIERLSPGTRKIELFGRPHNVQPNWITLGNQLDGIHLLDPDVVARFKQRYPDGIISKPKNL,Protein,212,polypeptide(L),1,24.427,mettl3,2.1.1.62,PDB Primary Data,Homo sapiens,9606,512,2,2,Hetero 2-mer,"A1, B1",EDO,C2 H6 O2,62.068,"1,2-ETHANEDIOL","InChI=1S/C2H6O2/c3-1-2-4/h3-4H,1-2H2",
673,ENTREZ_GENE,braf,BRAF1BrafBRAF1NS7RAFB1,Homo sapiens,0.8580986577016243,1.62547e-11,NO,54092,5VR3,X-RAY DIFFRACTION,2.58,52.44,"VAPOR DIFFUSION, HANGING DROP",6.5,"0.1 M Bis-Tris pH 6.5, 2.0 M ammonium sulphate",293.15,2017-05-10,2018-02-14,510,1,88,13.0,0,9.64,1,2.102,experimental,39.57218347825871,0.2244,0.2095,Crystal structure of the BRS domain of BRAF,GAMDPGGGGSSAADPAIPEEVWNIKQMIKLTQEHIEALLDKFGGEHNPPSIYLEAYEEYTSKLDALQQREQQLLESLGNGTDFSVSSS,Protein,88,polypeptide(L),1,9.544,braf,2.7.11.1,PDB Primary Data,Homo sapiens,9606,88,1,1,Monomer,A1,SO4,O4 S,96.063,SULFATE ION,"InChI=1S/H2O4S/c1-5(2,3)4/h(H2,1,2,3,4)/p-2",
5771,ENTREZ_GENE,ptpn2,PTN2PTPTTCPTPTCELLPTPTCPTP,Homo sapiens,0.5908148060005673,6.83517e-11,NO,55668,8U0H,X-RAY DIFFRACTION,2.41,49.06,"VAPOR DIFFUSION, HANGING DROP",6.9,"0.49M Sodium phosphate monobasic monohydrate, 0.91M Potassium phosphate dibasic",296.0,2023-08-29,2024-09-04,5135,2,648,385.0,0,78.03,1,1.93,experimental,38.32,0.1917,0.1726,Crystal structure of PTPN2 with a PROTAC,MAMPTTIEREFEELDTQRRWQPLYLEIRNESHDYPHRVAKFPENRNRNRYRDVSPYDHSRVKLQNAENDYINASLVDIEEAQRSYILTQGPLPNTCCHFWLMVWQQKTKAVVMLNRIVEKESVKCAQYWPTDDQEMLFKETGFSVKLLSEDVKSYYTVHLLQLENINSGETRTISHFHYTTWPDFGVPESPASFLNFLFKVRESGSLNPDHGPAVIHCSAGIGRSGTFSLVDTCLVLMEKGDDINIKQVLLNMRKYRMGLIQTPDQLRFSYMAIIEGAKCIKGDSSIQKRWKELSKEDLSPAFDHSPNKIMTEKYNHHHHHHHH,Protein,324,polypeptide(L),2,37.966,ptpn2,3.1.3.48,PDB Primary Data,Homo sapiens,9606,324,1,1,Monomer,A1,UB0,C46 H49 Cl N6 O12 S2,977.497,"(5P)-3-(carboxymethoxy)-4-chloro-5-(3-{[(4S)-1-({3-[2-(4-{3-[(3R)-2,6-dioxopiperidin-3-yl]-2-oxo-2,3-dihydro-1,3-benzoxazol-6-yl}piperidin-1-yl)acetamido]phenyl}methanesulfonyl)-2,2-dimethylpiperidin-4-yl]amino}phenyl)thiophene-2-carboxylic acid","InChI=1S/C46H49ClN6O12S2/c1-46(2)22-32(48-31-8-4-6-29(20-31)41-39(47)40(64-24-38(56)57)42(66-41)44(59)60)15-18-52(46)67(62,63)25-26-5-3-7-30(19-26)49-37(55)23-51-16-13-27(14-17-51)28-9-10-33-35(21-28)65-45(61)53(33)34-11-12-36(54)50-43(34)58/h3-10,19-21,27,32,34,48H,11-18,22-25H2,1-2H3,(H,49,55)(H,56,57)(H,59,60)(H,50,54,58)/t32-,34+/m0/s1",
4193,ENTREZ_GENE,mdm2,ACTFSHDMXhdm2,Homo sapiens,0.6157379373301928,0.6143285247871149,YES,58657,4UD7,X-RAY DIFFRACTION,2.8,56.0,Desconocido,4.0,0.1 M SODIUM CITRATE PH 4.0 AND 15 % PEG8000,289.6514371309434,2014-12-08,2016-01-13,4008,8,520,262.0,0,58.68,2,1.6,experimental,23.018,0.17838,0.13846,Structure of the stapled peptide YS-02 bound to MDM2,GPLGSSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDAAQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSEN,Protein,114,polypeptide(L),4,12.831,mdm2,6.3.2,PDB Primary Data,Homo sapiens,9606,130,2,2,Hetero 2-mer,"A1, B1",Desconocido,Desconocido,246.2971348233669,Desconocido,Desconocido,
1387,ENTREZ_GENE,crebbp,CBPKAT3ARSTSRSTS1,Homo sapiens,0.814636824708945,7.07045e-11,NO,60020,6YIK,X-RAY DIFFRACTION,3.42,64.06,"VAPOR DIFFUSION, SITTING DROP",7.5,"21% PEG3350
15% ethylene glycol
0.25M sodium formate",277.0,2020-04-01,2020-04-15,3453,3,357,385.0,0,44.74,1,1.7,experimental,32.625,0.184,0.156,Crystal structure of the CREBBP bromodomain in complex with a tetrahydroquinoxaline ligand,SMRKKIFKPEELRQALMPTLEALYRQDPESLPFRQPVDPQLLGIPDYFDIVKNPMDLSTIKRKLDTGQYQEPWQYVDDVWLMFNNAWLYNRKTSRVYKFCSKLAEVFEQEIDPVMQSLG,Protein,119,polypeptide(L),3,14.223,crebbp,2.3.1.48,PDB Primary Data,Homo sapiens,9606,119,1,1,Monomer,A1,OSQ,C22 H24 F2 N4 O2,414.448,"(3~{R})-~{N}-[3-(3,4-dihydro-2~{H}-quinolin-1-yl)-2,2-bis(fluoranyl)propyl]-3-methyl-2-oxidanylidene-3,4-dihydro-1~{H}-quinoxaline-5-carboxamide","InChI=1S/C22H24F2N4O2/c1-14-20(29)27-17-9-4-8-16(19(17)26-14)21(30)25-12-22(23,24)13-28-11-5-7-15-6-2-3-10-18(15)28/h2-4,6,8-10,14,26H,5,7,11-13H2,1H3,(H,25,30)(H,27,29)/t14-/m1/s1",
1387,ENTREZ_GENE,crebbp,CBPKAT3ARSTSRSTS1,Homo sapiens,0.814636824708945,7.07045e-11,NO,60020,6SXX,X-RAY DIFFRACTION,2.18,43.67,"VAPOR DIFFUSION, HANGING DROP",6.982430939226492,"25% PEG3350, 0.2 M Potassium thiocyanate, 5% EtGly",277.0,2019-09-26,2020-07-29,1940,2,238,81.0,0,28.95,1,2.01,experimental,52.99,0.2533,0.1955,Crystal structure of the bromodomain of human CREBBP in complex with ACA007,SMRKKIFKPEELRQALMPTLEALYRQDPESLPFRQPVDPQLLGIPDYFDIVKNPMDLSTIKRKLDTGQYQEPWQYVDDVWLMFNNAWLYNRKTSRVYKFCSKLAEVFEQEIDPVMQSLG,Protein,119,polypeptide(L),2,14.223,crebbp,2.3.1.48,PDB Primary Data,Homo sapiens,9606,119,1,1,Monomer,A1,EDO,C2 H6 O2,62.068,"1,2-ETHANEDIOL","InChI=1S/C2H6O2/c3-1-2-4/h3-4H,1-2H2",
1387,ENTREZ_GENE,crebbp,CBPKAT3ARSTSRSTS1,Homo sapiens,0.814636824708945,7.07045e-11,NO,60020,6YIL,X-RAY DIFFRACTION,2.2,44.01,"VAPOR DIFFUSION, SITTING DROP",7.5,"20% PEG3350
10% ethylene glycol
0.2M sodium acetate",277.0,2020-04-01,2020-04-15,1160,1,119,154.0,0,14.64,1,1.22,experimental,12.75,0.1511,0.1321,Crystal structure of the CREBBP bromodomain in complex with a tetrahydroquinoxaline ligand,SMRKKIFKPEELRQALMPTLEALYRQDPESLPFRQPVDPQLLGIPDYFDIVKNPMDLSTIKRKLDTGQYQEPWQYVDDVWLMFNNAWLYNRKTSRVYKFCSKLAEVFEQEIDPVMQSLG,Protein,119,polypeptide(L),1,14.223,crebbp,2.3.1.48,PDB Primary Data,Homo sapiens,9606,119,1,1,Monomer,A1,OSQ,C22 H24 F2 N4 O2,414.448,"(3~{R})-~{N}-[3-(3,4-dihydro-2~{H}-quinolin-1-yl)-2,2-bis(fluoranyl)propyl]-3-methyl-2-oxidanylidene-3,4-dihydro-1~{H}-quinoxaline-5-carboxamide","InChI=1S/C22H24F2N4O2/c1-14-20(29)27-17-9-4-8-16(19(17)26-14)21(30)25-12-22(23,24)13-28-11-5-7-15-6-2-3-10-18(15)28/h2-4,6,8-10,14,26H,5,7,11-13H2,1H3,(H,25,30)(H,27,29)/t14-/m1/s1",
1387,ENTREZ_GENE,crebbp,CBPKAT3ARSTSRSTS1,Homo sapiens,0.814636824708945,7.07045e-11,NO,60020,6YIM,X-RAY DIFFRACTION,2.2,44.12,"VAPOR DIFFUSION, SITTING DROP",7.5,"20% PEG3350
10% ethylene glycol
0.2M sodium fluoride",277.0,2020-04-01,2020-04-15,1174,1,119,163.0,0,14.65,1,1.23,experimental,12.85,0.167,0.1397,Crystal structure of the CREBBP bromodomain in complex with a benzo-diazepine ligand,SMRKKIFKPEELRQALMPTLEALYRQDPESLPFRQPVDPQLLGIPDYFDIVKNPMDLSTIKRKLDTGQYQEPWQYVDDVWLMFNNAWLYNRKTSRVYKFCSKLAEVFEQEIDPVMQSLG,Protein,119,polypeptide(L),1,14.223,crebbp,2.3.1.48,PDB Primary Data,Homo sapiens,9606,119,1,1,Monomer,A1,OS8,C24 H30 N4 O3,422.52,"(4~{R})-~{N}-[3-(7-methoxy-3,4-dihydro-2~{H}-quinolin-1-yl)propyl]-4-methyl-2-oxidanylidene-1,3,4,5-tetrahydro-1,5-benzodiazepine-6-carboxamide","InChI=1S/C24H30N4O3/c1-16-14-22(29)27-20-8-3-7-19(23(20)26-16)24(30)25-11-5-13-28-12-4-6-17-9-10-18(31-2)15-21(17)28/h3,7-10,15-16,26H,4-6,11-14H2,1-2H3,(H,25,30)(H,27,29)/t16-/m1/s1",
1387,ENTREZ_GENE,crebbp,CBPKAT3ARSTSRSTS1,Homo sapiens,0.814636824708945,7.07045e-11,NO,60020,6YIJ,X-RAY DIFFRACTION,2.95,58.37,"VAPOR DIFFUSION, SITTING DROP",8.3,"20% ethylene glycol
21% PEG6K
0.1M tris pH 8.3
0.125M lithium chloride",277.0,2020-04-01,2020-04-15,7177,7,833,224.0,0,102.4,1,2.2,experimental,44.856,0.2693,0.2022,Crystal structure of the CREBBP bromodomain in complex with a benzo-diazepine ligand,SMRKKIFKPEELRQALMPTLEALYRQDPESLPFRQPVDPQLLGIPDYFDIVKNPMDLSTIKRKLDTGQYQEPWQYVDDVWLMFNNAWLYNRKTSRVYKFCSKLAEVFEQEIDPVMQSLG,Protein,119,polypeptide(L),7,14.223,crebbp,2.3.1.48,PDB Primary Data,Homo sapiens,9606,119,1,1,Monomer,A1,OSN,C25 H31 N3 O2,405.533,"(4~{R})-6-[(~{E})-5-(7-methoxy-3,4-dihydro-2~{H}-quinolin-1-yl)pent-1-enyl]-4-methyl-1,3,4,5-tetrahydro-1,5-benzodiazepin-2-one","InChI=1S/C25H31N3O2/c1-18-16-24(29)27-22-11-6-9-20(25(22)26-18)8-4-3-5-14-28-15-7-10-19-12-13-21(30-2)17-23(19)28/h4,6,8-9,11-13,17-18,26H,3,5,7,10,14-16H2,1-2H3,(H,27,29)/b8-4+/t18-/m1/s1",
2534,ENTREZ_GENE,fyn,SLKSYNp59FYN,Homo sapiens,0.7182847544804092,9.65136e-11,NO,65990,6EDF,X-RAY DIFFRACTION,2.0,37.6,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"20% PEG3350, 0.2 M magnesium acetate",291.0,2018-08-09,2018-08-29,693,1,79,61.0,0,8.94,1,1.4,experimental,12.097,0.1721,0.1434,Fragment of a tyrosine-protein kinase,GGVTLFVALYDYEARTEDDISVHKGEKVQILNSSEGDWWEVRSLTTGETGYVPSNYVAPVDGSAAMGPVLRLRAFYNGG,Protein,79,polypeptide(L),1,8.591,fyn,2.7.10.2,PDB Primary Data,Homo sapiens,9606,79,1,1,Monomer,A1,GOL,C3 H8 O3,92.094,GLYCEROL,"InChI=1S/C3H8O3/c4-1-3(6)2-5/h3-6H,1-2H2",
6730,ENTREZ_GENE,braf,BRAF1BrafBRAF1NS7RAFB1,Homo sapiens,0.6267097169963932,1.611e-11,NO,67102,5VR3,X-RAY DIFFRACTION,2.58,52.44,"VAPOR DIFFUSION, HANGING DROP",6.5,"0.1 M Bis-Tris pH 6.5, 2.0 M ammonium sulphate",293.15,2017-05-10,2018-02-14,510,1,88,13.0,0,9.64,1,2.102,experimental,39.57218347825871,0.2244,0.2095,Crystal structure of the BRS domain of BRAF,GAMDPGGGGSSAADPAIPEEVWNIKQMIKLTQEHIEALLDKFGGEHNPPSIYLEAYEEYTSKLDALQQREQQLLESLGNGTDFSVSSS,Protein,88,polypeptide(L),1,9.544,braf,2.7.11.1,PDB Primary Data,Homo sapiens,9606,88,1,1,Monomer,A1,SO4,O4 S,96.063,SULFATE ION,"InChI=1S/H2O4S/c1-5(2,3)4/h(H2,1,2,3,4)/p-2",
57710,ENTREZ_GENE,ptpn2,PTN2PTPTTCPTPTCELLPTPTCPTP,Homo sapiens,0.6039786551178994,5.4616e-12,NO,67477,8U0H,X-RAY DIFFRACTION,2.41,49.06,"VAPOR DIFFUSION, HANGING DROP",6.9,"0.49M Sodium phosphate monobasic monohydrate, 0.91M Potassium phosphate dibasic",296.0,2023-08-29,2024-09-04,5135,2,648,385.0,0,78.03,1,1.93,experimental,38.32,0.1917,0.1726,Crystal structure of PTPN2 with a PROTAC,MAMPTTIEREFEELDTQRRWQPLYLEIRNESHDYPHRVAKFPENRNRNRYRDVSPYDHSRVKLQNAENDYINASLVDIEEAQRSYILTQGPLPNTCCHFWLMVWQQKTKAVVMLNRIVEKESVKCAQYWPTDDQEMLFKETGFSVKLLSEDVKSYYTVHLLQLENINSGETRTISHFHYTTWPDFGVPESPASFLNFLFKVRESGSLNPDHGPAVIHCSAGIGRSGTFSLVDTCLVLMEKGDDINIKQVLLNMRKYRMGLIQTPDQLRFSYMAIIEGAKCIKGDSSIQKRWKELSKEDLSPAFDHSPNKIMTEKYNHHHHHHHH,Protein,324,polypeptide(L),2,37.966,ptpn2,3.1.3.48,PDB Primary Data,Homo sapiens,9606,324,1,1,Monomer,A1,UB0,C46 H49 Cl N6 O12 S2,977.497,"(5P)-3-(carboxymethoxy)-4-chloro-5-(3-{[(4S)-1-({3-[2-(4-{3-[(3R)-2,6-dioxopiperidin-3-yl]-2-oxo-2,3-dihydro-1,3-benzoxazol-6-yl}piperidin-1-yl)acetamido]phenyl}methanesulfonyl)-2,2-dimethylpiperidin-4-yl]amino}phenyl)thiophene-2-carboxylic acid","InChI=1S/C46H49ClN6O12S2/c1-46(2)22-32(48-31-8-4-6-29(20-31)41-39(47)40(64-24-38(56)57)42(66-41)44(59)60)15-18-52(46)67(62,63)25-26-5-3-7-30(19-26)49-37(55)23-51-16-13-27(14-17-51)28-9-10-33-35(21-28)65-45(61)53(33)34-11-12-36(54)50-43(34)58/h3-10,19-21,27,32,34,48H,11-18,22-25H2,1-2H3,(H,49,55)(H,56,57)(H,59,60)(H,50,54,58)/t32-,34+/m0/s1",
25340,ENTREZ_GENE,fyn,SLKSYNp59FYN,Homo sapiens,0.643023957378449,2.32831e-11,NO,68911,6EDF,X-RAY DIFFRACTION,2.0,37.6,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"20% PEG3350, 0.2 M magnesium acetate",291.0,2018-08-09,2018-08-29,693,1,79,61.0,0,8.94,1,1.4,experimental,12.097,0.1721,0.1434,Fragment of a tyrosine-protein kinase,GGVTLFVALYDYEARTEDDISVHKGEKVQILNSSEGDWWEVRSLTTGETGYVPSNYVAPVDGSAAMGPVLRLRAFYNGG,Protein,79,polypeptide(L),1,8.591,fyn,2.7.10.2,PDB Primary Data,Homo sapiens,9606,79,1,1,Monomer,A1,GOL,C3 H8 O3,92.094,GLYCEROL,"InChI=1S/C3H8O3/c4-1-3(6)2-5/h3-6H,1-2H2",
2534,ENTREZ_GENE,fyn,SLKSYNp59FYN,Homo sapiens,0.6183421451813246,4.36503e-11,NO,72851,6EDF,X-RAY DIFFRACTION,2.0,37.6,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"20% PEG3350, 0.2 M magnesium acetate",291.0,2018-08-09,2018-08-29,693,1,79,61.0,0,8.94,1,1.4,experimental,12.097,0.1721,0.1434,Fragment of a tyrosine-protein kinase,GGVTLFVALYDYEARTEDDISVHKGEKVQILNSSEGDWWEVRSLTTGETGYVPSNYVAPVDGSAAMGPVLRLRAFYNGG,Protein,79,polypeptide(L),1,8.591,fyn,2.7.10.2,PDB Primary Data,Homo sapiens,9606,79,1,1,Monomer,A1,GOL,C3 H8 O3,92.094,GLYCEROL,"InChI=1S/C3H8O3/c4-1-3(6)2-5/h3-6H,1-2H2",
673,ENTREZ_GENE,braf,BRAF1BrafBRAF1NS7RAFB1,Homo sapiens,0.6153471394298694,2.18218e-11,NO,74236,5VR3,X-RAY DIFFRACTION,2.58,52.44,"VAPOR DIFFUSION, HANGING DROP",6.5,"0.1 M Bis-Tris pH 6.5, 2.0 M ammonium sulphate",293.15,2017-05-10,2018-02-14,510,1,88,13.0,0,9.64,1,2.102,experimental,39.57218347825871,0.2244,0.2095,Crystal structure of the BRS domain of BRAF,GAMDPGGGGSSAADPAIPEEVWNIKQMIKLTQEHIEALLDKFGGEHNPPSIYLEAYEEYTSKLDALQQREQQLLESLGNGTDFSVSSS,Protein,88,polypeptide(L),1,9.544,braf,2.7.11.1,PDB Primary Data,Homo sapiens,9606,88,1,1,Monomer,A1,SO4,O4 S,96.063,SULFATE ION,"InChI=1S/H2O4S/c1-5(2,3)4/h(H2,1,2,3,4)/p-2",
5771,ENTREZ_GENE,ptpn2,PTN2PTPTTCPTPTCELLPTPTCPTP,Homo sapiens,0.6153471394298694,2.8338e-12,YES,74237,8U0H,X-RAY DIFFRACTION,2.41,49.06,"VAPOR DIFFUSION, HANGING DROP",6.9,"0.49M Sodium phosphate monobasic monohydrate, 0.91M Potassium phosphate dibasic",296.0,2023-08-29,2024-09-04,5135,2,648,385.0,0,78.03,1,1.93,experimental,38.32,0.1917,0.1726,Crystal structure of PTPN2 with a PROTAC,MAMPTTIEREFEELDTQRRWQPLYLEIRNESHDYPHRVAKFPENRNRNRYRDVSPYDHSRVKLQNAENDYINASLVDIEEAQRSYILTQGPLPNTCCHFWLMVWQQKTKAVVMLNRIVEKESVKCAQYWPTDDQEMLFKETGFSVKLLSEDVKSYYTVHLLQLENINSGETRTISHFHYTTWPDFGVPESPASFLNFLFKVRESGSLNPDHGPAVIHCSAGIGRSGTFSLVDTCLVLMEKGDDINIKQVLLNMRKYRMGLIQTPDQLRFSYMAIIEGAKCIKGDSSIQKRWKELSKEDLSPAFDHSPNKIMTEKYNHHHHHHHH,Protein,324,polypeptide(L),2,37.966,ptpn2,3.1.3.48,PDB Primary Data,Homo sapiens,9606,324,1,1,Monomer,A1,UB0,C46 H49 Cl N6 O12 S2,977.497,"(5P)-3-(carboxymethoxy)-4-chloro-5-(3-{[(4S)-1-({3-[2-(4-{3-[(3R)-2,6-dioxopiperidin-3-yl]-2-oxo-2,3-dihydro-1,3-benzoxazol-6-yl}piperidin-1-yl)acetamido]phenyl}methanesulfonyl)-2,2-dimethylpiperidin-4-yl]amino}phenyl)thiophene-2-carboxylic acid","InChI=1S/C46H49ClN6O12S2/c1-46(2)22-32(48-31-8-4-6-29(20-31)41-39(47)40(64-24-38(56)57)42(66-41)44(59)60)15-18-52(46)67(62,63)25-26-5-3-7-30(19-26)49-37(55)23-51-16-13-27(14-17-51)28-9-10-33-35(21-28)65-45(61)53(33)34-11-12-36(54)50-43(34)58/h3-10,19-21,27,32,34,48H,11-18,22-25H2,1-2H3,(H,49,55)(H,56,57)(H,59,60)(H,50,54,58)/t32-,34+/m0/s1",
25340,ENTREZ_GENE,fyn,SLKSYNp59FYN,Homo sapiens,0.6157353650378212,1.91697e-11,NO,76811,6EDF,X-RAY DIFFRACTION,2.0,37.6,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"20% PEG3350, 0.2 M magnesium acetate",291.0,2018-08-09,2018-08-29,693,1,79,61.0,0,8.94,1,1.4,experimental,12.097,0.1721,0.1434,Fragment of a tyrosine-protein kinase,GGVTLFVALYDYEARTEDDISVHKGEKVQILNSSEGDWWEVRSLTTGETGYVPSNYVAPVDGSAAMGPVLRLRAFYNGG,Protein,79,polypeptide(L),1,8.591,fyn,2.7.10.2,PDB Primary Data,Homo sapiens,9606,79,1,1,Monomer,A1,GOL,C3 H8 O3,92.094,GLYCEROL,"InChI=1S/C3H8O3/c4-1-3(6)2-5/h3-6H,1-2H2",
6730,ENTREZ_GENE,braf,BRAF1BrafBRAF1NS7RAFB1,Homo sapiens,0.6157353650378212,1.91697e-11,NO,77194,5VR3,X-RAY DIFFRACTION,2.58,52.44,"VAPOR DIFFUSION, HANGING DROP",6.5,"0.1 M Bis-Tris pH 6.5, 2.0 M ammonium sulphate",293.15,2017-05-10,2018-02-14,510,1,88,13.0,0,9.64,1,2.102,experimental,39.57218347825871,0.2244,0.2095,Crystal structure of the BRS domain of BRAF,GAMDPGGGGSSAADPAIPEEVWNIKQMIKLTQEHIEALLDKFGGEHNPPSIYLEAYEEYTSKLDALQQREQQLLESLGNGTDFSVSSS,Protein,88,polypeptide(L),1,9.544,braf,2.7.11.1,PDB Primary Data,Homo sapiens,9606,88,1,1,Monomer,A1,SO4,O4 S,96.063,SULFATE ION,"InChI=1S/H2O4S/c1-5(2,3)4/h(H2,1,2,3,4)/p-2",
563390,ENTREZ_GENE,mettl3,IME4M6AMTA70Spo8hMETTL3,Homo sapiens,0.6157353650378212,1.91697e-11,NO,77738,5IL1,X-RAY DIFFRACTION,2.58,52.33,"VAPOR DIFFUSION, HANGING DROP",5.7,"PEG 8000, sodium citrate",291.0,2016-03-04,2016-05-25,4336,2,512,337.0,0,59.81,2,1.71,experimental,39.57218347825871,0.2069,0.1798,Crystal structure of SAM-bound METTL3-METTL14 complex,FPPQWICCDIRYLDVSILGKFAVVMADPPWDIHMELPYGTLTDDEMRRLNIPVLQDDGFLFLWVTGRAMELGRECLNLWGYERVDEIIWVKTNQLQRIIRTGRTGHWLNHGKEHCLVGVKGNPQGFNQGLDCDVIVAEVRSTSHKPDEIYGMIERLSPGTRKIELFGRPHNVQPNWITLGNQLDGIHLLDPDVVARFKQRYPDGIISKPKNL,Protein,212,polypeptide(L),1,24.427,mettl3,2.1.1.62,PDB Primary Data,Homo sapiens,9606,512,2,2,Hetero 2-mer,"A1, B1",SAM,C15 H22 N6 O5 S,398.437,S-ADENOSYLMETHIONINE,"InChI=1S/C15H22N6O5S/c1-27(3-2-7(16)15(24)25)4-8-10(22)11(23)14(26-8)21-6-20-9-12(17)18-5-19-13(9)21/h5-8,10-11,14,22-23H,2-4,16H2,1H3,(H2-,17,18,19,24,25)/t7-,8+,10+,11+,14+,27-/m0/s1",
563390,ENTREZ_GENE,mettl3,IME4M6AMTA70Spo8hMETTL3,Homo sapiens,0.6157353650378212,1.91697e-11,NO,77738,5IL0,X-RAY DIFFRACTION,2.55,51.69,"VAPOR DIFFUSION, HANGING DROP",5.7,"PEG 8000, sodium citrate",291.0,2016-03-04,2016-05-25,4347,2,512,331.0,0,59.43,2,1.882,experimental,39.57218347825871,0.205,0.1747,Crystal structural of the METTL3-METTL14 complex for N6-adenosine methylation,FPPQWICCDIRYLDVSILGKFAVVMADPPWDIHMELPYGTLTDDEMRRLNIPVLQDDGFLFLWVTGRAMELGRECLNLWGYERVDEIIWVKTNQLQRIIRTGRTGHWLNHGKEHCLVGVKGNPQGFNQGLDCDVIVAEVRSTSHKPDEIYGMIERLSPGTRKIELFGRPHNVQPNWITLGNQLDGIHLLDPDVVARFKQRYPDGIISKPKNL,Protein,212,polypeptide(L),1,24.427,mettl3,2.1.1.62,PDB Primary Data,Homo sapiens,9606,512,2,2,Hetero 2-mer,"A1, B1",EDO,C2 H6 O2,62.068,"1,2-ETHANEDIOL","InChI=1S/C2H6O2/c3-1-2-4/h3-4H,1-2H2",
563390,ENTREZ_GENE,mettl3,IME4M6AMTA70Spo8hMETTL3,Homo sapiens,0.6157353650378212,1.91697e-11,NO,77738,5IL2,X-RAY DIFFRACTION,2.66,53.7,"VAPOR DIFFUSION, HANGING DROP",5.7,"PEG 8000, sodium citrate",291.0,2016-03-04,2016-05-25,4393,2,512,376.0,1,59.85,2,1.606,experimental,39.57218347825871,0.1992,0.1848,Crystal structure of SAH-bound METTL3-METTL14 complex,FPPQWICCDIRYLDVSILGKFAVVMADPPWDIHMELPYGTLTDDEMRRLNIPVLQDDGFLFLWVTGRAMELGRECLNLWGYERVDEIIWVKTNQLQRIIRTGRTGHWLNHGKEHCLVGVKGNPQGFNQGLDCDVIVAEVRSTSHKPDEIYGMIERLSPGTRKIELFGRPHNVQPNWITLGNQLDGIHLLDPDVVARFKQRYPDGIISKPKNL,Protein,212,polypeptide(L),1,24.427,mettl3,2.1.1.62,PDB Primary Data,Homo sapiens,9606,512,2,2,Hetero 2-mer,"A1, B1",EDO,C2 H6 O2,62.068,"1,2-ETHANEDIOL","InChI=1S/C2H6O2/c3-1-2-4/h3-4H,1-2H2",
41930,ENTREZ_GENE,mdm2,ACTFSHDMXhdm2,Homo sapiens,0.6157353650378212,1.91697e-11,NO,78571,4UD7,X-RAY DIFFRACTION,2.8,56.0,Desconocido,4.0,0.1 M SODIUM CITRATE PH 4.0 AND 15 % PEG8000,289.6514371309434,2014-12-08,2016-01-13,4008,8,520,262.0,0,58.68,2,1.6,experimental,23.018,0.17838,0.13846,Structure of the stapled peptide YS-02 bound to MDM2,GPLGSSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDAAQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSEN,Protein,114,polypeptide(L),4,12.831,mdm2,6.3.2,PDB Primary Data,Homo sapiens,9606,130,2,2,Hetero 2-mer,"A1, B1",Desconocido,Desconocido,246.2971348233669,Desconocido,Desconocido,
57710,ENTREZ_GENE,ptpn2,PTN2PTPTTCPTPTCELLPTPTCPTP,Homo sapiens,0.6157353650378212,1.91697e-11,NO,79610,8U0H,X-RAY DIFFRACTION,2.41,49.06,"VAPOR DIFFUSION, HANGING DROP",6.9,"0.49M Sodium phosphate monobasic monohydrate, 0.91M Potassium phosphate dibasic",296.0,2023-08-29,2024-09-04,5135,2,648,385.0,0,78.03,1,1.93,experimental,38.32,0.1917,0.1726,Crystal structure of PTPN2 with a PROTAC,MAMPTTIEREFEELDTQRRWQPLYLEIRNESHDYPHRVAKFPENRNRNRYRDVSPYDHSRVKLQNAENDYINASLVDIEEAQRSYILTQGPLPNTCCHFWLMVWQQKTKAVVMLNRIVEKESVKCAQYWPTDDQEMLFKETGFSVKLLSEDVKSYYTVHLLQLENINSGETRTISHFHYTTWPDFGVPESPASFLNFLFKVRESGSLNPDHGPAVIHCSAGIGRSGTFSLVDTCLVLMEKGDDINIKQVLLNMRKYRMGLIQTPDQLRFSYMAIIEGAKCIKGDSSIQKRWKELSKEDLSPAFDHSPNKIMTEKYNHHHHHHHH,Protein,324,polypeptide(L),2,37.966,ptpn2,3.1.3.48,PDB Primary Data,Homo sapiens,9606,324,1,1,Monomer,A1,UB0,C46 H49 Cl N6 O12 S2,977.497,"(5P)-3-(carboxymethoxy)-4-chloro-5-(3-{[(4S)-1-({3-[2-(4-{3-[(3R)-2,6-dioxopiperidin-3-yl]-2-oxo-2,3-dihydro-1,3-benzoxazol-6-yl}piperidin-1-yl)acetamido]phenyl}methanesulfonyl)-2,2-dimethylpiperidin-4-yl]amino}phenyl)thiophene-2-carboxylic acid","InChI=1S/C46H49ClN6O12S2/c1-46(2)22-32(48-31-8-4-6-29(20-31)41-39(47)40(64-24-38(56)57)42(66-41)44(59)60)15-18-52(46)67(62,63)25-26-5-3-7-30(19-26)49-37(55)23-51-16-13-27(14-17-51)28-9-10-33-35(21-28)65-45(61)53(33)34-11-12-36(54)50-43(34)58/h3-10,19-21,27,32,34,48H,11-18,22-25H2,1-2H3,(H,49,55)(H,56,57)(H,59,60)(H,50,54,58)/t32-,34+/m0/s1",
13870,ENTREZ_GENE,crebbp,CBPKAT3ARSTSRSTS1,Homo sapiens,0.6157353650378212,1.91697e-11,NO,80552,6YIK,X-RAY DIFFRACTION,3.42,64.06,"VAPOR DIFFUSION, SITTING DROP",7.5,"21% PEG3350
15% ethylene glycol
0.25M sodium formate",277.0,2020-04-01,2020-04-15,3453,3,357,385.0,0,44.74,1,1.7,experimental,32.625,0.184,0.156,Crystal structure of the CREBBP bromodomain in complex with a tetrahydroquinoxaline ligand,SMRKKIFKPEELRQALMPTLEALYRQDPESLPFRQPVDPQLLGIPDYFDIVKNPMDLSTIKRKLDTGQYQEPWQYVDDVWLMFNNAWLYNRKTSRVYKFCSKLAEVFEQEIDPVMQSLG,Protein,119,polypeptide(L),3,14.223,crebbp,2.3.1.48,PDB Primary Data,Homo sapiens,9606,119,1,1,Monomer,A1,OSQ,C22 H24 F2 N4 O2,414.448,"(3~{R})-~{N}-[3-(3,4-dihydro-2~{H}-quinolin-1-yl)-2,2-bis(fluoranyl)propyl]-3-methyl-2-oxidanylidene-3,4-dihydro-1~{H}-quinoxaline-5-carboxamide","InChI=1S/C22H24F2N4O2/c1-14-20(29)27-17-9-4-8-16(19(17)26-14)21(30)25-12-22(23,24)13-28-11-5-7-15-6-2-3-10-18(15)28/h2-4,6,8-10,14,26H,5,7,11-13H2,1H3,(H,25,30)(H,27,29)/t14-/m1/s1",
13870,ENTREZ_GENE,crebbp,CBPKAT3ARSTSRSTS1,Homo sapiens,0.6157353650378212,1.91697e-11,NO,80552,6SXX,X-RAY DIFFRACTION,2.18,43.67,"VAPOR DIFFUSION, HANGING DROP",6.982430939226492,"25% PEG3350, 0.2 M Potassium thiocyanate, 5% EtGly",277.0,2019-09-26,2020-07-29,1940,2,238,81.0,0,28.95,1,2.01,experimental,52.99,0.2533,0.1955,Crystal structure of the bromodomain of human CREBBP in complex with ACA007,SMRKKIFKPEELRQALMPTLEALYRQDPESLPFRQPVDPQLLGIPDYFDIVKNPMDLSTIKRKLDTGQYQEPWQYVDDVWLMFNNAWLYNRKTSRVYKFCSKLAEVFEQEIDPVMQSLG,Protein,119,polypeptide(L),2,14.223,crebbp,2.3.1.48,PDB Primary Data,Homo sapiens,9606,119,1,1,Monomer,A1,EDO,C2 H6 O2,62.068,"1,2-ETHANEDIOL","InChI=1S/C2H6O2/c3-1-2-4/h3-4H,1-2H2",
13870,ENTREZ_GENE,crebbp,CBPKAT3ARSTSRSTS1,Homo sapiens,0.6157353650378212,1.91697e-11,NO,80552,6YIL,X-RAY DIFFRACTION,2.2,44.01,"VAPOR DIFFUSION, SITTING DROP",7.5,"20% PEG3350
10% ethylene glycol
0.2M sodium acetate",277.0,2020-04-01,2020-04-15,1160,1,119,154.0,0,14.64,1,1.22,experimental,12.75,0.1511,0.1321,Crystal structure of the CREBBP bromodomain in complex with a tetrahydroquinoxaline ligand,SMRKKIFKPEELRQALMPTLEALYRQDPESLPFRQPVDPQLLGIPDYFDIVKNPMDLSTIKRKLDTGQYQEPWQYVDDVWLMFNNAWLYNRKTSRVYKFCSKLAEVFEQEIDPVMQSLG,Protein,119,polypeptide(L),1,14.223,crebbp,2.3.1.48,PDB Primary Data,Homo sapiens,9606,119,1,1,Monomer,A1,OSQ,C22 H24 F2 N4 O2,414.448,"(3~{R})-~{N}-[3-(3,4-dihydro-2~{H}-quinolin-1-yl)-2,2-bis(fluoranyl)propyl]-3-methyl-2-oxidanylidene-3,4-dihydro-1~{H}-quinoxaline-5-carboxamide","InChI=1S/C22H24F2N4O2/c1-14-20(29)27-17-9-4-8-16(19(17)26-14)21(30)25-12-22(23,24)13-28-11-5-7-15-6-2-3-10-18(15)28/h2-4,6,8-10,14,26H,5,7,11-13H2,1H3,(H,25,30)(H,27,29)/t14-/m1/s1",
13870,ENTREZ_GENE,crebbp,CBPKAT3ARSTSRSTS1,Homo sapiens,0.6157353650378212,1.91697e-11,NO,80552,6YIM,X-RAY DIFFRACTION,2.2,44.12,"VAPOR DIFFUSION, SITTING DROP",7.5,"20% PEG3350
10% ethylene glycol
0.2M sodium fluoride",277.0,2020-04-01,2020-04-15,1174,1,119,163.0,0,14.65,1,1.23,experimental,12.85,0.167,0.1397,Crystal structure of the CREBBP bromodomain in complex with a benzo-diazepine ligand,SMRKKIFKPEELRQALMPTLEALYRQDPESLPFRQPVDPQLLGIPDYFDIVKNPMDLSTIKRKLDTGQYQEPWQYVDDVWLMFNNAWLYNRKTSRVYKFCSKLAEVFEQEIDPVMQSLG,Protein,119,polypeptide(L),1,14.223,crebbp,2.3.1.48,PDB Primary Data,Homo sapiens,9606,119,1,1,Monomer,A1,OS8,C24 H30 N4 O3,422.52,"(4~{R})-~{N}-[3-(7-methoxy-3,4-dihydro-2~{H}-quinolin-1-yl)propyl]-4-methyl-2-oxidanylidene-1,3,4,5-tetrahydro-1,5-benzodiazepine-6-carboxamide","InChI=1S/C24H30N4O3/c1-16-14-22(29)27-20-8-3-7-19(23(20)26-16)24(30)25-11-5-13-28-12-4-6-17-9-10-18(31-2)15-21(17)28/h3,7-10,15-16,26H,4-6,11-14H2,1-2H3,(H,25,30)(H,27,29)/t16-/m1/s1",
13870,ENTREZ_GENE,crebbp,CBPKAT3ARSTSRSTS1,Homo sapiens,0.6157353650378212,1.91697e-11,NO,80552,6YIJ,X-RAY DIFFRACTION,2.95,58.37,"VAPOR DIFFUSION, SITTING DROP",8.3,"20% ethylene glycol
21% PEG6K
0.1M tris pH 8.3
0.125M lithium chloride",277.0,2020-04-01,2020-04-15,7177,7,833,224.0,0,102.4,1,2.2,experimental,44.856,0.2693,0.2022,Crystal structure of the CREBBP bromodomain in complex with a benzo-diazepine ligand,SMRKKIFKPEELRQALMPTLEALYRQDPESLPFRQPVDPQLLGIPDYFDIVKNPMDLSTIKRKLDTGQYQEPWQYVDDVWLMFNNAWLYNRKTSRVYKFCSKLAEVFEQEIDPVMQSLG,Protein,119,polypeptide(L),7,14.223,crebbp,2.3.1.48,PDB Primary Data,Homo sapiens,9606,119,1,1,Monomer,A1,OSN,C25 H31 N3 O2,405.533,"(4~{R})-6-[(~{E})-5-(7-methoxy-3,4-dihydro-2~{H}-quinolin-1-yl)pent-1-enyl]-4-methyl-1,3,4,5-tetrahydro-1,5-benzodiazepin-2-one","InChI=1S/C25H31N3O2/c1-18-16-24(29)27-22-11-6-9-20(25(22)26-18)8-4-3-5-14-28-15-7-10-19-12-13-21(30-2)17-23(19)28/h4,6,8-9,11-13,17-18,26H,3,5,7,10,14-16H2,1-2H3,(H,27,29)/b8-4+/t18-/m1/s1",
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.5949024643894701,6.8022e-11,NO,86751,7QXZ,X-RAY DIFFRACTION,3.8,67.66,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NAH2PO4, PH 5.5, 2 M NACL; RESERVOIR SOLUTION: 3.0-3.2M NACL",293.15,2022-01-27,2022-04-13,4278,1,480,568.0,3,52.89,1,1.8,experimental,27.27,0.2173,0.1815,X-ray structure of furin in complex with the dichlorophenylpyridine-based inhibitor 5,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHH,Protein,480,polypeptide(L),1,52.112,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,480,1,1,Monomer,A1,CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.5949024643894701,6.8022e-11,NO,86751,8B4V,X-RAY DIFFRACTION,3.75,67.16,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NAH2PO4, PH 5.5, 2 M NACL; RESERVOIR SOLUTION: 3.0-3.2M NACL",293.15,2022-09-21,2023-10-04,4300,1,480,508.0,4,52.95,1,1.6,experimental,26.89,0.1658,0.1535,X-ray structure of furin (PCSK3) in complex with benzamidine,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHH,Protein,480,polypeptide(L),1,52.112,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,480,1,1,Monomer,A1,BEN,C7 H8 N2,120.152,BENZAMIDINE,"InChI=1S/C7H8N2/c8-7(9)6-4-2-1-3-5-6/h1-5H,(H3,8,9)",
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.5949024643894701,6.8022e-11,NO,86751,8B4W,X-RAY DIFFRACTION,3.75,67.17,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NAH2PO4, PH 5.5, 2 M NACL; RESERVOIR SOLUTION: 3.0-3.2M NACL",293.15,2022-09-21,2023-10-04,4403,1,480,497.0,4,53.21,1,1.6,experimental,27.18,0.179,0.1659,X-ray structure of furin (PCSK3) in complex with 1H-isoindol-3-amine,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHH,Protein,480,polypeptide(L),1,52.112,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,480,1,1,Monomer,A1,F05,C8 H8 N2,132.163,1H-isoindol-3-amine,"InChI=1S/C8H8N2/c9-8-7-4-2-1-3-6(7)5-10-8/h1-4H,5H2,(H2,9,10)",
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.5949024643894701,6.8022e-11,NO,86751,8B4X,X-RAY DIFFRACTION,3.75,67.24,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NAH2PO4, PH 5.5, 2 M NACL; RESERVOIR SOLUTION: 3.0-3.2M NACL",293.15,2022-09-21,2023-10-04,4276,2,485,462.0,4,53.27,2,1.6,experimental,28.95,0.1695,0.158,X-ray structure of furin (PCSK3) in complex with Guanidinomethyl-Phac-R-Tle-K-6-(aminomethyl)-3-amino-isoindol,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHH,Protein,480,polypeptide(L),1,52.112,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,485,2,2,Hetero 2-mer,"A1, B1",CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.5949024643894701,6.8022e-11,NO,86751,8OYH,X-RAY DIFFRACTION,3.76,67.27,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NAH2PO4, PH 5.5, 2 M NACL; RESERVOIR SOLUTION: 3.0-3.2M NACL",293.15,2023-05-04,2024-03-13,4092,2,485,340.0,4,53.27,2,1.8,experimental,36.56,0.188,0.1735,X-ray structure of furin (PCSK3) in complex with Guanidinomethyl-Phac-Can-Tle-Can-6-(aminomethyl)-3-amino-isoindol,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHH,Protein,480,polypeptide(L),1,52.112,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,485,2,2,Hetero 2-mer,"A1, B1",CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.5949024643894701,6.8022e-11,NO,86751,4Z2A,X-RAY DIFFRACTION,2.36,47.94,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"Well 13% PEG 8K, 0.110M K-dihydrogen phosphate, 0.1M HEPES pH 7.5, 350 uL protein with 350uL well drops, MRC sitting drop",277.0,2015-03-29,2016-05-04,4016,1,465,408.0,4,50.92,1,1.89,experimental,16.9953,0.1834,0.1479,Crystal structure of unglycosylated apo human furin @1.89A,YQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKDLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQDWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTA,Protein,465,polypeptide(L),1,50.506,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,465,1,1,Monomer,A1,EDO,C2 H6 O2,62.068,"1,2-ETHANEDIOL","InChI=1S/C2H6O2/c3-1-2-4/h3-4H,1-2H2",
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.5949024643894701,6.8022e-11,NO,86751,7O1U,X-RAY DIFFRACTION,3.74,67.12,"VAPOR DIFFUSION, SITTING DROP",5.5,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NAH2PO4, PH 5.5, 2 M NACL; RESERVOIR SOLUTION: 3.0-3.2M NACL",293.15,2021-03-30,2021-09-01,4375,1,480,519.0,4,53.19,1,1.7,experimental,26.23,0.1666,0.155,X-ray structure of furin in complex with the guanylhydrazone-based inhibitor 1 (BEV241),DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHH,Protein,480,polypeptide(L),1,52.112,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,480,1,1,Monomer,A1,Desconocido,Na,22.99,SODIUM ION,InChI=1S/Na/q+1,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.5949024643894701,6.8022e-11,NO,86751,7O1W,X-RAY DIFFRACTION,3.74,67.1,"VAPOR DIFFUSION, SITTING DROP",5.5,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NAH2PO4, PH 5.5, 2 M NACL; RESERVOIR SOLUTION: 3.0-3.2M NACL",293.15,2021-03-30,2021-09-01,4335,1,480,424.0,4,53.69,1,1.8,experimental,29.36,0.1791,0.16,X-ray structure of furin in complex with the guanylhydrazone-based inhibitor 2 (mi307) soaked at 1 M NaCl,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHH,Protein,480,polypeptide(L),1,52.112,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,480,1,1,Monomer,A1,CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.5949024643894701,6.8022e-11,NO,86751,7O1Y,X-RAY DIFFRACTION,3.72,66.95,"VAPOR DIFFUSION, SITTING DROP",5.5,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NAH2PO4, PH 5.5, 2 M NACL; RESERVOIR SOLUTION: 3.0-3.2M NACL",293.15,2021-03-30,2021-09-01,4321,1,480,475.0,4,53.91,1,1.7,experimental,29.48,0.177,0.1622,X-ray structure of furin in complex with the guanylhydrazone-based inhibitor 2 (mi307) soaked at 0.25 M NaCl,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHH,Protein,480,polypeptide(L),1,52.112,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,480,1,1,Monomer,A1,CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.5949024643894701,6.8022e-11,NO,86751,7O20,X-RAY DIFFRACTION,3.67,66.48,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NAH2PO4, PH 5.5, 2 M NACL; RESERVOIR SOLUTION: 3.0-3.2M NACL",293.15,2021-03-30,2021-09-01,4190,1,480,376.0,4,53.54,1,1.8,experimental,33.26,0.1761,0.1624,X-ray structure of furin in complex with the guanylhydrazone-based inhibitor 3 (mi300),DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHH,Protein,480,polypeptide(L),1,52.112,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,480,1,1,Monomer,A1,CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.5949024643894701,6.8022e-11,NO,86751,7O22,X-RAY DIFFRACTION,3.69,66.7,"VAPOR DIFFUSION, SITTING DROP",5.5,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NAH2PO4, PH 5.5, 2 M NACL; RESERVOIR SOLUTION: 3.0-3.2M NACL",293.15,2021-03-30,2021-09-01,4130,1,480,427.0,4,53.15,1,1.8,experimental,33.5,0.1825,0.169,X-ray structure of furin in complex with the guanylhydrazone-based inhibitor 4 (mi359),DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHH,Protein,480,polypeptide(L),1,52.112,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,480,1,1,Monomer,A1,CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.5949024643894701,6.8022e-11,NO,86751,7QY0,X-RAY DIFFRACTION,3.72,66.91,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NAH2PO4, PH 5.5, 2 M NACL; RESERVOIR SOLUTION: 3.0-3.2M NACL",293.15,2022-01-27,2022-04-20,4378,1,480,476.0,4,53.68,1,1.54,experimental,26.16,0.1725,0.1493,X-ray structure of furin in complex with the dichlorophenylpyridine-based inhibitor 1,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHH,Protein,480,polypeptide(L),1,52.112,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,480,1,1,Monomer,A1,I0T,C32 H42 Cl2 N6 O3,629.62,"N-[[1-[[2-[3,5-bis(chloranyl)phenyl]-6-[6-[4-(2-methoxyethyl)piperazin-4-ium-1-yl]pyridin-3-yl]oxy-pyridin-4-yl]methyl]piperidin-1-ium-4-yl]methyl]ethanamide","InChI=1S/C32H40Cl2N6O3/c1-23(41)35-20-24-5-7-39(8-6-24)22-25-15-30(26-17-27(33)19-28(34)18-26)37-32(16-25)43-29-3-4-31(36-21-29)40-11-9-38(10-12-40)13-14-42-2/h3-4,15-19,21,24H,5-14,20,22H2,1-2H3,(H,35,41)/p+2",
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.5949024643894701,6.8022e-11,NO,86751,7QY1,X-RAY DIFFRACTION,2.568825997777984,50.34669344500458,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NAH2PO4, PH 5.5, 2 M NACL; RESERVOIR SOLUTION: 3.0-3.2M NACL",293.15,2022-01-27,2022-04-20,4387,1,480,483.0,4,53.77,1,1.45,experimental,25.78,0.1754,0.1502,X-ray structure of furin in complex with the dichlorophenylpyridine-based inhibitor 4,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHH,Protein,480,polypeptide(L),1,52.112,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,480,1,1,Monomer,A1,I0W,C32 H39 Cl2 N6 O4,642.596,"3-[4-[5-[4-[[4-(acetamidomethyl)piperidin-1-ium-1-yl]methyl]-6-[3,5-bis(chloranyl)phenyl]pyridin-2-yl]oxypyridin-2-yl]piperazin-1-ium-1-yl]propanoate","InChI=1S/C32H38Cl2N6O4/c1-22(41)35-19-23-4-7-39(8-5-23)21-24-14-29(25-16-26(33)18-27(34)17-25)37-31(15-24)44-28-2-3-30(36-20-28)40-12-10-38(11-13-40)9-6-32(42)43/h2-3,14-18,20,23H,4-13,19,21H2,1H3,(H,35,41)(H,42,43)/p+1",
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.5949024643894701,6.8022e-11,NO,86751,7QY2,X-RAY DIFFRACTION,3.71,66.87,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NAH2PO4, PH 5.5, 2 M NACL; RESERVOIR SOLUTION: 3.0-3.2M NACL",293.15,2022-01-27,2022-04-20,4373,1,480,471.0,4,53.72,1,1.55,experimental,27.19,0.1877,0.1645,X-ray structure of furin in complex with the dichlorophenylpyridine-based inhibitor 2,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHH,Protein,480,polypeptide(L),1,52.112,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,480,1,1,Monomer,A1,I0Q,C33 H42 Cl2 N7 O4,671.637,"(2R)-4-[4-[5-[4-[[4-(acetamidomethyl)piperidin-1-ium-1-yl]methyl]-6-[3,5-bis(chloranyl)phenyl]pyridin-2-yl]oxypyrimidin-2-yl]piperazin-1-ium-1-yl]-2-methyl-butanoate","InChI=1S/C33H41Cl2N7O4/c1-22(32(44)45)3-6-40-9-11-42(12-10-40)33-37-19-29(20-38-33)46-31-14-25(13-30(39-31)26-15-27(34)17-28(35)16-26)21-41-7-4-24(5-8-41)18-36-23(2)43/h13-17,19-20,22,24H,3-12,18,21H2,1-2H3,(H,36,43)(H,44,45)/p+1/t22-/m1/s1",
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.5949024643894701,6.8022e-11,NO,86751,7LCU,X-RAY DIFFRACTION,2.25,45.43,VAPOR DIFFUSION,7.5,"PEG8000, potassium dihydrogen phosphate",277.0,2021-01-11,2022-01-12,4057,1,490,352.0,5,54.37,1,1.24,experimental,14.5,0.1944,0.1764,"X-ray structure of Furin bound to BOS-318, a small molecule inhibitor",DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKDLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQDWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTAGENLYFQGDYKDDDDKGHHHHHH,Protein,490,polypeptide(L),1,53.512,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,490,1,1,Monomer,A1,CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.5949024643894701,6.8022e-11,NO,86751,6HLB,X-RAY DIFFRACTION,3.77,67.33,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NaH2PO4, PH 5.5-6.0, 2 M NaCL, 3% DMSO; RESERVOIR SOLUTION: 3-4M NaCL",293.15,2018-09-11,2019-02-06,4028,2,491,338.0,3,54.39,2,2.0,experimental,39.57218347825871,0.1874,0.1686,X-ray structure of furin in complex with the cyclic peptide c[succinyl-Phe-2-Nal-(Arg)4-Lys]-Arg-4-Amba,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHHHH,Protein,482,polypeptide(L),1,52.389,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,491,2,2,Hetero 2-mer,"A1, B1",CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.5949024643894701,6.8022e-11,NO,86751,6HLD,X-RAY DIFFRACTION,3.78,67.46,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NaH2PO4, PH 5.5-6.0, 2 M NaCL, 3% DMSO; RESERVOIR SOLUTION: 3-4M NaCL",293.15,2018-09-11,2019-02-06,4067,2,489,343.0,3,54.06,2,2.1,experimental,39.57218347825871,0.1959,0.17,X-ray structure of furin in complex with the cyclic peptide c[succinyl-Phe-2-Nal-(Arg)3-Lys]-Lys-4-Amba,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHHHH,Protein,482,polypeptide(L),1,52.389,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,489,2,2,Hetero 2-mer,"A1, B1",CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.5949024643894701,6.8022e-11,NO,86751,6HLE,X-RAY DIFFRACTION,3.84,68.01,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NaH2PO4, PH 5.5-6.0, 2 M NaCL, 3% DMSO; RESERVOIR SOLUTION: 3-4M NaCL",293.15,2018-09-11,2019-02-06,4127,2,488,390.0,3,53.91,2,1.994,experimental,39.57218347825871,0.1908,0.1667,X-ray structure of furin in complex with the P6-P2-cyclized peptide H-Lys-Arg-Arg-Tle-Lys-4-Amba,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHHHH,Protein,482,polypeptide(L),1,52.389,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,488,2,2,Hetero 2-mer,"A1, B1",CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.5949024643894701,6.8022e-11,NO,86751,6HZA,X-RAY DIFFRACTION,3.64,66.19,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NaH2PO4, PH 5.5-6.0, 2 M NaCL, 3% DMSO; RESERVOIR SOLUTION: 3-4M NaCL",293.15,2018-10-23,2019-02-06,4150,2,487,416.0,3,53.73,2,1.9,experimental,39.57218347825871,0.1859,0.1661,X-ray structure of furin in complex with the cyclic peptide c[glutaryl-Arg-Arg-Lys]-Arg-4-Amba,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHHHH,Protein,482,polypeptide(L),1,52.389,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,487,2,2,Hetero 2-mer,"A1, B1",CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.5949024643894701,6.8022e-11,NO,86751,6HZB,X-RAY DIFFRACTION,3.66,66.41,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NaH2PO4, PH 5.5-6.0, 2 M NaCL, 3% DMSO; RESERVOIR SOLUTION: 3-4M NaCL",293.15,2018-10-23,2019-02-06,4150,2,487,418.0,3,53.7,2,1.9,experimental,39.57218347825871,0.1824,0.1646,X-ray structure of furin in complex with the cyclic inhibitor c[glutaryl-Arg-Arg-Lys]-Lys-4-Amba,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHHHH,Protein,482,polypeptide(L),1,52.389,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,487,2,2,Hetero 2-mer,"A1, B1",CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.5949024643894701,6.8022e-11,NO,86751,6HZD,X-RAY DIFFRACTION,3.64,66.22,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NaH2PO4, PH 5.5-6.0, 2 M NaCL, 3% DMSO; RESERVOIR SOLUTION: 3-4M NaCL",293.15,2018-10-23,2019-02-06,4163,2,488,418.0,3,53.89,2,1.9,experimental,39.57218347825871,0.1827,0.1641,X-ray structure of furin in complex with the cyclic inhibitor c[glutaryl-Arg-Arg-Arg-Lys]-Arg-4-Amba,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHHHH,Protein,482,polypeptide(L),1,52.389,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,488,2,2,Hetero 2-mer,"A1, B1",CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.5949024643894701,6.8022e-11,NO,86751,6YD2,X-RAY DIFFRACTION,3.7,66.74,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100MM MES, 200MM K/NAH2PO4, PH 5.5-6.0, 2 M NACL; RESERVOIR SOLUTION: 3-4M NACL",293.15,2020-03-20,2021-02-17,4179,2,487,444.0,3,53.58,2,1.8,experimental,32.05,0.1771,0.1575,X-ray structure of furin in complex with the canavanine-based inhibitor 4-aminomethyl-phenylacetyl-canavanine-Tle-Arg-Amba,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHHHH,Protein,482,polypeptide(L),1,52.389,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,487,2,2,Hetero 2-mer,"A1, B1",CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.5949024643894701,6.8022e-11,NO,86751,6YD3,X-RAY DIFFRACTION,3.72,66.96,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100MM MES, 200MM K/NAH2PO4, PH 5.5-6.0, 2 M NACL; RESERVOIR SOLUTION: 3-4M NACL",293.15,2020-03-20,2021-02-17,4159,2,485,418.0,3,53.34,2,2.0,experimental,32.04,0.1854,0.1595,X-ray structure of furin in complex with the canavanine derived inhibitor 4-guanidinomethyl-phenylacetyl-Canavanine-Tle-Arg-Amba,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHH,Protein,480,polypeptide(L),1,52.112,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,485,2,2,Hetero 2-mer,"A1, B1",CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.5949024643894701,6.8022e-11,NO,86751,6YD4,X-RAY DIFFRACTION,3.73,67.06,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100MM MES, 200MM K/NAH2PO4, PH 5.5-6.0, 2 M NACL; RESERVOIR SOLUTION: 3-4M NACL",291.15,2020-03-20,2021-02-17,4237,2,485,477.0,3,53.37,2,1.7,experimental,31.24,0.1694,0.1532,X-ray structure of furin in complex with the canavanine-based inhibitor 4-guanidinomethyl-phenylacetyl-Canavanine-Tle-Canavanine-Amba,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHH,Protein,480,polypeptide(L),1,52.112,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,485,2,2,Hetero 2-mer,"A1, B1",CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.5949024643894701,6.8022e-11,NO,86751,6YD7,X-RAY DIFFRACTION,3.74,67.08,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100MM MES, 200MM K/NAH2PO4, PH 5.5-6.0, 2 M NACL; RESERVOIR SOLUTION: 3-4M NACL",291.15,2020-03-20,2021-02-17,4211,2,485,465.0,3,53.37,2,1.8,experimental,29.7,0.1709,0.1538,X-ray structure of furin in complex with the canavanine-based inhibitor 4-guanidinomethyl-phenylacetyl-Arg-Tle-Canavanine-Amba,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHH,Protein,480,polypeptide(L),1,52.112,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,485,2,2,Hetero 2-mer,"A1, B1",CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.5949024643894701,6.8022e-11,NO,86751,7QXY,X-RAY DIFFRACTION,2.568825997777984,50.34669344500458,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NAH2PO4, PH 5.5, 2 M NACL; RESERVOIR SOLUTION: 3.0-3.2M NACL",293.15,2022-01-27,2022-04-20,4386,1,480,661.0,2,53.0,1,1.478,experimental,24.97,0.1823,0.1705,X-ray structure of furin in complex with the dichlorophenylpyridine-based inhibitor 3,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHH,Protein,480,polypeptide(L),1,52.112,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,480,1,1,Monomer,A1,CL,Cl,35.453,CHLORIDE ION,InChI=1S/ClH/h1H/p-1,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.5949024643894701,6.8022e-11,NO,86751,4RYD,X-RAY DIFFRACTION,2.86,56.93,"VAPOR DIFFUSION, SITTING DROP",8.5,"50mM Tris, 2.8M sodium formate, 15mM Cymal-7, pH 8.5, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293.0,2014-12-15,2015-05-27,23768,12,2922,2034.0,18,320.52,2,2.15,experimental,39.57218347825871,0.2186,0.1862,X-ray structure of human furin in complex with the competitive inhibitor para-guanidinomethyl-Phac-R-Tle-R-Amba,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHHHH,Protein,482,polypeptide(L),6,52.389,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,487,2,2,Hetero 2-mer,"A1, B1",FMT,C H2 O2,46.025,FORMIC ACID,"InChI=1S/CH2O2/c2-1-3/h1H,(H,2,3)",
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.5949024643894701,6.8022e-11,NO,86751,5JXH,X-RAY DIFFRACTION,3.67,66.49,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"crystallization solution: 100 mM MES, 200 mM K/NaH2PO4, pH 5.5-6.0, 3-4 M NaCl, 3% DMSO; reservoir solution: 3-4 M NaCl",293.15,2016-05-13,2016-10-05,4261,2,487,534.0,3,53.39,2,2.0,experimental,39.57218347825871,0.1853,0.1566,Structure the proprotein convertase furin in complex with meta-guanidinomethyl-Phac-RVR-Amba at 2.0 Angstrom resolution.,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHHHH,Protein,482,polypeptide(L),1,52.389,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,487,2,2,Hetero 2-mer,"A1, B1",CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.5949024643894701,6.8022e-11,NO,86751,5JXG,X-RAY DIFFRACTION,3.73,67.05,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"crystallization solution: 100 mM MES, 200 mM K/NaH2PO4, pH 5.5-6.0, 3-4 M NaCl, 3% DMSO; reservoir solution: 3-4 M NaCl",293.15,2016-05-13,2016-10-05,4360,1,482,645.0,3,52.73,1,1.8,experimental,39.57218347825871,0.1733,0.154,Structure of the unliganded form of the proprotein convertase furin.,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHHHH,Protein,482,polypeptide(L),1,52.389,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,482,1,1,Monomer,A1,CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.5949024643894701,6.8022e-11,NO,86751,5JXI,X-RAY DIFFRACTION,3.76,67.3,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"crystallization solution: 100 mM MES, 200 mM K/NaH2PO4, pH 5.5-6.0, 3-4 M NaCl, 3% DMSO; reservoir solution: 3-4 M NaCl",293.15,2016-05-13,2016-10-05,4164,1,482,521.0,3,52.63,1,2.0,experimental,39.57218347825871,0.1851,0.1576,Structure of the unliganded form of the proprotein convertase furin in presence of EDTA.,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHHHH,Protein,482,polypeptide(L),1,52.389,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,482,1,1,Monomer,A1,CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.5949024643894701,6.8022e-11,NO,86751,5MIM,X-RAY DIFFRACTION,3.75,67.2,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100 MM MES, 200 MM K/NAH2PO4, PH 5.5-6.0, 3-4 M NACL, 3% DMSO; RESERVOIR SOLUTION: 3-4 M NACL",293.15,2016-11-28,2017-05-10,4275,1,482,486.0,3,53.81,1,1.9,experimental,39.57218347825871,0.1838,0.1647,"Xray structure of human furin bound with the 2,5-dideoxystreptamine derived small molecule inhibitor 1n",DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHHHH,Protein,482,polypeptide(L),1,52.389,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,482,1,1,Monomer,A1,CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.5949024643894701,6.8022e-11,NO,86751,5JXJ,X-RAY DIFFRACTION,3.69,66.65,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"crystallization solution: 100 mM MES, 200 mM K/NaH2PO4, pH 5.5-6.0, 3-4 M NaCl, 3% DMSO; reservoir solution: 3-4 M NaCl",293.15,2016-05-13,2016-10-05,4185,2,487,461.0,3,53.35,2,2.0,experimental,39.57218347825871,0.1889,0.1668,Structure of the proprotein convertase furin complexed to meta-guanidinomethyl-Phac-RVR-Amba in presence of EDTA,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHHHH,Protein,482,polypeptide(L),1,52.389,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,487,2,2,Hetero 2-mer,"A1, B1",CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.5949024643894701,6.8022e-11,NO,86751,6EQV,X-RAY DIFFRACTION,3.67,66.45,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NaH2PO4, PH 5.5-6.0, 3-4M NaCl, 3% DMSO; RESERVOIR SOLUTION: 3-4 M NaCl",293.15,2017-10-16,2018-02-28,4212,2,487,510.0,3,53.3,2,1.895,experimental,39.57218347825871,0.1821,0.1637,X-ray structure of the proprotein convertase furin bound with the competitive inhibitor Phac-Cit-Val-Arg-Amba,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHHHH,Protein,482,polypeptide(L),1,52.389,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,487,2,2,Hetero 2-mer,"A1, B1",CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.5949024643894701,6.8022e-11,NO,86751,6EQW,X-RAY DIFFRACTION,3.66,66.42,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NaH2PO4, PH 5.5-6.0, 3-4 M NaCL, 3% DMSO; RESERVOIR SOLUTION: 3-4M NaCL",293.15,2017-10-16,2018-02-28,4183,2,487,486.0,3,53.36,2,1.994,experimental,39.57218347825871,0.1842,0.1619,X-ray structure of the proprotein convertase furin bound with the competitive inhibitor 4-aminomethyl-phenylacetyl-Arg-Val-Arg-Amba,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHHHH,Protein,482,polypeptide(L),1,52.389,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,487,2,2,Hetero 2-mer,"A1, B1",CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.5949024643894701,6.8022e-11,NO,86751,6EQX,X-RAY DIFFRACTION,3.66,66.36,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"100mM MES, 200mM K/NaH2PO4, PH 5.5-6.0, 3-4 M NaCL, 3% DMSO; RESERVOIR SOLUTION: 3-4M NaCL",293.15,2017-10-16,2018-02-28,4186,2,488,471.0,3,53.51,2,1.994,experimental,39.57218347825871,0.1837,0.162,X-ray structure of the proprotein convertase furin bound with the competitive inhibitor Arg-Arg-Arg-Val-Arg-Amba,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHHHH,Protein,482,polypeptide(L),1,52.389,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,488,2,2,Hetero 2-mer,"A1, B1",CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
56339,ENTREZ_GENE,mettl3,IME4M6AMTA70Spo8hMETTL3,Homo sapiens,0.5908148060005673,1.11343e-11,NO,89361,5IL1,X-RAY DIFFRACTION,2.58,52.33,"VAPOR DIFFUSION, HANGING DROP",5.7,"PEG 8000, sodium citrate",291.0,2016-03-04,2016-05-25,4336,2,512,337.0,0,59.81,2,1.71,experimental,39.57218347825871,0.2069,0.1798,Crystal structure of SAM-bound METTL3-METTL14 complex,FPPQWICCDIRYLDVSILGKFAVVMADPPWDIHMELPYGTLTDDEMRRLNIPVLQDDGFLFLWVTGRAMELGRECLNLWGYERVDEIIWVKTNQLQRIIRTGRTGHWLNHGKEHCLVGVKGNPQGFNQGLDCDVIVAEVRSTSHKPDEIYGMIERLSPGTRKIELFGRPHNVQPNWITLGNQLDGIHLLDPDVVARFKQRYPDGIISKPKNL,Protein,212,polypeptide(L),1,24.427,mettl3,2.1.1.62,PDB Primary Data,Homo sapiens,9606,512,2,2,Hetero 2-mer,"A1, B1",SAM,C15 H22 N6 O5 S,398.437,S-ADENOSYLMETHIONINE,"InChI=1S/C15H22N6O5S/c1-27(3-2-7(16)15(24)25)4-8-10(22)11(23)14(26-8)21-6-20-9-12(17)18-5-19-13(9)21/h5-8,10-11,14,22-23H,2-4,16H2,1H3,(H2-,17,18,19,24,25)/t7-,8+,10+,11+,14+,27-/m0/s1",
56339,ENTREZ_GENE,mettl3,IME4M6AMTA70Spo8hMETTL3,Homo sapiens,0.5908148060005673,1.11343e-11,NO,89361,5IL0,X-RAY DIFFRACTION,2.55,51.69,"VAPOR DIFFUSION, HANGING DROP",5.7,"PEG 8000, sodium citrate",291.0,2016-03-04,2016-05-25,4347,2,512,331.0,0,59.43,2,1.882,experimental,39.57218347825871,0.205,0.1747,Crystal structural of the METTL3-METTL14 complex for N6-adenosine methylation,FPPQWICCDIRYLDVSILGKFAVVMADPPWDIHMELPYGTLTDDEMRRLNIPVLQDDGFLFLWVTGRAMELGRECLNLWGYERVDEIIWVKTNQLQRIIRTGRTGHWLNHGKEHCLVGVKGNPQGFNQGLDCDVIVAEVRSTSHKPDEIYGMIERLSPGTRKIELFGRPHNVQPNWITLGNQLDGIHLLDPDVVARFKQRYPDGIISKPKNL,Protein,212,polypeptide(L),1,24.427,mettl3,2.1.1.62,PDB Primary Data,Homo sapiens,9606,512,2,2,Hetero 2-mer,"A1, B1",EDO,C2 H6 O2,62.068,"1,2-ETHANEDIOL","InChI=1S/C2H6O2/c3-1-2-4/h3-4H,1-2H2",
56339,ENTREZ_GENE,mettl3,IME4M6AMTA70Spo8hMETTL3,Homo sapiens,0.5908148060005673,1.11343e-11,NO,89361,5IL2,X-RAY DIFFRACTION,2.66,53.7,"VAPOR DIFFUSION, HANGING DROP",5.7,"PEG 8000, sodium citrate",291.0,2016-03-04,2016-05-25,4393,2,512,376.0,1,59.85,2,1.606,experimental,39.57218347825871,0.1992,0.1848,Crystal structure of SAH-bound METTL3-METTL14 complex,FPPQWICCDIRYLDVSILGKFAVVMADPPWDIHMELPYGTLTDDEMRRLNIPVLQDDGFLFLWVTGRAMELGRECLNLWGYERVDEIIWVKTNQLQRIIRTGRTGHWLNHGKEHCLVGVKGNPQGFNQGLDCDVIVAEVRSTSHKPDEIYGMIERLSPGTRKIELFGRPHNVQPNWITLGNQLDGIHLLDPDVVARFKQRYPDGIISKPKNL,Protein,212,polypeptide(L),1,24.427,mettl3,2.1.1.62,PDB Primary Data,Homo sapiens,9606,512,2,2,Hetero 2-mer,"A1, B1",EDO,C2 H6 O2,62.068,"1,2-ETHANEDIOL","InChI=1S/C2H6O2/c3-1-2-4/h3-4H,1-2H2",
4193,ENTREZ_GENE,mdm2,ACTFSHDMXhdm2,Homo sapiens,0.6037791595539606,1.7596e-12,NO,90079,4UD7,X-RAY DIFFRACTION,2.8,56.0,Desconocido,4.0,0.1 M SODIUM CITRATE PH 4.0 AND 15 % PEG8000,289.6514371309434,2014-12-08,2016-01-13,4008,8,520,262.0,0,58.68,2,1.6,experimental,23.018,0.17838,0.13846,Structure of the stapled peptide YS-02 bound to MDM2,GPLGSSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDAAQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSEN,Protein,114,polypeptide(L),4,12.831,mdm2,6.3.2,PDB Primary Data,Homo sapiens,9606,130,2,2,Hetero 2-mer,"A1, B1",Desconocido,Desconocido,246.2971348233669,Desconocido,Desconocido,
1387,ENTREZ_GENE,crebbp,CBPKAT3ARSTSRSTS1,Homo sapiens,0.6261975450041602,1e-16,NO,91927,6YIK,X-RAY DIFFRACTION,3.42,64.06,"VAPOR DIFFUSION, SITTING DROP",7.5,"21% PEG3350
15% ethylene glycol
0.25M sodium formate",277.0,2020-04-01,2020-04-15,3453,3,357,385.0,0,44.74,1,1.7,experimental,32.625,0.184,0.156,Crystal structure of the CREBBP bromodomain in complex with a tetrahydroquinoxaline ligand,SMRKKIFKPEELRQALMPTLEALYRQDPESLPFRQPVDPQLLGIPDYFDIVKNPMDLSTIKRKLDTGQYQEPWQYVDDVWLMFNNAWLYNRKTSRVYKFCSKLAEVFEQEIDPVMQSLG,Protein,119,polypeptide(L),3,14.223,crebbp,2.3.1.48,PDB Primary Data,Homo sapiens,9606,119,1,1,Monomer,A1,OSQ,C22 H24 F2 N4 O2,414.448,"(3~{R})-~{N}-[3-(3,4-dihydro-2~{H}-quinolin-1-yl)-2,2-bis(fluoranyl)propyl]-3-methyl-2-oxidanylidene-3,4-dihydro-1~{H}-quinoxaline-5-carboxamide","InChI=1S/C22H24F2N4O2/c1-14-20(29)27-17-9-4-8-16(19(17)26-14)21(30)25-12-22(23,24)13-28-11-5-7-15-6-2-3-10-18(15)28/h2-4,6,8-10,14,26H,5,7,11-13H2,1H3,(H,25,30)(H,27,29)/t14-/m1/s1",
1387,ENTREZ_GENE,crebbp,CBPKAT3ARSTSRSTS1,Homo sapiens,0.6261975450041602,1e-16,NO,91927,6SXX,X-RAY DIFFRACTION,2.18,43.67,"VAPOR DIFFUSION, HANGING DROP",6.982430939226492,"25% PEG3350, 0.2 M Potassium thiocyanate, 5% EtGly",277.0,2019-09-26,2020-07-29,1940,2,238,81.0,0,28.95,1,2.01,experimental,52.99,0.2533,0.1955,Crystal structure of the bromodomain of human CREBBP in complex with ACA007,SMRKKIFKPEELRQALMPTLEALYRQDPESLPFRQPVDPQLLGIPDYFDIVKNPMDLSTIKRKLDTGQYQEPWQYVDDVWLMFNNAWLYNRKTSRVYKFCSKLAEVFEQEIDPVMQSLG,Protein,119,polypeptide(L),2,14.223,crebbp,2.3.1.48,PDB Primary Data,Homo sapiens,9606,119,1,1,Monomer,A1,EDO,C2 H6 O2,62.068,"1,2-ETHANEDIOL","InChI=1S/C2H6O2/c3-1-2-4/h3-4H,1-2H2",
1387,ENTREZ_GENE,crebbp,CBPKAT3ARSTSRSTS1,Homo sapiens,0.6261975450041602,1e-16,NO,91927,6YIL,X-RAY DIFFRACTION,2.2,44.01,"VAPOR DIFFUSION, SITTING DROP",7.5,"20% PEG3350
10% ethylene glycol
0.2M sodium acetate",277.0,2020-04-01,2020-04-15,1160,1,119,154.0,0,14.64,1,1.22,experimental,12.75,0.1511,0.1321,Crystal structure of the CREBBP bromodomain in complex with a tetrahydroquinoxaline ligand,SMRKKIFKPEELRQALMPTLEALYRQDPESLPFRQPVDPQLLGIPDYFDIVKNPMDLSTIKRKLDTGQYQEPWQYVDDVWLMFNNAWLYNRKTSRVYKFCSKLAEVFEQEIDPVMQSLG,Protein,119,polypeptide(L),1,14.223,crebbp,2.3.1.48,PDB Primary Data,Homo sapiens,9606,119,1,1,Monomer,A1,OSQ,C22 H24 F2 N4 O2,414.448,"(3~{R})-~{N}-[3-(3,4-dihydro-2~{H}-quinolin-1-yl)-2,2-bis(fluoranyl)propyl]-3-methyl-2-oxidanylidene-3,4-dihydro-1~{H}-quinoxaline-5-carboxamide","InChI=1S/C22H24F2N4O2/c1-14-20(29)27-17-9-4-8-16(19(17)26-14)21(30)25-12-22(23,24)13-28-11-5-7-15-6-2-3-10-18(15)28/h2-4,6,8-10,14,26H,5,7,11-13H2,1H3,(H,25,30)(H,27,29)/t14-/m1/s1",
1387,ENTREZ_GENE,crebbp,CBPKAT3ARSTSRSTS1,Homo sapiens,0.6261975450041602,1e-16,NO,91927,6YIM,X-RAY DIFFRACTION,2.2,44.12,"VAPOR DIFFUSION, SITTING DROP",7.5,"20% PEG3350
10% ethylene glycol
0.2M sodium fluoride",277.0,2020-04-01,2020-04-15,1174,1,119,163.0,0,14.65,1,1.23,experimental,12.85,0.167,0.1397,Crystal structure of the CREBBP bromodomain in complex with a benzo-diazepine ligand,SMRKKIFKPEELRQALMPTLEALYRQDPESLPFRQPVDPQLLGIPDYFDIVKNPMDLSTIKRKLDTGQYQEPWQYVDDVWLMFNNAWLYNRKTSRVYKFCSKLAEVFEQEIDPVMQSLG,Protein,119,polypeptide(L),1,14.223,crebbp,2.3.1.48,PDB Primary Data,Homo sapiens,9606,119,1,1,Monomer,A1,OS8,C24 H30 N4 O3,422.52,"(4~{R})-~{N}-[3-(7-methoxy-3,4-dihydro-2~{H}-quinolin-1-yl)propyl]-4-methyl-2-oxidanylidene-1,3,4,5-tetrahydro-1,5-benzodiazepine-6-carboxamide","InChI=1S/C24H30N4O3/c1-16-14-22(29)27-20-8-3-7-19(23(20)26-16)24(30)25-11-5-13-28-12-4-6-17-9-10-18(31-2)15-21(17)28/h3,7-10,15-16,26H,4-6,11-14H2,1-2H3,(H,25,30)(H,27,29)/t16-/m1/s1",
1387,ENTREZ_GENE,crebbp,CBPKAT3ARSTSRSTS1,Homo sapiens,0.6261975450041602,1e-16,NO,91927,6YIJ,X-RAY DIFFRACTION,2.95,58.37,"VAPOR DIFFUSION, SITTING DROP",8.3,"20% ethylene glycol
21% PEG6K
0.1M tris pH 8.3
0.125M lithium chloride",277.0,2020-04-01,2020-04-15,7177,7,833,224.0,0,102.4,1,2.2,experimental,44.856,0.2693,0.2022,Crystal structure of the CREBBP bromodomain in complex with a benzo-diazepine ligand,SMRKKIFKPEELRQALMPTLEALYRQDPESLPFRQPVDPQLLGIPDYFDIVKNPMDLSTIKRKLDTGQYQEPWQYVDDVWLMFNNAWLYNRKTSRVYKFCSKLAEVFEQEIDPVMQSLG,Protein,119,polypeptide(L),7,14.223,crebbp,2.3.1.48,PDB Primary Data,Homo sapiens,9606,119,1,1,Monomer,A1,OSN,C25 H31 N3 O2,405.533,"(4~{R})-6-[(~{E})-5-(7-methoxy-3,4-dihydro-2~{H}-quinolin-1-yl)pent-1-enyl]-4-methyl-1,3,4,5-tetrahydro-1,5-benzodiazepin-2-one","InChI=1S/C25H31N3O2/c1-18-16-24(29)27-22-11-6-9-20(25(22)26-18)8-4-3-5-14-28-15-7-10-19-12-13-21(30-2)17-23(19)28/h4,6,8-9,11-13,17-18,26H,3,5,7,10,14-16H2,1-2H3,(H,27,29)/b8-4+/t18-/m1/s1",
147111,ENTREZ_GENE,notum,hNOTUM,Homo sapiens,0.6556411467317501,0.0,YES,98758,4UZ1,X-RAY DIFFRACTION,1.9,34.0,Desconocido,4.6,"1.5 M AMMONIUM SULPHATE, 0.1 M SODIUM ACETATE PH 4.6",289.6514371309434,2014-09-04,2015-02-25,3212,1,383,287.0,7,44.17,1,1.4,experimental,18.766,0.18045,0.14387,STRUCTURE OF THE WNT DEACYLASE NOTUM - CRYSTAL FORM III - 1.4A,ETGSAQQLNEDLRLHLLLNTSVTCNDGSPAGYYLKESRGSRRWLLFLEGGWYCFNRENCDSRYDTMRRLMSSRDWPRTRTGTGILSSQPEENPYWWNANMVFIPYCSSDVWSGASSKSEKNEYAFMGALIIQEVVRELLGRGLSGAKVLLLAGSSAGGTGVLLNVDRVAEQLEKLGYPAIQVRGLADSGWFLDNKQYRHTDCVDTITCAPTEAIRRGIRYWNGVVPERCRRQFQEGEEWNCFFGYKVYPTLRSPVFVVQWLFDEAQLTVDNVHLTGQPVQEGLRLYIQNLGRELRHTLKDVPASFAPACLSHEIIIRSHWTDVQVKGTSLPRALHCWDRSLHDSHKASKTPLKGCPVHLVDSCPWPHCNPSCPTGTKHHHHHH,Protein,383,polypeptide(L),1,43.567,notum,3.1.1.1,PDB Primary Data,Homo sapiens,9606,383,1,1,Monomer,A1,NAG,C8 H15 N O6,221.208,2-acetamido-2-deoxy-beta-D-glucopyranose,"InChI=1S/C8H15NO6/c1-3(11)9-5-7(13)6(12)4(2-10)15-8(5)14/h4-8,10,12-14H,2H2,1H3,(H,9,11)/t4-,5-,6-,7-,8-/m1/s1",
147111,ENTREZ_GENE,notum,hNOTUM,Homo sapiens,0.6556411467317501,0.0,YES,98758,4UZ5,X-RAY DIFFRACTION,2.5,52.0,Desconocido,6.0,"10 %W/V PEG4000, 0.01 M CACL2, 0.05 M NACACOD PH 6.0, 0.20 M KCL, 1 MM HEPARIN HEXAMER",289.6514371309434,2014-09-04,2015-02-25,2901,1,383,84.0,7,43.82,1,2.1,experimental,43.492,0.2371,0.18746,STRUCTURE OF THE WNT DEACYLASE NOTUM - CRYSTAL FORM IV - 2.1A,ETGSAQQLNEDLRLHLLLNTSVTCNDGSPAGYYLKESRGSRRWLLFLEGGWYCFNRENCDSRYDTMRRLMSSRDWPRTRTGTGILSSQPEENPYWWNANMVFIPYCSSDVWSGASSKSEKNEYAFMGALIIQEVVRELLGRGLSGAKVLLLAGSSAGGTGVLLNVDRVAEQLEKLGYPAIQVRGLADSGWFLDNKQYRHTDCVDTITCAPTEAIRRGIRYWNGVVPERCRRQFQEGEEWNCFFGYKVYPTLRSPVFVVQWLFDEAQLTVDNVHLTGQPVQEGLRLYIQNLGRELRHTLKDVPASFAPACLSHEIIIRSHWTDVQVKGTSLPRALHCWDRSLHDSHKASKTPLKGCPVHLVDSCPWPHCNPSCPTGTKHHHHHH,Protein,383,polypeptide(L),1,43.567,notum,3.1.1.1,PDB Primary Data,Homo sapiens,9606,383,1,1,Monomer,A1,NAG,C8 H15 N O6,221.208,2-acetamido-2-deoxy-beta-D-glucopyranose,"InChI=1S/C8H15NO6/c1-3(11)9-5-7(13)6(12)4(2-10)15-8(5)14/h4-8,10,12-14H,2H2,1H3,(H,9,11)/t4-,5-,6-,7-,8-/m1/s1",
56339,ENTREZ_GENE,mettl3,IME4M6AMTA70Spo8hMETTL3,Homo sapiens,0.6484192929930565,3.49726e-11,BioGRID ORCS,104243,5IL1,X-RAY DIFFRACTION,2.58,52.33,"VAPOR DIFFUSION, HANGING DROP",5.7,"PEG 8000, sodium citrate",291.0,2016-03-04,2016-05-25,4336,2,512,337.0,0,59.81,2,1.71,experimental,39.57218347825871,0.2069,0.1798,Crystal structure of SAM-bound METTL3-METTL14 complex,FPPQWICCDIRYLDVSILGKFAVVMADPPWDIHMELPYGTLTDDEMRRLNIPVLQDDGFLFLWVTGRAMELGRECLNLWGYERVDEIIWVKTNQLQRIIRTGRTGHWLNHGKEHCLVGVKGNPQGFNQGLDCDVIVAEVRSTSHKPDEIYGMIERLSPGTRKIELFGRPHNVQPNWITLGNQLDGIHLLDPDVVARFKQRYPDGIISKPKNL,Protein,212,polypeptide(L),1,24.427,mettl3,2.1.1.62,PDB Primary Data,Homo sapiens,9606,512,2,2,Hetero 2-mer,"A1, B1",SAM,C15 H22 N6 O5 S,398.437,S-ADENOSYLMETHIONINE,"InChI=1S/C15H22N6O5S/c1-27(3-2-7(16)15(24)25)4-8-10(22)11(23)14(26-8)21-6-20-9-12(17)18-5-19-13(9)21/h5-8,10-11,14,22-23H,2-4,16H2,1H3,(H2-,17,18,19,24,25)/t7-,8+,10+,11+,14+,27-/m0/s1",
56339,ENTREZ_GENE,mettl3,IME4M6AMTA70Spo8hMETTL3,Homo sapiens,0.6484192929930565,3.49726e-11,BioGRID ORCS,104243,5IL0,X-RAY DIFFRACTION,2.55,51.69,"VAPOR DIFFUSION, HANGING DROP",5.7,"PEG 8000, sodium citrate",291.0,2016-03-04,2016-05-25,4347,2,512,331.0,0,59.43,2,1.882,experimental,39.57218347825871,0.205,0.1747,Crystal structural of the METTL3-METTL14 complex for N6-adenosine methylation,FPPQWICCDIRYLDVSILGKFAVVMADPPWDIHMELPYGTLTDDEMRRLNIPVLQDDGFLFLWVTGRAMELGRECLNLWGYERVDEIIWVKTNQLQRIIRTGRTGHWLNHGKEHCLVGVKGNPQGFNQGLDCDVIVAEVRSTSHKPDEIYGMIERLSPGTRKIELFGRPHNVQPNWITLGNQLDGIHLLDPDVVARFKQRYPDGIISKPKNL,Protein,212,polypeptide(L),1,24.427,mettl3,2.1.1.62,PDB Primary Data,Homo sapiens,9606,512,2,2,Hetero 2-mer,"A1, B1",EDO,C2 H6 O2,62.068,"1,2-ETHANEDIOL","InChI=1S/C2H6O2/c3-1-2-4/h3-4H,1-2H2",
56339,ENTREZ_GENE,mettl3,IME4M6AMTA70Spo8hMETTL3,Homo sapiens,0.6484192929930565,3.49726e-11,BioGRID ORCS,104243,5IL2,X-RAY DIFFRACTION,2.66,53.7,"VAPOR DIFFUSION, HANGING DROP",5.7,"PEG 8000, sodium citrate",291.0,2016-03-04,2016-05-25,4393,2,512,376.0,1,59.85,2,1.606,experimental,39.57218347825871,0.1992,0.1848,Crystal structure of SAH-bound METTL3-METTL14 complex,FPPQWICCDIRYLDVSILGKFAVVMADPPWDIHMELPYGTLTDDEMRRLNIPVLQDDGFLFLWVTGRAMELGRECLNLWGYERVDEIIWVKTNQLQRIIRTGRTGHWLNHGKEHCLVGVKGNPQGFNQGLDCDVIVAEVRSTSHKPDEIYGMIERLSPGTRKIELFGRPHNVQPNWITLGNQLDGIHLLDPDVVARFKQRYPDGIISKPKNL,Protein,212,polypeptide(L),1,24.427,mettl3,2.1.1.62,PDB Primary Data,Homo sapiens,9606,512,2,2,Hetero 2-mer,"A1, B1",EDO,C2 H6 O2,62.068,"1,2-ETHANEDIOL","InChI=1S/C2H6O2/c3-1-2-4/h3-4H,1-2H2",
5771,ENTREZ_GENE,ptpn2,PTN2PTPTTCPTPTCELLPTPTCPTP,Homo sapiens,0.6413290072456712,3.49726e-11,BioGRID ORCS,104662,8U0H,X-RAY DIFFRACTION,2.41,49.06,"VAPOR DIFFUSION, HANGING DROP",6.9,"0.49M Sodium phosphate monobasic monohydrate, 0.91M Potassium phosphate dibasic",296.0,2023-08-29,2024-09-04,5135,2,648,385.0,0,78.03,1,1.93,experimental,38.32,0.1917,0.1726,Crystal structure of PTPN2 with a PROTAC,MAMPTTIEREFEELDTQRRWQPLYLEIRNESHDYPHRVAKFPENRNRNRYRDVSPYDHSRVKLQNAENDYINASLVDIEEAQRSYILTQGPLPNTCCHFWLMVWQQKTKAVVMLNRIVEKESVKCAQYWPTDDQEMLFKETGFSVKLLSEDVKSYYTVHLLQLENINSGETRTISHFHYTTWPDFGVPESPASFLNFLFKVRESGSLNPDHGPAVIHCSAGIGRSGTFSLVDTCLVLMEKGDDINIKQVLLNMRKYRMGLIQTPDQLRFSYMAIIEGAKCIKGDSSIQKRWKELSKEDLSPAFDHSPNKIMTEKYNHHHHHHHH,Protein,324,polypeptide(L),2,37.966,ptpn2,3.1.3.48,PDB Primary Data,Homo sapiens,9606,324,1,1,Monomer,A1,UB0,C46 H49 Cl N6 O12 S2,977.497,"(5P)-3-(carboxymethoxy)-4-chloro-5-(3-{[(4S)-1-({3-[2-(4-{3-[(3R)-2,6-dioxopiperidin-3-yl]-2-oxo-2,3-dihydro-1,3-benzoxazol-6-yl}piperidin-1-yl)acetamido]phenyl}methanesulfonyl)-2,2-dimethylpiperidin-4-yl]amino}phenyl)thiophene-2-carboxylic acid","InChI=1S/C46H49ClN6O12S2/c1-46(2)22-32(48-31-8-4-6-29(20-31)41-39(47)40(64-24-38(56)57)42(66-41)44(59)60)15-18-52(46)67(62,63)25-26-5-3-7-30(19-26)49-37(55)23-51-16-13-27(14-17-51)28-9-10-33-35(21-28)65-45(61)53(33)34-11-12-36(54)50-43(34)58/h3-10,19-21,27,32,34,48H,11-18,22-25H2,1-2H3,(H,49,55)(H,56,57)(H,59,60)(H,50,54,58)/t32-,34+/m0/s1",
2534,ENTREZ_GENE,fyn,SLKSYNp59FYN,Homo sapiens,0.6348981810463207,3.49726e-11,BioGRID ORCS,105044,6EDF,X-RAY DIFFRACTION,2.0,37.6,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"20% PEG3350, 0.2 M magnesium acetate",291.0,2018-08-09,2018-08-29,693,1,79,61.0,0,8.94,1,1.4,experimental,12.097,0.1721,0.1434,Fragment of a tyrosine-protein kinase,GGVTLFVALYDYEARTEDDISVHKGEKVQILNSSEGDWWEVRSLTTGETGYVPSNYVAPVDGSAAMGPVLRLRAFYNGG,Protein,79,polypeptide(L),1,8.591,fyn,2.7.10.2,PDB Primary Data,Homo sapiens,9606,79,1,1,Monomer,A1,GOL,C3 H8 O3,92.094,GLYCEROL,"InChI=1S/C3H8O3/c4-1-3(6)2-5/h3-6H,1-2H2",
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.6283460760251489,3.49726e-11,BioGRID ORCS,105441,7QXZ,X-RAY DIFFRACTION,3.8,67.66,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NAH2PO4, PH 5.5, 2 M NACL; RESERVOIR SOLUTION: 3.0-3.2M NACL",293.15,2022-01-27,2022-04-13,4278,1,480,568.0,3,52.89,1,1.8,experimental,27.27,0.2173,0.1815,X-ray structure of furin in complex with the dichlorophenylpyridine-based inhibitor 5,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHH,Protein,480,polypeptide(L),1,52.112,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,480,1,1,Monomer,A1,CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.6283460760251489,3.49726e-11,BioGRID ORCS,105441,8B4V,X-RAY DIFFRACTION,3.75,67.16,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NAH2PO4, PH 5.5, 2 M NACL; RESERVOIR SOLUTION: 3.0-3.2M NACL",293.15,2022-09-21,2023-10-04,4300,1,480,508.0,4,52.95,1,1.6,experimental,26.89,0.1658,0.1535,X-ray structure of furin (PCSK3) in complex with benzamidine,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHH,Protein,480,polypeptide(L),1,52.112,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,480,1,1,Monomer,A1,BEN,C7 H8 N2,120.152,BENZAMIDINE,"InChI=1S/C7H8N2/c8-7(9)6-4-2-1-3-5-6/h1-5H,(H3,8,9)",
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.6283460760251489,3.49726e-11,BioGRID ORCS,105441,8B4W,X-RAY DIFFRACTION,3.75,67.17,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NAH2PO4, PH 5.5, 2 M NACL; RESERVOIR SOLUTION: 3.0-3.2M NACL",293.15,2022-09-21,2023-10-04,4403,1,480,497.0,4,53.21,1,1.6,experimental,27.18,0.179,0.1659,X-ray structure of furin (PCSK3) in complex with 1H-isoindol-3-amine,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHH,Protein,480,polypeptide(L),1,52.112,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,480,1,1,Monomer,A1,F05,C8 H8 N2,132.163,1H-isoindol-3-amine,"InChI=1S/C8H8N2/c9-8-7-4-2-1-3-6(7)5-10-8/h1-4H,5H2,(H2,9,10)",
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.6283460760251489,3.49726e-11,BioGRID ORCS,105441,8B4X,X-RAY DIFFRACTION,3.75,67.24,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NAH2PO4, PH 5.5, 2 M NACL; RESERVOIR SOLUTION: 3.0-3.2M NACL",293.15,2022-09-21,2023-10-04,4276,2,485,462.0,4,53.27,2,1.6,experimental,28.95,0.1695,0.158,X-ray structure of furin (PCSK3) in complex with Guanidinomethyl-Phac-R-Tle-K-6-(aminomethyl)-3-amino-isoindol,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHH,Protein,480,polypeptide(L),1,52.112,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,485,2,2,Hetero 2-mer,"A1, B1",CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.6283460760251489,3.49726e-11,BioGRID ORCS,105441,8OYH,X-RAY DIFFRACTION,3.76,67.27,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NAH2PO4, PH 5.5, 2 M NACL; RESERVOIR SOLUTION: 3.0-3.2M NACL",293.15,2023-05-04,2024-03-13,4092,2,485,340.0,4,53.27,2,1.8,experimental,36.56,0.188,0.1735,X-ray structure of furin (PCSK3) in complex with Guanidinomethyl-Phac-Can-Tle-Can-6-(aminomethyl)-3-amino-isoindol,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHH,Protein,480,polypeptide(L),1,52.112,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,485,2,2,Hetero 2-mer,"A1, B1",CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.6283460760251489,3.49726e-11,BioGRID ORCS,105441,4Z2A,X-RAY DIFFRACTION,2.36,47.94,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"Well 13% PEG 8K, 0.110M K-dihydrogen phosphate, 0.1M HEPES pH 7.5, 350 uL protein with 350uL well drops, MRC sitting drop",277.0,2015-03-29,2016-05-04,4016,1,465,408.0,4,50.92,1,1.89,experimental,16.9953,0.1834,0.1479,Crystal structure of unglycosylated apo human furin @1.89A,YQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKDLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQDWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTA,Protein,465,polypeptide(L),1,50.506,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,465,1,1,Monomer,A1,EDO,C2 H6 O2,62.068,"1,2-ETHANEDIOL","InChI=1S/C2H6O2/c3-1-2-4/h3-4H,1-2H2",
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.6283460760251489,3.49726e-11,BioGRID ORCS,105441,7O1U,X-RAY DIFFRACTION,3.74,67.12,"VAPOR DIFFUSION, SITTING DROP",5.5,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NAH2PO4, PH 5.5, 2 M NACL; RESERVOIR SOLUTION: 3.0-3.2M NACL",293.15,2021-03-30,2021-09-01,4375,1,480,519.0,4,53.19,1,1.7,experimental,26.23,0.1666,0.155,X-ray structure of furin in complex with the guanylhydrazone-based inhibitor 1 (BEV241),DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHH,Protein,480,polypeptide(L),1,52.112,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,480,1,1,Monomer,A1,Desconocido,Na,22.99,SODIUM ION,InChI=1S/Na/q+1,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.6283460760251489,3.49726e-11,BioGRID ORCS,105441,7O1W,X-RAY DIFFRACTION,3.74,67.1,"VAPOR DIFFUSION, SITTING DROP",5.5,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NAH2PO4, PH 5.5, 2 M NACL; RESERVOIR SOLUTION: 3.0-3.2M NACL",293.15,2021-03-30,2021-09-01,4335,1,480,424.0,4,53.69,1,1.8,experimental,29.36,0.1791,0.16,X-ray structure of furin in complex with the guanylhydrazone-based inhibitor 2 (mi307) soaked at 1 M NaCl,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHH,Protein,480,polypeptide(L),1,52.112,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,480,1,1,Monomer,A1,CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.6283460760251489,3.49726e-11,BioGRID ORCS,105441,7O1Y,X-RAY DIFFRACTION,3.72,66.95,"VAPOR DIFFUSION, SITTING DROP",5.5,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NAH2PO4, PH 5.5, 2 M NACL; RESERVOIR SOLUTION: 3.0-3.2M NACL",293.15,2021-03-30,2021-09-01,4321,1,480,475.0,4,53.91,1,1.7,experimental,29.48,0.177,0.1622,X-ray structure of furin in complex with the guanylhydrazone-based inhibitor 2 (mi307) soaked at 0.25 M NaCl,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHH,Protein,480,polypeptide(L),1,52.112,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,480,1,1,Monomer,A1,CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.6283460760251489,3.49726e-11,BioGRID ORCS,105441,7O20,X-RAY DIFFRACTION,3.67,66.48,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NAH2PO4, PH 5.5, 2 M NACL; RESERVOIR SOLUTION: 3.0-3.2M NACL",293.15,2021-03-30,2021-09-01,4190,1,480,376.0,4,53.54,1,1.8,experimental,33.26,0.1761,0.1624,X-ray structure of furin in complex with the guanylhydrazone-based inhibitor 3 (mi300),DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHH,Protein,480,polypeptide(L),1,52.112,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,480,1,1,Monomer,A1,CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.6283460760251489,3.49726e-11,BioGRID ORCS,105441,7O22,X-RAY DIFFRACTION,3.69,66.7,"VAPOR DIFFUSION, SITTING DROP",5.5,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NAH2PO4, PH 5.5, 2 M NACL; RESERVOIR SOLUTION: 3.0-3.2M NACL",293.15,2021-03-30,2021-09-01,4130,1,480,427.0,4,53.15,1,1.8,experimental,33.5,0.1825,0.169,X-ray structure of furin in complex with the guanylhydrazone-based inhibitor 4 (mi359),DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHH,Protein,480,polypeptide(L),1,52.112,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,480,1,1,Monomer,A1,CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.6283460760251489,3.49726e-11,BioGRID ORCS,105441,7QY0,X-RAY DIFFRACTION,3.72,66.91,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NAH2PO4, PH 5.5, 2 M NACL; RESERVOIR SOLUTION: 3.0-3.2M NACL",293.15,2022-01-27,2022-04-20,4378,1,480,476.0,4,53.68,1,1.54,experimental,26.16,0.1725,0.1493,X-ray structure of furin in complex with the dichlorophenylpyridine-based inhibitor 1,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHH,Protein,480,polypeptide(L),1,52.112,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,480,1,1,Monomer,A1,I0T,C32 H42 Cl2 N6 O3,629.62,"N-[[1-[[2-[3,5-bis(chloranyl)phenyl]-6-[6-[4-(2-methoxyethyl)piperazin-4-ium-1-yl]pyridin-3-yl]oxy-pyridin-4-yl]methyl]piperidin-1-ium-4-yl]methyl]ethanamide","InChI=1S/C32H40Cl2N6O3/c1-23(41)35-20-24-5-7-39(8-6-24)22-25-15-30(26-17-27(33)19-28(34)18-26)37-32(16-25)43-29-3-4-31(36-21-29)40-11-9-38(10-12-40)13-14-42-2/h3-4,15-19,21,24H,5-14,20,22H2,1-2H3,(H,35,41)/p+2",
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.6283460760251489,3.49726e-11,BioGRID ORCS,105441,7QY1,X-RAY DIFFRACTION,2.568825997777984,50.34669344500458,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NAH2PO4, PH 5.5, 2 M NACL; RESERVOIR SOLUTION: 3.0-3.2M NACL",293.15,2022-01-27,2022-04-20,4387,1,480,483.0,4,53.77,1,1.45,experimental,25.78,0.1754,0.1502,X-ray structure of furin in complex with the dichlorophenylpyridine-based inhibitor 4,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHH,Protein,480,polypeptide(L),1,52.112,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,480,1,1,Monomer,A1,I0W,C32 H39 Cl2 N6 O4,642.596,"3-[4-[5-[4-[[4-(acetamidomethyl)piperidin-1-ium-1-yl]methyl]-6-[3,5-bis(chloranyl)phenyl]pyridin-2-yl]oxypyridin-2-yl]piperazin-1-ium-1-yl]propanoate","InChI=1S/C32H38Cl2N6O4/c1-22(41)35-19-23-4-7-39(8-5-23)21-24-14-29(25-16-26(33)18-27(34)17-25)37-31(15-24)44-28-2-3-30(36-20-28)40-12-10-38(11-13-40)9-6-32(42)43/h2-3,14-18,20,23H,4-13,19,21H2,1H3,(H,35,41)(H,42,43)/p+1",
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.6283460760251489,3.49726e-11,BioGRID ORCS,105441,7QY2,X-RAY DIFFRACTION,3.71,66.87,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NAH2PO4, PH 5.5, 2 M NACL; RESERVOIR SOLUTION: 3.0-3.2M NACL",293.15,2022-01-27,2022-04-20,4373,1,480,471.0,4,53.72,1,1.55,experimental,27.19,0.1877,0.1645,X-ray structure of furin in complex with the dichlorophenylpyridine-based inhibitor 2,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHH,Protein,480,polypeptide(L),1,52.112,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,480,1,1,Monomer,A1,I0Q,C33 H42 Cl2 N7 O4,671.637,"(2R)-4-[4-[5-[4-[[4-(acetamidomethyl)piperidin-1-ium-1-yl]methyl]-6-[3,5-bis(chloranyl)phenyl]pyridin-2-yl]oxypyrimidin-2-yl]piperazin-1-ium-1-yl]-2-methyl-butanoate","InChI=1S/C33H41Cl2N7O4/c1-22(32(44)45)3-6-40-9-11-42(12-10-40)33-37-19-29(20-38-33)46-31-14-25(13-30(39-31)26-15-27(34)17-28(35)16-26)21-41-7-4-24(5-8-41)18-36-23(2)43/h13-17,19-20,22,24H,3-12,18,21H2,1-2H3,(H,36,43)(H,44,45)/p+1/t22-/m1/s1",
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.6283460760251489,3.49726e-11,BioGRID ORCS,105441,7LCU,X-RAY DIFFRACTION,2.25,45.43,VAPOR DIFFUSION,7.5,"PEG8000, potassium dihydrogen phosphate",277.0,2021-01-11,2022-01-12,4057,1,490,352.0,5,54.37,1,1.24,experimental,14.5,0.1944,0.1764,"X-ray structure of Furin bound to BOS-318, a small molecule inhibitor",DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKDLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQDWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTAGENLYFQGDYKDDDDKGHHHHHH,Protein,490,polypeptide(L),1,53.512,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,490,1,1,Monomer,A1,CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.6283460760251489,3.49726e-11,BioGRID ORCS,105441,6HLB,X-RAY DIFFRACTION,3.77,67.33,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NaH2PO4, PH 5.5-6.0, 2 M NaCL, 3% DMSO; RESERVOIR SOLUTION: 3-4M NaCL",293.15,2018-09-11,2019-02-06,4028,2,491,338.0,3,54.39,2,2.0,experimental,39.57218347825871,0.1874,0.1686,X-ray structure of furin in complex with the cyclic peptide c[succinyl-Phe-2-Nal-(Arg)4-Lys]-Arg-4-Amba,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHHHH,Protein,482,polypeptide(L),1,52.389,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,491,2,2,Hetero 2-mer,"A1, B1",CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.6283460760251489,3.49726e-11,BioGRID ORCS,105441,6HLD,X-RAY DIFFRACTION,3.78,67.46,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NaH2PO4, PH 5.5-6.0, 2 M NaCL, 3% DMSO; RESERVOIR SOLUTION: 3-4M NaCL",293.15,2018-09-11,2019-02-06,4067,2,489,343.0,3,54.06,2,2.1,experimental,39.57218347825871,0.1959,0.17,X-ray structure of furin in complex with the cyclic peptide c[succinyl-Phe-2-Nal-(Arg)3-Lys]-Lys-4-Amba,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHHHH,Protein,482,polypeptide(L),1,52.389,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,489,2,2,Hetero 2-mer,"A1, B1",CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.6283460760251489,3.49726e-11,BioGRID ORCS,105441,6HLE,X-RAY DIFFRACTION,3.84,68.01,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NaH2PO4, PH 5.5-6.0, 2 M NaCL, 3% DMSO; RESERVOIR SOLUTION: 3-4M NaCL",293.15,2018-09-11,2019-02-06,4127,2,488,390.0,3,53.91,2,1.994,experimental,39.57218347825871,0.1908,0.1667,X-ray structure of furin in complex with the P6-P2-cyclized peptide H-Lys-Arg-Arg-Tle-Lys-4-Amba,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHHHH,Protein,482,polypeptide(L),1,52.389,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,488,2,2,Hetero 2-mer,"A1, B1",CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.6283460760251489,3.49726e-11,BioGRID ORCS,105441,6HZA,X-RAY DIFFRACTION,3.64,66.19,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NaH2PO4, PH 5.5-6.0, 2 M NaCL, 3% DMSO; RESERVOIR SOLUTION: 3-4M NaCL",293.15,2018-10-23,2019-02-06,4150,2,487,416.0,3,53.73,2,1.9,experimental,39.57218347825871,0.1859,0.1661,X-ray structure of furin in complex with the cyclic peptide c[glutaryl-Arg-Arg-Lys]-Arg-4-Amba,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHHHH,Protein,482,polypeptide(L),1,52.389,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,487,2,2,Hetero 2-mer,"A1, B1",CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.6283460760251489,3.49726e-11,BioGRID ORCS,105441,6HZB,X-RAY DIFFRACTION,3.66,66.41,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NaH2PO4, PH 5.5-6.0, 2 M NaCL, 3% DMSO; RESERVOIR SOLUTION: 3-4M NaCL",293.15,2018-10-23,2019-02-06,4150,2,487,418.0,3,53.7,2,1.9,experimental,39.57218347825871,0.1824,0.1646,X-ray structure of furin in complex with the cyclic inhibitor c[glutaryl-Arg-Arg-Lys]-Lys-4-Amba,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHHHH,Protein,482,polypeptide(L),1,52.389,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,487,2,2,Hetero 2-mer,"A1, B1",CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.6283460760251489,3.49726e-11,BioGRID ORCS,105441,6HZD,X-RAY DIFFRACTION,3.64,66.22,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NaH2PO4, PH 5.5-6.0, 2 M NaCL, 3% DMSO; RESERVOIR SOLUTION: 3-4M NaCL",293.15,2018-10-23,2019-02-06,4163,2,488,418.0,3,53.89,2,1.9,experimental,39.57218347825871,0.1827,0.1641,X-ray structure of furin in complex with the cyclic inhibitor c[glutaryl-Arg-Arg-Arg-Lys]-Arg-4-Amba,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHHHH,Protein,482,polypeptide(L),1,52.389,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,488,2,2,Hetero 2-mer,"A1, B1",CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.6283460760251489,3.49726e-11,BioGRID ORCS,105441,6YD2,X-RAY DIFFRACTION,3.7,66.74,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100MM MES, 200MM K/NAH2PO4, PH 5.5-6.0, 2 M NACL; RESERVOIR SOLUTION: 3-4M NACL",293.15,2020-03-20,2021-02-17,4179,2,487,444.0,3,53.58,2,1.8,experimental,32.05,0.1771,0.1575,X-ray structure of furin in complex with the canavanine-based inhibitor 4-aminomethyl-phenylacetyl-canavanine-Tle-Arg-Amba,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHHHH,Protein,482,polypeptide(L),1,52.389,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,487,2,2,Hetero 2-mer,"A1, B1",CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.6283460760251489,3.49726e-11,BioGRID ORCS,105441,6YD3,X-RAY DIFFRACTION,3.72,66.96,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100MM MES, 200MM K/NAH2PO4, PH 5.5-6.0, 2 M NACL; RESERVOIR SOLUTION: 3-4M NACL",293.15,2020-03-20,2021-02-17,4159,2,485,418.0,3,53.34,2,2.0,experimental,32.04,0.1854,0.1595,X-ray structure of furin in complex with the canavanine derived inhibitor 4-guanidinomethyl-phenylacetyl-Canavanine-Tle-Arg-Amba,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHH,Protein,480,polypeptide(L),1,52.112,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,485,2,2,Hetero 2-mer,"A1, B1",CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.6283460760251489,3.49726e-11,BioGRID ORCS,105441,6YD4,X-RAY DIFFRACTION,3.73,67.06,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100MM MES, 200MM K/NAH2PO4, PH 5.5-6.0, 2 M NACL; RESERVOIR SOLUTION: 3-4M NACL",291.15,2020-03-20,2021-02-17,4237,2,485,477.0,3,53.37,2,1.7,experimental,31.24,0.1694,0.1532,X-ray structure of furin in complex with the canavanine-based inhibitor 4-guanidinomethyl-phenylacetyl-Canavanine-Tle-Canavanine-Amba,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHH,Protein,480,polypeptide(L),1,52.112,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,485,2,2,Hetero 2-mer,"A1, B1",CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.6283460760251489,3.49726e-11,BioGRID ORCS,105441,6YD7,X-RAY DIFFRACTION,3.74,67.08,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100MM MES, 200MM K/NAH2PO4, PH 5.5-6.0, 2 M NACL; RESERVOIR SOLUTION: 3-4M NACL",291.15,2020-03-20,2021-02-17,4211,2,485,465.0,3,53.37,2,1.8,experimental,29.7,0.1709,0.1538,X-ray structure of furin in complex with the canavanine-based inhibitor 4-guanidinomethyl-phenylacetyl-Arg-Tle-Canavanine-Amba,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHH,Protein,480,polypeptide(L),1,52.112,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,485,2,2,Hetero 2-mer,"A1, B1",CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.6283460760251489,3.49726e-11,BioGRID ORCS,105441,7QXY,X-RAY DIFFRACTION,2.568825997777984,50.34669344500458,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NAH2PO4, PH 5.5, 2 M NACL; RESERVOIR SOLUTION: 3.0-3.2M NACL",293.15,2022-01-27,2022-04-20,4386,1,480,661.0,2,53.0,1,1.478,experimental,24.97,0.1823,0.1705,X-ray structure of furin in complex with the dichlorophenylpyridine-based inhibitor 3,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHH,Protein,480,polypeptide(L),1,52.112,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,480,1,1,Monomer,A1,CL,Cl,35.453,CHLORIDE ION,InChI=1S/ClH/h1H/p-1,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.6283460760251489,3.49726e-11,BioGRID ORCS,105441,4RYD,X-RAY DIFFRACTION,2.86,56.93,"VAPOR DIFFUSION, SITTING DROP",8.5,"50mM Tris, 2.8M sodium formate, 15mM Cymal-7, pH 8.5, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293.0,2014-12-15,2015-05-27,23768,12,2922,2034.0,18,320.52,2,2.15,experimental,39.57218347825871,0.2186,0.1862,X-ray structure of human furin in complex with the competitive inhibitor para-guanidinomethyl-Phac-R-Tle-R-Amba,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHHHH,Protein,482,polypeptide(L),6,52.389,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,487,2,2,Hetero 2-mer,"A1, B1",FMT,C H2 O2,46.025,FORMIC ACID,"InChI=1S/CH2O2/c2-1-3/h1H,(H,2,3)",
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.6283460760251489,3.49726e-11,BioGRID ORCS,105441,5JXH,X-RAY DIFFRACTION,3.67,66.49,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"crystallization solution: 100 mM MES, 200 mM K/NaH2PO4, pH 5.5-6.0, 3-4 M NaCl, 3% DMSO; reservoir solution: 3-4 M NaCl",293.15,2016-05-13,2016-10-05,4261,2,487,534.0,3,53.39,2,2.0,experimental,39.57218347825871,0.1853,0.1566,Structure the proprotein convertase furin in complex with meta-guanidinomethyl-Phac-RVR-Amba at 2.0 Angstrom resolution.,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHHHH,Protein,482,polypeptide(L),1,52.389,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,487,2,2,Hetero 2-mer,"A1, B1",CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.6283460760251489,3.49726e-11,BioGRID ORCS,105441,5JXG,X-RAY DIFFRACTION,3.73,67.05,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"crystallization solution: 100 mM MES, 200 mM K/NaH2PO4, pH 5.5-6.0, 3-4 M NaCl, 3% DMSO; reservoir solution: 3-4 M NaCl",293.15,2016-05-13,2016-10-05,4360,1,482,645.0,3,52.73,1,1.8,experimental,39.57218347825871,0.1733,0.154,Structure of the unliganded form of the proprotein convertase furin.,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHHHH,Protein,482,polypeptide(L),1,52.389,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,482,1,1,Monomer,A1,CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.6283460760251489,3.49726e-11,BioGRID ORCS,105441,5JXI,X-RAY DIFFRACTION,3.76,67.3,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"crystallization solution: 100 mM MES, 200 mM K/NaH2PO4, pH 5.5-6.0, 3-4 M NaCl, 3% DMSO; reservoir solution: 3-4 M NaCl",293.15,2016-05-13,2016-10-05,4164,1,482,521.0,3,52.63,1,2.0,experimental,39.57218347825871,0.1851,0.1576,Structure of the unliganded form of the proprotein convertase furin in presence of EDTA.,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHHHH,Protein,482,polypeptide(L),1,52.389,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,482,1,1,Monomer,A1,CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.6283460760251489,3.49726e-11,BioGRID ORCS,105441,5MIM,X-RAY DIFFRACTION,3.75,67.2,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100 MM MES, 200 MM K/NAH2PO4, PH 5.5-6.0, 3-4 M NACL, 3% DMSO; RESERVOIR SOLUTION: 3-4 M NACL",293.15,2016-11-28,2017-05-10,4275,1,482,486.0,3,53.81,1,1.9,experimental,39.57218347825871,0.1838,0.1647,"Xray structure of human furin bound with the 2,5-dideoxystreptamine derived small molecule inhibitor 1n",DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHHHH,Protein,482,polypeptide(L),1,52.389,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,482,1,1,Monomer,A1,CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.6283460760251489,3.49726e-11,BioGRID ORCS,105441,5JXJ,X-RAY DIFFRACTION,3.69,66.65,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"crystallization solution: 100 mM MES, 200 mM K/NaH2PO4, pH 5.5-6.0, 3-4 M NaCl, 3% DMSO; reservoir solution: 3-4 M NaCl",293.15,2016-05-13,2016-10-05,4185,2,487,461.0,3,53.35,2,2.0,experimental,39.57218347825871,0.1889,0.1668,Structure of the proprotein convertase furin complexed to meta-guanidinomethyl-Phac-RVR-Amba in presence of EDTA,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHHHH,Protein,482,polypeptide(L),1,52.389,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,487,2,2,Hetero 2-mer,"A1, B1",CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.6283460760251489,3.49726e-11,BioGRID ORCS,105441,6EQV,X-RAY DIFFRACTION,3.67,66.45,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NaH2PO4, PH 5.5-6.0, 3-4M NaCl, 3% DMSO; RESERVOIR SOLUTION: 3-4 M NaCl",293.15,2017-10-16,2018-02-28,4212,2,487,510.0,3,53.3,2,1.895,experimental,39.57218347825871,0.1821,0.1637,X-ray structure of the proprotein convertase furin bound with the competitive inhibitor Phac-Cit-Val-Arg-Amba,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHHHH,Protein,482,polypeptide(L),1,52.389,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,487,2,2,Hetero 2-mer,"A1, B1",CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.6283460760251489,3.49726e-11,BioGRID ORCS,105441,6EQW,X-RAY DIFFRACTION,3.66,66.42,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NaH2PO4, PH 5.5-6.0, 3-4 M NaCL, 3% DMSO; RESERVOIR SOLUTION: 3-4M NaCL",293.15,2017-10-16,2018-02-28,4183,2,487,486.0,3,53.36,2,1.994,experimental,39.57218347825871,0.1842,0.1619,X-ray structure of the proprotein convertase furin bound with the competitive inhibitor 4-aminomethyl-phenylacetyl-Arg-Val-Arg-Amba,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHHHH,Protein,482,polypeptide(L),1,52.389,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,487,2,2,Hetero 2-mer,"A1, B1",CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.6283460760251489,3.49726e-11,BioGRID ORCS,105441,6EQX,X-RAY DIFFRACTION,3.66,66.36,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"100mM MES, 200mM K/NaH2PO4, PH 5.5-6.0, 3-4 M NaCL, 3% DMSO; RESERVOIR SOLUTION: 3-4M NaCL",293.15,2017-10-16,2018-02-28,4186,2,488,471.0,3,53.51,2,1.994,experimental,39.57218347825871,0.1837,0.162,X-ray structure of the proprotein convertase furin bound with the competitive inhibitor Arg-Arg-Arg-Val-Arg-Amba,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHHHH,Protein,482,polypeptide(L),1,52.389,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,488,2,2,Hetero 2-mer,"A1, B1",CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
1387,ENTREZ_GENE,crebbp,CBPKAT3ARSTSRSTS1,Homo sapiens,0.5907230609059765,3.49726e-11,BioGRID ORCS,108032,6YIK,X-RAY DIFFRACTION,3.42,64.06,"VAPOR DIFFUSION, SITTING DROP",7.5,"21% PEG3350
15% ethylene glycol
0.25M sodium formate",277.0,2020-04-01,2020-04-15,3453,3,357,385.0,0,44.74,1,1.7,experimental,32.625,0.184,0.156,Crystal structure of the CREBBP bromodomain in complex with a tetrahydroquinoxaline ligand,SMRKKIFKPEELRQALMPTLEALYRQDPESLPFRQPVDPQLLGIPDYFDIVKNPMDLSTIKRKLDTGQYQEPWQYVDDVWLMFNNAWLYNRKTSRVYKFCSKLAEVFEQEIDPVMQSLG,Protein,119,polypeptide(L),3,14.223,crebbp,2.3.1.48,PDB Primary Data,Homo sapiens,9606,119,1,1,Monomer,A1,OSQ,C22 H24 F2 N4 O2,414.448,"(3~{R})-~{N}-[3-(3,4-dihydro-2~{H}-quinolin-1-yl)-2,2-bis(fluoranyl)propyl]-3-methyl-2-oxidanylidene-3,4-dihydro-1~{H}-quinoxaline-5-carboxamide","InChI=1S/C22H24F2N4O2/c1-14-20(29)27-17-9-4-8-16(19(17)26-14)21(30)25-12-22(23,24)13-28-11-5-7-15-6-2-3-10-18(15)28/h2-4,6,8-10,14,26H,5,7,11-13H2,1H3,(H,25,30)(H,27,29)/t14-/m1/s1",
1387,ENTREZ_GENE,crebbp,CBPKAT3ARSTSRSTS1,Homo sapiens,0.5907230609059765,3.49726e-11,BioGRID ORCS,108032,6SXX,X-RAY DIFFRACTION,2.18,43.67,"VAPOR DIFFUSION, HANGING DROP",6.982430939226492,"25% PEG3350, 0.2 M Potassium thiocyanate, 5% EtGly",277.0,2019-09-26,2020-07-29,1940,2,238,81.0,0,28.95,1,2.01,experimental,52.99,0.2533,0.1955,Crystal structure of the bromodomain of human CREBBP in complex with ACA007,SMRKKIFKPEELRQALMPTLEALYRQDPESLPFRQPVDPQLLGIPDYFDIVKNPMDLSTIKRKLDTGQYQEPWQYVDDVWLMFNNAWLYNRKTSRVYKFCSKLAEVFEQEIDPVMQSLG,Protein,119,polypeptide(L),2,14.223,crebbp,2.3.1.48,PDB Primary Data,Homo sapiens,9606,119,1,1,Monomer,A1,EDO,C2 H6 O2,62.068,"1,2-ETHANEDIOL","InChI=1S/C2H6O2/c3-1-2-4/h3-4H,1-2H2",
1387,ENTREZ_GENE,crebbp,CBPKAT3ARSTSRSTS1,Homo sapiens,0.5907230609059765,3.49726e-11,BioGRID ORCS,108032,6YIL,X-RAY DIFFRACTION,2.2,44.01,"VAPOR DIFFUSION, SITTING DROP",7.5,"20% PEG3350
10% ethylene glycol
0.2M sodium acetate",277.0,2020-04-01,2020-04-15,1160,1,119,154.0,0,14.64,1,1.22,experimental,12.75,0.1511,0.1321,Crystal structure of the CREBBP bromodomain in complex with a tetrahydroquinoxaline ligand,SMRKKIFKPEELRQALMPTLEALYRQDPESLPFRQPVDPQLLGIPDYFDIVKNPMDLSTIKRKLDTGQYQEPWQYVDDVWLMFNNAWLYNRKTSRVYKFCSKLAEVFEQEIDPVMQSLG,Protein,119,polypeptide(L),1,14.223,crebbp,2.3.1.48,PDB Primary Data,Homo sapiens,9606,119,1,1,Monomer,A1,OSQ,C22 H24 F2 N4 O2,414.448,"(3~{R})-~{N}-[3-(3,4-dihydro-2~{H}-quinolin-1-yl)-2,2-bis(fluoranyl)propyl]-3-methyl-2-oxidanylidene-3,4-dihydro-1~{H}-quinoxaline-5-carboxamide","InChI=1S/C22H24F2N4O2/c1-14-20(29)27-17-9-4-8-16(19(17)26-14)21(30)25-12-22(23,24)13-28-11-5-7-15-6-2-3-10-18(15)28/h2-4,6,8-10,14,26H,5,7,11-13H2,1H3,(H,25,30)(H,27,29)/t14-/m1/s1",
1387,ENTREZ_GENE,crebbp,CBPKAT3ARSTSRSTS1,Homo sapiens,0.5907230609059765,3.49726e-11,BioGRID ORCS,108032,6YIM,X-RAY DIFFRACTION,2.2,44.12,"VAPOR DIFFUSION, SITTING DROP",7.5,"20% PEG3350
10% ethylene glycol
0.2M sodium fluoride",277.0,2020-04-01,2020-04-15,1174,1,119,163.0,0,14.65,1,1.23,experimental,12.85,0.167,0.1397,Crystal structure of the CREBBP bromodomain in complex with a benzo-diazepine ligand,SMRKKIFKPEELRQALMPTLEALYRQDPESLPFRQPVDPQLLGIPDYFDIVKNPMDLSTIKRKLDTGQYQEPWQYVDDVWLMFNNAWLYNRKTSRVYKFCSKLAEVFEQEIDPVMQSLG,Protein,119,polypeptide(L),1,14.223,crebbp,2.3.1.48,PDB Primary Data,Homo sapiens,9606,119,1,1,Monomer,A1,OS8,C24 H30 N4 O3,422.52,"(4~{R})-~{N}-[3-(7-methoxy-3,4-dihydro-2~{H}-quinolin-1-yl)propyl]-4-methyl-2-oxidanylidene-1,3,4,5-tetrahydro-1,5-benzodiazepine-6-carboxamide","InChI=1S/C24H30N4O3/c1-16-14-22(29)27-20-8-3-7-19(23(20)26-16)24(30)25-11-5-13-28-12-4-6-17-9-10-18(31-2)15-21(17)28/h3,7-10,15-16,26H,4-6,11-14H2,1-2H3,(H,25,30)(H,27,29)/t16-/m1/s1",
1387,ENTREZ_GENE,crebbp,CBPKAT3ARSTSRSTS1,Homo sapiens,0.5907230609059765,3.49726e-11,BioGRID ORCS,108032,6YIJ,X-RAY DIFFRACTION,2.95,58.37,"VAPOR DIFFUSION, SITTING DROP",8.3,"20% ethylene glycol
21% PEG6K
0.1M tris pH 8.3
0.125M lithium chloride",277.0,2020-04-01,2020-04-15,7177,7,833,224.0,0,102.4,1,2.2,experimental,44.856,0.2693,0.2022,Crystal structure of the CREBBP bromodomain in complex with a benzo-diazepine ligand,SMRKKIFKPEELRQALMPTLEALYRQDPESLPFRQPVDPQLLGIPDYFDIVKNPMDLSTIKRKLDTGQYQEPWQYVDDVWLMFNNAWLYNRKTSRVYKFCSKLAEVFEQEIDPVMQSLG,Protein,119,polypeptide(L),7,14.223,crebbp,2.3.1.48,PDB Primary Data,Homo sapiens,9606,119,1,1,Monomer,A1,OSN,C25 H31 N3 O2,405.533,"(4~{R})-6-[(~{E})-5-(7-methoxy-3,4-dihydro-2~{H}-quinolin-1-yl)pent-1-enyl]-4-methyl-1,3,4,5-tetrahydro-1,5-benzodiazepin-2-one","InChI=1S/C25H31N3O2/c1-18-16-24(29)27-22-11-6-9-20(25(22)26-18)8-4-3-5-14-28-15-7-10-19-12-13-21(30-2)17-23(19)28/h4,6,8-9,11-13,17-18,26H,3,5,7,10,14-16H2,1-2H3,(H,27,29)/b8-4+/t18-/m1/s1",
673,ENTREZ_GENE,braf,BRAF1BrafBRAF1NS7RAFB1,Homo sapiens,0.5773163683347378,3.49726e-11,BioGRID ORCS,108887,5VR3,X-RAY DIFFRACTION,2.58,52.44,"VAPOR DIFFUSION, HANGING DROP",6.5,"0.1 M Bis-Tris pH 6.5, 2.0 M ammonium sulphate",293.15,2017-05-10,2018-02-14,510,1,88,13.0,0,9.64,1,2.102,experimental,39.57218347825871,0.2244,0.2095,Crystal structure of the BRS domain of BRAF,GAMDPGGGGSSAADPAIPEEVWNIKQMIKLTQEHIEALLDKFGGEHNPPSIYLEAYEEYTSKLDALQQREQQLLESLGNGTDFSVSSS,Protein,88,polypeptide(L),1,9.544,braf,2.7.11.1,PDB Primary Data,Homo sapiens,9606,88,1,1,Monomer,A1,SO4,O4 S,96.063,SULFATE ION,"InChI=1S/H2O4S/c1-5(2,3)4/h(H2,1,2,3,4)/p-2",
147111,ENTREZ_GENE,notum,hNOTUM,Homo sapiens,0.575413538870291,3.49726e-11,BioGRID ORCS,109000,4UZ1,X-RAY DIFFRACTION,1.9,34.0,Desconocido,4.6,"1.5 M AMMONIUM SULPHATE, 0.1 M SODIUM ACETATE PH 4.6",289.6514371309434,2014-09-04,2015-02-25,3212,1,383,287.0,7,44.17,1,1.4,experimental,18.766,0.18045,0.14387,STRUCTURE OF THE WNT DEACYLASE NOTUM - CRYSTAL FORM III - 1.4A,ETGSAQQLNEDLRLHLLLNTSVTCNDGSPAGYYLKESRGSRRWLLFLEGGWYCFNRENCDSRYDTMRRLMSSRDWPRTRTGTGILSSQPEENPYWWNANMVFIPYCSSDVWSGASSKSEKNEYAFMGALIIQEVVRELLGRGLSGAKVLLLAGSSAGGTGVLLNVDRVAEQLEKLGYPAIQVRGLADSGWFLDNKQYRHTDCVDTITCAPTEAIRRGIRYWNGVVPERCRRQFQEGEEWNCFFGYKVYPTLRSPVFVVQWLFDEAQLTVDNVHLTGQPVQEGLRLYIQNLGRELRHTLKDVPASFAPACLSHEIIIRSHWTDVQVKGTSLPRALHCWDRSLHDSHKASKTPLKGCPVHLVDSCPWPHCNPSCPTGTKHHHHHH,Protein,383,polypeptide(L),1,43.567,notum,3.1.1.1,PDB Primary Data,Homo sapiens,9606,383,1,1,Monomer,A1,NAG,C8 H15 N O6,221.208,2-acetamido-2-deoxy-beta-D-glucopyranose,"InChI=1S/C8H15NO6/c1-3(11)9-5-7(13)6(12)4(2-10)15-8(5)14/h4-8,10,12-14H,2H2,1H3,(H,9,11)/t4-,5-,6-,7-,8-/m1/s1",
147111,ENTREZ_GENE,notum,hNOTUM,Homo sapiens,0.575413538870291,3.49726e-11,BioGRID ORCS,109000,4UZ5,X-RAY DIFFRACTION,2.5,52.0,Desconocido,6.0,"10 %W/V PEG4000, 0.01 M CACL2, 0.05 M NACACOD PH 6.0, 0.20 M KCL, 1 MM HEPARIN HEXAMER",289.6514371309434,2014-09-04,2015-02-25,2901,1,383,84.0,7,43.82,1,2.1,experimental,43.492,0.2371,0.18746,STRUCTURE OF THE WNT DEACYLASE NOTUM - CRYSTAL FORM IV - 2.1A,ETGSAQQLNEDLRLHLLLNTSVTCNDGSPAGYYLKESRGSRRWLLFLEGGWYCFNRENCDSRYDTMRRLMSSRDWPRTRTGTGILSSQPEENPYWWNANMVFIPYCSSDVWSGASSKSEKNEYAFMGALIIQEVVRELLGRGLSGAKVLLLAGSSAGGTGVLLNVDRVAEQLEKLGYPAIQVRGLADSGWFLDNKQYRHTDCVDTITCAPTEAIRRGIRYWNGVVPERCRRQFQEGEEWNCFFGYKVYPTLRSPVFVVQWLFDEAQLTVDNVHLTGQPVQEGLRLYIQNLGRELRHTLKDVPASFAPACLSHEIIIRSHWTDVQVKGTSLPRALHCWDRSLHDSHKASKTPLKGCPVHLVDSCPWPHCNPSCPTGTKHHHHHH,Protein,383,polypeptide(L),1,43.567,notum,3.1.1.1,PDB Primary Data,Homo sapiens,9606,383,1,1,Monomer,A1,NAG,C8 H15 N O6,221.208,2-acetamido-2-deoxy-beta-D-glucopyranose,"InChI=1S/C8H15NO6/c1-3(11)9-5-7(13)6(12)4(2-10)15-8(5)14/h4-8,10,12-14H,2H2,1H3,(H,9,11)/t4-,5-,6-,7-,8-/m1/s1",
4193,ENTREZ_GENE,mdm2,ACTFSHDMXhdm2,Homo sapiens,0.528561805612056,3.49726e-11,BioGRID ORCS,110625,4UD7,X-RAY DIFFRACTION,2.8,56.0,Desconocido,4.0,0.1 M SODIUM CITRATE PH 4.0 AND 15 % PEG8000,289.6514371309434,2014-12-08,2016-01-13,4008,8,520,262.0,0,58.68,2,1.6,experimental,23.018,0.17838,0.13846,Structure of the stapled peptide YS-02 bound to MDM2,GPLGSSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDAAQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSEN,Protein,114,polypeptide(L),4,12.831,mdm2,6.3.2,PDB Primary Data,Homo sapiens,9606,130,2,2,Hetero 2-mer,"A1, B1",Desconocido,Desconocido,246.2971348233669,Desconocido,Desconocido,
147111,ENTREZ_GENE,notum,hNOTUM,Homo sapiens,0.5885940602529954,9.661e-11,NO,120899,4UZ1,X-RAY DIFFRACTION,1.9,34.0,Desconocido,4.6,"1.5 M AMMONIUM SULPHATE, 0.1 M SODIUM ACETATE PH 4.6",289.6514371309434,2014-09-04,2015-02-25,3212,1,383,287.0,7,44.17,1,1.4,experimental,18.766,0.18045,0.14387,STRUCTURE OF THE WNT DEACYLASE NOTUM - CRYSTAL FORM III - 1.4A,ETGSAQQLNEDLRLHLLLNTSVTCNDGSPAGYYLKESRGSRRWLLFLEGGWYCFNRENCDSRYDTMRRLMSSRDWPRTRTGTGILSSQPEENPYWWNANMVFIPYCSSDVWSGASSKSEKNEYAFMGALIIQEVVRELLGRGLSGAKVLLLAGSSAGGTGVLLNVDRVAEQLEKLGYPAIQVRGLADSGWFLDNKQYRHTDCVDTITCAPTEAIRRGIRYWNGVVPERCRRQFQEGEEWNCFFGYKVYPTLRSPVFVVQWLFDEAQLTVDNVHLTGQPVQEGLRLYIQNLGRELRHTLKDVPASFAPACLSHEIIIRSHWTDVQVKGTSLPRALHCWDRSLHDSHKASKTPLKGCPVHLVDSCPWPHCNPSCPTGTKHHHHHH,Protein,383,polypeptide(L),1,43.567,notum,3.1.1.1,PDB Primary Data,Homo sapiens,9606,383,1,1,Monomer,A1,NAG,C8 H15 N O6,221.208,2-acetamido-2-deoxy-beta-D-glucopyranose,"InChI=1S/C8H15NO6/c1-3(11)9-5-7(13)6(12)4(2-10)15-8(5)14/h4-8,10,12-14H,2H2,1H3,(H,9,11)/t4-,5-,6-,7-,8-/m1/s1",
147111,ENTREZ_GENE,notum,hNOTUM,Homo sapiens,0.5885940602529954,9.661e-11,NO,120899,4UZ5,X-RAY DIFFRACTION,2.5,52.0,Desconocido,6.0,"10 %W/V PEG4000, 0.01 M CACL2, 0.05 M NACACOD PH 6.0, 0.20 M KCL, 1 MM HEPARIN HEXAMER",289.6514371309434,2014-09-04,2015-02-25,2901,1,383,84.0,7,43.82,1,2.1,experimental,43.492,0.2371,0.18746,STRUCTURE OF THE WNT DEACYLASE NOTUM - CRYSTAL FORM IV - 2.1A,ETGSAQQLNEDLRLHLLLNTSVTCNDGSPAGYYLKESRGSRRWLLFLEGGWYCFNRENCDSRYDTMRRLMSSRDWPRTRTGTGILSSQPEENPYWWNANMVFIPYCSSDVWSGASSKSEKNEYAFMGALIIQEVVRELLGRGLSGAKVLLLAGSSAGGTGVLLNVDRVAEQLEKLGYPAIQVRGLADSGWFLDNKQYRHTDCVDTITCAPTEAIRRGIRYWNGVVPERCRRQFQEGEEWNCFFGYKVYPTLRSPVFVVQWLFDEAQLTVDNVHLTGQPVQEGLRLYIQNLGRELRHTLKDVPASFAPACLSHEIIIRSHWTDVQVKGTSLPRALHCWDRSLHDSHKASKTPLKGCPVHLVDSCPWPHCNPSCPTGTKHHHHHH,Protein,383,polypeptide(L),1,43.567,notum,3.1.1.1,PDB Primary Data,Homo sapiens,9606,383,1,1,Monomer,A1,NAG,C8 H15 N O6,221.208,2-acetamido-2-deoxy-beta-D-glucopyranose,"InChI=1S/C8H15NO6/c1-3(11)9-5-7(13)6(12)4(2-10)15-8(5)14/h4-8,10,12-14H,2H2,1H3,(H,9,11)/t4-,5-,6-,7-,8-/m1/s1",
4193,ENTREZ_GENE,mdm2,ACTFSHDMXhdm2,Homo sapiens,0.5674988810528183,9.20616e-11,NO,122269,4UD7,X-RAY DIFFRACTION,2.8,56.0,Desconocido,4.0,0.1 M SODIUM CITRATE PH 4.0 AND 15 % PEG8000,289.6514371309434,2014-12-08,2016-01-13,4008,8,520,262.0,0,58.68,2,1.6,experimental,23.018,0.17838,0.13846,Structure of the stapled peptide YS-02 bound to MDM2,GPLGSSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDAAQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSEN,Protein,114,polypeptide(L),4,12.831,mdm2,6.3.2,PDB Primary Data,Homo sapiens,9606,130,2,2,Hetero 2-mer,"A1, B1",Desconocido,Desconocido,246.2971348233669,Desconocido,Desconocido,
5771,ENTREZ_GENE,ptpn2,PTN2PTPTTCPTPTCELLPTPTCPTP,Homo sapiens,0.5578231556616058,9.03135e-11,NO,122854,8U0H,X-RAY DIFFRACTION,2.41,49.06,"VAPOR DIFFUSION, HANGING DROP",6.9,"0.49M Sodium phosphate monobasic monohydrate, 0.91M Potassium phosphate dibasic",296.0,2023-08-29,2024-09-04,5135,2,648,385.0,0,78.03,1,1.93,experimental,38.32,0.1917,0.1726,Crystal structure of PTPN2 with a PROTAC,MAMPTTIEREFEELDTQRRWQPLYLEIRNESHDYPHRVAKFPENRNRNRYRDVSPYDHSRVKLQNAENDYINASLVDIEEAQRSYILTQGPLPNTCCHFWLMVWQQKTKAVVMLNRIVEKESVKCAQYWPTDDQEMLFKETGFSVKLLSEDVKSYYTVHLLQLENINSGETRTISHFHYTTWPDFGVPESPASFLNFLFKVRESGSLNPDHGPAVIHCSAGIGRSGTFSLVDTCLVLMEKGDDINIKQVLLNMRKYRMGLIQTPDQLRFSYMAIIEGAKCIKGDSSIQKRWKELSKEDLSPAFDHSPNKIMTEKYNHHHHHHHH,Protein,324,polypeptide(L),2,37.966,ptpn2,3.1.3.48,PDB Primary Data,Homo sapiens,9606,324,1,1,Monomer,A1,UB0,C46 H49 Cl N6 O12 S2,977.497,"(5P)-3-(carboxymethoxy)-4-chloro-5-(3-{[(4S)-1-({3-[2-(4-{3-[(3R)-2,6-dioxopiperidin-3-yl]-2-oxo-2,3-dihydro-1,3-benzoxazol-6-yl}piperidin-1-yl)acetamido]phenyl}methanesulfonyl)-2,2-dimethylpiperidin-4-yl]amino}phenyl)thiophene-2-carboxylic acid","InChI=1S/C46H49ClN6O12S2/c1-46(2)22-32(48-31-8-4-6-29(20-31)41-39(47)40(64-24-38(56)57)42(66-41)44(59)60)15-18-52(46)67(62,63)25-26-5-3-7-30(19-26)49-37(55)23-51-16-13-27(14-17-51)28-9-10-33-35(21-28)65-45(61)53(33)34-11-12-36(54)50-43(34)58/h3-10,19-21,27,32,34,48H,11-18,22-25H2,1-2H3,(H,49,55)(H,56,57)(H,59,60)(H,50,54,58)/t32-,34+/m0/s1",
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.5523515087066379,9.18367e-11,NO,123156,7QXZ,X-RAY DIFFRACTION,3.8,67.66,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NAH2PO4, PH 5.5, 2 M NACL; RESERVOIR SOLUTION: 3.0-3.2M NACL",293.15,2022-01-27,2022-04-13,4278,1,480,568.0,3,52.89,1,1.8,experimental,27.27,0.2173,0.1815,X-ray structure of furin in complex with the dichlorophenylpyridine-based inhibitor 5,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHH,Protein,480,polypeptide(L),1,52.112,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,480,1,1,Monomer,A1,CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.5523515087066379,9.18367e-11,NO,123156,8B4V,X-RAY DIFFRACTION,3.75,67.16,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NAH2PO4, PH 5.5, 2 M NACL; RESERVOIR SOLUTION: 3.0-3.2M NACL",293.15,2022-09-21,2023-10-04,4300,1,480,508.0,4,52.95,1,1.6,experimental,26.89,0.1658,0.1535,X-ray structure of furin (PCSK3) in complex with benzamidine,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHH,Protein,480,polypeptide(L),1,52.112,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,480,1,1,Monomer,A1,BEN,C7 H8 N2,120.152,BENZAMIDINE,"InChI=1S/C7H8N2/c8-7(9)6-4-2-1-3-5-6/h1-5H,(H3,8,9)",
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.5523515087066379,9.18367e-11,NO,123156,8B4W,X-RAY DIFFRACTION,3.75,67.17,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NAH2PO4, PH 5.5, 2 M NACL; RESERVOIR SOLUTION: 3.0-3.2M NACL",293.15,2022-09-21,2023-10-04,4403,1,480,497.0,4,53.21,1,1.6,experimental,27.18,0.179,0.1659,X-ray structure of furin (PCSK3) in complex with 1H-isoindol-3-amine,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHH,Protein,480,polypeptide(L),1,52.112,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,480,1,1,Monomer,A1,F05,C8 H8 N2,132.163,1H-isoindol-3-amine,"InChI=1S/C8H8N2/c9-8-7-4-2-1-3-6(7)5-10-8/h1-4H,5H2,(H2,9,10)",
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.5523515087066379,9.18367e-11,NO,123156,8B4X,X-RAY DIFFRACTION,3.75,67.24,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NAH2PO4, PH 5.5, 2 M NACL; RESERVOIR SOLUTION: 3.0-3.2M NACL",293.15,2022-09-21,2023-10-04,4276,2,485,462.0,4,53.27,2,1.6,experimental,28.95,0.1695,0.158,X-ray structure of furin (PCSK3) in complex with Guanidinomethyl-Phac-R-Tle-K-6-(aminomethyl)-3-amino-isoindol,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHH,Protein,480,polypeptide(L),1,52.112,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,485,2,2,Hetero 2-mer,"A1, B1",CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.5523515087066379,9.18367e-11,NO,123156,8OYH,X-RAY DIFFRACTION,3.76,67.27,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NAH2PO4, PH 5.5, 2 M NACL; RESERVOIR SOLUTION: 3.0-3.2M NACL",293.15,2023-05-04,2024-03-13,4092,2,485,340.0,4,53.27,2,1.8,experimental,36.56,0.188,0.1735,X-ray structure of furin (PCSK3) in complex with Guanidinomethyl-Phac-Can-Tle-Can-6-(aminomethyl)-3-amino-isoindol,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHH,Protein,480,polypeptide(L),1,52.112,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,485,2,2,Hetero 2-mer,"A1, B1",CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.5523515087066379,9.18367e-11,NO,123156,4Z2A,X-RAY DIFFRACTION,2.36,47.94,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"Well 13% PEG 8K, 0.110M K-dihydrogen phosphate, 0.1M HEPES pH 7.5, 350 uL protein with 350uL well drops, MRC sitting drop",277.0,2015-03-29,2016-05-04,4016,1,465,408.0,4,50.92,1,1.89,experimental,16.9953,0.1834,0.1479,Crystal structure of unglycosylated apo human furin @1.89A,YQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKDLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQDWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTA,Protein,465,polypeptide(L),1,50.506,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,465,1,1,Monomer,A1,EDO,C2 H6 O2,62.068,"1,2-ETHANEDIOL","InChI=1S/C2H6O2/c3-1-2-4/h3-4H,1-2H2",
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.5523515087066379,9.18367e-11,NO,123156,7O1U,X-RAY DIFFRACTION,3.74,67.12,"VAPOR DIFFUSION, SITTING DROP",5.5,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NAH2PO4, PH 5.5, 2 M NACL; RESERVOIR SOLUTION: 3.0-3.2M NACL",293.15,2021-03-30,2021-09-01,4375,1,480,519.0,4,53.19,1,1.7,experimental,26.23,0.1666,0.155,X-ray structure of furin in complex with the guanylhydrazone-based inhibitor 1 (BEV241),DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHH,Protein,480,polypeptide(L),1,52.112,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,480,1,1,Monomer,A1,Desconocido,Na,22.99,SODIUM ION,InChI=1S/Na/q+1,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.5523515087066379,9.18367e-11,NO,123156,7O1W,X-RAY DIFFRACTION,3.74,67.1,"VAPOR DIFFUSION, SITTING DROP",5.5,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NAH2PO4, PH 5.5, 2 M NACL; RESERVOIR SOLUTION: 3.0-3.2M NACL",293.15,2021-03-30,2021-09-01,4335,1,480,424.0,4,53.69,1,1.8,experimental,29.36,0.1791,0.16,X-ray structure of furin in complex with the guanylhydrazone-based inhibitor 2 (mi307) soaked at 1 M NaCl,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHH,Protein,480,polypeptide(L),1,52.112,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,480,1,1,Monomer,A1,CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.5523515087066379,9.18367e-11,NO,123156,7O1Y,X-RAY DIFFRACTION,3.72,66.95,"VAPOR DIFFUSION, SITTING DROP",5.5,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NAH2PO4, PH 5.5, 2 M NACL; RESERVOIR SOLUTION: 3.0-3.2M NACL",293.15,2021-03-30,2021-09-01,4321,1,480,475.0,4,53.91,1,1.7,experimental,29.48,0.177,0.1622,X-ray structure of furin in complex with the guanylhydrazone-based inhibitor 2 (mi307) soaked at 0.25 M NaCl,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHH,Protein,480,polypeptide(L),1,52.112,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,480,1,1,Monomer,A1,CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.5523515087066379,9.18367e-11,NO,123156,7O20,X-RAY DIFFRACTION,3.67,66.48,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NAH2PO4, PH 5.5, 2 M NACL; RESERVOIR SOLUTION: 3.0-3.2M NACL",293.15,2021-03-30,2021-09-01,4190,1,480,376.0,4,53.54,1,1.8,experimental,33.26,0.1761,0.1624,X-ray structure of furin in complex with the guanylhydrazone-based inhibitor 3 (mi300),DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHH,Protein,480,polypeptide(L),1,52.112,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,480,1,1,Monomer,A1,CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.5523515087066379,9.18367e-11,NO,123156,7O22,X-RAY DIFFRACTION,3.69,66.7,"VAPOR DIFFUSION, SITTING DROP",5.5,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NAH2PO4, PH 5.5, 2 M NACL; RESERVOIR SOLUTION: 3.0-3.2M NACL",293.15,2021-03-30,2021-09-01,4130,1,480,427.0,4,53.15,1,1.8,experimental,33.5,0.1825,0.169,X-ray structure of furin in complex with the guanylhydrazone-based inhibitor 4 (mi359),DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHH,Protein,480,polypeptide(L),1,52.112,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,480,1,1,Monomer,A1,CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.5523515087066379,9.18367e-11,NO,123156,7QY0,X-RAY DIFFRACTION,3.72,66.91,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NAH2PO4, PH 5.5, 2 M NACL; RESERVOIR SOLUTION: 3.0-3.2M NACL",293.15,2022-01-27,2022-04-20,4378,1,480,476.0,4,53.68,1,1.54,experimental,26.16,0.1725,0.1493,X-ray structure of furin in complex with the dichlorophenylpyridine-based inhibitor 1,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHH,Protein,480,polypeptide(L),1,52.112,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,480,1,1,Monomer,A1,I0T,C32 H42 Cl2 N6 O3,629.62,"N-[[1-[[2-[3,5-bis(chloranyl)phenyl]-6-[6-[4-(2-methoxyethyl)piperazin-4-ium-1-yl]pyridin-3-yl]oxy-pyridin-4-yl]methyl]piperidin-1-ium-4-yl]methyl]ethanamide","InChI=1S/C32H40Cl2N6O3/c1-23(41)35-20-24-5-7-39(8-6-24)22-25-15-30(26-17-27(33)19-28(34)18-26)37-32(16-25)43-29-3-4-31(36-21-29)40-11-9-38(10-12-40)13-14-42-2/h3-4,15-19,21,24H,5-14,20,22H2,1-2H3,(H,35,41)/p+2",
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.5523515087066379,9.18367e-11,NO,123156,7QY1,X-RAY DIFFRACTION,2.568825997777984,50.34669344500458,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NAH2PO4, PH 5.5, 2 M NACL; RESERVOIR SOLUTION: 3.0-3.2M NACL",293.15,2022-01-27,2022-04-20,4387,1,480,483.0,4,53.77,1,1.45,experimental,25.78,0.1754,0.1502,X-ray structure of furin in complex with the dichlorophenylpyridine-based inhibitor 4,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHH,Protein,480,polypeptide(L),1,52.112,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,480,1,1,Monomer,A1,I0W,C32 H39 Cl2 N6 O4,642.596,"3-[4-[5-[4-[[4-(acetamidomethyl)piperidin-1-ium-1-yl]methyl]-6-[3,5-bis(chloranyl)phenyl]pyridin-2-yl]oxypyridin-2-yl]piperazin-1-ium-1-yl]propanoate","InChI=1S/C32H38Cl2N6O4/c1-22(41)35-19-23-4-7-39(8-5-23)21-24-14-29(25-16-26(33)18-27(34)17-25)37-31(15-24)44-28-2-3-30(36-20-28)40-12-10-38(11-13-40)9-6-32(42)43/h2-3,14-18,20,23H,4-13,19,21H2,1H3,(H,35,41)(H,42,43)/p+1",
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.5523515087066379,9.18367e-11,NO,123156,7QY2,X-RAY DIFFRACTION,3.71,66.87,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NAH2PO4, PH 5.5, 2 M NACL; RESERVOIR SOLUTION: 3.0-3.2M NACL",293.15,2022-01-27,2022-04-20,4373,1,480,471.0,4,53.72,1,1.55,experimental,27.19,0.1877,0.1645,X-ray structure of furin in complex with the dichlorophenylpyridine-based inhibitor 2,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHH,Protein,480,polypeptide(L),1,52.112,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,480,1,1,Monomer,A1,I0Q,C33 H42 Cl2 N7 O4,671.637,"(2R)-4-[4-[5-[4-[[4-(acetamidomethyl)piperidin-1-ium-1-yl]methyl]-6-[3,5-bis(chloranyl)phenyl]pyridin-2-yl]oxypyrimidin-2-yl]piperazin-1-ium-1-yl]-2-methyl-butanoate","InChI=1S/C33H41Cl2N7O4/c1-22(32(44)45)3-6-40-9-11-42(12-10-40)33-37-19-29(20-38-33)46-31-14-25(13-30(39-31)26-15-27(34)17-28(35)16-26)21-41-7-4-24(5-8-41)18-36-23(2)43/h13-17,19-20,22,24H,3-12,18,21H2,1-2H3,(H,36,43)(H,44,45)/p+1/t22-/m1/s1",
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.5523515087066379,9.18367e-11,NO,123156,7LCU,X-RAY DIFFRACTION,2.25,45.43,VAPOR DIFFUSION,7.5,"PEG8000, potassium dihydrogen phosphate",277.0,2021-01-11,2022-01-12,4057,1,490,352.0,5,54.37,1,1.24,experimental,14.5,0.1944,0.1764,"X-ray structure of Furin bound to BOS-318, a small molecule inhibitor",DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKDLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQDWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTAGENLYFQGDYKDDDDKGHHHHHH,Protein,490,polypeptide(L),1,53.512,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,490,1,1,Monomer,A1,CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.5523515087066379,9.18367e-11,NO,123156,6HLB,X-RAY DIFFRACTION,3.77,67.33,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NaH2PO4, PH 5.5-6.0, 2 M NaCL, 3% DMSO; RESERVOIR SOLUTION: 3-4M NaCL",293.15,2018-09-11,2019-02-06,4028,2,491,338.0,3,54.39,2,2.0,experimental,39.57218347825871,0.1874,0.1686,X-ray structure of furin in complex with the cyclic peptide c[succinyl-Phe-2-Nal-(Arg)4-Lys]-Arg-4-Amba,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHHHH,Protein,482,polypeptide(L),1,52.389,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,491,2,2,Hetero 2-mer,"A1, B1",CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.5523515087066379,9.18367e-11,NO,123156,6HLD,X-RAY DIFFRACTION,3.78,67.46,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NaH2PO4, PH 5.5-6.0, 2 M NaCL, 3% DMSO; RESERVOIR SOLUTION: 3-4M NaCL",293.15,2018-09-11,2019-02-06,4067,2,489,343.0,3,54.06,2,2.1,experimental,39.57218347825871,0.1959,0.17,X-ray structure of furin in complex with the cyclic peptide c[succinyl-Phe-2-Nal-(Arg)3-Lys]-Lys-4-Amba,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHHHH,Protein,482,polypeptide(L),1,52.389,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,489,2,2,Hetero 2-mer,"A1, B1",CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.5523515087066379,9.18367e-11,NO,123156,6HLE,X-RAY DIFFRACTION,3.84,68.01,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NaH2PO4, PH 5.5-6.0, 2 M NaCL, 3% DMSO; RESERVOIR SOLUTION: 3-4M NaCL",293.15,2018-09-11,2019-02-06,4127,2,488,390.0,3,53.91,2,1.994,experimental,39.57218347825871,0.1908,0.1667,X-ray structure of furin in complex with the P6-P2-cyclized peptide H-Lys-Arg-Arg-Tle-Lys-4-Amba,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHHHH,Protein,482,polypeptide(L),1,52.389,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,488,2,2,Hetero 2-mer,"A1, B1",CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.5523515087066379,9.18367e-11,NO,123156,6HZA,X-RAY DIFFRACTION,3.64,66.19,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NaH2PO4, PH 5.5-6.0, 2 M NaCL, 3% DMSO; RESERVOIR SOLUTION: 3-4M NaCL",293.15,2018-10-23,2019-02-06,4150,2,487,416.0,3,53.73,2,1.9,experimental,39.57218347825871,0.1859,0.1661,X-ray structure of furin in complex with the cyclic peptide c[glutaryl-Arg-Arg-Lys]-Arg-4-Amba,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHHHH,Protein,482,polypeptide(L),1,52.389,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,487,2,2,Hetero 2-mer,"A1, B1",CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.5523515087066379,9.18367e-11,NO,123156,6HZB,X-RAY DIFFRACTION,3.66,66.41,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NaH2PO4, PH 5.5-6.0, 2 M NaCL, 3% DMSO; RESERVOIR SOLUTION: 3-4M NaCL",293.15,2018-10-23,2019-02-06,4150,2,487,418.0,3,53.7,2,1.9,experimental,39.57218347825871,0.1824,0.1646,X-ray structure of furin in complex with the cyclic inhibitor c[glutaryl-Arg-Arg-Lys]-Lys-4-Amba,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHHHH,Protein,482,polypeptide(L),1,52.389,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,487,2,2,Hetero 2-mer,"A1, B1",CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.5523515087066379,9.18367e-11,NO,123156,6HZD,X-RAY DIFFRACTION,3.64,66.22,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NaH2PO4, PH 5.5-6.0, 2 M NaCL, 3% DMSO; RESERVOIR SOLUTION: 3-4M NaCL",293.15,2018-10-23,2019-02-06,4163,2,488,418.0,3,53.89,2,1.9,experimental,39.57218347825871,0.1827,0.1641,X-ray structure of furin in complex with the cyclic inhibitor c[glutaryl-Arg-Arg-Arg-Lys]-Arg-4-Amba,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHHHH,Protein,482,polypeptide(L),1,52.389,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,488,2,2,Hetero 2-mer,"A1, B1",CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.5523515087066379,9.18367e-11,NO,123156,6YD2,X-RAY DIFFRACTION,3.7,66.74,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100MM MES, 200MM K/NAH2PO4, PH 5.5-6.0, 2 M NACL; RESERVOIR SOLUTION: 3-4M NACL",293.15,2020-03-20,2021-02-17,4179,2,487,444.0,3,53.58,2,1.8,experimental,32.05,0.1771,0.1575,X-ray structure of furin in complex with the canavanine-based inhibitor 4-aminomethyl-phenylacetyl-canavanine-Tle-Arg-Amba,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHHHH,Protein,482,polypeptide(L),1,52.389,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,487,2,2,Hetero 2-mer,"A1, B1",CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.5523515087066379,9.18367e-11,NO,123156,6YD3,X-RAY DIFFRACTION,3.72,66.96,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100MM MES, 200MM K/NAH2PO4, PH 5.5-6.0, 2 M NACL; RESERVOIR SOLUTION: 3-4M NACL",293.15,2020-03-20,2021-02-17,4159,2,485,418.0,3,53.34,2,2.0,experimental,32.04,0.1854,0.1595,X-ray structure of furin in complex with the canavanine derived inhibitor 4-guanidinomethyl-phenylacetyl-Canavanine-Tle-Arg-Amba,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHH,Protein,480,polypeptide(L),1,52.112,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,485,2,2,Hetero 2-mer,"A1, B1",CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.5523515087066379,9.18367e-11,NO,123156,6YD4,X-RAY DIFFRACTION,3.73,67.06,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100MM MES, 200MM K/NAH2PO4, PH 5.5-6.0, 2 M NACL; RESERVOIR SOLUTION: 3-4M NACL",291.15,2020-03-20,2021-02-17,4237,2,485,477.0,3,53.37,2,1.7,experimental,31.24,0.1694,0.1532,X-ray structure of furin in complex with the canavanine-based inhibitor 4-guanidinomethyl-phenylacetyl-Canavanine-Tle-Canavanine-Amba,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHH,Protein,480,polypeptide(L),1,52.112,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,485,2,2,Hetero 2-mer,"A1, B1",CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.5523515087066379,9.18367e-11,NO,123156,6YD7,X-RAY DIFFRACTION,3.74,67.08,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100MM MES, 200MM K/NAH2PO4, PH 5.5-6.0, 2 M NACL; RESERVOIR SOLUTION: 3-4M NACL",291.15,2020-03-20,2021-02-17,4211,2,485,465.0,3,53.37,2,1.8,experimental,29.7,0.1709,0.1538,X-ray structure of furin in complex with the canavanine-based inhibitor 4-guanidinomethyl-phenylacetyl-Arg-Tle-Canavanine-Amba,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHH,Protein,480,polypeptide(L),1,52.112,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,485,2,2,Hetero 2-mer,"A1, B1",CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.5523515087066379,9.18367e-11,NO,123156,7QXY,X-RAY DIFFRACTION,2.568825997777984,50.34669344500458,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NAH2PO4, PH 5.5, 2 M NACL; RESERVOIR SOLUTION: 3.0-3.2M NACL",293.15,2022-01-27,2022-04-20,4386,1,480,661.0,2,53.0,1,1.478,experimental,24.97,0.1823,0.1705,X-ray structure of furin in complex with the dichlorophenylpyridine-based inhibitor 3,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHH,Protein,480,polypeptide(L),1,52.112,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,480,1,1,Monomer,A1,CL,Cl,35.453,CHLORIDE ION,InChI=1S/ClH/h1H/p-1,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.5523515087066379,9.18367e-11,NO,123156,4RYD,X-RAY DIFFRACTION,2.86,56.93,"VAPOR DIFFUSION, SITTING DROP",8.5,"50mM Tris, 2.8M sodium formate, 15mM Cymal-7, pH 8.5, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293.0,2014-12-15,2015-05-27,23768,12,2922,2034.0,18,320.52,2,2.15,experimental,39.57218347825871,0.2186,0.1862,X-ray structure of human furin in complex with the competitive inhibitor para-guanidinomethyl-Phac-R-Tle-R-Amba,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHHHH,Protein,482,polypeptide(L),6,52.389,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,487,2,2,Hetero 2-mer,"A1, B1",FMT,C H2 O2,46.025,FORMIC ACID,"InChI=1S/CH2O2/c2-1-3/h1H,(H,2,3)",
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.5523515087066379,9.18367e-11,NO,123156,5JXH,X-RAY DIFFRACTION,3.67,66.49,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"crystallization solution: 100 mM MES, 200 mM K/NaH2PO4, pH 5.5-6.0, 3-4 M NaCl, 3% DMSO; reservoir solution: 3-4 M NaCl",293.15,2016-05-13,2016-10-05,4261,2,487,534.0,3,53.39,2,2.0,experimental,39.57218347825871,0.1853,0.1566,Structure the proprotein convertase furin in complex with meta-guanidinomethyl-Phac-RVR-Amba at 2.0 Angstrom resolution.,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHHHH,Protein,482,polypeptide(L),1,52.389,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,487,2,2,Hetero 2-mer,"A1, B1",CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.5523515087066379,9.18367e-11,NO,123156,5JXG,X-RAY DIFFRACTION,3.73,67.05,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"crystallization solution: 100 mM MES, 200 mM K/NaH2PO4, pH 5.5-6.0, 3-4 M NaCl, 3% DMSO; reservoir solution: 3-4 M NaCl",293.15,2016-05-13,2016-10-05,4360,1,482,645.0,3,52.73,1,1.8,experimental,39.57218347825871,0.1733,0.154,Structure of the unliganded form of the proprotein convertase furin.,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHHHH,Protein,482,polypeptide(L),1,52.389,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,482,1,1,Monomer,A1,CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.5523515087066379,9.18367e-11,NO,123156,5JXI,X-RAY DIFFRACTION,3.76,67.3,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"crystallization solution: 100 mM MES, 200 mM K/NaH2PO4, pH 5.5-6.0, 3-4 M NaCl, 3% DMSO; reservoir solution: 3-4 M NaCl",293.15,2016-05-13,2016-10-05,4164,1,482,521.0,3,52.63,1,2.0,experimental,39.57218347825871,0.1851,0.1576,Structure of the unliganded form of the proprotein convertase furin in presence of EDTA.,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHHHH,Protein,482,polypeptide(L),1,52.389,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,482,1,1,Monomer,A1,CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.5523515087066379,9.18367e-11,NO,123156,5MIM,X-RAY DIFFRACTION,3.75,67.2,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100 MM MES, 200 MM K/NAH2PO4, PH 5.5-6.0, 3-4 M NACL, 3% DMSO; RESERVOIR SOLUTION: 3-4 M NACL",293.15,2016-11-28,2017-05-10,4275,1,482,486.0,3,53.81,1,1.9,experimental,39.57218347825871,0.1838,0.1647,"Xray structure of human furin bound with the 2,5-dideoxystreptamine derived small molecule inhibitor 1n",DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHHHH,Protein,482,polypeptide(L),1,52.389,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,482,1,1,Monomer,A1,CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.5523515087066379,9.18367e-11,NO,123156,5JXJ,X-RAY DIFFRACTION,3.69,66.65,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"crystallization solution: 100 mM MES, 200 mM K/NaH2PO4, pH 5.5-6.0, 3-4 M NaCl, 3% DMSO; reservoir solution: 3-4 M NaCl",293.15,2016-05-13,2016-10-05,4185,2,487,461.0,3,53.35,2,2.0,experimental,39.57218347825871,0.1889,0.1668,Structure of the proprotein convertase furin complexed to meta-guanidinomethyl-Phac-RVR-Amba in presence of EDTA,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHHHH,Protein,482,polypeptide(L),1,52.389,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,487,2,2,Hetero 2-mer,"A1, B1",CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.5523515087066379,9.18367e-11,NO,123156,6EQV,X-RAY DIFFRACTION,3.67,66.45,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NaH2PO4, PH 5.5-6.0, 3-4M NaCl, 3% DMSO; RESERVOIR SOLUTION: 3-4 M NaCl",293.15,2017-10-16,2018-02-28,4212,2,487,510.0,3,53.3,2,1.895,experimental,39.57218347825871,0.1821,0.1637,X-ray structure of the proprotein convertase furin bound with the competitive inhibitor Phac-Cit-Val-Arg-Amba,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHHHH,Protein,482,polypeptide(L),1,52.389,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,487,2,2,Hetero 2-mer,"A1, B1",CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.5523515087066379,9.18367e-11,NO,123156,6EQW,X-RAY DIFFRACTION,3.66,66.42,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NaH2PO4, PH 5.5-6.0, 3-4 M NaCL, 3% DMSO; RESERVOIR SOLUTION: 3-4M NaCL",293.15,2017-10-16,2018-02-28,4183,2,487,486.0,3,53.36,2,1.994,experimental,39.57218347825871,0.1842,0.1619,X-ray structure of the proprotein convertase furin bound with the competitive inhibitor 4-aminomethyl-phenylacetyl-Arg-Val-Arg-Amba,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHHHH,Protein,482,polypeptide(L),1,52.389,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,487,2,2,Hetero 2-mer,"A1, B1",CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.5523515087066379,9.18367e-11,NO,123156,6EQX,X-RAY DIFFRACTION,3.66,66.36,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"100mM MES, 200mM K/NaH2PO4, PH 5.5-6.0, 3-4 M NaCL, 3% DMSO; RESERVOIR SOLUTION: 3-4M NaCL",293.15,2017-10-16,2018-02-28,4186,2,488,471.0,3,53.51,2,1.994,experimental,39.57218347825871,0.1837,0.162,X-ray structure of the proprotein convertase furin bound with the competitive inhibitor Arg-Arg-Arg-Val-Arg-Amba,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHHHH,Protein,482,polypeptide(L),1,52.389,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,488,2,2,Hetero 2-mer,"A1, B1",CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
56339,ENTREZ_GENE,mettl3,IME4M6AMTA70Spo8hMETTL3,Homo sapiens,0.4273236183884225,8.44143e-11,NO,125631,5IL1,X-RAY DIFFRACTION,2.58,52.33,"VAPOR DIFFUSION, HANGING DROP",5.7,"PEG 8000, sodium citrate",291.0,2016-03-04,2016-05-25,4336,2,512,337.0,0,59.81,2,1.71,experimental,39.57218347825871,0.2069,0.1798,Crystal structure of SAM-bound METTL3-METTL14 complex,FPPQWICCDIRYLDVSILGKFAVVMADPPWDIHMELPYGTLTDDEMRRLNIPVLQDDGFLFLWVTGRAMELGRECLNLWGYERVDEIIWVKTNQLQRIIRTGRTGHWLNHGKEHCLVGVKGNPQGFNQGLDCDVIVAEVRSTSHKPDEIYGMIERLSPGTRKIELFGRPHNVQPNWITLGNQLDGIHLLDPDVVARFKQRYPDGIISKPKNL,Protein,212,polypeptide(L),1,24.427,mettl3,2.1.1.62,PDB Primary Data,Homo sapiens,9606,512,2,2,Hetero 2-mer,"A1, B1",SAM,C15 H22 N6 O5 S,398.437,S-ADENOSYLMETHIONINE,"InChI=1S/C15H22N6O5S/c1-27(3-2-7(16)15(24)25)4-8-10(22)11(23)14(26-8)21-6-20-9-12(17)18-5-19-13(9)21/h5-8,10-11,14,22-23H,2-4,16H2,1H3,(H2-,17,18,19,24,25)/t7-,8+,10+,11+,14+,27-/m0/s1",
56339,ENTREZ_GENE,mettl3,IME4M6AMTA70Spo8hMETTL3,Homo sapiens,0.4273236183884225,8.44143e-11,NO,125631,5IL0,X-RAY DIFFRACTION,2.55,51.69,"VAPOR DIFFUSION, HANGING DROP",5.7,"PEG 8000, sodium citrate",291.0,2016-03-04,2016-05-25,4347,2,512,331.0,0,59.43,2,1.882,experimental,39.57218347825871,0.205,0.1747,Crystal structural of the METTL3-METTL14 complex for N6-adenosine methylation,FPPQWICCDIRYLDVSILGKFAVVMADPPWDIHMELPYGTLTDDEMRRLNIPVLQDDGFLFLWVTGRAMELGRECLNLWGYERVDEIIWVKTNQLQRIIRTGRTGHWLNHGKEHCLVGVKGNPQGFNQGLDCDVIVAEVRSTSHKPDEIYGMIERLSPGTRKIELFGRPHNVQPNWITLGNQLDGIHLLDPDVVARFKQRYPDGIISKPKNL,Protein,212,polypeptide(L),1,24.427,mettl3,2.1.1.62,PDB Primary Data,Homo sapiens,9606,512,2,2,Hetero 2-mer,"A1, B1",EDO,C2 H6 O2,62.068,"1,2-ETHANEDIOL","InChI=1S/C2H6O2/c3-1-2-4/h3-4H,1-2H2",
56339,ENTREZ_GENE,mettl3,IME4M6AMTA70Spo8hMETTL3,Homo sapiens,0.4273236183884225,8.44143e-11,NO,125631,5IL2,X-RAY DIFFRACTION,2.66,53.7,"VAPOR DIFFUSION, HANGING DROP",5.7,"PEG 8000, sodium citrate",291.0,2016-03-04,2016-05-25,4393,2,512,376.0,1,59.85,2,1.606,experimental,39.57218347825871,0.1992,0.1848,Crystal structure of SAH-bound METTL3-METTL14 complex,FPPQWICCDIRYLDVSILGKFAVVMADPPWDIHMELPYGTLTDDEMRRLNIPVLQDDGFLFLWVTGRAMELGRECLNLWGYERVDEIIWVKTNQLQRIIRTGRTGHWLNHGKEHCLVGVKGNPQGFNQGLDCDVIVAEVRSTSHKPDEIYGMIERLSPGTRKIELFGRPHNVQPNWITLGNQLDGIHLLDPDVVARFKQRYPDGIISKPKNL,Protein,212,polypeptide(L),1,24.427,mettl3,2.1.1.62,PDB Primary Data,Homo sapiens,9606,512,2,2,Hetero 2-mer,"A1, B1",EDO,C2 H6 O2,62.068,"1,2-ETHANEDIOL","InChI=1S/C2H6O2/c3-1-2-4/h3-4H,1-2H2",
1387,ENTREZ_GENE,crebbp,CBPKAT3ARSTSRSTS1,Homo sapiens,0.6132399556270038,8.98509e-11,NO,125743,6YIK,X-RAY DIFFRACTION,3.42,64.06,"VAPOR DIFFUSION, SITTING DROP",7.5,"21% PEG3350
15% ethylene glycol
0.25M sodium formate",277.0,2020-04-01,2020-04-15,3453,3,357,385.0,0,44.74,1,1.7,experimental,32.625,0.184,0.156,Crystal structure of the CREBBP bromodomain in complex with a tetrahydroquinoxaline ligand,SMRKKIFKPEELRQALMPTLEALYRQDPESLPFRQPVDPQLLGIPDYFDIVKNPMDLSTIKRKLDTGQYQEPWQYVDDVWLMFNNAWLYNRKTSRVYKFCSKLAEVFEQEIDPVMQSLG,Protein,119,polypeptide(L),3,14.223,crebbp,2.3.1.48,PDB Primary Data,Homo sapiens,9606,119,1,1,Monomer,A1,OSQ,C22 H24 F2 N4 O2,414.448,"(3~{R})-~{N}-[3-(3,4-dihydro-2~{H}-quinolin-1-yl)-2,2-bis(fluoranyl)propyl]-3-methyl-2-oxidanylidene-3,4-dihydro-1~{H}-quinoxaline-5-carboxamide","InChI=1S/C22H24F2N4O2/c1-14-20(29)27-17-9-4-8-16(19(17)26-14)21(30)25-12-22(23,24)13-28-11-5-7-15-6-2-3-10-18(15)28/h2-4,6,8-10,14,26H,5,7,11-13H2,1H3,(H,25,30)(H,27,29)/t14-/m1/s1",
1387,ENTREZ_GENE,crebbp,CBPKAT3ARSTSRSTS1,Homo sapiens,0.6132399556270038,8.98509e-11,NO,125743,6SXX,X-RAY DIFFRACTION,2.18,43.67,"VAPOR DIFFUSION, HANGING DROP",6.982430939226492,"25% PEG3350, 0.2 M Potassium thiocyanate, 5% EtGly",277.0,2019-09-26,2020-07-29,1940,2,238,81.0,0,28.95,1,2.01,experimental,52.99,0.2533,0.1955,Crystal structure of the bromodomain of human CREBBP in complex with ACA007,SMRKKIFKPEELRQALMPTLEALYRQDPESLPFRQPVDPQLLGIPDYFDIVKNPMDLSTIKRKLDTGQYQEPWQYVDDVWLMFNNAWLYNRKTSRVYKFCSKLAEVFEQEIDPVMQSLG,Protein,119,polypeptide(L),2,14.223,crebbp,2.3.1.48,PDB Primary Data,Homo sapiens,9606,119,1,1,Monomer,A1,EDO,C2 H6 O2,62.068,"1,2-ETHANEDIOL","InChI=1S/C2H6O2/c3-1-2-4/h3-4H,1-2H2",
1387,ENTREZ_GENE,crebbp,CBPKAT3ARSTSRSTS1,Homo sapiens,0.6132399556270038,8.98509e-11,NO,125743,6YIL,X-RAY DIFFRACTION,2.2,44.01,"VAPOR DIFFUSION, SITTING DROP",7.5,"20% PEG3350
10% ethylene glycol
0.2M sodium acetate",277.0,2020-04-01,2020-04-15,1160,1,119,154.0,0,14.64,1,1.22,experimental,12.75,0.1511,0.1321,Crystal structure of the CREBBP bromodomain in complex with a tetrahydroquinoxaline ligand,SMRKKIFKPEELRQALMPTLEALYRQDPESLPFRQPVDPQLLGIPDYFDIVKNPMDLSTIKRKLDTGQYQEPWQYVDDVWLMFNNAWLYNRKTSRVYKFCSKLAEVFEQEIDPVMQSLG,Protein,119,polypeptide(L),1,14.223,crebbp,2.3.1.48,PDB Primary Data,Homo sapiens,9606,119,1,1,Monomer,A1,OSQ,C22 H24 F2 N4 O2,414.448,"(3~{R})-~{N}-[3-(3,4-dihydro-2~{H}-quinolin-1-yl)-2,2-bis(fluoranyl)propyl]-3-methyl-2-oxidanylidene-3,4-dihydro-1~{H}-quinoxaline-5-carboxamide","InChI=1S/C22H24F2N4O2/c1-14-20(29)27-17-9-4-8-16(19(17)26-14)21(30)25-12-22(23,24)13-28-11-5-7-15-6-2-3-10-18(15)28/h2-4,6,8-10,14,26H,5,7,11-13H2,1H3,(H,25,30)(H,27,29)/t14-/m1/s1",
1387,ENTREZ_GENE,crebbp,CBPKAT3ARSTSRSTS1,Homo sapiens,0.6132399556270038,8.98509e-11,NO,125743,6YIM,X-RAY DIFFRACTION,2.2,44.12,"VAPOR DIFFUSION, SITTING DROP",7.5,"20% PEG3350
10% ethylene glycol
0.2M sodium fluoride",277.0,2020-04-01,2020-04-15,1174,1,119,163.0,0,14.65,1,1.23,experimental,12.85,0.167,0.1397,Crystal structure of the CREBBP bromodomain in complex with a benzo-diazepine ligand,SMRKKIFKPEELRQALMPTLEALYRQDPESLPFRQPVDPQLLGIPDYFDIVKNPMDLSTIKRKLDTGQYQEPWQYVDDVWLMFNNAWLYNRKTSRVYKFCSKLAEVFEQEIDPVMQSLG,Protein,119,polypeptide(L),1,14.223,crebbp,2.3.1.48,PDB Primary Data,Homo sapiens,9606,119,1,1,Monomer,A1,OS8,C24 H30 N4 O3,422.52,"(4~{R})-~{N}-[3-(7-methoxy-3,4-dihydro-2~{H}-quinolin-1-yl)propyl]-4-methyl-2-oxidanylidene-1,3,4,5-tetrahydro-1,5-benzodiazepine-6-carboxamide","InChI=1S/C24H30N4O3/c1-16-14-22(29)27-20-8-3-7-19(23(20)26-16)24(30)25-11-5-13-28-12-4-6-17-9-10-18(31-2)15-21(17)28/h3,7-10,15-16,26H,4-6,11-14H2,1-2H3,(H,25,30)(H,27,29)/t16-/m1/s1",
1387,ENTREZ_GENE,crebbp,CBPKAT3ARSTSRSTS1,Homo sapiens,0.6132399556270038,8.98509e-11,NO,125743,6YIJ,X-RAY DIFFRACTION,2.95,58.37,"VAPOR DIFFUSION, SITTING DROP",8.3,"20% ethylene glycol
21% PEG6K
0.1M tris pH 8.3
0.125M lithium chloride",277.0,2020-04-01,2020-04-15,7177,7,833,224.0,0,102.4,1,2.2,experimental,44.856,0.2693,0.2022,Crystal structure of the CREBBP bromodomain in complex with a benzo-diazepine ligand,SMRKKIFKPEELRQALMPTLEALYRQDPESLPFRQPVDPQLLGIPDYFDIVKNPMDLSTIKRKLDTGQYQEPWQYVDDVWLMFNNAWLYNRKTSRVYKFCSKLAEVFEQEIDPVMQSLG,Protein,119,polypeptide(L),7,14.223,crebbp,2.3.1.48,PDB Primary Data,Homo sapiens,9606,119,1,1,Monomer,A1,OSN,C25 H31 N3 O2,405.533,"(4~{R})-6-[(~{E})-5-(7-methoxy-3,4-dihydro-2~{H}-quinolin-1-yl)pent-1-enyl]-4-methyl-1,3,4,5-tetrahydro-1,5-benzodiazepin-2-one","InChI=1S/C25H31N3O2/c1-18-16-24(29)27-22-11-6-9-20(25(22)26-18)8-4-3-5-14-28-15-7-10-19-12-13-21(30-2)17-23(19)28/h4,6,8-9,11-13,17-18,26H,3,5,7,10,14-16H2,1-2H3,(H,27,29)/b8-4+/t18-/m1/s1",
2534,ENTREZ_GENE,fyn,SLKSYNp59FYN,Homo sapiens,0.6251309963707811,9.80873e-11,NO,129756,6EDF,X-RAY DIFFRACTION,2.0,37.6,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"20% PEG3350, 0.2 M magnesium acetate",291.0,2018-08-09,2018-08-29,693,1,79,61.0,0,8.94,1,1.4,experimental,12.097,0.1721,0.1434,Fragment of a tyrosine-protein kinase,GGVTLFVALYDYEARTEDDISVHKGEKVQILNSSEGDWWEVRSLTTGETGYVPSNYVAPVDGSAAMGPVLRLRAFYNGG,Protein,79,polypeptide(L),1,8.591,fyn,2.7.10.2,PDB Primary Data,Homo sapiens,9606,79,1,1,Monomer,A1,GOL,C3 H8 O3,92.094,GLYCEROL,"InChI=1S/C3H8O3/c4-1-3(6)2-5/h3-6H,1-2H2",
673,ENTREZ_GENE,braf,BRAF1BrafBRAF1NS7RAFB1,Homo sapiens,0.6646679875546778,6.70308e-11,NO,134069,5VR3,X-RAY DIFFRACTION,2.58,52.44,"VAPOR DIFFUSION, HANGING DROP",6.5,"0.1 M Bis-Tris pH 6.5, 2.0 M ammonium sulphate",293.15,2017-05-10,2018-02-14,510,1,88,13.0,0,9.64,1,2.102,experimental,39.57218347825871,0.2244,0.2095,Crystal structure of the BRS domain of BRAF,GAMDPGGGGSSAADPAIPEEVWNIKQMIKLTQEHIEALLDKFGGEHNPPSIYLEAYEEYTSKLDALQQREQQLLESLGNGTDFSVSSS,Protein,88,polypeptide(L),1,9.544,braf,2.7.11.1,PDB Primary Data,Homo sapiens,9606,88,1,1,Monomer,A1,SO4,O4 S,96.063,SULFATE ION,"InChI=1S/H2O4S/c1-5(2,3)4/h(H2,1,2,3,4)/p-2",
56339,ENTREZ_GENE,mettl3,IME4M6AMTA70Spo8hMETTL3,Homo sapiens,0.5957229303859563,3.49726e-11,BioGRID ORCS,143957,5IL1,X-RAY DIFFRACTION,2.58,52.33,"VAPOR DIFFUSION, HANGING DROP",5.7,"PEG 8000, sodium citrate",291.0,2016-03-04,2016-05-25,4336,2,512,337.0,0,59.81,2,1.71,experimental,39.57218347825871,0.2069,0.1798,Crystal structure of SAM-bound METTL3-METTL14 complex,FPPQWICCDIRYLDVSILGKFAVVMADPPWDIHMELPYGTLTDDEMRRLNIPVLQDDGFLFLWVTGRAMELGRECLNLWGYERVDEIIWVKTNQLQRIIRTGRTGHWLNHGKEHCLVGVKGNPQGFNQGLDCDVIVAEVRSTSHKPDEIYGMIERLSPGTRKIELFGRPHNVQPNWITLGNQLDGIHLLDPDVVARFKQRYPDGIISKPKNL,Protein,212,polypeptide(L),1,24.427,mettl3,2.1.1.62,PDB Primary Data,Homo sapiens,9606,512,2,2,Hetero 2-mer,"A1, B1",SAM,C15 H22 N6 O5 S,398.437,S-ADENOSYLMETHIONINE,"InChI=1S/C15H22N6O5S/c1-27(3-2-7(16)15(24)25)4-8-10(22)11(23)14(26-8)21-6-20-9-12(17)18-5-19-13(9)21/h5-8,10-11,14,22-23H,2-4,16H2,1H3,(H2-,17,18,19,24,25)/t7-,8+,10+,11+,14+,27-/m0/s1",
56339,ENTREZ_GENE,mettl3,IME4M6AMTA70Spo8hMETTL3,Homo sapiens,0.5957229303859563,3.49726e-11,BioGRID ORCS,143957,5IL0,X-RAY DIFFRACTION,2.55,51.69,"VAPOR DIFFUSION, HANGING DROP",5.7,"PEG 8000, sodium citrate",291.0,2016-03-04,2016-05-25,4347,2,512,331.0,0,59.43,2,1.882,experimental,39.57218347825871,0.205,0.1747,Crystal structural of the METTL3-METTL14 complex for N6-adenosine methylation,FPPQWICCDIRYLDVSILGKFAVVMADPPWDIHMELPYGTLTDDEMRRLNIPVLQDDGFLFLWVTGRAMELGRECLNLWGYERVDEIIWVKTNQLQRIIRTGRTGHWLNHGKEHCLVGVKGNPQGFNQGLDCDVIVAEVRSTSHKPDEIYGMIERLSPGTRKIELFGRPHNVQPNWITLGNQLDGIHLLDPDVVARFKQRYPDGIISKPKNL,Protein,212,polypeptide(L),1,24.427,mettl3,2.1.1.62,PDB Primary Data,Homo sapiens,9606,512,2,2,Hetero 2-mer,"A1, B1",EDO,C2 H6 O2,62.068,"1,2-ETHANEDIOL","InChI=1S/C2H6O2/c3-1-2-4/h3-4H,1-2H2",
56339,ENTREZ_GENE,mettl3,IME4M6AMTA70Spo8hMETTL3,Homo sapiens,0.5957229303859563,3.49726e-11,BioGRID ORCS,143957,5IL2,X-RAY DIFFRACTION,2.66,53.7,"VAPOR DIFFUSION, HANGING DROP",5.7,"PEG 8000, sodium citrate",291.0,2016-03-04,2016-05-25,4393,2,512,376.0,1,59.85,2,1.606,experimental,39.57218347825871,0.1992,0.1848,Crystal structure of SAH-bound METTL3-METTL14 complex,FPPQWICCDIRYLDVSILGKFAVVMADPPWDIHMELPYGTLTDDEMRRLNIPVLQDDGFLFLWVTGRAMELGRECLNLWGYERVDEIIWVKTNQLQRIIRTGRTGHWLNHGKEHCLVGVKGNPQGFNQGLDCDVIVAEVRSTSHKPDEIYGMIERLSPGTRKIELFGRPHNVQPNWITLGNQLDGIHLLDPDVVARFKQRYPDGIISKPKNL,Protein,212,polypeptide(L),1,24.427,mettl3,2.1.1.62,PDB Primary Data,Homo sapiens,9606,512,2,2,Hetero 2-mer,"A1, B1",EDO,C2 H6 O2,62.068,"1,2-ETHANEDIOL","InChI=1S/C2H6O2/c3-1-2-4/h3-4H,1-2H2",
2534,ENTREZ_GENE,fyn,SLKSYNp59FYN,Homo sapiens,0.6368310205884375,3.49726e-11,BioGRID ORCS,147255,6EDF,X-RAY DIFFRACTION,2.0,37.6,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"20% PEG3350, 0.2 M magnesium acetate",291.0,2018-08-09,2018-08-29,693,1,79,61.0,0,8.94,1,1.4,experimental,12.097,0.1721,0.1434,Fragment of a tyrosine-protein kinase,GGVTLFVALYDYEARTEDDISVHKGEKVQILNSSEGDWWEVRSLTTGETGYVPSNYVAPVDGSAAMGPVLRLRAFYNGG,Protein,79,polypeptide(L),1,8.591,fyn,2.7.10.2,PDB Primary Data,Homo sapiens,9606,79,1,1,Monomer,A1,GOL,C3 H8 O3,92.094,GLYCEROL,"InChI=1S/C3H8O3/c4-1-3(6)2-5/h3-6H,1-2H2",
4193,ENTREZ_GENE,mdm2,ACTFSHDMXhdm2,Homo sapiens,0.6445174112754434,3.49726e-11,BioGRID ORCS,149157,4UD7,X-RAY DIFFRACTION,2.8,56.0,Desconocido,4.0,0.1 M SODIUM CITRATE PH 4.0 AND 15 % PEG8000,289.6514371309434,2014-12-08,2016-01-13,4008,8,520,262.0,0,58.68,2,1.6,experimental,23.018,0.17838,0.13846,Structure of the stapled peptide YS-02 bound to MDM2,GPLGSSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDAAQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSEN,Protein,114,polypeptide(L),4,12.831,mdm2,6.3.2,PDB Primary Data,Homo sapiens,9606,130,2,2,Hetero 2-mer,"A1, B1",Desconocido,Desconocido,246.2971348233669,Desconocido,Desconocido,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.6465466641464552,3.49726e-11,BioGRID ORCS,149575,7QXZ,X-RAY DIFFRACTION,3.8,67.66,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NAH2PO4, PH 5.5, 2 M NACL; RESERVOIR SOLUTION: 3.0-3.2M NACL",293.15,2022-01-27,2022-04-13,4278,1,480,568.0,3,52.89,1,1.8,experimental,27.27,0.2173,0.1815,X-ray structure of furin in complex with the dichlorophenylpyridine-based inhibitor 5,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHH,Protein,480,polypeptide(L),1,52.112,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,480,1,1,Monomer,A1,CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.6465466641464552,3.49726e-11,BioGRID ORCS,149575,8B4V,X-RAY DIFFRACTION,3.75,67.16,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NAH2PO4, PH 5.5, 2 M NACL; RESERVOIR SOLUTION: 3.0-3.2M NACL",293.15,2022-09-21,2023-10-04,4300,1,480,508.0,4,52.95,1,1.6,experimental,26.89,0.1658,0.1535,X-ray structure of furin (PCSK3) in complex with benzamidine,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHH,Protein,480,polypeptide(L),1,52.112,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,480,1,1,Monomer,A1,BEN,C7 H8 N2,120.152,BENZAMIDINE,"InChI=1S/C7H8N2/c8-7(9)6-4-2-1-3-5-6/h1-5H,(H3,8,9)",
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.6465466641464552,3.49726e-11,BioGRID ORCS,149575,8B4W,X-RAY DIFFRACTION,3.75,67.17,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NAH2PO4, PH 5.5, 2 M NACL; RESERVOIR SOLUTION: 3.0-3.2M NACL",293.15,2022-09-21,2023-10-04,4403,1,480,497.0,4,53.21,1,1.6,experimental,27.18,0.179,0.1659,X-ray structure of furin (PCSK3) in complex with 1H-isoindol-3-amine,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHH,Protein,480,polypeptide(L),1,52.112,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,480,1,1,Monomer,A1,F05,C8 H8 N2,132.163,1H-isoindol-3-amine,"InChI=1S/C8H8N2/c9-8-7-4-2-1-3-6(7)5-10-8/h1-4H,5H2,(H2,9,10)",
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.6465466641464552,3.49726e-11,BioGRID ORCS,149575,8B4X,X-RAY DIFFRACTION,3.75,67.24,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NAH2PO4, PH 5.5, 2 M NACL; RESERVOIR SOLUTION: 3.0-3.2M NACL",293.15,2022-09-21,2023-10-04,4276,2,485,462.0,4,53.27,2,1.6,experimental,28.95,0.1695,0.158,X-ray structure of furin (PCSK3) in complex with Guanidinomethyl-Phac-R-Tle-K-6-(aminomethyl)-3-amino-isoindol,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHH,Protein,480,polypeptide(L),1,52.112,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,485,2,2,Hetero 2-mer,"A1, B1",CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.6465466641464552,3.49726e-11,BioGRID ORCS,149575,8OYH,X-RAY DIFFRACTION,3.76,67.27,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NAH2PO4, PH 5.5, 2 M NACL; RESERVOIR SOLUTION: 3.0-3.2M NACL",293.15,2023-05-04,2024-03-13,4092,2,485,340.0,4,53.27,2,1.8,experimental,36.56,0.188,0.1735,X-ray structure of furin (PCSK3) in complex with Guanidinomethyl-Phac-Can-Tle-Can-6-(aminomethyl)-3-amino-isoindol,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHH,Protein,480,polypeptide(L),1,52.112,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,485,2,2,Hetero 2-mer,"A1, B1",CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.6465466641464552,3.49726e-11,BioGRID ORCS,149575,4Z2A,X-RAY DIFFRACTION,2.36,47.94,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"Well 13% PEG 8K, 0.110M K-dihydrogen phosphate, 0.1M HEPES pH 7.5, 350 uL protein with 350uL well drops, MRC sitting drop",277.0,2015-03-29,2016-05-04,4016,1,465,408.0,4,50.92,1,1.89,experimental,16.9953,0.1834,0.1479,Crystal structure of unglycosylated apo human furin @1.89A,YQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKDLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQDWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTA,Protein,465,polypeptide(L),1,50.506,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,465,1,1,Monomer,A1,EDO,C2 H6 O2,62.068,"1,2-ETHANEDIOL","InChI=1S/C2H6O2/c3-1-2-4/h3-4H,1-2H2",
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.6465466641464552,3.49726e-11,BioGRID ORCS,149575,7O1U,X-RAY DIFFRACTION,3.74,67.12,"VAPOR DIFFUSION, SITTING DROP",5.5,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NAH2PO4, PH 5.5, 2 M NACL; RESERVOIR SOLUTION: 3.0-3.2M NACL",293.15,2021-03-30,2021-09-01,4375,1,480,519.0,4,53.19,1,1.7,experimental,26.23,0.1666,0.155,X-ray structure of furin in complex with the guanylhydrazone-based inhibitor 1 (BEV241),DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHH,Protein,480,polypeptide(L),1,52.112,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,480,1,1,Monomer,A1,Desconocido,Na,22.99,SODIUM ION,InChI=1S/Na/q+1,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.6465466641464552,3.49726e-11,BioGRID ORCS,149575,7O1W,X-RAY DIFFRACTION,3.74,67.1,"VAPOR DIFFUSION, SITTING DROP",5.5,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NAH2PO4, PH 5.5, 2 M NACL; RESERVOIR SOLUTION: 3.0-3.2M NACL",293.15,2021-03-30,2021-09-01,4335,1,480,424.0,4,53.69,1,1.8,experimental,29.36,0.1791,0.16,X-ray structure of furin in complex with the guanylhydrazone-based inhibitor 2 (mi307) soaked at 1 M NaCl,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHH,Protein,480,polypeptide(L),1,52.112,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,480,1,1,Monomer,A1,CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.6465466641464552,3.49726e-11,BioGRID ORCS,149575,7O1Y,X-RAY DIFFRACTION,3.72,66.95,"VAPOR DIFFUSION, SITTING DROP",5.5,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NAH2PO4, PH 5.5, 2 M NACL; RESERVOIR SOLUTION: 3.0-3.2M NACL",293.15,2021-03-30,2021-09-01,4321,1,480,475.0,4,53.91,1,1.7,experimental,29.48,0.177,0.1622,X-ray structure of furin in complex with the guanylhydrazone-based inhibitor 2 (mi307) soaked at 0.25 M NaCl,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHH,Protein,480,polypeptide(L),1,52.112,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,480,1,1,Monomer,A1,CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.6465466641464552,3.49726e-11,BioGRID ORCS,149575,7O20,X-RAY DIFFRACTION,3.67,66.48,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NAH2PO4, PH 5.5, 2 M NACL; RESERVOIR SOLUTION: 3.0-3.2M NACL",293.15,2021-03-30,2021-09-01,4190,1,480,376.0,4,53.54,1,1.8,experimental,33.26,0.1761,0.1624,X-ray structure of furin in complex with the guanylhydrazone-based inhibitor 3 (mi300),DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHH,Protein,480,polypeptide(L),1,52.112,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,480,1,1,Monomer,A1,CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.6465466641464552,3.49726e-11,BioGRID ORCS,149575,7O22,X-RAY DIFFRACTION,3.69,66.7,"VAPOR DIFFUSION, SITTING DROP",5.5,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NAH2PO4, PH 5.5, 2 M NACL; RESERVOIR SOLUTION: 3.0-3.2M NACL",293.15,2021-03-30,2021-09-01,4130,1,480,427.0,4,53.15,1,1.8,experimental,33.5,0.1825,0.169,X-ray structure of furin in complex with the guanylhydrazone-based inhibitor 4 (mi359),DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHH,Protein,480,polypeptide(L),1,52.112,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,480,1,1,Monomer,A1,CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.6465466641464552,3.49726e-11,BioGRID ORCS,149575,7QY0,X-RAY DIFFRACTION,3.72,66.91,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NAH2PO4, PH 5.5, 2 M NACL; RESERVOIR SOLUTION: 3.0-3.2M NACL",293.15,2022-01-27,2022-04-20,4378,1,480,476.0,4,53.68,1,1.54,experimental,26.16,0.1725,0.1493,X-ray structure of furin in complex with the dichlorophenylpyridine-based inhibitor 1,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHH,Protein,480,polypeptide(L),1,52.112,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,480,1,1,Monomer,A1,I0T,C32 H42 Cl2 N6 O3,629.62,"N-[[1-[[2-[3,5-bis(chloranyl)phenyl]-6-[6-[4-(2-methoxyethyl)piperazin-4-ium-1-yl]pyridin-3-yl]oxy-pyridin-4-yl]methyl]piperidin-1-ium-4-yl]methyl]ethanamide","InChI=1S/C32H40Cl2N6O3/c1-23(41)35-20-24-5-7-39(8-6-24)22-25-15-30(26-17-27(33)19-28(34)18-26)37-32(16-25)43-29-3-4-31(36-21-29)40-11-9-38(10-12-40)13-14-42-2/h3-4,15-19,21,24H,5-14,20,22H2,1-2H3,(H,35,41)/p+2",
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.6465466641464552,3.49726e-11,BioGRID ORCS,149575,7QY1,X-RAY DIFFRACTION,2.568825997777984,50.34669344500458,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NAH2PO4, PH 5.5, 2 M NACL; RESERVOIR SOLUTION: 3.0-3.2M NACL",293.15,2022-01-27,2022-04-20,4387,1,480,483.0,4,53.77,1,1.45,experimental,25.78,0.1754,0.1502,X-ray structure of furin in complex with the dichlorophenylpyridine-based inhibitor 4,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHH,Protein,480,polypeptide(L),1,52.112,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,480,1,1,Monomer,A1,I0W,C32 H39 Cl2 N6 O4,642.596,"3-[4-[5-[4-[[4-(acetamidomethyl)piperidin-1-ium-1-yl]methyl]-6-[3,5-bis(chloranyl)phenyl]pyridin-2-yl]oxypyridin-2-yl]piperazin-1-ium-1-yl]propanoate","InChI=1S/C32H38Cl2N6O4/c1-22(41)35-19-23-4-7-39(8-5-23)21-24-14-29(25-16-26(33)18-27(34)17-25)37-31(15-24)44-28-2-3-30(36-20-28)40-12-10-38(11-13-40)9-6-32(42)43/h2-3,14-18,20,23H,4-13,19,21H2,1H3,(H,35,41)(H,42,43)/p+1",
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.6465466641464552,3.49726e-11,BioGRID ORCS,149575,7QY2,X-RAY DIFFRACTION,3.71,66.87,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NAH2PO4, PH 5.5, 2 M NACL; RESERVOIR SOLUTION: 3.0-3.2M NACL",293.15,2022-01-27,2022-04-20,4373,1,480,471.0,4,53.72,1,1.55,experimental,27.19,0.1877,0.1645,X-ray structure of furin in complex with the dichlorophenylpyridine-based inhibitor 2,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHH,Protein,480,polypeptide(L),1,52.112,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,480,1,1,Monomer,A1,I0Q,C33 H42 Cl2 N7 O4,671.637,"(2R)-4-[4-[5-[4-[[4-(acetamidomethyl)piperidin-1-ium-1-yl]methyl]-6-[3,5-bis(chloranyl)phenyl]pyridin-2-yl]oxypyrimidin-2-yl]piperazin-1-ium-1-yl]-2-methyl-butanoate","InChI=1S/C33H41Cl2N7O4/c1-22(32(44)45)3-6-40-9-11-42(12-10-40)33-37-19-29(20-38-33)46-31-14-25(13-30(39-31)26-15-27(34)17-28(35)16-26)21-41-7-4-24(5-8-41)18-36-23(2)43/h13-17,19-20,22,24H,3-12,18,21H2,1-2H3,(H,36,43)(H,44,45)/p+1/t22-/m1/s1",
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.6465466641464552,3.49726e-11,BioGRID ORCS,149575,7LCU,X-RAY DIFFRACTION,2.25,45.43,VAPOR DIFFUSION,7.5,"PEG8000, potassium dihydrogen phosphate",277.0,2021-01-11,2022-01-12,4057,1,490,352.0,5,54.37,1,1.24,experimental,14.5,0.1944,0.1764,"X-ray structure of Furin bound to BOS-318, a small molecule inhibitor",DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKDLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQDWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTAGENLYFQGDYKDDDDKGHHHHHH,Protein,490,polypeptide(L),1,53.512,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,490,1,1,Monomer,A1,CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.6465466641464552,3.49726e-11,BioGRID ORCS,149575,6HLB,X-RAY DIFFRACTION,3.77,67.33,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NaH2PO4, PH 5.5-6.0, 2 M NaCL, 3% DMSO; RESERVOIR SOLUTION: 3-4M NaCL",293.15,2018-09-11,2019-02-06,4028,2,491,338.0,3,54.39,2,2.0,experimental,39.57218347825871,0.1874,0.1686,X-ray structure of furin in complex with the cyclic peptide c[succinyl-Phe-2-Nal-(Arg)4-Lys]-Arg-4-Amba,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHHHH,Protein,482,polypeptide(L),1,52.389,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,491,2,2,Hetero 2-mer,"A1, B1",CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.6465466641464552,3.49726e-11,BioGRID ORCS,149575,6HLD,X-RAY DIFFRACTION,3.78,67.46,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NaH2PO4, PH 5.5-6.0, 2 M NaCL, 3% DMSO; RESERVOIR SOLUTION: 3-4M NaCL",293.15,2018-09-11,2019-02-06,4067,2,489,343.0,3,54.06,2,2.1,experimental,39.57218347825871,0.1959,0.17,X-ray structure of furin in complex with the cyclic peptide c[succinyl-Phe-2-Nal-(Arg)3-Lys]-Lys-4-Amba,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHHHH,Protein,482,polypeptide(L),1,52.389,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,489,2,2,Hetero 2-mer,"A1, B1",CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.6465466641464552,3.49726e-11,BioGRID ORCS,149575,6HLE,X-RAY DIFFRACTION,3.84,68.01,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NaH2PO4, PH 5.5-6.0, 2 M NaCL, 3% DMSO; RESERVOIR SOLUTION: 3-4M NaCL",293.15,2018-09-11,2019-02-06,4127,2,488,390.0,3,53.91,2,1.994,experimental,39.57218347825871,0.1908,0.1667,X-ray structure of furin in complex with the P6-P2-cyclized peptide H-Lys-Arg-Arg-Tle-Lys-4-Amba,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHHHH,Protein,482,polypeptide(L),1,52.389,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,488,2,2,Hetero 2-mer,"A1, B1",CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.6465466641464552,3.49726e-11,BioGRID ORCS,149575,6HZA,X-RAY DIFFRACTION,3.64,66.19,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NaH2PO4, PH 5.5-6.0, 2 M NaCL, 3% DMSO; RESERVOIR SOLUTION: 3-4M NaCL",293.15,2018-10-23,2019-02-06,4150,2,487,416.0,3,53.73,2,1.9,experimental,39.57218347825871,0.1859,0.1661,X-ray structure of furin in complex with the cyclic peptide c[glutaryl-Arg-Arg-Lys]-Arg-4-Amba,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHHHH,Protein,482,polypeptide(L),1,52.389,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,487,2,2,Hetero 2-mer,"A1, B1",CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.6465466641464552,3.49726e-11,BioGRID ORCS,149575,6HZB,X-RAY DIFFRACTION,3.66,66.41,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NaH2PO4, PH 5.5-6.0, 2 M NaCL, 3% DMSO; RESERVOIR SOLUTION: 3-4M NaCL",293.15,2018-10-23,2019-02-06,4150,2,487,418.0,3,53.7,2,1.9,experimental,39.57218347825871,0.1824,0.1646,X-ray structure of furin in complex with the cyclic inhibitor c[glutaryl-Arg-Arg-Lys]-Lys-4-Amba,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHHHH,Protein,482,polypeptide(L),1,52.389,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,487,2,2,Hetero 2-mer,"A1, B1",CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.6465466641464552,3.49726e-11,BioGRID ORCS,149575,6HZD,X-RAY DIFFRACTION,3.64,66.22,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NaH2PO4, PH 5.5-6.0, 2 M NaCL, 3% DMSO; RESERVOIR SOLUTION: 3-4M NaCL",293.15,2018-10-23,2019-02-06,4163,2,488,418.0,3,53.89,2,1.9,experimental,39.57218347825871,0.1827,0.1641,X-ray structure of furin in complex with the cyclic inhibitor c[glutaryl-Arg-Arg-Arg-Lys]-Arg-4-Amba,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHHHH,Protein,482,polypeptide(L),1,52.389,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,488,2,2,Hetero 2-mer,"A1, B1",CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.6465466641464552,3.49726e-11,BioGRID ORCS,149575,6YD2,X-RAY DIFFRACTION,3.7,66.74,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100MM MES, 200MM K/NAH2PO4, PH 5.5-6.0, 2 M NACL; RESERVOIR SOLUTION: 3-4M NACL",293.15,2020-03-20,2021-02-17,4179,2,487,444.0,3,53.58,2,1.8,experimental,32.05,0.1771,0.1575,X-ray structure of furin in complex with the canavanine-based inhibitor 4-aminomethyl-phenylacetyl-canavanine-Tle-Arg-Amba,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHHHH,Protein,482,polypeptide(L),1,52.389,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,487,2,2,Hetero 2-mer,"A1, B1",CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.6465466641464552,3.49726e-11,BioGRID ORCS,149575,6YD3,X-RAY DIFFRACTION,3.72,66.96,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100MM MES, 200MM K/NAH2PO4, PH 5.5-6.0, 2 M NACL; RESERVOIR SOLUTION: 3-4M NACL",293.15,2020-03-20,2021-02-17,4159,2,485,418.0,3,53.34,2,2.0,experimental,32.04,0.1854,0.1595,X-ray structure of furin in complex with the canavanine derived inhibitor 4-guanidinomethyl-phenylacetyl-Canavanine-Tle-Arg-Amba,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHH,Protein,480,polypeptide(L),1,52.112,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,485,2,2,Hetero 2-mer,"A1, B1",CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.6465466641464552,3.49726e-11,BioGRID ORCS,149575,6YD4,X-RAY DIFFRACTION,3.73,67.06,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100MM MES, 200MM K/NAH2PO4, PH 5.5-6.0, 2 M NACL; RESERVOIR SOLUTION: 3-4M NACL",291.15,2020-03-20,2021-02-17,4237,2,485,477.0,3,53.37,2,1.7,experimental,31.24,0.1694,0.1532,X-ray structure of furin in complex with the canavanine-based inhibitor 4-guanidinomethyl-phenylacetyl-Canavanine-Tle-Canavanine-Amba,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHH,Protein,480,polypeptide(L),1,52.112,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,485,2,2,Hetero 2-mer,"A1, B1",CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.6465466641464552,3.49726e-11,BioGRID ORCS,149575,6YD7,X-RAY DIFFRACTION,3.74,67.08,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100MM MES, 200MM K/NAH2PO4, PH 5.5-6.0, 2 M NACL; RESERVOIR SOLUTION: 3-4M NACL",291.15,2020-03-20,2021-02-17,4211,2,485,465.0,3,53.37,2,1.8,experimental,29.7,0.1709,0.1538,X-ray structure of furin in complex with the canavanine-based inhibitor 4-guanidinomethyl-phenylacetyl-Arg-Tle-Canavanine-Amba,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHH,Protein,480,polypeptide(L),1,52.112,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,485,2,2,Hetero 2-mer,"A1, B1",CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.6465466641464552,3.49726e-11,BioGRID ORCS,149575,7QXY,X-RAY DIFFRACTION,2.568825997777984,50.34669344500458,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NAH2PO4, PH 5.5, 2 M NACL; RESERVOIR SOLUTION: 3.0-3.2M NACL",293.15,2022-01-27,2022-04-20,4386,1,480,661.0,2,53.0,1,1.478,experimental,24.97,0.1823,0.1705,X-ray structure of furin in complex with the dichlorophenylpyridine-based inhibitor 3,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHH,Protein,480,polypeptide(L),1,52.112,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,480,1,1,Monomer,A1,CL,Cl,35.453,CHLORIDE ION,InChI=1S/ClH/h1H/p-1,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.6465466641464552,3.49726e-11,BioGRID ORCS,149575,4RYD,X-RAY DIFFRACTION,2.86,56.93,"VAPOR DIFFUSION, SITTING DROP",8.5,"50mM Tris, 2.8M sodium formate, 15mM Cymal-7, pH 8.5, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293.0,2014-12-15,2015-05-27,23768,12,2922,2034.0,18,320.52,2,2.15,experimental,39.57218347825871,0.2186,0.1862,X-ray structure of human furin in complex with the competitive inhibitor para-guanidinomethyl-Phac-R-Tle-R-Amba,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHHHH,Protein,482,polypeptide(L),6,52.389,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,487,2,2,Hetero 2-mer,"A1, B1",FMT,C H2 O2,46.025,FORMIC ACID,"InChI=1S/CH2O2/c2-1-3/h1H,(H,2,3)",
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.6465466641464552,3.49726e-11,BioGRID ORCS,149575,5JXH,X-RAY DIFFRACTION,3.67,66.49,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"crystallization solution: 100 mM MES, 200 mM K/NaH2PO4, pH 5.5-6.0, 3-4 M NaCl, 3% DMSO; reservoir solution: 3-4 M NaCl",293.15,2016-05-13,2016-10-05,4261,2,487,534.0,3,53.39,2,2.0,experimental,39.57218347825871,0.1853,0.1566,Structure the proprotein convertase furin in complex with meta-guanidinomethyl-Phac-RVR-Amba at 2.0 Angstrom resolution.,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHHHH,Protein,482,polypeptide(L),1,52.389,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,487,2,2,Hetero 2-mer,"A1, B1",CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.6465466641464552,3.49726e-11,BioGRID ORCS,149575,5JXG,X-RAY DIFFRACTION,3.73,67.05,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"crystallization solution: 100 mM MES, 200 mM K/NaH2PO4, pH 5.5-6.0, 3-4 M NaCl, 3% DMSO; reservoir solution: 3-4 M NaCl",293.15,2016-05-13,2016-10-05,4360,1,482,645.0,3,52.73,1,1.8,experimental,39.57218347825871,0.1733,0.154,Structure of the unliganded form of the proprotein convertase furin.,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHHHH,Protein,482,polypeptide(L),1,52.389,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,482,1,1,Monomer,A1,CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.6465466641464552,3.49726e-11,BioGRID ORCS,149575,5JXI,X-RAY DIFFRACTION,3.76,67.3,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"crystallization solution: 100 mM MES, 200 mM K/NaH2PO4, pH 5.5-6.0, 3-4 M NaCl, 3% DMSO; reservoir solution: 3-4 M NaCl",293.15,2016-05-13,2016-10-05,4164,1,482,521.0,3,52.63,1,2.0,experimental,39.57218347825871,0.1851,0.1576,Structure of the unliganded form of the proprotein convertase furin in presence of EDTA.,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHHHH,Protein,482,polypeptide(L),1,52.389,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,482,1,1,Monomer,A1,CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.6465466641464552,3.49726e-11,BioGRID ORCS,149575,5MIM,X-RAY DIFFRACTION,3.75,67.2,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100 MM MES, 200 MM K/NAH2PO4, PH 5.5-6.0, 3-4 M NACL, 3% DMSO; RESERVOIR SOLUTION: 3-4 M NACL",293.15,2016-11-28,2017-05-10,4275,1,482,486.0,3,53.81,1,1.9,experimental,39.57218347825871,0.1838,0.1647,"Xray structure of human furin bound with the 2,5-dideoxystreptamine derived small molecule inhibitor 1n",DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHHHH,Protein,482,polypeptide(L),1,52.389,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,482,1,1,Monomer,A1,CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.6465466641464552,3.49726e-11,BioGRID ORCS,149575,5JXJ,X-RAY DIFFRACTION,3.69,66.65,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"crystallization solution: 100 mM MES, 200 mM K/NaH2PO4, pH 5.5-6.0, 3-4 M NaCl, 3% DMSO; reservoir solution: 3-4 M NaCl",293.15,2016-05-13,2016-10-05,4185,2,487,461.0,3,53.35,2,2.0,experimental,39.57218347825871,0.1889,0.1668,Structure of the proprotein convertase furin complexed to meta-guanidinomethyl-Phac-RVR-Amba in presence of EDTA,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHHHH,Protein,482,polypeptide(L),1,52.389,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,487,2,2,Hetero 2-mer,"A1, B1",CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.6465466641464552,3.49726e-11,BioGRID ORCS,149575,6EQV,X-RAY DIFFRACTION,3.67,66.45,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NaH2PO4, PH 5.5-6.0, 3-4M NaCl, 3% DMSO; RESERVOIR SOLUTION: 3-4 M NaCl",293.15,2017-10-16,2018-02-28,4212,2,487,510.0,3,53.3,2,1.895,experimental,39.57218347825871,0.1821,0.1637,X-ray structure of the proprotein convertase furin bound with the competitive inhibitor Phac-Cit-Val-Arg-Amba,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHHHH,Protein,482,polypeptide(L),1,52.389,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,487,2,2,Hetero 2-mer,"A1, B1",CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.6465466641464552,3.49726e-11,BioGRID ORCS,149575,6EQW,X-RAY DIFFRACTION,3.66,66.42,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NaH2PO4, PH 5.5-6.0, 3-4 M NaCL, 3% DMSO; RESERVOIR SOLUTION: 3-4M NaCL",293.15,2017-10-16,2018-02-28,4183,2,487,486.0,3,53.36,2,1.994,experimental,39.57218347825871,0.1842,0.1619,X-ray structure of the proprotein convertase furin bound with the competitive inhibitor 4-aminomethyl-phenylacetyl-Arg-Val-Arg-Amba,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHHHH,Protein,482,polypeptide(L),1,52.389,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,487,2,2,Hetero 2-mer,"A1, B1",CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.6465466641464552,3.49726e-11,BioGRID ORCS,149575,6EQX,X-RAY DIFFRACTION,3.66,66.36,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"100mM MES, 200mM K/NaH2PO4, PH 5.5-6.0, 3-4 M NaCL, 3% DMSO; RESERVOIR SOLUTION: 3-4M NaCL",293.15,2017-10-16,2018-02-28,4186,2,488,471.0,3,53.51,2,1.994,experimental,39.57218347825871,0.1837,0.162,X-ray structure of the proprotein convertase furin bound with the competitive inhibitor Arg-Arg-Arg-Val-Arg-Amba,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHHHH,Protein,482,polypeptide(L),1,52.389,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,488,2,2,Hetero 2-mer,"A1, B1",CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
147111,ENTREZ_GENE,notum,hNOTUM,Homo sapiens,0.7158547003498507,3.49726e-11,BioGRID ORCS,155461,4UZ1,X-RAY DIFFRACTION,1.9,34.0,Desconocido,4.6,"1.5 M AMMONIUM SULPHATE, 0.1 M SODIUM ACETATE PH 4.6",289.6514371309434,2014-09-04,2015-02-25,3212,1,383,287.0,7,44.17,1,1.4,experimental,18.766,0.18045,0.14387,STRUCTURE OF THE WNT DEACYLASE NOTUM - CRYSTAL FORM III - 1.4A,ETGSAQQLNEDLRLHLLLNTSVTCNDGSPAGYYLKESRGSRRWLLFLEGGWYCFNRENCDSRYDTMRRLMSSRDWPRTRTGTGILSSQPEENPYWWNANMVFIPYCSSDVWSGASSKSEKNEYAFMGALIIQEVVRELLGRGLSGAKVLLLAGSSAGGTGVLLNVDRVAEQLEKLGYPAIQVRGLADSGWFLDNKQYRHTDCVDTITCAPTEAIRRGIRYWNGVVPERCRRQFQEGEEWNCFFGYKVYPTLRSPVFVVQWLFDEAQLTVDNVHLTGQPVQEGLRLYIQNLGRELRHTLKDVPASFAPACLSHEIIIRSHWTDVQVKGTSLPRALHCWDRSLHDSHKASKTPLKGCPVHLVDSCPWPHCNPSCPTGTKHHHHHH,Protein,383,polypeptide(L),1,43.567,notum,3.1.1.1,PDB Primary Data,Homo sapiens,9606,383,1,1,Monomer,A1,NAG,C8 H15 N O6,221.208,2-acetamido-2-deoxy-beta-D-glucopyranose,"InChI=1S/C8H15NO6/c1-3(11)9-5-7(13)6(12)4(2-10)15-8(5)14/h4-8,10,12-14H,2H2,1H3,(H,9,11)/t4-,5-,6-,7-,8-/m1/s1",
147111,ENTREZ_GENE,notum,hNOTUM,Homo sapiens,0.7158547003498507,3.49726e-11,BioGRID ORCS,155461,4UZ5,X-RAY DIFFRACTION,2.5,52.0,Desconocido,6.0,"10 %W/V PEG4000, 0.01 M CACL2, 0.05 M NACACOD PH 6.0, 0.20 M KCL, 1 MM HEPARIN HEXAMER",289.6514371309434,2014-09-04,2015-02-25,2901,1,383,84.0,7,43.82,1,2.1,experimental,43.492,0.2371,0.18746,STRUCTURE OF THE WNT DEACYLASE NOTUM - CRYSTAL FORM IV - 2.1A,ETGSAQQLNEDLRLHLLLNTSVTCNDGSPAGYYLKESRGSRRWLLFLEGGWYCFNRENCDSRYDTMRRLMSSRDWPRTRTGTGILSSQPEENPYWWNANMVFIPYCSSDVWSGASSKSEKNEYAFMGALIIQEVVRELLGRGLSGAKVLLLAGSSAGGTGVLLNVDRVAEQLEKLGYPAIQVRGLADSGWFLDNKQYRHTDCVDTITCAPTEAIRRGIRYWNGVVPERCRRQFQEGEEWNCFFGYKVYPTLRSPVFVVQWLFDEAQLTVDNVHLTGQPVQEGLRLYIQNLGRELRHTLKDVPASFAPACLSHEIIIRSHWTDVQVKGTSLPRALHCWDRSLHDSHKASKTPLKGCPVHLVDSCPWPHCNPSCPTGTKHHHHHH,Protein,383,polypeptide(L),1,43.567,notum,3.1.1.1,PDB Primary Data,Homo sapiens,9606,383,1,1,Monomer,A1,NAG,C8 H15 N O6,221.208,2-acetamido-2-deoxy-beta-D-glucopyranose,"InChI=1S/C8H15NO6/c1-3(11)9-5-7(13)6(12)4(2-10)15-8(5)14/h4-8,10,12-14H,2H2,1H3,(H,9,11)/t4-,5-,6-,7-,8-/m1/s1",
25340,ENTREZ_GENE,fyn,SLKSYNp59FYN,Homo sapiens,0.6147638006820194,3.49726e-11,BioGRID ORCS,155727,6EDF,X-RAY DIFFRACTION,2.0,37.6,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"20% PEG3350, 0.2 M magnesium acetate",291.0,2018-08-09,2018-08-29,693,1,79,61.0,0,8.94,1,1.4,experimental,12.097,0.1721,0.1434,Fragment of a tyrosine-protein kinase,GGVTLFVALYDYEARTEDDISVHKGEKVQILNSSEGDWWEVRSLTTGETGYVPSNYVAPVDGSAAMGPVLRLRAFYNGG,Protein,79,polypeptide(L),1,8.591,fyn,2.7.10.2,PDB Primary Data,Homo sapiens,9606,79,1,1,Monomer,A1,GOL,C3 H8 O3,92.094,GLYCEROL,"InChI=1S/C3H8O3/c4-1-3(6)2-5/h3-6H,1-2H2",
13870,ENTREZ_GENE,crebbp,CBPKAT3ARSTSRSTS1,Homo sapiens,0.6103940475630197,3.49726e-11,BioGRID ORCS,156326,6YIK,X-RAY DIFFRACTION,3.42,64.06,"VAPOR DIFFUSION, SITTING DROP",7.5,"21% PEG3350
15% ethylene glycol
0.25M sodium formate",277.0,2020-04-01,2020-04-15,3453,3,357,385.0,0,44.74,1,1.7,experimental,32.625,0.184,0.156,Crystal structure of the CREBBP bromodomain in complex with a tetrahydroquinoxaline ligand,SMRKKIFKPEELRQALMPTLEALYRQDPESLPFRQPVDPQLLGIPDYFDIVKNPMDLSTIKRKLDTGQYQEPWQYVDDVWLMFNNAWLYNRKTSRVYKFCSKLAEVFEQEIDPVMQSLG,Protein,119,polypeptide(L),3,14.223,crebbp,2.3.1.48,PDB Primary Data,Homo sapiens,9606,119,1,1,Monomer,A1,OSQ,C22 H24 F2 N4 O2,414.448,"(3~{R})-~{N}-[3-(3,4-dihydro-2~{H}-quinolin-1-yl)-2,2-bis(fluoranyl)propyl]-3-methyl-2-oxidanylidene-3,4-dihydro-1~{H}-quinoxaline-5-carboxamide","InChI=1S/C22H24F2N4O2/c1-14-20(29)27-17-9-4-8-16(19(17)26-14)21(30)25-12-22(23,24)13-28-11-5-7-15-6-2-3-10-18(15)28/h2-4,6,8-10,14,26H,5,7,11-13H2,1H3,(H,25,30)(H,27,29)/t14-/m1/s1",
13870,ENTREZ_GENE,crebbp,CBPKAT3ARSTSRSTS1,Homo sapiens,0.6103940475630197,3.49726e-11,BioGRID ORCS,156326,6SXX,X-RAY DIFFRACTION,2.18,43.67,"VAPOR DIFFUSION, HANGING DROP",6.982430939226492,"25% PEG3350, 0.2 M Potassium thiocyanate, 5% EtGly",277.0,2019-09-26,2020-07-29,1940,2,238,81.0,0,28.95,1,2.01,experimental,52.99,0.2533,0.1955,Crystal structure of the bromodomain of human CREBBP in complex with ACA007,SMRKKIFKPEELRQALMPTLEALYRQDPESLPFRQPVDPQLLGIPDYFDIVKNPMDLSTIKRKLDTGQYQEPWQYVDDVWLMFNNAWLYNRKTSRVYKFCSKLAEVFEQEIDPVMQSLG,Protein,119,polypeptide(L),2,14.223,crebbp,2.3.1.48,PDB Primary Data,Homo sapiens,9606,119,1,1,Monomer,A1,EDO,C2 H6 O2,62.068,"1,2-ETHANEDIOL","InChI=1S/C2H6O2/c3-1-2-4/h3-4H,1-2H2",
13870,ENTREZ_GENE,crebbp,CBPKAT3ARSTSRSTS1,Homo sapiens,0.6103940475630197,3.49726e-11,BioGRID ORCS,156326,6YIL,X-RAY DIFFRACTION,2.2,44.01,"VAPOR DIFFUSION, SITTING DROP",7.5,"20% PEG3350
10% ethylene glycol
0.2M sodium acetate",277.0,2020-04-01,2020-04-15,1160,1,119,154.0,0,14.64,1,1.22,experimental,12.75,0.1511,0.1321,Crystal structure of the CREBBP bromodomain in complex with a tetrahydroquinoxaline ligand,SMRKKIFKPEELRQALMPTLEALYRQDPESLPFRQPVDPQLLGIPDYFDIVKNPMDLSTIKRKLDTGQYQEPWQYVDDVWLMFNNAWLYNRKTSRVYKFCSKLAEVFEQEIDPVMQSLG,Protein,119,polypeptide(L),1,14.223,crebbp,2.3.1.48,PDB Primary Data,Homo sapiens,9606,119,1,1,Monomer,A1,OSQ,C22 H24 F2 N4 O2,414.448,"(3~{R})-~{N}-[3-(3,4-dihydro-2~{H}-quinolin-1-yl)-2,2-bis(fluoranyl)propyl]-3-methyl-2-oxidanylidene-3,4-dihydro-1~{H}-quinoxaline-5-carboxamide","InChI=1S/C22H24F2N4O2/c1-14-20(29)27-17-9-4-8-16(19(17)26-14)21(30)25-12-22(23,24)13-28-11-5-7-15-6-2-3-10-18(15)28/h2-4,6,8-10,14,26H,5,7,11-13H2,1H3,(H,25,30)(H,27,29)/t14-/m1/s1",
13870,ENTREZ_GENE,crebbp,CBPKAT3ARSTSRSTS1,Homo sapiens,0.6103940475630197,3.49726e-11,BioGRID ORCS,156326,6YIM,X-RAY DIFFRACTION,2.2,44.12,"VAPOR DIFFUSION, SITTING DROP",7.5,"20% PEG3350
10% ethylene glycol
0.2M sodium fluoride",277.0,2020-04-01,2020-04-15,1174,1,119,163.0,0,14.65,1,1.23,experimental,12.85,0.167,0.1397,Crystal structure of the CREBBP bromodomain in complex with a benzo-diazepine ligand,SMRKKIFKPEELRQALMPTLEALYRQDPESLPFRQPVDPQLLGIPDYFDIVKNPMDLSTIKRKLDTGQYQEPWQYVDDVWLMFNNAWLYNRKTSRVYKFCSKLAEVFEQEIDPVMQSLG,Protein,119,polypeptide(L),1,14.223,crebbp,2.3.1.48,PDB Primary Data,Homo sapiens,9606,119,1,1,Monomer,A1,OS8,C24 H30 N4 O3,422.52,"(4~{R})-~{N}-[3-(7-methoxy-3,4-dihydro-2~{H}-quinolin-1-yl)propyl]-4-methyl-2-oxidanylidene-1,3,4,5-tetrahydro-1,5-benzodiazepine-6-carboxamide","InChI=1S/C24H30N4O3/c1-16-14-22(29)27-20-8-3-7-19(23(20)26-16)24(30)25-11-5-13-28-12-4-6-17-9-10-18(31-2)15-21(17)28/h3,7-10,15-16,26H,4-6,11-14H2,1-2H3,(H,25,30)(H,27,29)/t16-/m1/s1",
13870,ENTREZ_GENE,crebbp,CBPKAT3ARSTSRSTS1,Homo sapiens,0.6103940475630197,3.49726e-11,BioGRID ORCS,156326,6YIJ,X-RAY DIFFRACTION,2.95,58.37,"VAPOR DIFFUSION, SITTING DROP",8.3,"20% ethylene glycol
21% PEG6K
0.1M tris pH 8.3
0.125M lithium chloride",277.0,2020-04-01,2020-04-15,7177,7,833,224.0,0,102.4,1,2.2,experimental,44.856,0.2693,0.2022,Crystal structure of the CREBBP bromodomain in complex with a benzo-diazepine ligand,SMRKKIFKPEELRQALMPTLEALYRQDPESLPFRQPVDPQLLGIPDYFDIVKNPMDLSTIKRKLDTGQYQEPWQYVDDVWLMFNNAWLYNRKTSRVYKFCSKLAEVFEQEIDPVMQSLG,Protein,119,polypeptide(L),7,14.223,crebbp,2.3.1.48,PDB Primary Data,Homo sapiens,9606,119,1,1,Monomer,A1,OSN,C25 H31 N3 O2,405.533,"(4~{R})-6-[(~{E})-5-(7-methoxy-3,4-dihydro-2~{H}-quinolin-1-yl)pent-1-enyl]-4-methyl-1,3,4,5-tetrahydro-1,5-benzodiazepin-2-one","InChI=1S/C25H31N3O2/c1-18-16-24(29)27-22-11-6-9-20(25(22)26-18)8-4-3-5-14-28-15-7-10-19-12-13-21(30-2)17-23(19)28/h4,6,8-9,11-13,17-18,26H,3,5,7,10,14-16H2,1-2H3,(H,27,29)/b8-4+/t18-/m1/s1",
57710,ENTREZ_GENE,ptpn2,PTN2PTPTTCPTPTCELLPTPTCPTP,Homo sapiens,0.6131297281353719,3.49726e-11,BioGRID ORCS,158692,8U0H,X-RAY DIFFRACTION,2.41,49.06,"VAPOR DIFFUSION, HANGING DROP",6.9,"0.49M Sodium phosphate monobasic monohydrate, 0.91M Potassium phosphate dibasic",296.0,2023-08-29,2024-09-04,5135,2,648,385.0,0,78.03,1,1.93,experimental,38.32,0.1917,0.1726,Crystal structure of PTPN2 with a PROTAC,MAMPTTIEREFEELDTQRRWQPLYLEIRNESHDYPHRVAKFPENRNRNRYRDVSPYDHSRVKLQNAENDYINASLVDIEEAQRSYILTQGPLPNTCCHFWLMVWQQKTKAVVMLNRIVEKESVKCAQYWPTDDQEMLFKETGFSVKLLSEDVKSYYTVHLLQLENINSGETRTISHFHYTTWPDFGVPESPASFLNFLFKVRESGSLNPDHGPAVIHCSAGIGRSGTFSLVDTCLVLMEKGDDINIKQVLLNMRKYRMGLIQTPDQLRFSYMAIIEGAKCIKGDSSIQKRWKELSKEDLSPAFDHSPNKIMTEKYNHHHHHHHH,Protein,324,polypeptide(L),2,37.966,ptpn2,3.1.3.48,PDB Primary Data,Homo sapiens,9606,324,1,1,Monomer,A1,UB0,C46 H49 Cl N6 O12 S2,977.497,"(5P)-3-(carboxymethoxy)-4-chloro-5-(3-{[(4S)-1-({3-[2-(4-{3-[(3R)-2,6-dioxopiperidin-3-yl]-2-oxo-2,3-dihydro-1,3-benzoxazol-6-yl}piperidin-1-yl)acetamido]phenyl}methanesulfonyl)-2,2-dimethylpiperidin-4-yl]amino}phenyl)thiophene-2-carboxylic acid","InChI=1S/C46H49ClN6O12S2/c1-46(2)22-32(48-31-8-4-6-29(20-31)41-39(47)40(64-24-38(56)57)42(66-41)44(59)60)15-18-52(46)67(62,63)25-26-5-3-7-30(19-26)49-37(55)23-51-16-13-27(14-17-51)28-9-10-33-35(21-28)65-45(61)53(33)34-11-12-36(54)50-43(34)58/h3-10,19-21,27,32,34,48H,11-18,22-25H2,1-2H3,(H,49,55)(H,56,57)(H,59,60)(H,50,54,58)/t32-,34+/m0/s1",
41930,ENTREZ_GENE,mdm2,ACTFSHDMXhdm2,Homo sapiens,0.613848350407956,3.49726e-11,BioGRID ORCS,160083,4UD7,X-RAY DIFFRACTION,2.8,56.0,Desconocido,4.0,0.1 M SODIUM CITRATE PH 4.0 AND 15 % PEG8000,289.6514371309434,2014-12-08,2016-01-13,4008,8,520,262.0,0,58.68,2,1.6,experimental,23.018,0.17838,0.13846,Structure of the stapled peptide YS-02 bound to MDM2,GPLGSSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDAAQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSEN,Protein,114,polypeptide(L),4,12.831,mdm2,6.3.2,PDB Primary Data,Homo sapiens,9606,130,2,2,Hetero 2-mer,"A1, B1",Desconocido,Desconocido,246.2971348233669,Desconocido,Desconocido,
563390,ENTREZ_GENE,mettl3,IME4M6AMTA70Spo8hMETTL3,Homo sapiens,0.614826297859643,3.49726e-11,BioGRID ORCS,162812,5IL1,X-RAY DIFFRACTION,2.58,52.33,"VAPOR DIFFUSION, HANGING DROP",5.7,"PEG 8000, sodium citrate",291.0,2016-03-04,2016-05-25,4336,2,512,337.0,0,59.81,2,1.71,experimental,39.57218347825871,0.2069,0.1798,Crystal structure of SAM-bound METTL3-METTL14 complex,FPPQWICCDIRYLDVSILGKFAVVMADPPWDIHMELPYGTLTDDEMRRLNIPVLQDDGFLFLWVTGRAMELGRECLNLWGYERVDEIIWVKTNQLQRIIRTGRTGHWLNHGKEHCLVGVKGNPQGFNQGLDCDVIVAEVRSTSHKPDEIYGMIERLSPGTRKIELFGRPHNVQPNWITLGNQLDGIHLLDPDVVARFKQRYPDGIISKPKNL,Protein,212,polypeptide(L),1,24.427,mettl3,2.1.1.62,PDB Primary Data,Homo sapiens,9606,512,2,2,Hetero 2-mer,"A1, B1",SAM,C15 H22 N6 O5 S,398.437,S-ADENOSYLMETHIONINE,"InChI=1S/C15H22N6O5S/c1-27(3-2-7(16)15(24)25)4-8-10(22)11(23)14(26-8)21-6-20-9-12(17)18-5-19-13(9)21/h5-8,10-11,14,22-23H,2-4,16H2,1H3,(H2-,17,18,19,24,25)/t7-,8+,10+,11+,14+,27-/m0/s1",
563390,ENTREZ_GENE,mettl3,IME4M6AMTA70Spo8hMETTL3,Homo sapiens,0.614826297859643,3.49726e-11,BioGRID ORCS,162812,5IL0,X-RAY DIFFRACTION,2.55,51.69,"VAPOR DIFFUSION, HANGING DROP",5.7,"PEG 8000, sodium citrate",291.0,2016-03-04,2016-05-25,4347,2,512,331.0,0,59.43,2,1.882,experimental,39.57218347825871,0.205,0.1747,Crystal structural of the METTL3-METTL14 complex for N6-adenosine methylation,FPPQWICCDIRYLDVSILGKFAVVMADPPWDIHMELPYGTLTDDEMRRLNIPVLQDDGFLFLWVTGRAMELGRECLNLWGYERVDEIIWVKTNQLQRIIRTGRTGHWLNHGKEHCLVGVKGNPQGFNQGLDCDVIVAEVRSTSHKPDEIYGMIERLSPGTRKIELFGRPHNVQPNWITLGNQLDGIHLLDPDVVARFKQRYPDGIISKPKNL,Protein,212,polypeptide(L),1,24.427,mettl3,2.1.1.62,PDB Primary Data,Homo sapiens,9606,512,2,2,Hetero 2-mer,"A1, B1",EDO,C2 H6 O2,62.068,"1,2-ETHANEDIOL","InChI=1S/C2H6O2/c3-1-2-4/h3-4H,1-2H2",
563390,ENTREZ_GENE,mettl3,IME4M6AMTA70Spo8hMETTL3,Homo sapiens,0.614826297859643,3.49726e-11,BioGRID ORCS,162812,5IL2,X-RAY DIFFRACTION,2.66,53.7,"VAPOR DIFFUSION, HANGING DROP",5.7,"PEG 8000, sodium citrate",291.0,2016-03-04,2016-05-25,4393,2,512,376.0,1,59.85,2,1.606,experimental,39.57218347825871,0.1992,0.1848,Crystal structure of SAH-bound METTL3-METTL14 complex,FPPQWICCDIRYLDVSILGKFAVVMADPPWDIHMELPYGTLTDDEMRRLNIPVLQDDGFLFLWVTGRAMELGRECLNLWGYERVDEIIWVKTNQLQRIIRTGRTGHWLNHGKEHCLVGVKGNPQGFNQGLDCDVIVAEVRSTSHKPDEIYGMIERLSPGTRKIELFGRPHNVQPNWITLGNQLDGIHLLDPDVVARFKQRYPDGIISKPKNL,Protein,212,polypeptide(L),1,24.427,mettl3,2.1.1.62,PDB Primary Data,Homo sapiens,9606,512,2,2,Hetero 2-mer,"A1, B1",EDO,C2 H6 O2,62.068,"1,2-ETHANEDIOL","InChI=1S/C2H6O2/c3-1-2-4/h3-4H,1-2H2",
1471110,ENTREZ_GENE,notum,hNOTUM,Homo sapiens,0.6150802879138269,3.49726e-11,BioGRID ORCS,163829,4UZ1,X-RAY DIFFRACTION,1.9,34.0,Desconocido,4.6,"1.5 M AMMONIUM SULPHATE, 0.1 M SODIUM ACETATE PH 4.6",289.6514371309434,2014-09-04,2015-02-25,3212,1,383,287.0,7,44.17,1,1.4,experimental,18.766,0.18045,0.14387,STRUCTURE OF THE WNT DEACYLASE NOTUM - CRYSTAL FORM III - 1.4A,ETGSAQQLNEDLRLHLLLNTSVTCNDGSPAGYYLKESRGSRRWLLFLEGGWYCFNRENCDSRYDTMRRLMSSRDWPRTRTGTGILSSQPEENPYWWNANMVFIPYCSSDVWSGASSKSEKNEYAFMGALIIQEVVRELLGRGLSGAKVLLLAGSSAGGTGVLLNVDRVAEQLEKLGYPAIQVRGLADSGWFLDNKQYRHTDCVDTITCAPTEAIRRGIRYWNGVVPERCRRQFQEGEEWNCFFGYKVYPTLRSPVFVVQWLFDEAQLTVDNVHLTGQPVQEGLRLYIQNLGRELRHTLKDVPASFAPACLSHEIIIRSHWTDVQVKGTSLPRALHCWDRSLHDSHKASKTPLKGCPVHLVDSCPWPHCNPSCPTGTKHHHHHH,Protein,383,polypeptide(L),1,43.567,notum,3.1.1.1,PDB Primary Data,Homo sapiens,9606,383,1,1,Monomer,A1,NAG,C8 H15 N O6,221.208,2-acetamido-2-deoxy-beta-D-glucopyranose,"InChI=1S/C8H15NO6/c1-3(11)9-5-7(13)6(12)4(2-10)15-8(5)14/h4-8,10,12-14H,2H2,1H3,(H,9,11)/t4-,5-,6-,7-,8-/m1/s1",
1471110,ENTREZ_GENE,notum,hNOTUM,Homo sapiens,0.6150802879138269,3.49726e-11,BioGRID ORCS,163829,4UZ5,X-RAY DIFFRACTION,2.5,52.0,Desconocido,6.0,"10 %W/V PEG4000, 0.01 M CACL2, 0.05 M NACACOD PH 6.0, 0.20 M KCL, 1 MM HEPARIN HEXAMER",289.6514371309434,2014-09-04,2015-02-25,2901,1,383,84.0,7,43.82,1,2.1,experimental,43.492,0.2371,0.18746,STRUCTURE OF THE WNT DEACYLASE NOTUM - CRYSTAL FORM IV - 2.1A,ETGSAQQLNEDLRLHLLLNTSVTCNDGSPAGYYLKESRGSRRWLLFLEGGWYCFNRENCDSRYDTMRRLMSSRDWPRTRTGTGILSSQPEENPYWWNANMVFIPYCSSDVWSGASSKSEKNEYAFMGALIIQEVVRELLGRGLSGAKVLLLAGSSAGGTGVLLNVDRVAEQLEKLGYPAIQVRGLADSGWFLDNKQYRHTDCVDTITCAPTEAIRRGIRYWNGVVPERCRRQFQEGEEWNCFFGYKVYPTLRSPVFVVQWLFDEAQLTVDNVHLTGQPVQEGLRLYIQNLGRELRHTLKDVPASFAPACLSHEIIIRSHWTDVQVKGTSLPRALHCWDRSLHDSHKASKTPLKGCPVHLVDSCPWPHCNPSCPTGTKHHHHHH,Protein,383,polypeptide(L),1,43.567,notum,3.1.1.1,PDB Primary Data,Homo sapiens,9606,383,1,1,Monomer,A1,NAG,C8 H15 N O6,221.208,2-acetamido-2-deoxy-beta-D-glucopyranose,"InChI=1S/C8H15NO6/c1-3(11)9-5-7(13)6(12)4(2-10)15-8(5)14/h4-8,10,12-14H,2H2,1H3,(H,9,11)/t4-,5-,6-,7-,8-/m1/s1",
6730,ENTREZ_GENE,braf,BRAF1BrafBRAF1NS7RAFB1,Homo sapiens,0.6164579886540946,3.49726e-11,BioGRID ORCS,168072,5VR3,X-RAY DIFFRACTION,2.58,52.44,"VAPOR DIFFUSION, HANGING DROP",6.5,"0.1 M Bis-Tris pH 6.5, 2.0 M ammonium sulphate",293.15,2017-05-10,2018-02-14,510,1,88,13.0,0,9.64,1,2.102,experimental,39.57218347825871,0.2244,0.2095,Crystal structure of the BRS domain of BRAF,GAMDPGGGGSSAADPAIPEEVWNIKQMIKLTQEHIEALLDKFGGEHNPPSIYLEAYEEYTSKLDALQQREQQLLESLGNGTDFSVSSS,Protein,88,polypeptide(L),1,9.544,braf,2.7.11.1,PDB Primary Data,Homo sapiens,9606,88,1,1,Monomer,A1,SO4,O4 S,96.063,SULFATE ION,"InChI=1S/H2O4S/c1-5(2,3)4/h(H2,1,2,3,4)/p-2",
50450,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.6179539195733728,3.49726e-11,BioGRID ORCS,170623,7QXZ,X-RAY DIFFRACTION,3.8,67.66,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NAH2PO4, PH 5.5, 2 M NACL; RESERVOIR SOLUTION: 3.0-3.2M NACL",293.15,2022-01-27,2022-04-13,4278,1,480,568.0,3,52.89,1,1.8,experimental,27.27,0.2173,0.1815,X-ray structure of furin in complex with the dichlorophenylpyridine-based inhibitor 5,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHH,Protein,480,polypeptide(L),1,52.112,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,480,1,1,Monomer,A1,CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
50450,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.6179539195733728,3.49726e-11,BioGRID ORCS,170623,8B4V,X-RAY DIFFRACTION,3.75,67.16,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NAH2PO4, PH 5.5, 2 M NACL; RESERVOIR SOLUTION: 3.0-3.2M NACL",293.15,2022-09-21,2023-10-04,4300,1,480,508.0,4,52.95,1,1.6,experimental,26.89,0.1658,0.1535,X-ray structure of furin (PCSK3) in complex with benzamidine,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHH,Protein,480,polypeptide(L),1,52.112,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,480,1,1,Monomer,A1,BEN,C7 H8 N2,120.152,BENZAMIDINE,"InChI=1S/C7H8N2/c8-7(9)6-4-2-1-3-5-6/h1-5H,(H3,8,9)",
50450,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.6179539195733728,3.49726e-11,BioGRID ORCS,170623,8B4W,X-RAY DIFFRACTION,3.75,67.17,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NAH2PO4, PH 5.5, 2 M NACL; RESERVOIR SOLUTION: 3.0-3.2M NACL",293.15,2022-09-21,2023-10-04,4403,1,480,497.0,4,53.21,1,1.6,experimental,27.18,0.179,0.1659,X-ray structure of furin (PCSK3) in complex with 1H-isoindol-3-amine,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHH,Protein,480,polypeptide(L),1,52.112,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,480,1,1,Monomer,A1,F05,C8 H8 N2,132.163,1H-isoindol-3-amine,"InChI=1S/C8H8N2/c9-8-7-4-2-1-3-6(7)5-10-8/h1-4H,5H2,(H2,9,10)",
50450,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.6179539195733728,3.49726e-11,BioGRID ORCS,170623,8B4X,X-RAY DIFFRACTION,3.75,67.24,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NAH2PO4, PH 5.5, 2 M NACL; RESERVOIR SOLUTION: 3.0-3.2M NACL",293.15,2022-09-21,2023-10-04,4276,2,485,462.0,4,53.27,2,1.6,experimental,28.95,0.1695,0.158,X-ray structure of furin (PCSK3) in complex with Guanidinomethyl-Phac-R-Tle-K-6-(aminomethyl)-3-amino-isoindol,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHH,Protein,480,polypeptide(L),1,52.112,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,485,2,2,Hetero 2-mer,"A1, B1",CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
50450,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.6179539195733728,3.49726e-11,BioGRID ORCS,170623,8OYH,X-RAY DIFFRACTION,3.76,67.27,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NAH2PO4, PH 5.5, 2 M NACL; RESERVOIR SOLUTION: 3.0-3.2M NACL",293.15,2023-05-04,2024-03-13,4092,2,485,340.0,4,53.27,2,1.8,experimental,36.56,0.188,0.1735,X-ray structure of furin (PCSK3) in complex with Guanidinomethyl-Phac-Can-Tle-Can-6-(aminomethyl)-3-amino-isoindol,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHH,Protein,480,polypeptide(L),1,52.112,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,485,2,2,Hetero 2-mer,"A1, B1",CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
50450,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.6179539195733728,3.49726e-11,BioGRID ORCS,170623,4Z2A,X-RAY DIFFRACTION,2.36,47.94,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"Well 13% PEG 8K, 0.110M K-dihydrogen phosphate, 0.1M HEPES pH 7.5, 350 uL protein with 350uL well drops, MRC sitting drop",277.0,2015-03-29,2016-05-04,4016,1,465,408.0,4,50.92,1,1.89,experimental,16.9953,0.1834,0.1479,Crystal structure of unglycosylated apo human furin @1.89A,YQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKDLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQDWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTA,Protein,465,polypeptide(L),1,50.506,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,465,1,1,Monomer,A1,EDO,C2 H6 O2,62.068,"1,2-ETHANEDIOL","InChI=1S/C2H6O2/c3-1-2-4/h3-4H,1-2H2",
50450,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.6179539195733728,3.49726e-11,BioGRID ORCS,170623,7O1U,X-RAY DIFFRACTION,3.74,67.12,"VAPOR DIFFUSION, SITTING DROP",5.5,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NAH2PO4, PH 5.5, 2 M NACL; RESERVOIR SOLUTION: 3.0-3.2M NACL",293.15,2021-03-30,2021-09-01,4375,1,480,519.0,4,53.19,1,1.7,experimental,26.23,0.1666,0.155,X-ray structure of furin in complex with the guanylhydrazone-based inhibitor 1 (BEV241),DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHH,Protein,480,polypeptide(L),1,52.112,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,480,1,1,Monomer,A1,Desconocido,Na,22.99,SODIUM ION,InChI=1S/Na/q+1,
50450,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.6179539195733728,3.49726e-11,BioGRID ORCS,170623,7O1W,X-RAY DIFFRACTION,3.74,67.1,"VAPOR DIFFUSION, SITTING DROP",5.5,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NAH2PO4, PH 5.5, 2 M NACL; RESERVOIR SOLUTION: 3.0-3.2M NACL",293.15,2021-03-30,2021-09-01,4335,1,480,424.0,4,53.69,1,1.8,experimental,29.36,0.1791,0.16,X-ray structure of furin in complex with the guanylhydrazone-based inhibitor 2 (mi307) soaked at 1 M NaCl,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHH,Protein,480,polypeptide(L),1,52.112,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,480,1,1,Monomer,A1,CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
50450,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.6179539195733728,3.49726e-11,BioGRID ORCS,170623,7O1Y,X-RAY DIFFRACTION,3.72,66.95,"VAPOR DIFFUSION, SITTING DROP",5.5,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NAH2PO4, PH 5.5, 2 M NACL; RESERVOIR SOLUTION: 3.0-3.2M NACL",293.15,2021-03-30,2021-09-01,4321,1,480,475.0,4,53.91,1,1.7,experimental,29.48,0.177,0.1622,X-ray structure of furin in complex with the guanylhydrazone-based inhibitor 2 (mi307) soaked at 0.25 M NaCl,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHH,Protein,480,polypeptide(L),1,52.112,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,480,1,1,Monomer,A1,CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
50450,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.6179539195733728,3.49726e-11,BioGRID ORCS,170623,7O20,X-RAY DIFFRACTION,3.67,66.48,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NAH2PO4, PH 5.5, 2 M NACL; RESERVOIR SOLUTION: 3.0-3.2M NACL",293.15,2021-03-30,2021-09-01,4190,1,480,376.0,4,53.54,1,1.8,experimental,33.26,0.1761,0.1624,X-ray structure of furin in complex with the guanylhydrazone-based inhibitor 3 (mi300),DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHH,Protein,480,polypeptide(L),1,52.112,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,480,1,1,Monomer,A1,CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
50450,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.6179539195733728,3.49726e-11,BioGRID ORCS,170623,7O22,X-RAY DIFFRACTION,3.69,66.7,"VAPOR DIFFUSION, SITTING DROP",5.5,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NAH2PO4, PH 5.5, 2 M NACL; RESERVOIR SOLUTION: 3.0-3.2M NACL",293.15,2021-03-30,2021-09-01,4130,1,480,427.0,4,53.15,1,1.8,experimental,33.5,0.1825,0.169,X-ray structure of furin in complex with the guanylhydrazone-based inhibitor 4 (mi359),DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHH,Protein,480,polypeptide(L),1,52.112,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,480,1,1,Monomer,A1,CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
50450,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.6179539195733728,3.49726e-11,BioGRID ORCS,170623,7QY0,X-RAY DIFFRACTION,3.72,66.91,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NAH2PO4, PH 5.5, 2 M NACL; RESERVOIR SOLUTION: 3.0-3.2M NACL",293.15,2022-01-27,2022-04-20,4378,1,480,476.0,4,53.68,1,1.54,experimental,26.16,0.1725,0.1493,X-ray structure of furin in complex with the dichlorophenylpyridine-based inhibitor 1,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHH,Protein,480,polypeptide(L),1,52.112,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,480,1,1,Monomer,A1,I0T,C32 H42 Cl2 N6 O3,629.62,"N-[[1-[[2-[3,5-bis(chloranyl)phenyl]-6-[6-[4-(2-methoxyethyl)piperazin-4-ium-1-yl]pyridin-3-yl]oxy-pyridin-4-yl]methyl]piperidin-1-ium-4-yl]methyl]ethanamide","InChI=1S/C32H40Cl2N6O3/c1-23(41)35-20-24-5-7-39(8-6-24)22-25-15-30(26-17-27(33)19-28(34)18-26)37-32(16-25)43-29-3-4-31(36-21-29)40-11-9-38(10-12-40)13-14-42-2/h3-4,15-19,21,24H,5-14,20,22H2,1-2H3,(H,35,41)/p+2",
50450,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.6179539195733728,3.49726e-11,BioGRID ORCS,170623,7QY1,X-RAY DIFFRACTION,2.568825997777984,50.34669344500458,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NAH2PO4, PH 5.5, 2 M NACL; RESERVOIR SOLUTION: 3.0-3.2M NACL",293.15,2022-01-27,2022-04-20,4387,1,480,483.0,4,53.77,1,1.45,experimental,25.78,0.1754,0.1502,X-ray structure of furin in complex with the dichlorophenylpyridine-based inhibitor 4,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHH,Protein,480,polypeptide(L),1,52.112,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,480,1,1,Monomer,A1,I0W,C32 H39 Cl2 N6 O4,642.596,"3-[4-[5-[4-[[4-(acetamidomethyl)piperidin-1-ium-1-yl]methyl]-6-[3,5-bis(chloranyl)phenyl]pyridin-2-yl]oxypyridin-2-yl]piperazin-1-ium-1-yl]propanoate","InChI=1S/C32H38Cl2N6O4/c1-22(41)35-19-23-4-7-39(8-5-23)21-24-14-29(25-16-26(33)18-27(34)17-25)37-31(15-24)44-28-2-3-30(36-20-28)40-12-10-38(11-13-40)9-6-32(42)43/h2-3,14-18,20,23H,4-13,19,21H2,1H3,(H,35,41)(H,42,43)/p+1",
50450,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.6179539195733728,3.49726e-11,BioGRID ORCS,170623,7QY2,X-RAY DIFFRACTION,3.71,66.87,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NAH2PO4, PH 5.5, 2 M NACL; RESERVOIR SOLUTION: 3.0-3.2M NACL",293.15,2022-01-27,2022-04-20,4373,1,480,471.0,4,53.72,1,1.55,experimental,27.19,0.1877,0.1645,X-ray structure of furin in complex with the dichlorophenylpyridine-based inhibitor 2,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHH,Protein,480,polypeptide(L),1,52.112,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,480,1,1,Monomer,A1,I0Q,C33 H42 Cl2 N7 O4,671.637,"(2R)-4-[4-[5-[4-[[4-(acetamidomethyl)piperidin-1-ium-1-yl]methyl]-6-[3,5-bis(chloranyl)phenyl]pyridin-2-yl]oxypyrimidin-2-yl]piperazin-1-ium-1-yl]-2-methyl-butanoate","InChI=1S/C33H41Cl2N7O4/c1-22(32(44)45)3-6-40-9-11-42(12-10-40)33-37-19-29(20-38-33)46-31-14-25(13-30(39-31)26-15-27(34)17-28(35)16-26)21-41-7-4-24(5-8-41)18-36-23(2)43/h13-17,19-20,22,24H,3-12,18,21H2,1-2H3,(H,36,43)(H,44,45)/p+1/t22-/m1/s1",
50450,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.6179539195733728,3.49726e-11,BioGRID ORCS,170623,7LCU,X-RAY DIFFRACTION,2.25,45.43,VAPOR DIFFUSION,7.5,"PEG8000, potassium dihydrogen phosphate",277.0,2021-01-11,2022-01-12,4057,1,490,352.0,5,54.37,1,1.24,experimental,14.5,0.1944,0.1764,"X-ray structure of Furin bound to BOS-318, a small molecule inhibitor",DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKDLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQDWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTAGENLYFQGDYKDDDDKGHHHHHH,Protein,490,polypeptide(L),1,53.512,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,490,1,1,Monomer,A1,CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
50450,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.6179539195733728,3.49726e-11,BioGRID ORCS,170623,6HLB,X-RAY DIFFRACTION,3.77,67.33,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NaH2PO4, PH 5.5-6.0, 2 M NaCL, 3% DMSO; RESERVOIR SOLUTION: 3-4M NaCL",293.15,2018-09-11,2019-02-06,4028,2,491,338.0,3,54.39,2,2.0,experimental,39.57218347825871,0.1874,0.1686,X-ray structure of furin in complex with the cyclic peptide c[succinyl-Phe-2-Nal-(Arg)4-Lys]-Arg-4-Amba,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHHHH,Protein,482,polypeptide(L),1,52.389,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,491,2,2,Hetero 2-mer,"A1, B1",CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
50450,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.6179539195733728,3.49726e-11,BioGRID ORCS,170623,6HLD,X-RAY DIFFRACTION,3.78,67.46,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NaH2PO4, PH 5.5-6.0, 2 M NaCL, 3% DMSO; RESERVOIR SOLUTION: 3-4M NaCL",293.15,2018-09-11,2019-02-06,4067,2,489,343.0,3,54.06,2,2.1,experimental,39.57218347825871,0.1959,0.17,X-ray structure of furin in complex with the cyclic peptide c[succinyl-Phe-2-Nal-(Arg)3-Lys]-Lys-4-Amba,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHHHH,Protein,482,polypeptide(L),1,52.389,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,489,2,2,Hetero 2-mer,"A1, B1",CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
50450,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.6179539195733728,3.49726e-11,BioGRID ORCS,170623,6HLE,X-RAY DIFFRACTION,3.84,68.01,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NaH2PO4, PH 5.5-6.0, 2 M NaCL, 3% DMSO; RESERVOIR SOLUTION: 3-4M NaCL",293.15,2018-09-11,2019-02-06,4127,2,488,390.0,3,53.91,2,1.994,experimental,39.57218347825871,0.1908,0.1667,X-ray structure of furin in complex with the P6-P2-cyclized peptide H-Lys-Arg-Arg-Tle-Lys-4-Amba,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHHHH,Protein,482,polypeptide(L),1,52.389,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,488,2,2,Hetero 2-mer,"A1, B1",CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
50450,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.6179539195733728,3.49726e-11,BioGRID ORCS,170623,6HZA,X-RAY DIFFRACTION,3.64,66.19,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NaH2PO4, PH 5.5-6.0, 2 M NaCL, 3% DMSO; RESERVOIR SOLUTION: 3-4M NaCL",293.15,2018-10-23,2019-02-06,4150,2,487,416.0,3,53.73,2,1.9,experimental,39.57218347825871,0.1859,0.1661,X-ray structure of furin in complex with the cyclic peptide c[glutaryl-Arg-Arg-Lys]-Arg-4-Amba,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHHHH,Protein,482,polypeptide(L),1,52.389,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,487,2,2,Hetero 2-mer,"A1, B1",CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
50450,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.6179539195733728,3.49726e-11,BioGRID ORCS,170623,6HZB,X-RAY DIFFRACTION,3.66,66.41,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NaH2PO4, PH 5.5-6.0, 2 M NaCL, 3% DMSO; RESERVOIR SOLUTION: 3-4M NaCL",293.15,2018-10-23,2019-02-06,4150,2,487,418.0,3,53.7,2,1.9,experimental,39.57218347825871,0.1824,0.1646,X-ray structure of furin in complex with the cyclic inhibitor c[glutaryl-Arg-Arg-Lys]-Lys-4-Amba,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHHHH,Protein,482,polypeptide(L),1,52.389,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,487,2,2,Hetero 2-mer,"A1, B1",CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
50450,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.6179539195733728,3.49726e-11,BioGRID ORCS,170623,6HZD,X-RAY DIFFRACTION,3.64,66.22,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NaH2PO4, PH 5.5-6.0, 2 M NaCL, 3% DMSO; RESERVOIR SOLUTION: 3-4M NaCL",293.15,2018-10-23,2019-02-06,4163,2,488,418.0,3,53.89,2,1.9,experimental,39.57218347825871,0.1827,0.1641,X-ray structure of furin in complex with the cyclic inhibitor c[glutaryl-Arg-Arg-Arg-Lys]-Arg-4-Amba,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHHHH,Protein,482,polypeptide(L),1,52.389,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,488,2,2,Hetero 2-mer,"A1, B1",CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
50450,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.6179539195733728,3.49726e-11,BioGRID ORCS,170623,6YD2,X-RAY DIFFRACTION,3.7,66.74,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100MM MES, 200MM K/NAH2PO4, PH 5.5-6.0, 2 M NACL; RESERVOIR SOLUTION: 3-4M NACL",293.15,2020-03-20,2021-02-17,4179,2,487,444.0,3,53.58,2,1.8,experimental,32.05,0.1771,0.1575,X-ray structure of furin in complex with the canavanine-based inhibitor 4-aminomethyl-phenylacetyl-canavanine-Tle-Arg-Amba,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHHHH,Protein,482,polypeptide(L),1,52.389,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,487,2,2,Hetero 2-mer,"A1, B1",CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
50450,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.6179539195733728,3.49726e-11,BioGRID ORCS,170623,6YD3,X-RAY DIFFRACTION,3.72,66.96,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100MM MES, 200MM K/NAH2PO4, PH 5.5-6.0, 2 M NACL; RESERVOIR SOLUTION: 3-4M NACL",293.15,2020-03-20,2021-02-17,4159,2,485,418.0,3,53.34,2,2.0,experimental,32.04,0.1854,0.1595,X-ray structure of furin in complex with the canavanine derived inhibitor 4-guanidinomethyl-phenylacetyl-Canavanine-Tle-Arg-Amba,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHH,Protein,480,polypeptide(L),1,52.112,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,485,2,2,Hetero 2-mer,"A1, B1",CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
50450,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.6179539195733728,3.49726e-11,BioGRID ORCS,170623,6YD4,X-RAY DIFFRACTION,3.73,67.06,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100MM MES, 200MM K/NAH2PO4, PH 5.5-6.0, 2 M NACL; RESERVOIR SOLUTION: 3-4M NACL",291.15,2020-03-20,2021-02-17,4237,2,485,477.0,3,53.37,2,1.7,experimental,31.24,0.1694,0.1532,X-ray structure of furin in complex with the canavanine-based inhibitor 4-guanidinomethyl-phenylacetyl-Canavanine-Tle-Canavanine-Amba,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHH,Protein,480,polypeptide(L),1,52.112,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,485,2,2,Hetero 2-mer,"A1, B1",CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
50450,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.6179539195733728,3.49726e-11,BioGRID ORCS,170623,6YD7,X-RAY DIFFRACTION,3.74,67.08,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100MM MES, 200MM K/NAH2PO4, PH 5.5-6.0, 2 M NACL; RESERVOIR SOLUTION: 3-4M NACL",291.15,2020-03-20,2021-02-17,4211,2,485,465.0,3,53.37,2,1.8,experimental,29.7,0.1709,0.1538,X-ray structure of furin in complex with the canavanine-based inhibitor 4-guanidinomethyl-phenylacetyl-Arg-Tle-Canavanine-Amba,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHH,Protein,480,polypeptide(L),1,52.112,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,485,2,2,Hetero 2-mer,"A1, B1",CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
50450,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.6179539195733728,3.49726e-11,BioGRID ORCS,170623,7QXY,X-RAY DIFFRACTION,2.568825997777984,50.34669344500458,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NAH2PO4, PH 5.5, 2 M NACL; RESERVOIR SOLUTION: 3.0-3.2M NACL",293.15,2022-01-27,2022-04-20,4386,1,480,661.0,2,53.0,1,1.478,experimental,24.97,0.1823,0.1705,X-ray structure of furin in complex with the dichlorophenylpyridine-based inhibitor 3,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHH,Protein,480,polypeptide(L),1,52.112,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,480,1,1,Monomer,A1,CL,Cl,35.453,CHLORIDE ION,InChI=1S/ClH/h1H/p-1,
50450,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.6179539195733728,3.49726e-11,BioGRID ORCS,170623,4RYD,X-RAY DIFFRACTION,2.86,56.93,"VAPOR DIFFUSION, SITTING DROP",8.5,"50mM Tris, 2.8M sodium formate, 15mM Cymal-7, pH 8.5, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293.0,2014-12-15,2015-05-27,23768,12,2922,2034.0,18,320.52,2,2.15,experimental,39.57218347825871,0.2186,0.1862,X-ray structure of human furin in complex with the competitive inhibitor para-guanidinomethyl-Phac-R-Tle-R-Amba,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHHHH,Protein,482,polypeptide(L),6,52.389,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,487,2,2,Hetero 2-mer,"A1, B1",FMT,C H2 O2,46.025,FORMIC ACID,"InChI=1S/CH2O2/c2-1-3/h1H,(H,2,3)",
50450,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.6179539195733728,3.49726e-11,BioGRID ORCS,170623,5JXH,X-RAY DIFFRACTION,3.67,66.49,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"crystallization solution: 100 mM MES, 200 mM K/NaH2PO4, pH 5.5-6.0, 3-4 M NaCl, 3% DMSO; reservoir solution: 3-4 M NaCl",293.15,2016-05-13,2016-10-05,4261,2,487,534.0,3,53.39,2,2.0,experimental,39.57218347825871,0.1853,0.1566,Structure the proprotein convertase furin in complex with meta-guanidinomethyl-Phac-RVR-Amba at 2.0 Angstrom resolution.,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHHHH,Protein,482,polypeptide(L),1,52.389,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,487,2,2,Hetero 2-mer,"A1, B1",CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
50450,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.6179539195733728,3.49726e-11,BioGRID ORCS,170623,5JXG,X-RAY DIFFRACTION,3.73,67.05,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"crystallization solution: 100 mM MES, 200 mM K/NaH2PO4, pH 5.5-6.0, 3-4 M NaCl, 3% DMSO; reservoir solution: 3-4 M NaCl",293.15,2016-05-13,2016-10-05,4360,1,482,645.0,3,52.73,1,1.8,experimental,39.57218347825871,0.1733,0.154,Structure of the unliganded form of the proprotein convertase furin.,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHHHH,Protein,482,polypeptide(L),1,52.389,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,482,1,1,Monomer,A1,CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
50450,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.6179539195733728,3.49726e-11,BioGRID ORCS,170623,5JXI,X-RAY DIFFRACTION,3.76,67.3,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"crystallization solution: 100 mM MES, 200 mM K/NaH2PO4, pH 5.5-6.0, 3-4 M NaCl, 3% DMSO; reservoir solution: 3-4 M NaCl",293.15,2016-05-13,2016-10-05,4164,1,482,521.0,3,52.63,1,2.0,experimental,39.57218347825871,0.1851,0.1576,Structure of the unliganded form of the proprotein convertase furin in presence of EDTA.,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHHHH,Protein,482,polypeptide(L),1,52.389,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,482,1,1,Monomer,A1,CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
50450,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.6179539195733728,3.49726e-11,BioGRID ORCS,170623,5MIM,X-RAY DIFFRACTION,3.75,67.2,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100 MM MES, 200 MM K/NAH2PO4, PH 5.5-6.0, 3-4 M NACL, 3% DMSO; RESERVOIR SOLUTION: 3-4 M NACL",293.15,2016-11-28,2017-05-10,4275,1,482,486.0,3,53.81,1,1.9,experimental,39.57218347825871,0.1838,0.1647,"Xray structure of human furin bound with the 2,5-dideoxystreptamine derived small molecule inhibitor 1n",DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHHHH,Protein,482,polypeptide(L),1,52.389,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,482,1,1,Monomer,A1,CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
50450,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.6179539195733728,3.49726e-11,BioGRID ORCS,170623,5JXJ,X-RAY DIFFRACTION,3.69,66.65,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"crystallization solution: 100 mM MES, 200 mM K/NaH2PO4, pH 5.5-6.0, 3-4 M NaCl, 3% DMSO; reservoir solution: 3-4 M NaCl",293.15,2016-05-13,2016-10-05,4185,2,487,461.0,3,53.35,2,2.0,experimental,39.57218347825871,0.1889,0.1668,Structure of the proprotein convertase furin complexed to meta-guanidinomethyl-Phac-RVR-Amba in presence of EDTA,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHHHH,Protein,482,polypeptide(L),1,52.389,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,487,2,2,Hetero 2-mer,"A1, B1",CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
50450,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.6179539195733728,3.49726e-11,BioGRID ORCS,170623,6EQV,X-RAY DIFFRACTION,3.67,66.45,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NaH2PO4, PH 5.5-6.0, 3-4M NaCl, 3% DMSO; RESERVOIR SOLUTION: 3-4 M NaCl",293.15,2017-10-16,2018-02-28,4212,2,487,510.0,3,53.3,2,1.895,experimental,39.57218347825871,0.1821,0.1637,X-ray structure of the proprotein convertase furin bound with the competitive inhibitor Phac-Cit-Val-Arg-Amba,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHHHH,Protein,482,polypeptide(L),1,52.389,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,487,2,2,Hetero 2-mer,"A1, B1",CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
50450,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.6179539195733728,3.49726e-11,BioGRID ORCS,170623,6EQW,X-RAY DIFFRACTION,3.66,66.42,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NaH2PO4, PH 5.5-6.0, 3-4 M NaCL, 3% DMSO; RESERVOIR SOLUTION: 3-4M NaCL",293.15,2017-10-16,2018-02-28,4183,2,487,486.0,3,53.36,2,1.994,experimental,39.57218347825871,0.1842,0.1619,X-ray structure of the proprotein convertase furin bound with the competitive inhibitor 4-aminomethyl-phenylacetyl-Arg-Val-Arg-Amba,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHHHH,Protein,482,polypeptide(L),1,52.389,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,487,2,2,Hetero 2-mer,"A1, B1",CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
50450,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.6179539195733728,3.49726e-11,BioGRID ORCS,170623,6EQX,X-RAY DIFFRACTION,3.66,66.36,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"100mM MES, 200mM K/NaH2PO4, PH 5.5-6.0, 3-4 M NaCL, 3% DMSO; RESERVOIR SOLUTION: 3-4M NaCL",293.15,2017-10-16,2018-02-28,4186,2,488,471.0,3,53.51,2,1.994,experimental,39.57218347825871,0.1837,0.162,X-ray structure of the proprotein convertase furin bound with the competitive inhibitor Arg-Arg-Arg-Val-Arg-Amba,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHHHH,Protein,482,polypeptide(L),1,52.389,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,488,2,2,Hetero 2-mer,"A1, B1",CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
1387,ENTREZ_GENE,crebbp,CBPKAT3ARSTSRSTS1,Homo sapiens,0.6569421550513057,3.49726e-11,BioGRID ORCS,175128,6YIK,X-RAY DIFFRACTION,3.42,64.06,"VAPOR DIFFUSION, SITTING DROP",7.5,"21% PEG3350
15% ethylene glycol
0.25M sodium formate",277.0,2020-04-01,2020-04-15,3453,3,357,385.0,0,44.74,1,1.7,experimental,32.625,0.184,0.156,Crystal structure of the CREBBP bromodomain in complex with a tetrahydroquinoxaline ligand,SMRKKIFKPEELRQALMPTLEALYRQDPESLPFRQPVDPQLLGIPDYFDIVKNPMDLSTIKRKLDTGQYQEPWQYVDDVWLMFNNAWLYNRKTSRVYKFCSKLAEVFEQEIDPVMQSLG,Protein,119,polypeptide(L),3,14.223,crebbp,2.3.1.48,PDB Primary Data,Homo sapiens,9606,119,1,1,Monomer,A1,OSQ,C22 H24 F2 N4 O2,414.448,"(3~{R})-~{N}-[3-(3,4-dihydro-2~{H}-quinolin-1-yl)-2,2-bis(fluoranyl)propyl]-3-methyl-2-oxidanylidene-3,4-dihydro-1~{H}-quinoxaline-5-carboxamide","InChI=1S/C22H24F2N4O2/c1-14-20(29)27-17-9-4-8-16(19(17)26-14)21(30)25-12-22(23,24)13-28-11-5-7-15-6-2-3-10-18(15)28/h2-4,6,8-10,14,26H,5,7,11-13H2,1H3,(H,25,30)(H,27,29)/t14-/m1/s1",
1387,ENTREZ_GENE,crebbp,CBPKAT3ARSTSRSTS1,Homo sapiens,0.6569421550513057,3.49726e-11,BioGRID ORCS,175128,6SXX,X-RAY DIFFRACTION,2.18,43.67,"VAPOR DIFFUSION, HANGING DROP",6.982430939226492,"25% PEG3350, 0.2 M Potassium thiocyanate, 5% EtGly",277.0,2019-09-26,2020-07-29,1940,2,238,81.0,0,28.95,1,2.01,experimental,52.99,0.2533,0.1955,Crystal structure of the bromodomain of human CREBBP in complex with ACA007,SMRKKIFKPEELRQALMPTLEALYRQDPESLPFRQPVDPQLLGIPDYFDIVKNPMDLSTIKRKLDTGQYQEPWQYVDDVWLMFNNAWLYNRKTSRVYKFCSKLAEVFEQEIDPVMQSLG,Protein,119,polypeptide(L),2,14.223,crebbp,2.3.1.48,PDB Primary Data,Homo sapiens,9606,119,1,1,Monomer,A1,EDO,C2 H6 O2,62.068,"1,2-ETHANEDIOL","InChI=1S/C2H6O2/c3-1-2-4/h3-4H,1-2H2",
1387,ENTREZ_GENE,crebbp,CBPKAT3ARSTSRSTS1,Homo sapiens,0.6569421550513057,3.49726e-11,BioGRID ORCS,175128,6YIL,X-RAY DIFFRACTION,2.2,44.01,"VAPOR DIFFUSION, SITTING DROP",7.5,"20% PEG3350
10% ethylene glycol
0.2M sodium acetate",277.0,2020-04-01,2020-04-15,1160,1,119,154.0,0,14.64,1,1.22,experimental,12.75,0.1511,0.1321,Crystal structure of the CREBBP bromodomain in complex with a tetrahydroquinoxaline ligand,SMRKKIFKPEELRQALMPTLEALYRQDPESLPFRQPVDPQLLGIPDYFDIVKNPMDLSTIKRKLDTGQYQEPWQYVDDVWLMFNNAWLYNRKTSRVYKFCSKLAEVFEQEIDPVMQSLG,Protein,119,polypeptide(L),1,14.223,crebbp,2.3.1.48,PDB Primary Data,Homo sapiens,9606,119,1,1,Monomer,A1,OSQ,C22 H24 F2 N4 O2,414.448,"(3~{R})-~{N}-[3-(3,4-dihydro-2~{H}-quinolin-1-yl)-2,2-bis(fluoranyl)propyl]-3-methyl-2-oxidanylidene-3,4-dihydro-1~{H}-quinoxaline-5-carboxamide","InChI=1S/C22H24F2N4O2/c1-14-20(29)27-17-9-4-8-16(19(17)26-14)21(30)25-12-22(23,24)13-28-11-5-7-15-6-2-3-10-18(15)28/h2-4,6,8-10,14,26H,5,7,11-13H2,1H3,(H,25,30)(H,27,29)/t14-/m1/s1",
1387,ENTREZ_GENE,crebbp,CBPKAT3ARSTSRSTS1,Homo sapiens,0.6569421550513057,3.49726e-11,BioGRID ORCS,175128,6YIM,X-RAY DIFFRACTION,2.2,44.12,"VAPOR DIFFUSION, SITTING DROP",7.5,"20% PEG3350
10% ethylene glycol
0.2M sodium fluoride",277.0,2020-04-01,2020-04-15,1174,1,119,163.0,0,14.65,1,1.23,experimental,12.85,0.167,0.1397,Crystal structure of the CREBBP bromodomain in complex with a benzo-diazepine ligand,SMRKKIFKPEELRQALMPTLEALYRQDPESLPFRQPVDPQLLGIPDYFDIVKNPMDLSTIKRKLDTGQYQEPWQYVDDVWLMFNNAWLYNRKTSRVYKFCSKLAEVFEQEIDPVMQSLG,Protein,119,polypeptide(L),1,14.223,crebbp,2.3.1.48,PDB Primary Data,Homo sapiens,9606,119,1,1,Monomer,A1,OS8,C24 H30 N4 O3,422.52,"(4~{R})-~{N}-[3-(7-methoxy-3,4-dihydro-2~{H}-quinolin-1-yl)propyl]-4-methyl-2-oxidanylidene-1,3,4,5-tetrahydro-1,5-benzodiazepine-6-carboxamide","InChI=1S/C24H30N4O3/c1-16-14-22(29)27-20-8-3-7-19(23(20)26-16)24(30)25-11-5-13-28-12-4-6-17-9-10-18(31-2)15-21(17)28/h3,7-10,15-16,26H,4-6,11-14H2,1-2H3,(H,25,30)(H,27,29)/t16-/m1/s1",
1387,ENTREZ_GENE,crebbp,CBPKAT3ARSTSRSTS1,Homo sapiens,0.6569421550513057,3.49726e-11,BioGRID ORCS,175128,6YIJ,X-RAY DIFFRACTION,2.95,58.37,"VAPOR DIFFUSION, SITTING DROP",8.3,"20% ethylene glycol
21% PEG6K
0.1M tris pH 8.3
0.125M lithium chloride",277.0,2020-04-01,2020-04-15,7177,7,833,224.0,0,102.4,1,2.2,experimental,44.856,0.2693,0.2022,Crystal structure of the CREBBP bromodomain in complex with a benzo-diazepine ligand,SMRKKIFKPEELRQALMPTLEALYRQDPESLPFRQPVDPQLLGIPDYFDIVKNPMDLSTIKRKLDTGQYQEPWQYVDDVWLMFNNAWLYNRKTSRVYKFCSKLAEVFEQEIDPVMQSLG,Protein,119,polypeptide(L),7,14.223,crebbp,2.3.1.48,PDB Primary Data,Homo sapiens,9606,119,1,1,Monomer,A1,OSN,C25 H31 N3 O2,405.533,"(4~{R})-6-[(~{E})-5-(7-methoxy-3,4-dihydro-2~{H}-quinolin-1-yl)pent-1-enyl]-4-methyl-1,3,4,5-tetrahydro-1,5-benzodiazepin-2-one","InChI=1S/C25H31N3O2/c1-18-16-24(29)27-22-11-6-9-20(25(22)26-18)8-4-3-5-14-28-15-7-10-19-12-13-21(30-2)17-23(19)28/h4,6,8-9,11-13,17-18,26H,3,5,7,10,14-16H2,1-2H3,(H,27,29)/b8-4+/t18-/m1/s1",
673,ENTREZ_GENE,braf,BRAF1BrafBRAF1NS7RAFB1,Homo sapiens,0.7030961301861938,3.49726e-11,BioGRID ORCS,176466,5VR3,X-RAY DIFFRACTION,2.58,52.44,"VAPOR DIFFUSION, HANGING DROP",6.5,"0.1 M Bis-Tris pH 6.5, 2.0 M ammonium sulphate",293.15,2017-05-10,2018-02-14,510,1,88,13.0,0,9.64,1,2.102,experimental,39.57218347825871,0.2244,0.2095,Crystal structure of the BRS domain of BRAF,GAMDPGGGGSSAADPAIPEEVWNIKQMIKLTQEHIEALLDKFGGEHNPPSIYLEAYEEYTSKLDALQQREQQLLESLGNGTDFSVSSS,Protein,88,polypeptide(L),1,9.544,braf,2.7.11.1,PDB Primary Data,Homo sapiens,9606,88,1,1,Monomer,A1,SO4,O4 S,96.063,SULFATE ION,"InChI=1S/H2O4S/c1-5(2,3)4/h(H2,1,2,3,4)/p-2",
147111,ENTREZ_GENE,notum,hNOTUM,Homo sapiens,0.6746122793235138,7.35631e-11,NO,182063,4UZ1,X-RAY DIFFRACTION,1.9,34.0,Desconocido,4.6,"1.5 M AMMONIUM SULPHATE, 0.1 M SODIUM ACETATE PH 4.6",289.6514371309434,2014-09-04,2015-02-25,3212,1,383,287.0,7,44.17,1,1.4,experimental,18.766,0.18045,0.14387,STRUCTURE OF THE WNT DEACYLASE NOTUM - CRYSTAL FORM III - 1.4A,ETGSAQQLNEDLRLHLLLNTSVTCNDGSPAGYYLKESRGSRRWLLFLEGGWYCFNRENCDSRYDTMRRLMSSRDWPRTRTGTGILSSQPEENPYWWNANMVFIPYCSSDVWSGASSKSEKNEYAFMGALIIQEVVRELLGRGLSGAKVLLLAGSSAGGTGVLLNVDRVAEQLEKLGYPAIQVRGLADSGWFLDNKQYRHTDCVDTITCAPTEAIRRGIRYWNGVVPERCRRQFQEGEEWNCFFGYKVYPTLRSPVFVVQWLFDEAQLTVDNVHLTGQPVQEGLRLYIQNLGRELRHTLKDVPASFAPACLSHEIIIRSHWTDVQVKGTSLPRALHCWDRSLHDSHKASKTPLKGCPVHLVDSCPWPHCNPSCPTGTKHHHHHH,Protein,383,polypeptide(L),1,43.567,notum,3.1.1.1,PDB Primary Data,Homo sapiens,9606,383,1,1,Monomer,A1,NAG,C8 H15 N O6,221.208,2-acetamido-2-deoxy-beta-D-glucopyranose,"InChI=1S/C8H15NO6/c1-3(11)9-5-7(13)6(12)4(2-10)15-8(5)14/h4-8,10,12-14H,2H2,1H3,(H,9,11)/t4-,5-,6-,7-,8-/m1/s1",
147111,ENTREZ_GENE,notum,hNOTUM,Homo sapiens,0.6746122793235138,7.35631e-11,NO,182063,4UZ5,X-RAY DIFFRACTION,2.5,52.0,Desconocido,6.0,"10 %W/V PEG4000, 0.01 M CACL2, 0.05 M NACACOD PH 6.0, 0.20 M KCL, 1 MM HEPARIN HEXAMER",289.6514371309434,2014-09-04,2015-02-25,2901,1,383,84.0,7,43.82,1,2.1,experimental,43.492,0.2371,0.18746,STRUCTURE OF THE WNT DEACYLASE NOTUM - CRYSTAL FORM IV - 2.1A,ETGSAQQLNEDLRLHLLLNTSVTCNDGSPAGYYLKESRGSRRWLLFLEGGWYCFNRENCDSRYDTMRRLMSSRDWPRTRTGTGILSSQPEENPYWWNANMVFIPYCSSDVWSGASSKSEKNEYAFMGALIIQEVVRELLGRGLSGAKVLLLAGSSAGGTGVLLNVDRVAEQLEKLGYPAIQVRGLADSGWFLDNKQYRHTDCVDTITCAPTEAIRRGIRYWNGVVPERCRRQFQEGEEWNCFFGYKVYPTLRSPVFVVQWLFDEAQLTVDNVHLTGQPVQEGLRLYIQNLGRELRHTLKDVPASFAPACLSHEIIIRSHWTDVQVKGTSLPRALHCWDRSLHDSHKASKTPLKGCPVHLVDSCPWPHCNPSCPTGTKHHHHHH,Protein,383,polypeptide(L),1,43.567,notum,3.1.1.1,PDB Primary Data,Homo sapiens,9606,383,1,1,Monomer,A1,NAG,C8 H15 N O6,221.208,2-acetamido-2-deoxy-beta-D-glucopyranose,"InChI=1S/C8H15NO6/c1-3(11)9-5-7(13)6(12)4(2-10)15-8(5)14/h4-8,10,12-14H,2H2,1H3,(H,9,11)/t4-,5-,6-,7-,8-/m1/s1",
2534,ENTREZ_GENE,fyn,SLKSYNp59FYN,Homo sapiens,0.6869021206549932,7.76834e-11,NO,182550,6EDF,X-RAY DIFFRACTION,2.0,37.6,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"20% PEG3350, 0.2 M magnesium acetate",291.0,2018-08-09,2018-08-29,693,1,79,61.0,0,8.94,1,1.4,experimental,12.097,0.1721,0.1434,Fragment of a tyrosine-protein kinase,GGVTLFVALYDYEARTEDDISVHKGEKVQILNSSEGDWWEVRSLTTGETGYVPSNYVAPVDGSAAMGPVLRLRAFYNGG,Protein,79,polypeptide(L),1,8.591,fyn,2.7.10.2,PDB Primary Data,Homo sapiens,9606,79,1,1,Monomer,A1,GOL,C3 H8 O3,92.094,GLYCEROL,"InChI=1S/C3H8O3/c4-1-3(6)2-5/h3-6H,1-2H2",
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.8021789269425141,9.79836e-11,NO,185495,7QXZ,X-RAY DIFFRACTION,3.8,67.66,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NAH2PO4, PH 5.5, 2 M NACL; RESERVOIR SOLUTION: 3.0-3.2M NACL",293.15,2022-01-27,2022-04-13,4278,1,480,568.0,3,52.89,1,1.8,experimental,27.27,0.2173,0.1815,X-ray structure of furin in complex with the dichlorophenylpyridine-based inhibitor 5,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHH,Protein,480,polypeptide(L),1,52.112,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,480,1,1,Monomer,A1,CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.8021789269425141,9.79836e-11,NO,185495,8B4V,X-RAY DIFFRACTION,3.75,67.16,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NAH2PO4, PH 5.5, 2 M NACL; RESERVOIR SOLUTION: 3.0-3.2M NACL",293.15,2022-09-21,2023-10-04,4300,1,480,508.0,4,52.95,1,1.6,experimental,26.89,0.1658,0.1535,X-ray structure of furin (PCSK3) in complex with benzamidine,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHH,Protein,480,polypeptide(L),1,52.112,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,480,1,1,Monomer,A1,BEN,C7 H8 N2,120.152,BENZAMIDINE,"InChI=1S/C7H8N2/c8-7(9)6-4-2-1-3-5-6/h1-5H,(H3,8,9)",
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.8021789269425141,9.79836e-11,NO,185495,8B4W,X-RAY DIFFRACTION,3.75,67.17,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NAH2PO4, PH 5.5, 2 M NACL; RESERVOIR SOLUTION: 3.0-3.2M NACL",293.15,2022-09-21,2023-10-04,4403,1,480,497.0,4,53.21,1,1.6,experimental,27.18,0.179,0.1659,X-ray structure of furin (PCSK3) in complex with 1H-isoindol-3-amine,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHH,Protein,480,polypeptide(L),1,52.112,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,480,1,1,Monomer,A1,F05,C8 H8 N2,132.163,1H-isoindol-3-amine,"InChI=1S/C8H8N2/c9-8-7-4-2-1-3-6(7)5-10-8/h1-4H,5H2,(H2,9,10)",
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.8021789269425141,9.79836e-11,NO,185495,8B4X,X-RAY DIFFRACTION,3.75,67.24,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NAH2PO4, PH 5.5, 2 M NACL; RESERVOIR SOLUTION: 3.0-3.2M NACL",293.15,2022-09-21,2023-10-04,4276,2,485,462.0,4,53.27,2,1.6,experimental,28.95,0.1695,0.158,X-ray structure of furin (PCSK3) in complex with Guanidinomethyl-Phac-R-Tle-K-6-(aminomethyl)-3-amino-isoindol,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHH,Protein,480,polypeptide(L),1,52.112,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,485,2,2,Hetero 2-mer,"A1, B1",CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.8021789269425141,9.79836e-11,NO,185495,8OYH,X-RAY DIFFRACTION,3.76,67.27,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NAH2PO4, PH 5.5, 2 M NACL; RESERVOIR SOLUTION: 3.0-3.2M NACL",293.15,2023-05-04,2024-03-13,4092,2,485,340.0,4,53.27,2,1.8,experimental,36.56,0.188,0.1735,X-ray structure of furin (PCSK3) in complex with Guanidinomethyl-Phac-Can-Tle-Can-6-(aminomethyl)-3-amino-isoindol,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHH,Protein,480,polypeptide(L),1,52.112,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,485,2,2,Hetero 2-mer,"A1, B1",CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.8021789269425141,9.79836e-11,NO,185495,4Z2A,X-RAY DIFFRACTION,2.36,47.94,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"Well 13% PEG 8K, 0.110M K-dihydrogen phosphate, 0.1M HEPES pH 7.5, 350 uL protein with 350uL well drops, MRC sitting drop",277.0,2015-03-29,2016-05-04,4016,1,465,408.0,4,50.92,1,1.89,experimental,16.9953,0.1834,0.1479,Crystal structure of unglycosylated apo human furin @1.89A,YQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKDLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQDWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTA,Protein,465,polypeptide(L),1,50.506,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,465,1,1,Monomer,A1,EDO,C2 H6 O2,62.068,"1,2-ETHANEDIOL","InChI=1S/C2H6O2/c3-1-2-4/h3-4H,1-2H2",
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.8021789269425141,9.79836e-11,NO,185495,7O1U,X-RAY DIFFRACTION,3.74,67.12,"VAPOR DIFFUSION, SITTING DROP",5.5,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NAH2PO4, PH 5.5, 2 M NACL; RESERVOIR SOLUTION: 3.0-3.2M NACL",293.15,2021-03-30,2021-09-01,4375,1,480,519.0,4,53.19,1,1.7,experimental,26.23,0.1666,0.155,X-ray structure of furin in complex with the guanylhydrazone-based inhibitor 1 (BEV241),DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHH,Protein,480,polypeptide(L),1,52.112,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,480,1,1,Monomer,A1,Desconocido,Na,22.99,SODIUM ION,InChI=1S/Na/q+1,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.8021789269425141,9.79836e-11,NO,185495,7O1W,X-RAY DIFFRACTION,3.74,67.1,"VAPOR DIFFUSION, SITTING DROP",5.5,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NAH2PO4, PH 5.5, 2 M NACL; RESERVOIR SOLUTION: 3.0-3.2M NACL",293.15,2021-03-30,2021-09-01,4335,1,480,424.0,4,53.69,1,1.8,experimental,29.36,0.1791,0.16,X-ray structure of furin in complex with the guanylhydrazone-based inhibitor 2 (mi307) soaked at 1 M NaCl,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHH,Protein,480,polypeptide(L),1,52.112,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,480,1,1,Monomer,A1,CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.8021789269425141,9.79836e-11,NO,185495,7O1Y,X-RAY DIFFRACTION,3.72,66.95,"VAPOR DIFFUSION, SITTING DROP",5.5,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NAH2PO4, PH 5.5, 2 M NACL; RESERVOIR SOLUTION: 3.0-3.2M NACL",293.15,2021-03-30,2021-09-01,4321,1,480,475.0,4,53.91,1,1.7,experimental,29.48,0.177,0.1622,X-ray structure of furin in complex with the guanylhydrazone-based inhibitor 2 (mi307) soaked at 0.25 M NaCl,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHH,Protein,480,polypeptide(L),1,52.112,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,480,1,1,Monomer,A1,CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.8021789269425141,9.79836e-11,NO,185495,7O20,X-RAY DIFFRACTION,3.67,66.48,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NAH2PO4, PH 5.5, 2 M NACL; RESERVOIR SOLUTION: 3.0-3.2M NACL",293.15,2021-03-30,2021-09-01,4190,1,480,376.0,4,53.54,1,1.8,experimental,33.26,0.1761,0.1624,X-ray structure of furin in complex with the guanylhydrazone-based inhibitor 3 (mi300),DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHH,Protein,480,polypeptide(L),1,52.112,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,480,1,1,Monomer,A1,CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.8021789269425141,9.79836e-11,NO,185495,7O22,X-RAY DIFFRACTION,3.69,66.7,"VAPOR DIFFUSION, SITTING DROP",5.5,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NAH2PO4, PH 5.5, 2 M NACL; RESERVOIR SOLUTION: 3.0-3.2M NACL",293.15,2021-03-30,2021-09-01,4130,1,480,427.0,4,53.15,1,1.8,experimental,33.5,0.1825,0.169,X-ray structure of furin in complex with the guanylhydrazone-based inhibitor 4 (mi359),DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHH,Protein,480,polypeptide(L),1,52.112,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,480,1,1,Monomer,A1,CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.8021789269425141,9.79836e-11,NO,185495,7QY0,X-RAY DIFFRACTION,3.72,66.91,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NAH2PO4, PH 5.5, 2 M NACL; RESERVOIR SOLUTION: 3.0-3.2M NACL",293.15,2022-01-27,2022-04-20,4378,1,480,476.0,4,53.68,1,1.54,experimental,26.16,0.1725,0.1493,X-ray structure of furin in complex with the dichlorophenylpyridine-based inhibitor 1,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHH,Protein,480,polypeptide(L),1,52.112,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,480,1,1,Monomer,A1,I0T,C32 H42 Cl2 N6 O3,629.62,"N-[[1-[[2-[3,5-bis(chloranyl)phenyl]-6-[6-[4-(2-methoxyethyl)piperazin-4-ium-1-yl]pyridin-3-yl]oxy-pyridin-4-yl]methyl]piperidin-1-ium-4-yl]methyl]ethanamide","InChI=1S/C32H40Cl2N6O3/c1-23(41)35-20-24-5-7-39(8-6-24)22-25-15-30(26-17-27(33)19-28(34)18-26)37-32(16-25)43-29-3-4-31(36-21-29)40-11-9-38(10-12-40)13-14-42-2/h3-4,15-19,21,24H,5-14,20,22H2,1-2H3,(H,35,41)/p+2",
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.8021789269425141,9.79836e-11,NO,185495,7QY1,X-RAY DIFFRACTION,2.568825997777984,50.34669344500458,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NAH2PO4, PH 5.5, 2 M NACL; RESERVOIR SOLUTION: 3.0-3.2M NACL",293.15,2022-01-27,2022-04-20,4387,1,480,483.0,4,53.77,1,1.45,experimental,25.78,0.1754,0.1502,X-ray structure of furin in complex with the dichlorophenylpyridine-based inhibitor 4,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHH,Protein,480,polypeptide(L),1,52.112,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,480,1,1,Monomer,A1,I0W,C32 H39 Cl2 N6 O4,642.596,"3-[4-[5-[4-[[4-(acetamidomethyl)piperidin-1-ium-1-yl]methyl]-6-[3,5-bis(chloranyl)phenyl]pyridin-2-yl]oxypyridin-2-yl]piperazin-1-ium-1-yl]propanoate","InChI=1S/C32H38Cl2N6O4/c1-22(41)35-19-23-4-7-39(8-5-23)21-24-14-29(25-16-26(33)18-27(34)17-25)37-31(15-24)44-28-2-3-30(36-20-28)40-12-10-38(11-13-40)9-6-32(42)43/h2-3,14-18,20,23H,4-13,19,21H2,1H3,(H,35,41)(H,42,43)/p+1",
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.8021789269425141,9.79836e-11,NO,185495,7QY2,X-RAY DIFFRACTION,3.71,66.87,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NAH2PO4, PH 5.5, 2 M NACL; RESERVOIR SOLUTION: 3.0-3.2M NACL",293.15,2022-01-27,2022-04-20,4373,1,480,471.0,4,53.72,1,1.55,experimental,27.19,0.1877,0.1645,X-ray structure of furin in complex with the dichlorophenylpyridine-based inhibitor 2,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHH,Protein,480,polypeptide(L),1,52.112,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,480,1,1,Monomer,A1,I0Q,C33 H42 Cl2 N7 O4,671.637,"(2R)-4-[4-[5-[4-[[4-(acetamidomethyl)piperidin-1-ium-1-yl]methyl]-6-[3,5-bis(chloranyl)phenyl]pyridin-2-yl]oxypyrimidin-2-yl]piperazin-1-ium-1-yl]-2-methyl-butanoate","InChI=1S/C33H41Cl2N7O4/c1-22(32(44)45)3-6-40-9-11-42(12-10-40)33-37-19-29(20-38-33)46-31-14-25(13-30(39-31)26-15-27(34)17-28(35)16-26)21-41-7-4-24(5-8-41)18-36-23(2)43/h13-17,19-20,22,24H,3-12,18,21H2,1-2H3,(H,36,43)(H,44,45)/p+1/t22-/m1/s1",
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.8021789269425141,9.79836e-11,NO,185495,7LCU,X-RAY DIFFRACTION,2.25,45.43,VAPOR DIFFUSION,7.5,"PEG8000, potassium dihydrogen phosphate",277.0,2021-01-11,2022-01-12,4057,1,490,352.0,5,54.37,1,1.24,experimental,14.5,0.1944,0.1764,"X-ray structure of Furin bound to BOS-318, a small molecule inhibitor",DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKDLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQDWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTAGENLYFQGDYKDDDDKGHHHHHH,Protein,490,polypeptide(L),1,53.512,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,490,1,1,Monomer,A1,CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.8021789269425141,9.79836e-11,NO,185495,6HLB,X-RAY DIFFRACTION,3.77,67.33,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NaH2PO4, PH 5.5-6.0, 2 M NaCL, 3% DMSO; RESERVOIR SOLUTION: 3-4M NaCL",293.15,2018-09-11,2019-02-06,4028,2,491,338.0,3,54.39,2,2.0,experimental,39.57218347825871,0.1874,0.1686,X-ray structure of furin in complex with the cyclic peptide c[succinyl-Phe-2-Nal-(Arg)4-Lys]-Arg-4-Amba,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHHHH,Protein,482,polypeptide(L),1,52.389,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,491,2,2,Hetero 2-mer,"A1, B1",CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.8021789269425141,9.79836e-11,NO,185495,6HLD,X-RAY DIFFRACTION,3.78,67.46,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NaH2PO4, PH 5.5-6.0, 2 M NaCL, 3% DMSO; RESERVOIR SOLUTION: 3-4M NaCL",293.15,2018-09-11,2019-02-06,4067,2,489,343.0,3,54.06,2,2.1,experimental,39.57218347825871,0.1959,0.17,X-ray structure of furin in complex with the cyclic peptide c[succinyl-Phe-2-Nal-(Arg)3-Lys]-Lys-4-Amba,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHHHH,Protein,482,polypeptide(L),1,52.389,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,489,2,2,Hetero 2-mer,"A1, B1",CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.8021789269425141,9.79836e-11,NO,185495,6HLE,X-RAY DIFFRACTION,3.84,68.01,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NaH2PO4, PH 5.5-6.0, 2 M NaCL, 3% DMSO; RESERVOIR SOLUTION: 3-4M NaCL",293.15,2018-09-11,2019-02-06,4127,2,488,390.0,3,53.91,2,1.994,experimental,39.57218347825871,0.1908,0.1667,X-ray structure of furin in complex with the P6-P2-cyclized peptide H-Lys-Arg-Arg-Tle-Lys-4-Amba,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHHHH,Protein,482,polypeptide(L),1,52.389,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,488,2,2,Hetero 2-mer,"A1, B1",CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.8021789269425141,9.79836e-11,NO,185495,6HZA,X-RAY DIFFRACTION,3.64,66.19,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NaH2PO4, PH 5.5-6.0, 2 M NaCL, 3% DMSO; RESERVOIR SOLUTION: 3-4M NaCL",293.15,2018-10-23,2019-02-06,4150,2,487,416.0,3,53.73,2,1.9,experimental,39.57218347825871,0.1859,0.1661,X-ray structure of furin in complex with the cyclic peptide c[glutaryl-Arg-Arg-Lys]-Arg-4-Amba,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHHHH,Protein,482,polypeptide(L),1,52.389,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,487,2,2,Hetero 2-mer,"A1, B1",CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.8021789269425141,9.79836e-11,NO,185495,6HZB,X-RAY DIFFRACTION,3.66,66.41,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NaH2PO4, PH 5.5-6.0, 2 M NaCL, 3% DMSO; RESERVOIR SOLUTION: 3-4M NaCL",293.15,2018-10-23,2019-02-06,4150,2,487,418.0,3,53.7,2,1.9,experimental,39.57218347825871,0.1824,0.1646,X-ray structure of furin in complex with the cyclic inhibitor c[glutaryl-Arg-Arg-Lys]-Lys-4-Amba,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHHHH,Protein,482,polypeptide(L),1,52.389,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,487,2,2,Hetero 2-mer,"A1, B1",CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.8021789269425141,9.79836e-11,NO,185495,6HZD,X-RAY DIFFRACTION,3.64,66.22,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NaH2PO4, PH 5.5-6.0, 2 M NaCL, 3% DMSO; RESERVOIR SOLUTION: 3-4M NaCL",293.15,2018-10-23,2019-02-06,4163,2,488,418.0,3,53.89,2,1.9,experimental,39.57218347825871,0.1827,0.1641,X-ray structure of furin in complex with the cyclic inhibitor c[glutaryl-Arg-Arg-Arg-Lys]-Arg-4-Amba,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHHHH,Protein,482,polypeptide(L),1,52.389,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,488,2,2,Hetero 2-mer,"A1, B1",CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.8021789269425141,9.79836e-11,NO,185495,6YD2,X-RAY DIFFRACTION,3.7,66.74,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100MM MES, 200MM K/NAH2PO4, PH 5.5-6.0, 2 M NACL; RESERVOIR SOLUTION: 3-4M NACL",293.15,2020-03-20,2021-02-17,4179,2,487,444.0,3,53.58,2,1.8,experimental,32.05,0.1771,0.1575,X-ray structure of furin in complex with the canavanine-based inhibitor 4-aminomethyl-phenylacetyl-canavanine-Tle-Arg-Amba,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHHHH,Protein,482,polypeptide(L),1,52.389,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,487,2,2,Hetero 2-mer,"A1, B1",CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.8021789269425141,9.79836e-11,NO,185495,6YD3,X-RAY DIFFRACTION,3.72,66.96,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100MM MES, 200MM K/NAH2PO4, PH 5.5-6.0, 2 M NACL; RESERVOIR SOLUTION: 3-4M NACL",293.15,2020-03-20,2021-02-17,4159,2,485,418.0,3,53.34,2,2.0,experimental,32.04,0.1854,0.1595,X-ray structure of furin in complex with the canavanine derived inhibitor 4-guanidinomethyl-phenylacetyl-Canavanine-Tle-Arg-Amba,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHH,Protein,480,polypeptide(L),1,52.112,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,485,2,2,Hetero 2-mer,"A1, B1",CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.8021789269425141,9.79836e-11,NO,185495,6YD4,X-RAY DIFFRACTION,3.73,67.06,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100MM MES, 200MM K/NAH2PO4, PH 5.5-6.0, 2 M NACL; RESERVOIR SOLUTION: 3-4M NACL",291.15,2020-03-20,2021-02-17,4237,2,485,477.0,3,53.37,2,1.7,experimental,31.24,0.1694,0.1532,X-ray structure of furin in complex with the canavanine-based inhibitor 4-guanidinomethyl-phenylacetyl-Canavanine-Tle-Canavanine-Amba,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHH,Protein,480,polypeptide(L),1,52.112,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,485,2,2,Hetero 2-mer,"A1, B1",CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.8021789269425141,9.79836e-11,NO,185495,6YD7,X-RAY DIFFRACTION,3.74,67.08,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100MM MES, 200MM K/NAH2PO4, PH 5.5-6.0, 2 M NACL; RESERVOIR SOLUTION: 3-4M NACL",291.15,2020-03-20,2021-02-17,4211,2,485,465.0,3,53.37,2,1.8,experimental,29.7,0.1709,0.1538,X-ray structure of furin in complex with the canavanine-based inhibitor 4-guanidinomethyl-phenylacetyl-Arg-Tle-Canavanine-Amba,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHH,Protein,480,polypeptide(L),1,52.112,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,485,2,2,Hetero 2-mer,"A1, B1",CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.8021789269425141,9.79836e-11,NO,185495,7QXY,X-RAY DIFFRACTION,2.568825997777984,50.34669344500458,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NAH2PO4, PH 5.5, 2 M NACL; RESERVOIR SOLUTION: 3.0-3.2M NACL",293.15,2022-01-27,2022-04-20,4386,1,480,661.0,2,53.0,1,1.478,experimental,24.97,0.1823,0.1705,X-ray structure of furin in complex with the dichlorophenylpyridine-based inhibitor 3,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHH,Protein,480,polypeptide(L),1,52.112,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,480,1,1,Monomer,A1,CL,Cl,35.453,CHLORIDE ION,InChI=1S/ClH/h1H/p-1,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.8021789269425141,9.79836e-11,NO,185495,4RYD,X-RAY DIFFRACTION,2.86,56.93,"VAPOR DIFFUSION, SITTING DROP",8.5,"50mM Tris, 2.8M sodium formate, 15mM Cymal-7, pH 8.5, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293.0,2014-12-15,2015-05-27,23768,12,2922,2034.0,18,320.52,2,2.15,experimental,39.57218347825871,0.2186,0.1862,X-ray structure of human furin in complex with the competitive inhibitor para-guanidinomethyl-Phac-R-Tle-R-Amba,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHHHH,Protein,482,polypeptide(L),6,52.389,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,487,2,2,Hetero 2-mer,"A1, B1",FMT,C H2 O2,46.025,FORMIC ACID,"InChI=1S/CH2O2/c2-1-3/h1H,(H,2,3)",
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.8021789269425141,9.79836e-11,NO,185495,5JXH,X-RAY DIFFRACTION,3.67,66.49,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"crystallization solution: 100 mM MES, 200 mM K/NaH2PO4, pH 5.5-6.0, 3-4 M NaCl, 3% DMSO; reservoir solution: 3-4 M NaCl",293.15,2016-05-13,2016-10-05,4261,2,487,534.0,3,53.39,2,2.0,experimental,39.57218347825871,0.1853,0.1566,Structure the proprotein convertase furin in complex with meta-guanidinomethyl-Phac-RVR-Amba at 2.0 Angstrom resolution.,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHHHH,Protein,482,polypeptide(L),1,52.389,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,487,2,2,Hetero 2-mer,"A1, B1",CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.8021789269425141,9.79836e-11,NO,185495,5JXG,X-RAY DIFFRACTION,3.73,67.05,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"crystallization solution: 100 mM MES, 200 mM K/NaH2PO4, pH 5.5-6.0, 3-4 M NaCl, 3% DMSO; reservoir solution: 3-4 M NaCl",293.15,2016-05-13,2016-10-05,4360,1,482,645.0,3,52.73,1,1.8,experimental,39.57218347825871,0.1733,0.154,Structure of the unliganded form of the proprotein convertase furin.,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHHHH,Protein,482,polypeptide(L),1,52.389,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,482,1,1,Monomer,A1,CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.8021789269425141,9.79836e-11,NO,185495,5JXI,X-RAY DIFFRACTION,3.76,67.3,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"crystallization solution: 100 mM MES, 200 mM K/NaH2PO4, pH 5.5-6.0, 3-4 M NaCl, 3% DMSO; reservoir solution: 3-4 M NaCl",293.15,2016-05-13,2016-10-05,4164,1,482,521.0,3,52.63,1,2.0,experimental,39.57218347825871,0.1851,0.1576,Structure of the unliganded form of the proprotein convertase furin in presence of EDTA.,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHHHH,Protein,482,polypeptide(L),1,52.389,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,482,1,1,Monomer,A1,CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.8021789269425141,9.79836e-11,NO,185495,5MIM,X-RAY DIFFRACTION,3.75,67.2,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100 MM MES, 200 MM K/NAH2PO4, PH 5.5-6.0, 3-4 M NACL, 3% DMSO; RESERVOIR SOLUTION: 3-4 M NACL",293.15,2016-11-28,2017-05-10,4275,1,482,486.0,3,53.81,1,1.9,experimental,39.57218347825871,0.1838,0.1647,"Xray structure of human furin bound with the 2,5-dideoxystreptamine derived small molecule inhibitor 1n",DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHHHH,Protein,482,polypeptide(L),1,52.389,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,482,1,1,Monomer,A1,CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.8021789269425141,9.79836e-11,NO,185495,5JXJ,X-RAY DIFFRACTION,3.69,66.65,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"crystallization solution: 100 mM MES, 200 mM K/NaH2PO4, pH 5.5-6.0, 3-4 M NaCl, 3% DMSO; reservoir solution: 3-4 M NaCl",293.15,2016-05-13,2016-10-05,4185,2,487,461.0,3,53.35,2,2.0,experimental,39.57218347825871,0.1889,0.1668,Structure of the proprotein convertase furin complexed to meta-guanidinomethyl-Phac-RVR-Amba in presence of EDTA,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHHHH,Protein,482,polypeptide(L),1,52.389,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,487,2,2,Hetero 2-mer,"A1, B1",CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.8021789269425141,9.79836e-11,NO,185495,6EQV,X-RAY DIFFRACTION,3.67,66.45,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NaH2PO4, PH 5.5-6.0, 3-4M NaCl, 3% DMSO; RESERVOIR SOLUTION: 3-4 M NaCl",293.15,2017-10-16,2018-02-28,4212,2,487,510.0,3,53.3,2,1.895,experimental,39.57218347825871,0.1821,0.1637,X-ray structure of the proprotein convertase furin bound with the competitive inhibitor Phac-Cit-Val-Arg-Amba,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHHHH,Protein,482,polypeptide(L),1,52.389,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,487,2,2,Hetero 2-mer,"A1, B1",CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.8021789269425141,9.79836e-11,NO,185495,6EQW,X-RAY DIFFRACTION,3.66,66.42,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NaH2PO4, PH 5.5-6.0, 3-4 M NaCL, 3% DMSO; RESERVOIR SOLUTION: 3-4M NaCL",293.15,2017-10-16,2018-02-28,4183,2,487,486.0,3,53.36,2,1.994,experimental,39.57218347825871,0.1842,0.1619,X-ray structure of the proprotein convertase furin bound with the competitive inhibitor 4-aminomethyl-phenylacetyl-Arg-Val-Arg-Amba,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHHHH,Protein,482,polypeptide(L),1,52.389,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,487,2,2,Hetero 2-mer,"A1, B1",CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.8021789269425141,9.79836e-11,NO,185495,6EQX,X-RAY DIFFRACTION,3.66,66.36,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"100mM MES, 200mM K/NaH2PO4, PH 5.5-6.0, 3-4 M NaCL, 3% DMSO; RESERVOIR SOLUTION: 3-4M NaCL",293.15,2017-10-16,2018-02-28,4186,2,488,471.0,3,53.51,2,1.994,experimental,39.57218347825871,0.1837,0.162,X-ray structure of the proprotein convertase furin bound with the competitive inhibitor Arg-Arg-Arg-Val-Arg-Amba,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHHHH,Protein,482,polypeptide(L),1,52.389,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,488,2,2,Hetero 2-mer,"A1, B1",CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
4193,ENTREZ_GENE,mdm2,ACTFSHDMXhdm2,Homo sapiens,0.813992417834789,9.85866e-11,NO,185651,4UD7,X-RAY DIFFRACTION,2.8,56.0,Desconocido,4.0,0.1 M SODIUM CITRATE PH 4.0 AND 15 % PEG8000,289.6514371309434,2014-12-08,2016-01-13,4008,8,520,262.0,0,58.68,2,1.6,experimental,23.018,0.17838,0.13846,Structure of the stapled peptide YS-02 bound to MDM2,GPLGSSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDAAQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSEN,Protein,114,polypeptide(L),4,12.831,mdm2,6.3.2,PDB Primary Data,Homo sapiens,9606,130,2,2,Hetero 2-mer,"A1, B1",Desconocido,Desconocido,246.2971348233669,Desconocido,Desconocido,
1387,ENTREZ_GENE,crebbp,CBPKAT3ARSTSRSTS1,Homo sapiens,0.6948095379457901,6.69303e-11,NO,188111,6YIK,X-RAY DIFFRACTION,3.42,64.06,"VAPOR DIFFUSION, SITTING DROP",7.5,"21% PEG3350
15% ethylene glycol
0.25M sodium formate",277.0,2020-04-01,2020-04-15,3453,3,357,385.0,0,44.74,1,1.7,experimental,32.625,0.184,0.156,Crystal structure of the CREBBP bromodomain in complex with a tetrahydroquinoxaline ligand,SMRKKIFKPEELRQALMPTLEALYRQDPESLPFRQPVDPQLLGIPDYFDIVKNPMDLSTIKRKLDTGQYQEPWQYVDDVWLMFNNAWLYNRKTSRVYKFCSKLAEVFEQEIDPVMQSLG,Protein,119,polypeptide(L),3,14.223,crebbp,2.3.1.48,PDB Primary Data,Homo sapiens,9606,119,1,1,Monomer,A1,OSQ,C22 H24 F2 N4 O2,414.448,"(3~{R})-~{N}-[3-(3,4-dihydro-2~{H}-quinolin-1-yl)-2,2-bis(fluoranyl)propyl]-3-methyl-2-oxidanylidene-3,4-dihydro-1~{H}-quinoxaline-5-carboxamide","InChI=1S/C22H24F2N4O2/c1-14-20(29)27-17-9-4-8-16(19(17)26-14)21(30)25-12-22(23,24)13-28-11-5-7-15-6-2-3-10-18(15)28/h2-4,6,8-10,14,26H,5,7,11-13H2,1H3,(H,25,30)(H,27,29)/t14-/m1/s1",
1387,ENTREZ_GENE,crebbp,CBPKAT3ARSTSRSTS1,Homo sapiens,0.6948095379457901,6.69303e-11,NO,188111,6SXX,X-RAY DIFFRACTION,2.18,43.67,"VAPOR DIFFUSION, HANGING DROP",6.982430939226492,"25% PEG3350, 0.2 M Potassium thiocyanate, 5% EtGly",277.0,2019-09-26,2020-07-29,1940,2,238,81.0,0,28.95,1,2.01,experimental,52.99,0.2533,0.1955,Crystal structure of the bromodomain of human CREBBP in complex with ACA007,SMRKKIFKPEELRQALMPTLEALYRQDPESLPFRQPVDPQLLGIPDYFDIVKNPMDLSTIKRKLDTGQYQEPWQYVDDVWLMFNNAWLYNRKTSRVYKFCSKLAEVFEQEIDPVMQSLG,Protein,119,polypeptide(L),2,14.223,crebbp,2.3.1.48,PDB Primary Data,Homo sapiens,9606,119,1,1,Monomer,A1,EDO,C2 H6 O2,62.068,"1,2-ETHANEDIOL","InChI=1S/C2H6O2/c3-1-2-4/h3-4H,1-2H2",
1387,ENTREZ_GENE,crebbp,CBPKAT3ARSTSRSTS1,Homo sapiens,0.6948095379457901,6.69303e-11,NO,188111,6YIL,X-RAY DIFFRACTION,2.2,44.01,"VAPOR DIFFUSION, SITTING DROP",7.5,"20% PEG3350
10% ethylene glycol
0.2M sodium acetate",277.0,2020-04-01,2020-04-15,1160,1,119,154.0,0,14.64,1,1.22,experimental,12.75,0.1511,0.1321,Crystal structure of the CREBBP bromodomain in complex with a tetrahydroquinoxaline ligand,SMRKKIFKPEELRQALMPTLEALYRQDPESLPFRQPVDPQLLGIPDYFDIVKNPMDLSTIKRKLDTGQYQEPWQYVDDVWLMFNNAWLYNRKTSRVYKFCSKLAEVFEQEIDPVMQSLG,Protein,119,polypeptide(L),1,14.223,crebbp,2.3.1.48,PDB Primary Data,Homo sapiens,9606,119,1,1,Monomer,A1,OSQ,C22 H24 F2 N4 O2,414.448,"(3~{R})-~{N}-[3-(3,4-dihydro-2~{H}-quinolin-1-yl)-2,2-bis(fluoranyl)propyl]-3-methyl-2-oxidanylidene-3,4-dihydro-1~{H}-quinoxaline-5-carboxamide","InChI=1S/C22H24F2N4O2/c1-14-20(29)27-17-9-4-8-16(19(17)26-14)21(30)25-12-22(23,24)13-28-11-5-7-15-6-2-3-10-18(15)28/h2-4,6,8-10,14,26H,5,7,11-13H2,1H3,(H,25,30)(H,27,29)/t14-/m1/s1",
1387,ENTREZ_GENE,crebbp,CBPKAT3ARSTSRSTS1,Homo sapiens,0.6948095379457901,6.69303e-11,NO,188111,6YIM,X-RAY DIFFRACTION,2.2,44.12,"VAPOR DIFFUSION, SITTING DROP",7.5,"20% PEG3350
10% ethylene glycol
0.2M sodium fluoride",277.0,2020-04-01,2020-04-15,1174,1,119,163.0,0,14.65,1,1.23,experimental,12.85,0.167,0.1397,Crystal structure of the CREBBP bromodomain in complex with a benzo-diazepine ligand,SMRKKIFKPEELRQALMPTLEALYRQDPESLPFRQPVDPQLLGIPDYFDIVKNPMDLSTIKRKLDTGQYQEPWQYVDDVWLMFNNAWLYNRKTSRVYKFCSKLAEVFEQEIDPVMQSLG,Protein,119,polypeptide(L),1,14.223,crebbp,2.3.1.48,PDB Primary Data,Homo sapiens,9606,119,1,1,Monomer,A1,OS8,C24 H30 N4 O3,422.52,"(4~{R})-~{N}-[3-(7-methoxy-3,4-dihydro-2~{H}-quinolin-1-yl)propyl]-4-methyl-2-oxidanylidene-1,3,4,5-tetrahydro-1,5-benzodiazepine-6-carboxamide","InChI=1S/C24H30N4O3/c1-16-14-22(29)27-20-8-3-7-19(23(20)26-16)24(30)25-11-5-13-28-12-4-6-17-9-10-18(31-2)15-21(17)28/h3,7-10,15-16,26H,4-6,11-14H2,1-2H3,(H,25,30)(H,27,29)/t16-/m1/s1",
1387,ENTREZ_GENE,crebbp,CBPKAT3ARSTSRSTS1,Homo sapiens,0.6948095379457901,6.69303e-11,NO,188111,6YIJ,X-RAY DIFFRACTION,2.95,58.37,"VAPOR DIFFUSION, SITTING DROP",8.3,"20% ethylene glycol
21% PEG6K
0.1M tris pH 8.3
0.125M lithium chloride",277.0,2020-04-01,2020-04-15,7177,7,833,224.0,0,102.4,1,2.2,experimental,44.856,0.2693,0.2022,Crystal structure of the CREBBP bromodomain in complex with a benzo-diazepine ligand,SMRKKIFKPEELRQALMPTLEALYRQDPESLPFRQPVDPQLLGIPDYFDIVKNPMDLSTIKRKLDTGQYQEPWQYVDDVWLMFNNAWLYNRKTSRVYKFCSKLAEVFEQEIDPVMQSLG,Protein,119,polypeptide(L),7,14.223,crebbp,2.3.1.48,PDB Primary Data,Homo sapiens,9606,119,1,1,Monomer,A1,OSN,C25 H31 N3 O2,405.533,"(4~{R})-6-[(~{E})-5-(7-methoxy-3,4-dihydro-2~{H}-quinolin-1-yl)pent-1-enyl]-4-methyl-1,3,4,5-tetrahydro-1,5-benzodiazepin-2-one","InChI=1S/C25H31N3O2/c1-18-16-24(29)27-22-11-6-9-20(25(22)26-18)8-4-3-5-14-28-15-7-10-19-12-13-21(30-2)17-23(19)28/h4,6,8-9,11-13,17-18,26H,3,5,7,10,14-16H2,1-2H3,(H,27,29)/b8-4+/t18-/m1/s1",
673,ENTREZ_GENE,braf,BRAF1BrafBRAF1NS7RAFB1,Homo sapiens,0.6424109896332805,6.69303e-11,NO,189872,5VR3,X-RAY DIFFRACTION,2.58,52.44,"VAPOR DIFFUSION, HANGING DROP",6.5,"0.1 M Bis-Tris pH 6.5, 2.0 M ammonium sulphate",293.15,2017-05-10,2018-02-14,510,1,88,13.0,0,9.64,1,2.102,experimental,39.57218347825871,0.2244,0.2095,Crystal structure of the BRS domain of BRAF,GAMDPGGGGSSAADPAIPEEVWNIKQMIKLTQEHIEALLDKFGGEHNPPSIYLEAYEEYTSKLDALQQREQQLLESLGNGTDFSVSSS,Protein,88,polypeptide(L),1,9.544,braf,2.7.11.1,PDB Primary Data,Homo sapiens,9606,88,1,1,Monomer,A1,SO4,O4 S,96.063,SULFATE ION,"InChI=1S/H2O4S/c1-5(2,3)4/h(H2,1,2,3,4)/p-2",
5771,ENTREZ_GENE,ptpn2,PTN2PTPTTCPTPTCELLPTPTCPTP,Homo sapiens,0.5214179780753041,6.69303e-11,NO,193954,8U0H,X-RAY DIFFRACTION,2.41,49.06,"VAPOR DIFFUSION, HANGING DROP",6.9,"0.49M Sodium phosphate monobasic monohydrate, 0.91M Potassium phosphate dibasic",296.0,2023-08-29,2024-09-04,5135,2,648,385.0,0,78.03,1,1.93,experimental,38.32,0.1917,0.1726,Crystal structure of PTPN2 with a PROTAC,MAMPTTIEREFEELDTQRRWQPLYLEIRNESHDYPHRVAKFPENRNRNRYRDVSPYDHSRVKLQNAENDYINASLVDIEEAQRSYILTQGPLPNTCCHFWLMVWQQKTKAVVMLNRIVEKESVKCAQYWPTDDQEMLFKETGFSVKLLSEDVKSYYTVHLLQLENINSGETRTISHFHYTTWPDFGVPESPASFLNFLFKVRESGSLNPDHGPAVIHCSAGIGRSGTFSLVDTCLVLMEKGDDINIKQVLLNMRKYRMGLIQTPDQLRFSYMAIIEGAKCIKGDSSIQKRWKELSKEDLSPAFDHSPNKIMTEKYNHHHHHHHH,Protein,324,polypeptide(L),2,37.966,ptpn2,3.1.3.48,PDB Primary Data,Homo sapiens,9606,324,1,1,Monomer,A1,UB0,C46 H49 Cl N6 O12 S2,977.497,"(5P)-3-(carboxymethoxy)-4-chloro-5-(3-{[(4S)-1-({3-[2-(4-{3-[(3R)-2,6-dioxopiperidin-3-yl]-2-oxo-2,3-dihydro-1,3-benzoxazol-6-yl}piperidin-1-yl)acetamido]phenyl}methanesulfonyl)-2,2-dimethylpiperidin-4-yl]amino}phenyl)thiophene-2-carboxylic acid","InChI=1S/C46H49ClN6O12S2/c1-46(2)22-32(48-31-8-4-6-29(20-31)41-39(47)40(64-24-38(56)57)42(66-41)44(59)60)15-18-52(46)67(62,63)25-26-5-3-7-30(19-26)49-37(55)23-51-16-13-27(14-17-51)28-9-10-33-35(21-28)65-45(61)53(33)34-11-12-36(54)50-43(34)58/h3-10,19-21,27,32,34,48H,11-18,22-25H2,1-2H3,(H,49,55)(H,56,57)(H,59,60)(H,50,54,58)/t32-,34+/m0/s1",
56339,ENTREZ_GENE,mettl3,IME4M6AMTA70Spo8hMETTL3,Homo sapiens,0.452823514829837,6.69303e-11,NO,194846,5IL1,X-RAY DIFFRACTION,2.58,52.33,"VAPOR DIFFUSION, HANGING DROP",5.7,"PEG 8000, sodium citrate",291.0,2016-03-04,2016-05-25,4336,2,512,337.0,0,59.81,2,1.71,experimental,39.57218347825871,0.2069,0.1798,Crystal structure of SAM-bound METTL3-METTL14 complex,FPPQWICCDIRYLDVSILGKFAVVMADPPWDIHMELPYGTLTDDEMRRLNIPVLQDDGFLFLWVTGRAMELGRECLNLWGYERVDEIIWVKTNQLQRIIRTGRTGHWLNHGKEHCLVGVKGNPQGFNQGLDCDVIVAEVRSTSHKPDEIYGMIERLSPGTRKIELFGRPHNVQPNWITLGNQLDGIHLLDPDVVARFKQRYPDGIISKPKNL,Protein,212,polypeptide(L),1,24.427,mettl3,2.1.1.62,PDB Primary Data,Homo sapiens,9606,512,2,2,Hetero 2-mer,"A1, B1",SAM,C15 H22 N6 O5 S,398.437,S-ADENOSYLMETHIONINE,"InChI=1S/C15H22N6O5S/c1-27(3-2-7(16)15(24)25)4-8-10(22)11(23)14(26-8)21-6-20-9-12(17)18-5-19-13(9)21/h5-8,10-11,14,22-23H,2-4,16H2,1H3,(H2-,17,18,19,24,25)/t7-,8+,10+,11+,14+,27-/m0/s1",
56339,ENTREZ_GENE,mettl3,IME4M6AMTA70Spo8hMETTL3,Homo sapiens,0.452823514829837,6.69303e-11,NO,194846,5IL0,X-RAY DIFFRACTION,2.55,51.69,"VAPOR DIFFUSION, HANGING DROP",5.7,"PEG 8000, sodium citrate",291.0,2016-03-04,2016-05-25,4347,2,512,331.0,0,59.43,2,1.882,experimental,39.57218347825871,0.205,0.1747,Crystal structural of the METTL3-METTL14 complex for N6-adenosine methylation,FPPQWICCDIRYLDVSILGKFAVVMADPPWDIHMELPYGTLTDDEMRRLNIPVLQDDGFLFLWVTGRAMELGRECLNLWGYERVDEIIWVKTNQLQRIIRTGRTGHWLNHGKEHCLVGVKGNPQGFNQGLDCDVIVAEVRSTSHKPDEIYGMIERLSPGTRKIELFGRPHNVQPNWITLGNQLDGIHLLDPDVVARFKQRYPDGIISKPKNL,Protein,212,polypeptide(L),1,24.427,mettl3,2.1.1.62,PDB Primary Data,Homo sapiens,9606,512,2,2,Hetero 2-mer,"A1, B1",EDO,C2 H6 O2,62.068,"1,2-ETHANEDIOL","InChI=1S/C2H6O2/c3-1-2-4/h3-4H,1-2H2",
56339,ENTREZ_GENE,mettl3,IME4M6AMTA70Spo8hMETTL3,Homo sapiens,0.452823514829837,6.69303e-11,NO,194846,5IL2,X-RAY DIFFRACTION,2.66,53.7,"VAPOR DIFFUSION, HANGING DROP",5.7,"PEG 8000, sodium citrate",291.0,2016-03-04,2016-05-25,4393,2,512,376.0,1,59.85,2,1.606,experimental,39.57218347825871,0.1992,0.1848,Crystal structure of SAH-bound METTL3-METTL14 complex,FPPQWICCDIRYLDVSILGKFAVVMADPPWDIHMELPYGTLTDDEMRRLNIPVLQDDGFLFLWVTGRAMELGRECLNLWGYERVDEIIWVKTNQLQRIIRTGRTGHWLNHGKEHCLVGVKGNPQGFNQGLDCDVIVAEVRSTSHKPDEIYGMIERLSPGTRKIELFGRPHNVQPNWITLGNQLDGIHLLDPDVVARFKQRYPDGIISKPKNL,Protein,212,polypeptide(L),1,24.427,mettl3,2.1.1.62,PDB Primary Data,Homo sapiens,9606,512,2,2,Hetero 2-mer,"A1, B1",EDO,C2 H6 O2,62.068,"1,2-ETHANEDIOL","InChI=1S/C2H6O2/c3-1-2-4/h3-4H,1-2H2",
5771,ENTREZ_GENE,ptpn2,PTN2PTPTTCPTPTCELLPTPTCPTP,Homo sapiens,0.6176407667946398,3.49726e-11,BioGRID ORCS,197213,8U0H,X-RAY DIFFRACTION,2.41,49.06,"VAPOR DIFFUSION, HANGING DROP",6.9,"0.49M Sodium phosphate monobasic monohydrate, 0.91M Potassium phosphate dibasic",296.0,2023-08-29,2024-09-04,5135,2,648,385.0,0,78.03,1,1.93,experimental,38.32,0.1917,0.1726,Crystal structure of PTPN2 with a PROTAC,MAMPTTIEREFEELDTQRRWQPLYLEIRNESHDYPHRVAKFPENRNRNRYRDVSPYDHSRVKLQNAENDYINASLVDIEEAQRSYILTQGPLPNTCCHFWLMVWQQKTKAVVMLNRIVEKESVKCAQYWPTDDQEMLFKETGFSVKLLSEDVKSYYTVHLLQLENINSGETRTISHFHYTTWPDFGVPESPASFLNFLFKVRESGSLNPDHGPAVIHCSAGIGRSGTFSLVDTCLVLMEKGDDINIKQVLLNMRKYRMGLIQTPDQLRFSYMAIIEGAKCIKGDSSIQKRWKELSKEDLSPAFDHSPNKIMTEKYNHHHHHHHH,Protein,324,polypeptide(L),2,37.966,ptpn2,3.1.3.48,PDB Primary Data,Homo sapiens,9606,324,1,1,Monomer,A1,UB0,C46 H49 Cl N6 O12 S2,977.497,"(5P)-3-(carboxymethoxy)-4-chloro-5-(3-{[(4S)-1-({3-[2-(4-{3-[(3R)-2,6-dioxopiperidin-3-yl]-2-oxo-2,3-dihydro-1,3-benzoxazol-6-yl}piperidin-1-yl)acetamido]phenyl}methanesulfonyl)-2,2-dimethylpiperidin-4-yl]amino}phenyl)thiophene-2-carboxylic acid","InChI=1S/C46H49ClN6O12S2/c1-46(2)22-32(48-31-8-4-6-29(20-31)41-39(47)40(64-24-38(56)57)42(66-41)44(59)60)15-18-52(46)67(62,63)25-26-5-3-7-30(19-26)49-37(55)23-51-16-13-27(14-17-51)28-9-10-33-35(21-28)65-45(61)53(33)34-11-12-36(54)50-43(34)58/h3-10,19-21,27,32,34,48H,11-18,22-25H2,1-2H3,(H,49,55)(H,56,57)(H,59,60)(H,50,54,58)/t32-,34+/m0/s1",
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.5966813474696359,3.49726e-11,BioGRID ORCS,199503,7QXZ,X-RAY DIFFRACTION,3.8,67.66,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NAH2PO4, PH 5.5, 2 M NACL; RESERVOIR SOLUTION: 3.0-3.2M NACL",293.15,2022-01-27,2022-04-13,4278,1,480,568.0,3,52.89,1,1.8,experimental,27.27,0.2173,0.1815,X-ray structure of furin in complex with the dichlorophenylpyridine-based inhibitor 5,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHH,Protein,480,polypeptide(L),1,52.112,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,480,1,1,Monomer,A1,CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.5966813474696359,3.49726e-11,BioGRID ORCS,199503,8B4V,X-RAY DIFFRACTION,3.75,67.16,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NAH2PO4, PH 5.5, 2 M NACL; RESERVOIR SOLUTION: 3.0-3.2M NACL",293.15,2022-09-21,2023-10-04,4300,1,480,508.0,4,52.95,1,1.6,experimental,26.89,0.1658,0.1535,X-ray structure of furin (PCSK3) in complex with benzamidine,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHH,Protein,480,polypeptide(L),1,52.112,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,480,1,1,Monomer,A1,BEN,C7 H8 N2,120.152,BENZAMIDINE,"InChI=1S/C7H8N2/c8-7(9)6-4-2-1-3-5-6/h1-5H,(H3,8,9)",
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.5966813474696359,3.49726e-11,BioGRID ORCS,199503,8B4W,X-RAY DIFFRACTION,3.75,67.17,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NAH2PO4, PH 5.5, 2 M NACL; RESERVOIR SOLUTION: 3.0-3.2M NACL",293.15,2022-09-21,2023-10-04,4403,1,480,497.0,4,53.21,1,1.6,experimental,27.18,0.179,0.1659,X-ray structure of furin (PCSK3) in complex with 1H-isoindol-3-amine,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHH,Protein,480,polypeptide(L),1,52.112,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,480,1,1,Monomer,A1,F05,C8 H8 N2,132.163,1H-isoindol-3-amine,"InChI=1S/C8H8N2/c9-8-7-4-2-1-3-6(7)5-10-8/h1-4H,5H2,(H2,9,10)",
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.5966813474696359,3.49726e-11,BioGRID ORCS,199503,8B4X,X-RAY DIFFRACTION,3.75,67.24,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NAH2PO4, PH 5.5, 2 M NACL; RESERVOIR SOLUTION: 3.0-3.2M NACL",293.15,2022-09-21,2023-10-04,4276,2,485,462.0,4,53.27,2,1.6,experimental,28.95,0.1695,0.158,X-ray structure of furin (PCSK3) in complex with Guanidinomethyl-Phac-R-Tle-K-6-(aminomethyl)-3-amino-isoindol,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHH,Protein,480,polypeptide(L),1,52.112,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,485,2,2,Hetero 2-mer,"A1, B1",CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.5966813474696359,3.49726e-11,BioGRID ORCS,199503,8OYH,X-RAY DIFFRACTION,3.76,67.27,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NAH2PO4, PH 5.5, 2 M NACL; RESERVOIR SOLUTION: 3.0-3.2M NACL",293.15,2023-05-04,2024-03-13,4092,2,485,340.0,4,53.27,2,1.8,experimental,36.56,0.188,0.1735,X-ray structure of furin (PCSK3) in complex with Guanidinomethyl-Phac-Can-Tle-Can-6-(aminomethyl)-3-amino-isoindol,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHH,Protein,480,polypeptide(L),1,52.112,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,485,2,2,Hetero 2-mer,"A1, B1",CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.5966813474696359,3.49726e-11,BioGRID ORCS,199503,4Z2A,X-RAY DIFFRACTION,2.36,47.94,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"Well 13% PEG 8K, 0.110M K-dihydrogen phosphate, 0.1M HEPES pH 7.5, 350 uL protein with 350uL well drops, MRC sitting drop",277.0,2015-03-29,2016-05-04,4016,1,465,408.0,4,50.92,1,1.89,experimental,16.9953,0.1834,0.1479,Crystal structure of unglycosylated apo human furin @1.89A,YQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKDLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQDWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTA,Protein,465,polypeptide(L),1,50.506,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,465,1,1,Monomer,A1,EDO,C2 H6 O2,62.068,"1,2-ETHANEDIOL","InChI=1S/C2H6O2/c3-1-2-4/h3-4H,1-2H2",
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.5966813474696359,3.49726e-11,BioGRID ORCS,199503,7O1U,X-RAY DIFFRACTION,3.74,67.12,"VAPOR DIFFUSION, SITTING DROP",5.5,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NAH2PO4, PH 5.5, 2 M NACL; RESERVOIR SOLUTION: 3.0-3.2M NACL",293.15,2021-03-30,2021-09-01,4375,1,480,519.0,4,53.19,1,1.7,experimental,26.23,0.1666,0.155,X-ray structure of furin in complex with the guanylhydrazone-based inhibitor 1 (BEV241),DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHH,Protein,480,polypeptide(L),1,52.112,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,480,1,1,Monomer,A1,Desconocido,Na,22.99,SODIUM ION,InChI=1S/Na/q+1,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.5966813474696359,3.49726e-11,BioGRID ORCS,199503,7O1W,X-RAY DIFFRACTION,3.74,67.1,"VAPOR DIFFUSION, SITTING DROP",5.5,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NAH2PO4, PH 5.5, 2 M NACL; RESERVOIR SOLUTION: 3.0-3.2M NACL",293.15,2021-03-30,2021-09-01,4335,1,480,424.0,4,53.69,1,1.8,experimental,29.36,0.1791,0.16,X-ray structure of furin in complex with the guanylhydrazone-based inhibitor 2 (mi307) soaked at 1 M NaCl,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHH,Protein,480,polypeptide(L),1,52.112,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,480,1,1,Monomer,A1,CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.5966813474696359,3.49726e-11,BioGRID ORCS,199503,7O1Y,X-RAY DIFFRACTION,3.72,66.95,"VAPOR DIFFUSION, SITTING DROP",5.5,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NAH2PO4, PH 5.5, 2 M NACL; RESERVOIR SOLUTION: 3.0-3.2M NACL",293.15,2021-03-30,2021-09-01,4321,1,480,475.0,4,53.91,1,1.7,experimental,29.48,0.177,0.1622,X-ray structure of furin in complex with the guanylhydrazone-based inhibitor 2 (mi307) soaked at 0.25 M NaCl,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHH,Protein,480,polypeptide(L),1,52.112,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,480,1,1,Monomer,A1,CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.5966813474696359,3.49726e-11,BioGRID ORCS,199503,7O20,X-RAY DIFFRACTION,3.67,66.48,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NAH2PO4, PH 5.5, 2 M NACL; RESERVOIR SOLUTION: 3.0-3.2M NACL",293.15,2021-03-30,2021-09-01,4190,1,480,376.0,4,53.54,1,1.8,experimental,33.26,0.1761,0.1624,X-ray structure of furin in complex with the guanylhydrazone-based inhibitor 3 (mi300),DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHH,Protein,480,polypeptide(L),1,52.112,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,480,1,1,Monomer,A1,CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.5966813474696359,3.49726e-11,BioGRID ORCS,199503,7O22,X-RAY DIFFRACTION,3.69,66.7,"VAPOR DIFFUSION, SITTING DROP",5.5,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NAH2PO4, PH 5.5, 2 M NACL; RESERVOIR SOLUTION: 3.0-3.2M NACL",293.15,2021-03-30,2021-09-01,4130,1,480,427.0,4,53.15,1,1.8,experimental,33.5,0.1825,0.169,X-ray structure of furin in complex with the guanylhydrazone-based inhibitor 4 (mi359),DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHH,Protein,480,polypeptide(L),1,52.112,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,480,1,1,Monomer,A1,CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.5966813474696359,3.49726e-11,BioGRID ORCS,199503,7QY0,X-RAY DIFFRACTION,3.72,66.91,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NAH2PO4, PH 5.5, 2 M NACL; RESERVOIR SOLUTION: 3.0-3.2M NACL",293.15,2022-01-27,2022-04-20,4378,1,480,476.0,4,53.68,1,1.54,experimental,26.16,0.1725,0.1493,X-ray structure of furin in complex with the dichlorophenylpyridine-based inhibitor 1,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHH,Protein,480,polypeptide(L),1,52.112,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,480,1,1,Monomer,A1,I0T,C32 H42 Cl2 N6 O3,629.62,"N-[[1-[[2-[3,5-bis(chloranyl)phenyl]-6-[6-[4-(2-methoxyethyl)piperazin-4-ium-1-yl]pyridin-3-yl]oxy-pyridin-4-yl]methyl]piperidin-1-ium-4-yl]methyl]ethanamide","InChI=1S/C32H40Cl2N6O3/c1-23(41)35-20-24-5-7-39(8-6-24)22-25-15-30(26-17-27(33)19-28(34)18-26)37-32(16-25)43-29-3-4-31(36-21-29)40-11-9-38(10-12-40)13-14-42-2/h3-4,15-19,21,24H,5-14,20,22H2,1-2H3,(H,35,41)/p+2",
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.5966813474696359,3.49726e-11,BioGRID ORCS,199503,7QY1,X-RAY DIFFRACTION,2.568825997777984,50.34669344500458,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NAH2PO4, PH 5.5, 2 M NACL; RESERVOIR SOLUTION: 3.0-3.2M NACL",293.15,2022-01-27,2022-04-20,4387,1,480,483.0,4,53.77,1,1.45,experimental,25.78,0.1754,0.1502,X-ray structure of furin in complex with the dichlorophenylpyridine-based inhibitor 4,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHH,Protein,480,polypeptide(L),1,52.112,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,480,1,1,Monomer,A1,I0W,C32 H39 Cl2 N6 O4,642.596,"3-[4-[5-[4-[[4-(acetamidomethyl)piperidin-1-ium-1-yl]methyl]-6-[3,5-bis(chloranyl)phenyl]pyridin-2-yl]oxypyridin-2-yl]piperazin-1-ium-1-yl]propanoate","InChI=1S/C32H38Cl2N6O4/c1-22(41)35-19-23-4-7-39(8-5-23)21-24-14-29(25-16-26(33)18-27(34)17-25)37-31(15-24)44-28-2-3-30(36-20-28)40-12-10-38(11-13-40)9-6-32(42)43/h2-3,14-18,20,23H,4-13,19,21H2,1H3,(H,35,41)(H,42,43)/p+1",
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.5966813474696359,3.49726e-11,BioGRID ORCS,199503,7QY2,X-RAY DIFFRACTION,3.71,66.87,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NAH2PO4, PH 5.5, 2 M NACL; RESERVOIR SOLUTION: 3.0-3.2M NACL",293.15,2022-01-27,2022-04-20,4373,1,480,471.0,4,53.72,1,1.55,experimental,27.19,0.1877,0.1645,X-ray structure of furin in complex with the dichlorophenylpyridine-based inhibitor 2,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHH,Protein,480,polypeptide(L),1,52.112,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,480,1,1,Monomer,A1,I0Q,C33 H42 Cl2 N7 O4,671.637,"(2R)-4-[4-[5-[4-[[4-(acetamidomethyl)piperidin-1-ium-1-yl]methyl]-6-[3,5-bis(chloranyl)phenyl]pyridin-2-yl]oxypyrimidin-2-yl]piperazin-1-ium-1-yl]-2-methyl-butanoate","InChI=1S/C33H41Cl2N7O4/c1-22(32(44)45)3-6-40-9-11-42(12-10-40)33-37-19-29(20-38-33)46-31-14-25(13-30(39-31)26-15-27(34)17-28(35)16-26)21-41-7-4-24(5-8-41)18-36-23(2)43/h13-17,19-20,22,24H,3-12,18,21H2,1-2H3,(H,36,43)(H,44,45)/p+1/t22-/m1/s1",
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.5966813474696359,3.49726e-11,BioGRID ORCS,199503,7LCU,X-RAY DIFFRACTION,2.25,45.43,VAPOR DIFFUSION,7.5,"PEG8000, potassium dihydrogen phosphate",277.0,2021-01-11,2022-01-12,4057,1,490,352.0,5,54.37,1,1.24,experimental,14.5,0.1944,0.1764,"X-ray structure of Furin bound to BOS-318, a small molecule inhibitor",DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKDLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQDWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTAGENLYFQGDYKDDDDKGHHHHHH,Protein,490,polypeptide(L),1,53.512,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,490,1,1,Monomer,A1,CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.5966813474696359,3.49726e-11,BioGRID ORCS,199503,6HLB,X-RAY DIFFRACTION,3.77,67.33,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NaH2PO4, PH 5.5-6.0, 2 M NaCL, 3% DMSO; RESERVOIR SOLUTION: 3-4M NaCL",293.15,2018-09-11,2019-02-06,4028,2,491,338.0,3,54.39,2,2.0,experimental,39.57218347825871,0.1874,0.1686,X-ray structure of furin in complex with the cyclic peptide c[succinyl-Phe-2-Nal-(Arg)4-Lys]-Arg-4-Amba,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHHHH,Protein,482,polypeptide(L),1,52.389,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,491,2,2,Hetero 2-mer,"A1, B1",CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.5966813474696359,3.49726e-11,BioGRID ORCS,199503,6HLD,X-RAY DIFFRACTION,3.78,67.46,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NaH2PO4, PH 5.5-6.0, 2 M NaCL, 3% DMSO; RESERVOIR SOLUTION: 3-4M NaCL",293.15,2018-09-11,2019-02-06,4067,2,489,343.0,3,54.06,2,2.1,experimental,39.57218347825871,0.1959,0.17,X-ray structure of furin in complex with the cyclic peptide c[succinyl-Phe-2-Nal-(Arg)3-Lys]-Lys-4-Amba,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHHHH,Protein,482,polypeptide(L),1,52.389,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,489,2,2,Hetero 2-mer,"A1, B1",CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.5966813474696359,3.49726e-11,BioGRID ORCS,199503,6HLE,X-RAY DIFFRACTION,3.84,68.01,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NaH2PO4, PH 5.5-6.0, 2 M NaCL, 3% DMSO; RESERVOIR SOLUTION: 3-4M NaCL",293.15,2018-09-11,2019-02-06,4127,2,488,390.0,3,53.91,2,1.994,experimental,39.57218347825871,0.1908,0.1667,X-ray structure of furin in complex with the P6-P2-cyclized peptide H-Lys-Arg-Arg-Tle-Lys-4-Amba,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHHHH,Protein,482,polypeptide(L),1,52.389,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,488,2,2,Hetero 2-mer,"A1, B1",CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.5966813474696359,3.49726e-11,BioGRID ORCS,199503,6HZA,X-RAY DIFFRACTION,3.64,66.19,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NaH2PO4, PH 5.5-6.0, 2 M NaCL, 3% DMSO; RESERVOIR SOLUTION: 3-4M NaCL",293.15,2018-10-23,2019-02-06,4150,2,487,416.0,3,53.73,2,1.9,experimental,39.57218347825871,0.1859,0.1661,X-ray structure of furin in complex with the cyclic peptide c[glutaryl-Arg-Arg-Lys]-Arg-4-Amba,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHHHH,Protein,482,polypeptide(L),1,52.389,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,487,2,2,Hetero 2-mer,"A1, B1",CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.5966813474696359,3.49726e-11,BioGRID ORCS,199503,6HZB,X-RAY DIFFRACTION,3.66,66.41,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NaH2PO4, PH 5.5-6.0, 2 M NaCL, 3% DMSO; RESERVOIR SOLUTION: 3-4M NaCL",293.15,2018-10-23,2019-02-06,4150,2,487,418.0,3,53.7,2,1.9,experimental,39.57218347825871,0.1824,0.1646,X-ray structure of furin in complex with the cyclic inhibitor c[glutaryl-Arg-Arg-Lys]-Lys-4-Amba,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHHHH,Protein,482,polypeptide(L),1,52.389,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,487,2,2,Hetero 2-mer,"A1, B1",CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.5966813474696359,3.49726e-11,BioGRID ORCS,199503,6HZD,X-RAY DIFFRACTION,3.64,66.22,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NaH2PO4, PH 5.5-6.0, 2 M NaCL, 3% DMSO; RESERVOIR SOLUTION: 3-4M NaCL",293.15,2018-10-23,2019-02-06,4163,2,488,418.0,3,53.89,2,1.9,experimental,39.57218347825871,0.1827,0.1641,X-ray structure of furin in complex with the cyclic inhibitor c[glutaryl-Arg-Arg-Arg-Lys]-Arg-4-Amba,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHHHH,Protein,482,polypeptide(L),1,52.389,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,488,2,2,Hetero 2-mer,"A1, B1",CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.5966813474696359,3.49726e-11,BioGRID ORCS,199503,6YD2,X-RAY DIFFRACTION,3.7,66.74,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100MM MES, 200MM K/NAH2PO4, PH 5.5-6.0, 2 M NACL; RESERVOIR SOLUTION: 3-4M NACL",293.15,2020-03-20,2021-02-17,4179,2,487,444.0,3,53.58,2,1.8,experimental,32.05,0.1771,0.1575,X-ray structure of furin in complex with the canavanine-based inhibitor 4-aminomethyl-phenylacetyl-canavanine-Tle-Arg-Amba,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHHHH,Protein,482,polypeptide(L),1,52.389,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,487,2,2,Hetero 2-mer,"A1, B1",CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.5966813474696359,3.49726e-11,BioGRID ORCS,199503,6YD3,X-RAY DIFFRACTION,3.72,66.96,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100MM MES, 200MM K/NAH2PO4, PH 5.5-6.0, 2 M NACL; RESERVOIR SOLUTION: 3-4M NACL",293.15,2020-03-20,2021-02-17,4159,2,485,418.0,3,53.34,2,2.0,experimental,32.04,0.1854,0.1595,X-ray structure of furin in complex with the canavanine derived inhibitor 4-guanidinomethyl-phenylacetyl-Canavanine-Tle-Arg-Amba,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHH,Protein,480,polypeptide(L),1,52.112,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,485,2,2,Hetero 2-mer,"A1, B1",CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.5966813474696359,3.49726e-11,BioGRID ORCS,199503,6YD4,X-RAY DIFFRACTION,3.73,67.06,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100MM MES, 200MM K/NAH2PO4, PH 5.5-6.0, 2 M NACL; RESERVOIR SOLUTION: 3-4M NACL",291.15,2020-03-20,2021-02-17,4237,2,485,477.0,3,53.37,2,1.7,experimental,31.24,0.1694,0.1532,X-ray structure of furin in complex with the canavanine-based inhibitor 4-guanidinomethyl-phenylacetyl-Canavanine-Tle-Canavanine-Amba,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHH,Protein,480,polypeptide(L),1,52.112,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,485,2,2,Hetero 2-mer,"A1, B1",CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.5966813474696359,3.49726e-11,BioGRID ORCS,199503,6YD7,X-RAY DIFFRACTION,3.74,67.08,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100MM MES, 200MM K/NAH2PO4, PH 5.5-6.0, 2 M NACL; RESERVOIR SOLUTION: 3-4M NACL",291.15,2020-03-20,2021-02-17,4211,2,485,465.0,3,53.37,2,1.8,experimental,29.7,0.1709,0.1538,X-ray structure of furin in complex with the canavanine-based inhibitor 4-guanidinomethyl-phenylacetyl-Arg-Tle-Canavanine-Amba,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHH,Protein,480,polypeptide(L),1,52.112,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,485,2,2,Hetero 2-mer,"A1, B1",CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.5966813474696359,3.49726e-11,BioGRID ORCS,199503,7QXY,X-RAY DIFFRACTION,2.568825997777984,50.34669344500458,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NAH2PO4, PH 5.5, 2 M NACL; RESERVOIR SOLUTION: 3.0-3.2M NACL",293.15,2022-01-27,2022-04-20,4386,1,480,661.0,2,53.0,1,1.478,experimental,24.97,0.1823,0.1705,X-ray structure of furin in complex with the dichlorophenylpyridine-based inhibitor 3,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHH,Protein,480,polypeptide(L),1,52.112,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,480,1,1,Monomer,A1,CL,Cl,35.453,CHLORIDE ION,InChI=1S/ClH/h1H/p-1,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.5966813474696359,3.49726e-11,BioGRID ORCS,199503,4RYD,X-RAY DIFFRACTION,2.86,56.93,"VAPOR DIFFUSION, SITTING DROP",8.5,"50mM Tris, 2.8M sodium formate, 15mM Cymal-7, pH 8.5, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293.0,2014-12-15,2015-05-27,23768,12,2922,2034.0,18,320.52,2,2.15,experimental,39.57218347825871,0.2186,0.1862,X-ray structure of human furin in complex with the competitive inhibitor para-guanidinomethyl-Phac-R-Tle-R-Amba,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHHHH,Protein,482,polypeptide(L),6,52.389,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,487,2,2,Hetero 2-mer,"A1, B1",FMT,C H2 O2,46.025,FORMIC ACID,"InChI=1S/CH2O2/c2-1-3/h1H,(H,2,3)",
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.5966813474696359,3.49726e-11,BioGRID ORCS,199503,5JXH,X-RAY DIFFRACTION,3.67,66.49,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"crystallization solution: 100 mM MES, 200 mM K/NaH2PO4, pH 5.5-6.0, 3-4 M NaCl, 3% DMSO; reservoir solution: 3-4 M NaCl",293.15,2016-05-13,2016-10-05,4261,2,487,534.0,3,53.39,2,2.0,experimental,39.57218347825871,0.1853,0.1566,Structure the proprotein convertase furin in complex with meta-guanidinomethyl-Phac-RVR-Amba at 2.0 Angstrom resolution.,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHHHH,Protein,482,polypeptide(L),1,52.389,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,487,2,2,Hetero 2-mer,"A1, B1",CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.5966813474696359,3.49726e-11,BioGRID ORCS,199503,5JXG,X-RAY DIFFRACTION,3.73,67.05,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"crystallization solution: 100 mM MES, 200 mM K/NaH2PO4, pH 5.5-6.0, 3-4 M NaCl, 3% DMSO; reservoir solution: 3-4 M NaCl",293.15,2016-05-13,2016-10-05,4360,1,482,645.0,3,52.73,1,1.8,experimental,39.57218347825871,0.1733,0.154,Structure of the unliganded form of the proprotein convertase furin.,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHHHH,Protein,482,polypeptide(L),1,52.389,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,482,1,1,Monomer,A1,CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.5966813474696359,3.49726e-11,BioGRID ORCS,199503,5JXI,X-RAY DIFFRACTION,3.76,67.3,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"crystallization solution: 100 mM MES, 200 mM K/NaH2PO4, pH 5.5-6.0, 3-4 M NaCl, 3% DMSO; reservoir solution: 3-4 M NaCl",293.15,2016-05-13,2016-10-05,4164,1,482,521.0,3,52.63,1,2.0,experimental,39.57218347825871,0.1851,0.1576,Structure of the unliganded form of the proprotein convertase furin in presence of EDTA.,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHHHH,Protein,482,polypeptide(L),1,52.389,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,482,1,1,Monomer,A1,CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.5966813474696359,3.49726e-11,BioGRID ORCS,199503,5MIM,X-RAY DIFFRACTION,3.75,67.2,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100 MM MES, 200 MM K/NAH2PO4, PH 5.5-6.0, 3-4 M NACL, 3% DMSO; RESERVOIR SOLUTION: 3-4 M NACL",293.15,2016-11-28,2017-05-10,4275,1,482,486.0,3,53.81,1,1.9,experimental,39.57218347825871,0.1838,0.1647,"Xray structure of human furin bound with the 2,5-dideoxystreptamine derived small molecule inhibitor 1n",DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHHHH,Protein,482,polypeptide(L),1,52.389,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,482,1,1,Monomer,A1,CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.5966813474696359,3.49726e-11,BioGRID ORCS,199503,5JXJ,X-RAY DIFFRACTION,3.69,66.65,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"crystallization solution: 100 mM MES, 200 mM K/NaH2PO4, pH 5.5-6.0, 3-4 M NaCl, 3% DMSO; reservoir solution: 3-4 M NaCl",293.15,2016-05-13,2016-10-05,4185,2,487,461.0,3,53.35,2,2.0,experimental,39.57218347825871,0.1889,0.1668,Structure of the proprotein convertase furin complexed to meta-guanidinomethyl-Phac-RVR-Amba in presence of EDTA,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHHHH,Protein,482,polypeptide(L),1,52.389,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,487,2,2,Hetero 2-mer,"A1, B1",CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.5966813474696359,3.49726e-11,BioGRID ORCS,199503,6EQV,X-RAY DIFFRACTION,3.67,66.45,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NaH2PO4, PH 5.5-6.0, 3-4M NaCl, 3% DMSO; RESERVOIR SOLUTION: 3-4 M NaCl",293.15,2017-10-16,2018-02-28,4212,2,487,510.0,3,53.3,2,1.895,experimental,39.57218347825871,0.1821,0.1637,X-ray structure of the proprotein convertase furin bound with the competitive inhibitor Phac-Cit-Val-Arg-Amba,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHHHH,Protein,482,polypeptide(L),1,52.389,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,487,2,2,Hetero 2-mer,"A1, B1",CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.5966813474696359,3.49726e-11,BioGRID ORCS,199503,6EQW,X-RAY DIFFRACTION,3.66,66.42,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NaH2PO4, PH 5.5-6.0, 3-4 M NaCL, 3% DMSO; RESERVOIR SOLUTION: 3-4M NaCL",293.15,2017-10-16,2018-02-28,4183,2,487,486.0,3,53.36,2,1.994,experimental,39.57218347825871,0.1842,0.1619,X-ray structure of the proprotein convertase furin bound with the competitive inhibitor 4-aminomethyl-phenylacetyl-Arg-Val-Arg-Amba,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHHHH,Protein,482,polypeptide(L),1,52.389,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,487,2,2,Hetero 2-mer,"A1, B1",CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.5966813474696359,3.49726e-11,BioGRID ORCS,199503,6EQX,X-RAY DIFFRACTION,3.66,66.36,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"100mM MES, 200mM K/NaH2PO4, PH 5.5-6.0, 3-4 M NaCL, 3% DMSO; RESERVOIR SOLUTION: 3-4M NaCL",293.15,2017-10-16,2018-02-28,4186,2,488,471.0,3,53.51,2,1.994,experimental,39.57218347825871,0.1837,0.162,X-ray structure of the proprotein convertase furin bound with the competitive inhibitor Arg-Arg-Arg-Val-Arg-Amba,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHHHH,Protein,482,polypeptide(L),1,52.389,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,488,2,2,Hetero 2-mer,"A1, B1",CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
673,ENTREZ_GENE,braf,BRAF1BrafBRAF1NS7RAFB1,Homo sapiens,0.5661949193605395,3.49726e-11,BioGRID ORCS,201860,5VR3,X-RAY DIFFRACTION,2.58,52.44,"VAPOR DIFFUSION, HANGING DROP",6.5,"0.1 M Bis-Tris pH 6.5, 2.0 M ammonium sulphate",293.15,2017-05-10,2018-02-14,510,1,88,13.0,0,9.64,1,2.102,experimental,39.57218347825871,0.2244,0.2095,Crystal structure of the BRS domain of BRAF,GAMDPGGGGSSAADPAIPEEVWNIKQMIKLTQEHIEALLDKFGGEHNPPSIYLEAYEEYTSKLDALQQREQQLLESLGNGTDFSVSSS,Protein,88,polypeptide(L),1,9.544,braf,2.7.11.1,PDB Primary Data,Homo sapiens,9606,88,1,1,Monomer,A1,SO4,O4 S,96.063,SULFATE ION,"InChI=1S/H2O4S/c1-5(2,3)4/h(H2,1,2,3,4)/p-2",
56339,ENTREZ_GENE,mettl3,IME4M6AMTA70Spo8hMETTL3,Homo sapiens,0.5037930118247326,3.49726e-11,BioGRID ORCS,204413,5IL1,X-RAY DIFFRACTION,2.58,52.33,"VAPOR DIFFUSION, HANGING DROP",5.7,"PEG 8000, sodium citrate",291.0,2016-03-04,2016-05-25,4336,2,512,337.0,0,59.81,2,1.71,experimental,39.57218347825871,0.2069,0.1798,Crystal structure of SAM-bound METTL3-METTL14 complex,FPPQWICCDIRYLDVSILGKFAVVMADPPWDIHMELPYGTLTDDEMRRLNIPVLQDDGFLFLWVTGRAMELGRECLNLWGYERVDEIIWVKTNQLQRIIRTGRTGHWLNHGKEHCLVGVKGNPQGFNQGLDCDVIVAEVRSTSHKPDEIYGMIERLSPGTRKIELFGRPHNVQPNWITLGNQLDGIHLLDPDVVARFKQRYPDGIISKPKNL,Protein,212,polypeptide(L),1,24.427,mettl3,2.1.1.62,PDB Primary Data,Homo sapiens,9606,512,2,2,Hetero 2-mer,"A1, B1",SAM,C15 H22 N6 O5 S,398.437,S-ADENOSYLMETHIONINE,"InChI=1S/C15H22N6O5S/c1-27(3-2-7(16)15(24)25)4-8-10(22)11(23)14(26-8)21-6-20-9-12(17)18-5-19-13(9)21/h5-8,10-11,14,22-23H,2-4,16H2,1H3,(H2-,17,18,19,24,25)/t7-,8+,10+,11+,14+,27-/m0/s1",
56339,ENTREZ_GENE,mettl3,IME4M6AMTA70Spo8hMETTL3,Homo sapiens,0.5037930118247326,3.49726e-11,BioGRID ORCS,204413,5IL0,X-RAY DIFFRACTION,2.55,51.69,"VAPOR DIFFUSION, HANGING DROP",5.7,"PEG 8000, sodium citrate",291.0,2016-03-04,2016-05-25,4347,2,512,331.0,0,59.43,2,1.882,experimental,39.57218347825871,0.205,0.1747,Crystal structural of the METTL3-METTL14 complex for N6-adenosine methylation,FPPQWICCDIRYLDVSILGKFAVVMADPPWDIHMELPYGTLTDDEMRRLNIPVLQDDGFLFLWVTGRAMELGRECLNLWGYERVDEIIWVKTNQLQRIIRTGRTGHWLNHGKEHCLVGVKGNPQGFNQGLDCDVIVAEVRSTSHKPDEIYGMIERLSPGTRKIELFGRPHNVQPNWITLGNQLDGIHLLDPDVVARFKQRYPDGIISKPKNL,Protein,212,polypeptide(L),1,24.427,mettl3,2.1.1.62,PDB Primary Data,Homo sapiens,9606,512,2,2,Hetero 2-mer,"A1, B1",EDO,C2 H6 O2,62.068,"1,2-ETHANEDIOL","InChI=1S/C2H6O2/c3-1-2-4/h3-4H,1-2H2",
56339,ENTREZ_GENE,mettl3,IME4M6AMTA70Spo8hMETTL3,Homo sapiens,0.5037930118247326,3.49726e-11,BioGRID ORCS,204413,5IL2,X-RAY DIFFRACTION,2.66,53.7,"VAPOR DIFFUSION, HANGING DROP",5.7,"PEG 8000, sodium citrate",291.0,2016-03-04,2016-05-25,4393,2,512,376.0,1,59.85,2,1.606,experimental,39.57218347825871,0.1992,0.1848,Crystal structure of SAH-bound METTL3-METTL14 complex,FPPQWICCDIRYLDVSILGKFAVVMADPPWDIHMELPYGTLTDDEMRRLNIPVLQDDGFLFLWVTGRAMELGRECLNLWGYERVDEIIWVKTNQLQRIIRTGRTGHWLNHGKEHCLVGVKGNPQGFNQGLDCDVIVAEVRSTSHKPDEIYGMIERLSPGTRKIELFGRPHNVQPNWITLGNQLDGIHLLDPDVVARFKQRYPDGIISKPKNL,Protein,212,polypeptide(L),1,24.427,mettl3,2.1.1.62,PDB Primary Data,Homo sapiens,9606,512,2,2,Hetero 2-mer,"A1, B1",EDO,C2 H6 O2,62.068,"1,2-ETHANEDIOL","InChI=1S/C2H6O2/c3-1-2-4/h3-4H,1-2H2",
147111,ENTREZ_GENE,notum,hNOTUM,Homo sapiens,0.7033838458514735,3.49726e-11,BioGRID ORCS,206987,4UZ1,X-RAY DIFFRACTION,1.9,34.0,Desconocido,4.6,"1.5 M AMMONIUM SULPHATE, 0.1 M SODIUM ACETATE PH 4.6",289.6514371309434,2014-09-04,2015-02-25,3212,1,383,287.0,7,44.17,1,1.4,experimental,18.766,0.18045,0.14387,STRUCTURE OF THE WNT DEACYLASE NOTUM - CRYSTAL FORM III - 1.4A,ETGSAQQLNEDLRLHLLLNTSVTCNDGSPAGYYLKESRGSRRWLLFLEGGWYCFNRENCDSRYDTMRRLMSSRDWPRTRTGTGILSSQPEENPYWWNANMVFIPYCSSDVWSGASSKSEKNEYAFMGALIIQEVVRELLGRGLSGAKVLLLAGSSAGGTGVLLNVDRVAEQLEKLGYPAIQVRGLADSGWFLDNKQYRHTDCVDTITCAPTEAIRRGIRYWNGVVPERCRRQFQEGEEWNCFFGYKVYPTLRSPVFVVQWLFDEAQLTVDNVHLTGQPVQEGLRLYIQNLGRELRHTLKDVPASFAPACLSHEIIIRSHWTDVQVKGTSLPRALHCWDRSLHDSHKASKTPLKGCPVHLVDSCPWPHCNPSCPTGTKHHHHHH,Protein,383,polypeptide(L),1,43.567,notum,3.1.1.1,PDB Primary Data,Homo sapiens,9606,383,1,1,Monomer,A1,NAG,C8 H15 N O6,221.208,2-acetamido-2-deoxy-beta-D-glucopyranose,"InChI=1S/C8H15NO6/c1-3(11)9-5-7(13)6(12)4(2-10)15-8(5)14/h4-8,10,12-14H,2H2,1H3,(H,9,11)/t4-,5-,6-,7-,8-/m1/s1",
147111,ENTREZ_GENE,notum,hNOTUM,Homo sapiens,0.7033838458514735,3.49726e-11,BioGRID ORCS,206987,4UZ5,X-RAY DIFFRACTION,2.5,52.0,Desconocido,6.0,"10 %W/V PEG4000, 0.01 M CACL2, 0.05 M NACACOD PH 6.0, 0.20 M KCL, 1 MM HEPARIN HEXAMER",289.6514371309434,2014-09-04,2015-02-25,2901,1,383,84.0,7,43.82,1,2.1,experimental,43.492,0.2371,0.18746,STRUCTURE OF THE WNT DEACYLASE NOTUM - CRYSTAL FORM IV - 2.1A,ETGSAQQLNEDLRLHLLLNTSVTCNDGSPAGYYLKESRGSRRWLLFLEGGWYCFNRENCDSRYDTMRRLMSSRDWPRTRTGTGILSSQPEENPYWWNANMVFIPYCSSDVWSGASSKSEKNEYAFMGALIIQEVVRELLGRGLSGAKVLLLAGSSAGGTGVLLNVDRVAEQLEKLGYPAIQVRGLADSGWFLDNKQYRHTDCVDTITCAPTEAIRRGIRYWNGVVPERCRRQFQEGEEWNCFFGYKVYPTLRSPVFVVQWLFDEAQLTVDNVHLTGQPVQEGLRLYIQNLGRELRHTLKDVPASFAPACLSHEIIIRSHWTDVQVKGTSLPRALHCWDRSLHDSHKASKTPLKGCPVHLVDSCPWPHCNPSCPTGTKHHHHHH,Protein,383,polypeptide(L),1,43.567,notum,3.1.1.1,PDB Primary Data,Homo sapiens,9606,383,1,1,Monomer,A1,NAG,C8 H15 N O6,221.208,2-acetamido-2-deoxy-beta-D-glucopyranose,"InChI=1S/C8H15NO6/c1-3(11)9-5-7(13)6(12)4(2-10)15-8(5)14/h4-8,10,12-14H,2H2,1H3,(H,9,11)/t4-,5-,6-,7-,8-/m1/s1",
1387,ENTREZ_GENE,crebbp,CBPKAT3ARSTSRSTS1,Homo sapiens,0.6409819383156667,3.49726e-11,BioGRID ORCS,208745,6YIK,X-RAY DIFFRACTION,3.42,64.06,"VAPOR DIFFUSION, SITTING DROP",7.5,"21% PEG3350
15% ethylene glycol
0.25M sodium formate",277.0,2020-04-01,2020-04-15,3453,3,357,385.0,0,44.74,1,1.7,experimental,32.625,0.184,0.156,Crystal structure of the CREBBP bromodomain in complex with a tetrahydroquinoxaline ligand,SMRKKIFKPEELRQALMPTLEALYRQDPESLPFRQPVDPQLLGIPDYFDIVKNPMDLSTIKRKLDTGQYQEPWQYVDDVWLMFNNAWLYNRKTSRVYKFCSKLAEVFEQEIDPVMQSLG,Protein,119,polypeptide(L),3,14.223,crebbp,2.3.1.48,PDB Primary Data,Homo sapiens,9606,119,1,1,Monomer,A1,OSQ,C22 H24 F2 N4 O2,414.448,"(3~{R})-~{N}-[3-(3,4-dihydro-2~{H}-quinolin-1-yl)-2,2-bis(fluoranyl)propyl]-3-methyl-2-oxidanylidene-3,4-dihydro-1~{H}-quinoxaline-5-carboxamide","InChI=1S/C22H24F2N4O2/c1-14-20(29)27-17-9-4-8-16(19(17)26-14)21(30)25-12-22(23,24)13-28-11-5-7-15-6-2-3-10-18(15)28/h2-4,6,8-10,14,26H,5,7,11-13H2,1H3,(H,25,30)(H,27,29)/t14-/m1/s1",
1387,ENTREZ_GENE,crebbp,CBPKAT3ARSTSRSTS1,Homo sapiens,0.6409819383156667,3.49726e-11,BioGRID ORCS,208745,6SXX,X-RAY DIFFRACTION,2.18,43.67,"VAPOR DIFFUSION, HANGING DROP",6.982430939226492,"25% PEG3350, 0.2 M Potassium thiocyanate, 5% EtGly",277.0,2019-09-26,2020-07-29,1940,2,238,81.0,0,28.95,1,2.01,experimental,52.99,0.2533,0.1955,Crystal structure of the bromodomain of human CREBBP in complex with ACA007,SMRKKIFKPEELRQALMPTLEALYRQDPESLPFRQPVDPQLLGIPDYFDIVKNPMDLSTIKRKLDTGQYQEPWQYVDDVWLMFNNAWLYNRKTSRVYKFCSKLAEVFEQEIDPVMQSLG,Protein,119,polypeptide(L),2,14.223,crebbp,2.3.1.48,PDB Primary Data,Homo sapiens,9606,119,1,1,Monomer,A1,EDO,C2 H6 O2,62.068,"1,2-ETHANEDIOL","InChI=1S/C2H6O2/c3-1-2-4/h3-4H,1-2H2",
1387,ENTREZ_GENE,crebbp,CBPKAT3ARSTSRSTS1,Homo sapiens,0.6409819383156667,3.49726e-11,BioGRID ORCS,208745,6YIL,X-RAY DIFFRACTION,2.2,44.01,"VAPOR DIFFUSION, SITTING DROP",7.5,"20% PEG3350
10% ethylene glycol
0.2M sodium acetate",277.0,2020-04-01,2020-04-15,1160,1,119,154.0,0,14.64,1,1.22,experimental,12.75,0.1511,0.1321,Crystal structure of the CREBBP bromodomain in complex with a tetrahydroquinoxaline ligand,SMRKKIFKPEELRQALMPTLEALYRQDPESLPFRQPVDPQLLGIPDYFDIVKNPMDLSTIKRKLDTGQYQEPWQYVDDVWLMFNNAWLYNRKTSRVYKFCSKLAEVFEQEIDPVMQSLG,Protein,119,polypeptide(L),1,14.223,crebbp,2.3.1.48,PDB Primary Data,Homo sapiens,9606,119,1,1,Monomer,A1,OSQ,C22 H24 F2 N4 O2,414.448,"(3~{R})-~{N}-[3-(3,4-dihydro-2~{H}-quinolin-1-yl)-2,2-bis(fluoranyl)propyl]-3-methyl-2-oxidanylidene-3,4-dihydro-1~{H}-quinoxaline-5-carboxamide","InChI=1S/C22H24F2N4O2/c1-14-20(29)27-17-9-4-8-16(19(17)26-14)21(30)25-12-22(23,24)13-28-11-5-7-15-6-2-3-10-18(15)28/h2-4,6,8-10,14,26H,5,7,11-13H2,1H3,(H,25,30)(H,27,29)/t14-/m1/s1",
1387,ENTREZ_GENE,crebbp,CBPKAT3ARSTSRSTS1,Homo sapiens,0.6409819383156667,3.49726e-11,BioGRID ORCS,208745,6YIM,X-RAY DIFFRACTION,2.2,44.12,"VAPOR DIFFUSION, SITTING DROP",7.5,"20% PEG3350
10% ethylene glycol
0.2M sodium fluoride",277.0,2020-04-01,2020-04-15,1174,1,119,163.0,0,14.65,1,1.23,experimental,12.85,0.167,0.1397,Crystal structure of the CREBBP bromodomain in complex with a benzo-diazepine ligand,SMRKKIFKPEELRQALMPTLEALYRQDPESLPFRQPVDPQLLGIPDYFDIVKNPMDLSTIKRKLDTGQYQEPWQYVDDVWLMFNNAWLYNRKTSRVYKFCSKLAEVFEQEIDPVMQSLG,Protein,119,polypeptide(L),1,14.223,crebbp,2.3.1.48,PDB Primary Data,Homo sapiens,9606,119,1,1,Monomer,A1,OS8,C24 H30 N4 O3,422.52,"(4~{R})-~{N}-[3-(7-methoxy-3,4-dihydro-2~{H}-quinolin-1-yl)propyl]-4-methyl-2-oxidanylidene-1,3,4,5-tetrahydro-1,5-benzodiazepine-6-carboxamide","InChI=1S/C24H30N4O3/c1-16-14-22(29)27-20-8-3-7-19(23(20)26-16)24(30)25-11-5-13-28-12-4-6-17-9-10-18(31-2)15-21(17)28/h3,7-10,15-16,26H,4-6,11-14H2,1-2H3,(H,25,30)(H,27,29)/t16-/m1/s1",
1387,ENTREZ_GENE,crebbp,CBPKAT3ARSTSRSTS1,Homo sapiens,0.6409819383156667,3.49726e-11,BioGRID ORCS,208745,6YIJ,X-RAY DIFFRACTION,2.95,58.37,"VAPOR DIFFUSION, SITTING DROP",8.3,"20% ethylene glycol
21% PEG6K
0.1M tris pH 8.3
0.125M lithium chloride",277.0,2020-04-01,2020-04-15,7177,7,833,224.0,0,102.4,1,2.2,experimental,44.856,0.2693,0.2022,Crystal structure of the CREBBP bromodomain in complex with a benzo-diazepine ligand,SMRKKIFKPEELRQALMPTLEALYRQDPESLPFRQPVDPQLLGIPDYFDIVKNPMDLSTIKRKLDTGQYQEPWQYVDDVWLMFNNAWLYNRKTSRVYKFCSKLAEVFEQEIDPVMQSLG,Protein,119,polypeptide(L),7,14.223,crebbp,2.3.1.48,PDB Primary Data,Homo sapiens,9606,119,1,1,Monomer,A1,OSN,C25 H31 N3 O2,405.533,"(4~{R})-6-[(~{E})-5-(7-methoxy-3,4-dihydro-2~{H}-quinolin-1-yl)pent-1-enyl]-4-methyl-1,3,4,5-tetrahydro-1,5-benzodiazepin-2-one","InChI=1S/C25H31N3O2/c1-18-16-24(29)27-22-11-6-9-20(25(22)26-18)8-4-3-5-14-28-15-7-10-19-12-13-21(30-2)17-23(19)28/h4,6,8-9,11-13,17-18,26H,3,5,7,10,14-16H2,1-2H3,(H,27,29)/b8-4+/t18-/m1/s1",
4193,ENTREZ_GENE,mdm2,ACTFSHDMXhdm2,Homo sapiens,0.5133200206088253,3.49726e-11,BioGRID ORCS,213278,4UD7,X-RAY DIFFRACTION,2.8,56.0,Desconocido,4.0,0.1 M SODIUM CITRATE PH 4.0 AND 15 % PEG8000,289.6514371309434,2014-12-08,2016-01-13,4008,8,520,262.0,0,58.68,2,1.6,experimental,23.018,0.17838,0.13846,Structure of the stapled peptide YS-02 bound to MDM2,GPLGSSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDAAQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSEN,Protein,114,polypeptide(L),4,12.831,mdm2,6.3.2,PDB Primary Data,Homo sapiens,9606,130,2,2,Hetero 2-mer,"A1, B1",Desconocido,Desconocido,246.2971348233669,Desconocido,Desconocido,
2534,ENTREZ_GENE,fyn,SLKSYNp59FYN,Homo sapiens,0.4237661380383545,3.49726e-11,BioGRID ORCS,213954,6EDF,X-RAY DIFFRACTION,2.0,37.6,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"20% PEG3350, 0.2 M magnesium acetate",291.0,2018-08-09,2018-08-29,693,1,79,61.0,0,8.94,1,1.4,experimental,12.097,0.1721,0.1434,Fragment of a tyrosine-protein kinase,GGVTLFVALYDYEARTEDDISVHKGEKVQILNSSEGDWWEVRSLTTGETGYVPSNYVAPVDGSAAMGPVLRLRAFYNGG,Protein,79,polypeptide(L),1,8.591,fyn,2.7.10.2,PDB Primary Data,Homo sapiens,9606,79,1,1,Monomer,A1,GOL,C3 H8 O3,92.094,GLYCEROL,"InChI=1S/C3H8O3/c4-1-3(6)2-5/h3-6H,1-2H2",
56339,ENTREZ_GENE,mettl3,IME4M6AMTA70Spo8hMETTL3,Homo sapiens,0.5652422184821301,3.49726e-11,BioGRID ORCS,221461,5IL1,X-RAY DIFFRACTION,2.58,52.33,"VAPOR DIFFUSION, HANGING DROP",5.7,"PEG 8000, sodium citrate",291.0,2016-03-04,2016-05-25,4336,2,512,337.0,0,59.81,2,1.71,experimental,39.57218347825871,0.2069,0.1798,Crystal structure of SAM-bound METTL3-METTL14 complex,FPPQWICCDIRYLDVSILGKFAVVMADPPWDIHMELPYGTLTDDEMRRLNIPVLQDDGFLFLWVTGRAMELGRECLNLWGYERVDEIIWVKTNQLQRIIRTGRTGHWLNHGKEHCLVGVKGNPQGFNQGLDCDVIVAEVRSTSHKPDEIYGMIERLSPGTRKIELFGRPHNVQPNWITLGNQLDGIHLLDPDVVARFKQRYPDGIISKPKNL,Protein,212,polypeptide(L),1,24.427,mettl3,2.1.1.62,PDB Primary Data,Homo sapiens,9606,512,2,2,Hetero 2-mer,"A1, B1",SAM,C15 H22 N6 O5 S,398.437,S-ADENOSYLMETHIONINE,"InChI=1S/C15H22N6O5S/c1-27(3-2-7(16)15(24)25)4-8-10(22)11(23)14(26-8)21-6-20-9-12(17)18-5-19-13(9)21/h5-8,10-11,14,22-23H,2-4,16H2,1H3,(H2-,17,18,19,24,25)/t7-,8+,10+,11+,14+,27-/m0/s1",
56339,ENTREZ_GENE,mettl3,IME4M6AMTA70Spo8hMETTL3,Homo sapiens,0.5652422184821301,3.49726e-11,BioGRID ORCS,221461,5IL0,X-RAY DIFFRACTION,2.55,51.69,"VAPOR DIFFUSION, HANGING DROP",5.7,"PEG 8000, sodium citrate",291.0,2016-03-04,2016-05-25,4347,2,512,331.0,0,59.43,2,1.882,experimental,39.57218347825871,0.205,0.1747,Crystal structural of the METTL3-METTL14 complex for N6-adenosine methylation,FPPQWICCDIRYLDVSILGKFAVVMADPPWDIHMELPYGTLTDDEMRRLNIPVLQDDGFLFLWVTGRAMELGRECLNLWGYERVDEIIWVKTNQLQRIIRTGRTGHWLNHGKEHCLVGVKGNPQGFNQGLDCDVIVAEVRSTSHKPDEIYGMIERLSPGTRKIELFGRPHNVQPNWITLGNQLDGIHLLDPDVVARFKQRYPDGIISKPKNL,Protein,212,polypeptide(L),1,24.427,mettl3,2.1.1.62,PDB Primary Data,Homo sapiens,9606,512,2,2,Hetero 2-mer,"A1, B1",EDO,C2 H6 O2,62.068,"1,2-ETHANEDIOL","InChI=1S/C2H6O2/c3-1-2-4/h3-4H,1-2H2",
56339,ENTREZ_GENE,mettl3,IME4M6AMTA70Spo8hMETTL3,Homo sapiens,0.5652422184821301,3.49726e-11,BioGRID ORCS,221461,5IL2,X-RAY DIFFRACTION,2.66,53.7,"VAPOR DIFFUSION, HANGING DROP",5.7,"PEG 8000, sodium citrate",291.0,2016-03-04,2016-05-25,4393,2,512,376.0,1,59.85,2,1.606,experimental,39.57218347825871,0.1992,0.1848,Crystal structure of SAH-bound METTL3-METTL14 complex,FPPQWICCDIRYLDVSILGKFAVVMADPPWDIHMELPYGTLTDDEMRRLNIPVLQDDGFLFLWVTGRAMELGRECLNLWGYERVDEIIWVKTNQLQRIIRTGRTGHWLNHGKEHCLVGVKGNPQGFNQGLDCDVIVAEVRSTSHKPDEIYGMIERLSPGTRKIELFGRPHNVQPNWITLGNQLDGIHLLDPDVVARFKQRYPDGIISKPKNL,Protein,212,polypeptide(L),1,24.427,mettl3,2.1.1.62,PDB Primary Data,Homo sapiens,9606,512,2,2,Hetero 2-mer,"A1, B1",EDO,C2 H6 O2,62.068,"1,2-ETHANEDIOL","InChI=1S/C2H6O2/c3-1-2-4/h3-4H,1-2H2",
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.5661949193605395,3.49726e-11,BioGRID ORCS,221554,7QXZ,X-RAY DIFFRACTION,3.8,67.66,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NAH2PO4, PH 5.5, 2 M NACL; RESERVOIR SOLUTION: 3.0-3.2M NACL",293.15,2022-01-27,2022-04-13,4278,1,480,568.0,3,52.89,1,1.8,experimental,27.27,0.2173,0.1815,X-ray structure of furin in complex with the dichlorophenylpyridine-based inhibitor 5,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHH,Protein,480,polypeptide(L),1,52.112,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,480,1,1,Monomer,A1,CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.5661949193605395,3.49726e-11,BioGRID ORCS,221554,8B4V,X-RAY DIFFRACTION,3.75,67.16,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NAH2PO4, PH 5.5, 2 M NACL; RESERVOIR SOLUTION: 3.0-3.2M NACL",293.15,2022-09-21,2023-10-04,4300,1,480,508.0,4,52.95,1,1.6,experimental,26.89,0.1658,0.1535,X-ray structure of furin (PCSK3) in complex with benzamidine,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHH,Protein,480,polypeptide(L),1,52.112,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,480,1,1,Monomer,A1,BEN,C7 H8 N2,120.152,BENZAMIDINE,"InChI=1S/C7H8N2/c8-7(9)6-4-2-1-3-5-6/h1-5H,(H3,8,9)",
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.5661949193605395,3.49726e-11,BioGRID ORCS,221554,8B4W,X-RAY DIFFRACTION,3.75,67.17,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NAH2PO4, PH 5.5, 2 M NACL; RESERVOIR SOLUTION: 3.0-3.2M NACL",293.15,2022-09-21,2023-10-04,4403,1,480,497.0,4,53.21,1,1.6,experimental,27.18,0.179,0.1659,X-ray structure of furin (PCSK3) in complex with 1H-isoindol-3-amine,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHH,Protein,480,polypeptide(L),1,52.112,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,480,1,1,Monomer,A1,F05,C8 H8 N2,132.163,1H-isoindol-3-amine,"InChI=1S/C8H8N2/c9-8-7-4-2-1-3-6(7)5-10-8/h1-4H,5H2,(H2,9,10)",
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.5661949193605395,3.49726e-11,BioGRID ORCS,221554,8B4X,X-RAY DIFFRACTION,3.75,67.24,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NAH2PO4, PH 5.5, 2 M NACL; RESERVOIR SOLUTION: 3.0-3.2M NACL",293.15,2022-09-21,2023-10-04,4276,2,485,462.0,4,53.27,2,1.6,experimental,28.95,0.1695,0.158,X-ray structure of furin (PCSK3) in complex with Guanidinomethyl-Phac-R-Tle-K-6-(aminomethyl)-3-amino-isoindol,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHH,Protein,480,polypeptide(L),1,52.112,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,485,2,2,Hetero 2-mer,"A1, B1",CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.5661949193605395,3.49726e-11,BioGRID ORCS,221554,8OYH,X-RAY DIFFRACTION,3.76,67.27,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NAH2PO4, PH 5.5, 2 M NACL; RESERVOIR SOLUTION: 3.0-3.2M NACL",293.15,2023-05-04,2024-03-13,4092,2,485,340.0,4,53.27,2,1.8,experimental,36.56,0.188,0.1735,X-ray structure of furin (PCSK3) in complex with Guanidinomethyl-Phac-Can-Tle-Can-6-(aminomethyl)-3-amino-isoindol,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHH,Protein,480,polypeptide(L),1,52.112,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,485,2,2,Hetero 2-mer,"A1, B1",CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.5661949193605395,3.49726e-11,BioGRID ORCS,221554,4Z2A,X-RAY DIFFRACTION,2.36,47.94,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"Well 13% PEG 8K, 0.110M K-dihydrogen phosphate, 0.1M HEPES pH 7.5, 350 uL protein with 350uL well drops, MRC sitting drop",277.0,2015-03-29,2016-05-04,4016,1,465,408.0,4,50.92,1,1.89,experimental,16.9953,0.1834,0.1479,Crystal structure of unglycosylated apo human furin @1.89A,YQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKDLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQDWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTA,Protein,465,polypeptide(L),1,50.506,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,465,1,1,Monomer,A1,EDO,C2 H6 O2,62.068,"1,2-ETHANEDIOL","InChI=1S/C2H6O2/c3-1-2-4/h3-4H,1-2H2",
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.5661949193605395,3.49726e-11,BioGRID ORCS,221554,7O1U,X-RAY DIFFRACTION,3.74,67.12,"VAPOR DIFFUSION, SITTING DROP",5.5,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NAH2PO4, PH 5.5, 2 M NACL; RESERVOIR SOLUTION: 3.0-3.2M NACL",293.15,2021-03-30,2021-09-01,4375,1,480,519.0,4,53.19,1,1.7,experimental,26.23,0.1666,0.155,X-ray structure of furin in complex with the guanylhydrazone-based inhibitor 1 (BEV241),DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHH,Protein,480,polypeptide(L),1,52.112,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,480,1,1,Monomer,A1,Desconocido,Na,22.99,SODIUM ION,InChI=1S/Na/q+1,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.5661949193605395,3.49726e-11,BioGRID ORCS,221554,7O1W,X-RAY DIFFRACTION,3.74,67.1,"VAPOR DIFFUSION, SITTING DROP",5.5,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NAH2PO4, PH 5.5, 2 M NACL; RESERVOIR SOLUTION: 3.0-3.2M NACL",293.15,2021-03-30,2021-09-01,4335,1,480,424.0,4,53.69,1,1.8,experimental,29.36,0.1791,0.16,X-ray structure of furin in complex with the guanylhydrazone-based inhibitor 2 (mi307) soaked at 1 M NaCl,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHH,Protein,480,polypeptide(L),1,52.112,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,480,1,1,Monomer,A1,CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.5661949193605395,3.49726e-11,BioGRID ORCS,221554,7O1Y,X-RAY DIFFRACTION,3.72,66.95,"VAPOR DIFFUSION, SITTING DROP",5.5,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NAH2PO4, PH 5.5, 2 M NACL; RESERVOIR SOLUTION: 3.0-3.2M NACL",293.15,2021-03-30,2021-09-01,4321,1,480,475.0,4,53.91,1,1.7,experimental,29.48,0.177,0.1622,X-ray structure of furin in complex with the guanylhydrazone-based inhibitor 2 (mi307) soaked at 0.25 M NaCl,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHH,Protein,480,polypeptide(L),1,52.112,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,480,1,1,Monomer,A1,CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.5661949193605395,3.49726e-11,BioGRID ORCS,221554,7O20,X-RAY DIFFRACTION,3.67,66.48,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NAH2PO4, PH 5.5, 2 M NACL; RESERVOIR SOLUTION: 3.0-3.2M NACL",293.15,2021-03-30,2021-09-01,4190,1,480,376.0,4,53.54,1,1.8,experimental,33.26,0.1761,0.1624,X-ray structure of furin in complex with the guanylhydrazone-based inhibitor 3 (mi300),DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHH,Protein,480,polypeptide(L),1,52.112,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,480,1,1,Monomer,A1,CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.5661949193605395,3.49726e-11,BioGRID ORCS,221554,7O22,X-RAY DIFFRACTION,3.69,66.7,"VAPOR DIFFUSION, SITTING DROP",5.5,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NAH2PO4, PH 5.5, 2 M NACL; RESERVOIR SOLUTION: 3.0-3.2M NACL",293.15,2021-03-30,2021-09-01,4130,1,480,427.0,4,53.15,1,1.8,experimental,33.5,0.1825,0.169,X-ray structure of furin in complex with the guanylhydrazone-based inhibitor 4 (mi359),DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHH,Protein,480,polypeptide(L),1,52.112,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,480,1,1,Monomer,A1,CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.5661949193605395,3.49726e-11,BioGRID ORCS,221554,7QY0,X-RAY DIFFRACTION,3.72,66.91,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NAH2PO4, PH 5.5, 2 M NACL; RESERVOIR SOLUTION: 3.0-3.2M NACL",293.15,2022-01-27,2022-04-20,4378,1,480,476.0,4,53.68,1,1.54,experimental,26.16,0.1725,0.1493,X-ray structure of furin in complex with the dichlorophenylpyridine-based inhibitor 1,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHH,Protein,480,polypeptide(L),1,52.112,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,480,1,1,Monomer,A1,I0T,C32 H42 Cl2 N6 O3,629.62,"N-[[1-[[2-[3,5-bis(chloranyl)phenyl]-6-[6-[4-(2-methoxyethyl)piperazin-4-ium-1-yl]pyridin-3-yl]oxy-pyridin-4-yl]methyl]piperidin-1-ium-4-yl]methyl]ethanamide","InChI=1S/C32H40Cl2N6O3/c1-23(41)35-20-24-5-7-39(8-6-24)22-25-15-30(26-17-27(33)19-28(34)18-26)37-32(16-25)43-29-3-4-31(36-21-29)40-11-9-38(10-12-40)13-14-42-2/h3-4,15-19,21,24H,5-14,20,22H2,1-2H3,(H,35,41)/p+2",
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.5661949193605395,3.49726e-11,BioGRID ORCS,221554,7QY1,X-RAY DIFFRACTION,2.568825997777984,50.34669344500458,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NAH2PO4, PH 5.5, 2 M NACL; RESERVOIR SOLUTION: 3.0-3.2M NACL",293.15,2022-01-27,2022-04-20,4387,1,480,483.0,4,53.77,1,1.45,experimental,25.78,0.1754,0.1502,X-ray structure of furin in complex with the dichlorophenylpyridine-based inhibitor 4,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHH,Protein,480,polypeptide(L),1,52.112,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,480,1,1,Monomer,A1,I0W,C32 H39 Cl2 N6 O4,642.596,"3-[4-[5-[4-[[4-(acetamidomethyl)piperidin-1-ium-1-yl]methyl]-6-[3,5-bis(chloranyl)phenyl]pyridin-2-yl]oxypyridin-2-yl]piperazin-1-ium-1-yl]propanoate","InChI=1S/C32H38Cl2N6O4/c1-22(41)35-19-23-4-7-39(8-5-23)21-24-14-29(25-16-26(33)18-27(34)17-25)37-31(15-24)44-28-2-3-30(36-20-28)40-12-10-38(11-13-40)9-6-32(42)43/h2-3,14-18,20,23H,4-13,19,21H2,1H3,(H,35,41)(H,42,43)/p+1",
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.5661949193605395,3.49726e-11,BioGRID ORCS,221554,7QY2,X-RAY DIFFRACTION,3.71,66.87,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NAH2PO4, PH 5.5, 2 M NACL; RESERVOIR SOLUTION: 3.0-3.2M NACL",293.15,2022-01-27,2022-04-20,4373,1,480,471.0,4,53.72,1,1.55,experimental,27.19,0.1877,0.1645,X-ray structure of furin in complex with the dichlorophenylpyridine-based inhibitor 2,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHH,Protein,480,polypeptide(L),1,52.112,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,480,1,1,Monomer,A1,I0Q,C33 H42 Cl2 N7 O4,671.637,"(2R)-4-[4-[5-[4-[[4-(acetamidomethyl)piperidin-1-ium-1-yl]methyl]-6-[3,5-bis(chloranyl)phenyl]pyridin-2-yl]oxypyrimidin-2-yl]piperazin-1-ium-1-yl]-2-methyl-butanoate","InChI=1S/C33H41Cl2N7O4/c1-22(32(44)45)3-6-40-9-11-42(12-10-40)33-37-19-29(20-38-33)46-31-14-25(13-30(39-31)26-15-27(34)17-28(35)16-26)21-41-7-4-24(5-8-41)18-36-23(2)43/h13-17,19-20,22,24H,3-12,18,21H2,1-2H3,(H,36,43)(H,44,45)/p+1/t22-/m1/s1",
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.5661949193605395,3.49726e-11,BioGRID ORCS,221554,7LCU,X-RAY DIFFRACTION,2.25,45.43,VAPOR DIFFUSION,7.5,"PEG8000, potassium dihydrogen phosphate",277.0,2021-01-11,2022-01-12,4057,1,490,352.0,5,54.37,1,1.24,experimental,14.5,0.1944,0.1764,"X-ray structure of Furin bound to BOS-318, a small molecule inhibitor",DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKDLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQDWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTAGENLYFQGDYKDDDDKGHHHHHH,Protein,490,polypeptide(L),1,53.512,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,490,1,1,Monomer,A1,CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.5661949193605395,3.49726e-11,BioGRID ORCS,221554,6HLB,X-RAY DIFFRACTION,3.77,67.33,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NaH2PO4, PH 5.5-6.0, 2 M NaCL, 3% DMSO; RESERVOIR SOLUTION: 3-4M NaCL",293.15,2018-09-11,2019-02-06,4028,2,491,338.0,3,54.39,2,2.0,experimental,39.57218347825871,0.1874,0.1686,X-ray structure of furin in complex with the cyclic peptide c[succinyl-Phe-2-Nal-(Arg)4-Lys]-Arg-4-Amba,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHHHH,Protein,482,polypeptide(L),1,52.389,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,491,2,2,Hetero 2-mer,"A1, B1",CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.5661949193605395,3.49726e-11,BioGRID ORCS,221554,6HLD,X-RAY DIFFRACTION,3.78,67.46,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NaH2PO4, PH 5.5-6.0, 2 M NaCL, 3% DMSO; RESERVOIR SOLUTION: 3-4M NaCL",293.15,2018-09-11,2019-02-06,4067,2,489,343.0,3,54.06,2,2.1,experimental,39.57218347825871,0.1959,0.17,X-ray structure of furin in complex with the cyclic peptide c[succinyl-Phe-2-Nal-(Arg)3-Lys]-Lys-4-Amba,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHHHH,Protein,482,polypeptide(L),1,52.389,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,489,2,2,Hetero 2-mer,"A1, B1",CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.5661949193605395,3.49726e-11,BioGRID ORCS,221554,6HLE,X-RAY DIFFRACTION,3.84,68.01,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NaH2PO4, PH 5.5-6.0, 2 M NaCL, 3% DMSO; RESERVOIR SOLUTION: 3-4M NaCL",293.15,2018-09-11,2019-02-06,4127,2,488,390.0,3,53.91,2,1.994,experimental,39.57218347825871,0.1908,0.1667,X-ray structure of furin in complex with the P6-P2-cyclized peptide H-Lys-Arg-Arg-Tle-Lys-4-Amba,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHHHH,Protein,482,polypeptide(L),1,52.389,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,488,2,2,Hetero 2-mer,"A1, B1",CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.5661949193605395,3.49726e-11,BioGRID ORCS,221554,6HZA,X-RAY DIFFRACTION,3.64,66.19,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NaH2PO4, PH 5.5-6.0, 2 M NaCL, 3% DMSO; RESERVOIR SOLUTION: 3-4M NaCL",293.15,2018-10-23,2019-02-06,4150,2,487,416.0,3,53.73,2,1.9,experimental,39.57218347825871,0.1859,0.1661,X-ray structure of furin in complex with the cyclic peptide c[glutaryl-Arg-Arg-Lys]-Arg-4-Amba,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHHHH,Protein,482,polypeptide(L),1,52.389,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,487,2,2,Hetero 2-mer,"A1, B1",CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.5661949193605395,3.49726e-11,BioGRID ORCS,221554,6HZB,X-RAY DIFFRACTION,3.66,66.41,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NaH2PO4, PH 5.5-6.0, 2 M NaCL, 3% DMSO; RESERVOIR SOLUTION: 3-4M NaCL",293.15,2018-10-23,2019-02-06,4150,2,487,418.0,3,53.7,2,1.9,experimental,39.57218347825871,0.1824,0.1646,X-ray structure of furin in complex with the cyclic inhibitor c[glutaryl-Arg-Arg-Lys]-Lys-4-Amba,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHHHH,Protein,482,polypeptide(L),1,52.389,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,487,2,2,Hetero 2-mer,"A1, B1",CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.5661949193605395,3.49726e-11,BioGRID ORCS,221554,6HZD,X-RAY DIFFRACTION,3.64,66.22,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NaH2PO4, PH 5.5-6.0, 2 M NaCL, 3% DMSO; RESERVOIR SOLUTION: 3-4M NaCL",293.15,2018-10-23,2019-02-06,4163,2,488,418.0,3,53.89,2,1.9,experimental,39.57218347825871,0.1827,0.1641,X-ray structure of furin in complex with the cyclic inhibitor c[glutaryl-Arg-Arg-Arg-Lys]-Arg-4-Amba,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHHHH,Protein,482,polypeptide(L),1,52.389,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,488,2,2,Hetero 2-mer,"A1, B1",CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.5661949193605395,3.49726e-11,BioGRID ORCS,221554,6YD2,X-RAY DIFFRACTION,3.7,66.74,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100MM MES, 200MM K/NAH2PO4, PH 5.5-6.0, 2 M NACL; RESERVOIR SOLUTION: 3-4M NACL",293.15,2020-03-20,2021-02-17,4179,2,487,444.0,3,53.58,2,1.8,experimental,32.05,0.1771,0.1575,X-ray structure of furin in complex with the canavanine-based inhibitor 4-aminomethyl-phenylacetyl-canavanine-Tle-Arg-Amba,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHHHH,Protein,482,polypeptide(L),1,52.389,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,487,2,2,Hetero 2-mer,"A1, B1",CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.5661949193605395,3.49726e-11,BioGRID ORCS,221554,6YD3,X-RAY DIFFRACTION,3.72,66.96,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100MM MES, 200MM K/NAH2PO4, PH 5.5-6.0, 2 M NACL; RESERVOIR SOLUTION: 3-4M NACL",293.15,2020-03-20,2021-02-17,4159,2,485,418.0,3,53.34,2,2.0,experimental,32.04,0.1854,0.1595,X-ray structure of furin in complex with the canavanine derived inhibitor 4-guanidinomethyl-phenylacetyl-Canavanine-Tle-Arg-Amba,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHH,Protein,480,polypeptide(L),1,52.112,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,485,2,2,Hetero 2-mer,"A1, B1",CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.5661949193605395,3.49726e-11,BioGRID ORCS,221554,6YD4,X-RAY DIFFRACTION,3.73,67.06,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100MM MES, 200MM K/NAH2PO4, PH 5.5-6.0, 2 M NACL; RESERVOIR SOLUTION: 3-4M NACL",291.15,2020-03-20,2021-02-17,4237,2,485,477.0,3,53.37,2,1.7,experimental,31.24,0.1694,0.1532,X-ray structure of furin in complex with the canavanine-based inhibitor 4-guanidinomethyl-phenylacetyl-Canavanine-Tle-Canavanine-Amba,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHH,Protein,480,polypeptide(L),1,52.112,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,485,2,2,Hetero 2-mer,"A1, B1",CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.5661949193605395,3.49726e-11,BioGRID ORCS,221554,6YD7,X-RAY DIFFRACTION,3.74,67.08,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100MM MES, 200MM K/NAH2PO4, PH 5.5-6.0, 2 M NACL; RESERVOIR SOLUTION: 3-4M NACL",291.15,2020-03-20,2021-02-17,4211,2,485,465.0,3,53.37,2,1.8,experimental,29.7,0.1709,0.1538,X-ray structure of furin in complex with the canavanine-based inhibitor 4-guanidinomethyl-phenylacetyl-Arg-Tle-Canavanine-Amba,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHH,Protein,480,polypeptide(L),1,52.112,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,485,2,2,Hetero 2-mer,"A1, B1",CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.5661949193605395,3.49726e-11,BioGRID ORCS,221554,7QXY,X-RAY DIFFRACTION,2.568825997777984,50.34669344500458,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NAH2PO4, PH 5.5, 2 M NACL; RESERVOIR SOLUTION: 3.0-3.2M NACL",293.15,2022-01-27,2022-04-20,4386,1,480,661.0,2,53.0,1,1.478,experimental,24.97,0.1823,0.1705,X-ray structure of furin in complex with the dichlorophenylpyridine-based inhibitor 3,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHH,Protein,480,polypeptide(L),1,52.112,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,480,1,1,Monomer,A1,CL,Cl,35.453,CHLORIDE ION,InChI=1S/ClH/h1H/p-1,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.5661949193605395,3.49726e-11,BioGRID ORCS,221554,4RYD,X-RAY DIFFRACTION,2.86,56.93,"VAPOR DIFFUSION, SITTING DROP",8.5,"50mM Tris, 2.8M sodium formate, 15mM Cymal-7, pH 8.5, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293.0,2014-12-15,2015-05-27,23768,12,2922,2034.0,18,320.52,2,2.15,experimental,39.57218347825871,0.2186,0.1862,X-ray structure of human furin in complex with the competitive inhibitor para-guanidinomethyl-Phac-R-Tle-R-Amba,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHHHH,Protein,482,polypeptide(L),6,52.389,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,487,2,2,Hetero 2-mer,"A1, B1",FMT,C H2 O2,46.025,FORMIC ACID,"InChI=1S/CH2O2/c2-1-3/h1H,(H,2,3)",
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.5661949193605395,3.49726e-11,BioGRID ORCS,221554,5JXH,X-RAY DIFFRACTION,3.67,66.49,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"crystallization solution: 100 mM MES, 200 mM K/NaH2PO4, pH 5.5-6.0, 3-4 M NaCl, 3% DMSO; reservoir solution: 3-4 M NaCl",293.15,2016-05-13,2016-10-05,4261,2,487,534.0,3,53.39,2,2.0,experimental,39.57218347825871,0.1853,0.1566,Structure the proprotein convertase furin in complex with meta-guanidinomethyl-Phac-RVR-Amba at 2.0 Angstrom resolution.,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHHHH,Protein,482,polypeptide(L),1,52.389,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,487,2,2,Hetero 2-mer,"A1, B1",CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.5661949193605395,3.49726e-11,BioGRID ORCS,221554,5JXG,X-RAY DIFFRACTION,3.73,67.05,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"crystallization solution: 100 mM MES, 200 mM K/NaH2PO4, pH 5.5-6.0, 3-4 M NaCl, 3% DMSO; reservoir solution: 3-4 M NaCl",293.15,2016-05-13,2016-10-05,4360,1,482,645.0,3,52.73,1,1.8,experimental,39.57218347825871,0.1733,0.154,Structure of the unliganded form of the proprotein convertase furin.,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHHHH,Protein,482,polypeptide(L),1,52.389,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,482,1,1,Monomer,A1,CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.5661949193605395,3.49726e-11,BioGRID ORCS,221554,5JXI,X-RAY DIFFRACTION,3.76,67.3,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"crystallization solution: 100 mM MES, 200 mM K/NaH2PO4, pH 5.5-6.0, 3-4 M NaCl, 3% DMSO; reservoir solution: 3-4 M NaCl",293.15,2016-05-13,2016-10-05,4164,1,482,521.0,3,52.63,1,2.0,experimental,39.57218347825871,0.1851,0.1576,Structure of the unliganded form of the proprotein convertase furin in presence of EDTA.,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHHHH,Protein,482,polypeptide(L),1,52.389,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,482,1,1,Monomer,A1,CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.5661949193605395,3.49726e-11,BioGRID ORCS,221554,5MIM,X-RAY DIFFRACTION,3.75,67.2,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100 MM MES, 200 MM K/NAH2PO4, PH 5.5-6.0, 3-4 M NACL, 3% DMSO; RESERVOIR SOLUTION: 3-4 M NACL",293.15,2016-11-28,2017-05-10,4275,1,482,486.0,3,53.81,1,1.9,experimental,39.57218347825871,0.1838,0.1647,"Xray structure of human furin bound with the 2,5-dideoxystreptamine derived small molecule inhibitor 1n",DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHHHH,Protein,482,polypeptide(L),1,52.389,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,482,1,1,Monomer,A1,CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.5661949193605395,3.49726e-11,BioGRID ORCS,221554,5JXJ,X-RAY DIFFRACTION,3.69,66.65,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"crystallization solution: 100 mM MES, 200 mM K/NaH2PO4, pH 5.5-6.0, 3-4 M NaCl, 3% DMSO; reservoir solution: 3-4 M NaCl",293.15,2016-05-13,2016-10-05,4185,2,487,461.0,3,53.35,2,2.0,experimental,39.57218347825871,0.1889,0.1668,Structure of the proprotein convertase furin complexed to meta-guanidinomethyl-Phac-RVR-Amba in presence of EDTA,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHHHH,Protein,482,polypeptide(L),1,52.389,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,487,2,2,Hetero 2-mer,"A1, B1",CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.5661949193605395,3.49726e-11,BioGRID ORCS,221554,6EQV,X-RAY DIFFRACTION,3.67,66.45,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NaH2PO4, PH 5.5-6.0, 3-4M NaCl, 3% DMSO; RESERVOIR SOLUTION: 3-4 M NaCl",293.15,2017-10-16,2018-02-28,4212,2,487,510.0,3,53.3,2,1.895,experimental,39.57218347825871,0.1821,0.1637,X-ray structure of the proprotein convertase furin bound with the competitive inhibitor Phac-Cit-Val-Arg-Amba,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHHHH,Protein,482,polypeptide(L),1,52.389,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,487,2,2,Hetero 2-mer,"A1, B1",CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.5661949193605395,3.49726e-11,BioGRID ORCS,221554,6EQW,X-RAY DIFFRACTION,3.66,66.42,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"CRYSTALLIZATION SOLUTION: 100mM MES, 200mM K/NaH2PO4, PH 5.5-6.0, 3-4 M NaCL, 3% DMSO; RESERVOIR SOLUTION: 3-4M NaCL",293.15,2017-10-16,2018-02-28,4183,2,487,486.0,3,53.36,2,1.994,experimental,39.57218347825871,0.1842,0.1619,X-ray structure of the proprotein convertase furin bound with the competitive inhibitor 4-aminomethyl-phenylacetyl-Arg-Val-Arg-Amba,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHHHH,Protein,482,polypeptide(L),1,52.389,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,487,2,2,Hetero 2-mer,"A1, B1",CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
5045,ENTREZ_GENE,furin,FURPACEPCSK3SPC1,Homo sapiens,0.5661949193605395,3.49726e-11,BioGRID ORCS,221554,6EQX,X-RAY DIFFRACTION,3.66,66.36,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"100mM MES, 200mM K/NaH2PO4, PH 5.5-6.0, 3-4 M NaCL, 3% DMSO; RESERVOIR SOLUTION: 3-4M NaCL",293.15,2017-10-16,2018-02-28,4186,2,488,471.0,3,53.51,2,1.994,experimental,39.57218347825871,0.1837,0.162,X-ray structure of the proprotein convertase furin bound with the competitive inhibitor Arg-Arg-Arg-Val-Arg-Amba,DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHHHH,Protein,482,polypeptide(L),1,52.389,furin,3.4.21.75,PDB Primary Data,Homo sapiens,9606,488,2,2,Hetero 2-mer,"A1, B1",CA,Ca,40.078,CALCIUM ION,InChI=1S/Ca/q+2,
1387,ENTREZ_GENE,crebbp,CBPKAT3ARSTSRSTS1,Homo sapiens,0.5757219281446321,3.49726e-11,BioGRID ORCS,222148,6YIK,X-RAY DIFFRACTION,3.42,64.06,"VAPOR DIFFUSION, SITTING DROP",7.5,"21% PEG3350
15% ethylene glycol
0.25M sodium formate",277.0,2020-04-01,2020-04-15,3453,3,357,385.0,0,44.74,1,1.7,experimental,32.625,0.184,0.156,Crystal structure of the CREBBP bromodomain in complex with a tetrahydroquinoxaline ligand,SMRKKIFKPEELRQALMPTLEALYRQDPESLPFRQPVDPQLLGIPDYFDIVKNPMDLSTIKRKLDTGQYQEPWQYVDDVWLMFNNAWLYNRKTSRVYKFCSKLAEVFEQEIDPVMQSLG,Protein,119,polypeptide(L),3,14.223,crebbp,2.3.1.48,PDB Primary Data,Homo sapiens,9606,119,1,1,Monomer,A1,OSQ,C22 H24 F2 N4 O2,414.448,"(3~{R})-~{N}-[3-(3,4-dihydro-2~{H}-quinolin-1-yl)-2,2-bis(fluoranyl)propyl]-3-methyl-2-oxidanylidene-3,4-dihydro-1~{H}-quinoxaline-5-carboxamide","InChI=1S/C22H24F2N4O2/c1-14-20(29)27-17-9-4-8-16(19(17)26-14)21(30)25-12-22(23,24)13-28-11-5-7-15-6-2-3-10-18(15)28/h2-4,6,8-10,14,26H,5,7,11-13H2,1H3,(H,25,30)(H,27,29)/t14-/m1/s1",
1387,ENTREZ_GENE,crebbp,CBPKAT3ARSTSRSTS1,Homo sapiens,0.5757219281446321,3.49726e-11,BioGRID ORCS,222148,6SXX,X-RAY DIFFRACTION,2.18,43.67,"VAPOR DIFFUSION, HANGING DROP",6.982430939226492,"25% PEG3350, 0.2 M Potassium thiocyanate, 5% EtGly",277.0,2019-09-26,2020-07-29,1940,2,238,81.0,0,28.95,1,2.01,experimental,52.99,0.2533,0.1955,Crystal structure of the bromodomain of human CREBBP in complex with ACA007,SMRKKIFKPEELRQALMPTLEALYRQDPESLPFRQPVDPQLLGIPDYFDIVKNPMDLSTIKRKLDTGQYQEPWQYVDDVWLMFNNAWLYNRKTSRVYKFCSKLAEVFEQEIDPVMQSLG,Protein,119,polypeptide(L),2,14.223,crebbp,2.3.1.48,PDB Primary Data,Homo sapiens,9606,119,1,1,Monomer,A1,EDO,C2 H6 O2,62.068,"1,2-ETHANEDIOL","InChI=1S/C2H6O2/c3-1-2-4/h3-4H,1-2H2",
1387,ENTREZ_GENE,crebbp,CBPKAT3ARSTSRSTS1,Homo sapiens,0.5757219281446321,3.49726e-11,BioGRID ORCS,222148,6YIL,X-RAY DIFFRACTION,2.2,44.01,"VAPOR DIFFUSION, SITTING DROP",7.5,"20% PEG3350
10% ethylene glycol
0.2M sodium acetate",277.0,2020-04-01,2020-04-15,1160,1,119,154.0,0,14.64,1,1.22,experimental,12.75,0.1511,0.1321,Crystal structure of the CREBBP bromodomain in complex with a tetrahydroquinoxaline ligand,SMRKKIFKPEELRQALMPTLEALYRQDPESLPFRQPVDPQLLGIPDYFDIVKNPMDLSTIKRKLDTGQYQEPWQYVDDVWLMFNNAWLYNRKTSRVYKFCSKLAEVFEQEIDPVMQSLG,Protein,119,polypeptide(L),1,14.223,crebbp,2.3.1.48,PDB Primary Data,Homo sapiens,9606,119,1,1,Monomer,A1,OSQ,C22 H24 F2 N4 O2,414.448,"(3~{R})-~{N}-[3-(3,4-dihydro-2~{H}-quinolin-1-yl)-2,2-bis(fluoranyl)propyl]-3-methyl-2-oxidanylidene-3,4-dihydro-1~{H}-quinoxaline-5-carboxamide","InChI=1S/C22H24F2N4O2/c1-14-20(29)27-17-9-4-8-16(19(17)26-14)21(30)25-12-22(23,24)13-28-11-5-7-15-6-2-3-10-18(15)28/h2-4,6,8-10,14,26H,5,7,11-13H2,1H3,(H,25,30)(H,27,29)/t14-/m1/s1",
1387,ENTREZ_GENE,crebbp,CBPKAT3ARSTSRSTS1,Homo sapiens,0.5757219281446321,3.49726e-11,BioGRID ORCS,222148,6YIM,X-RAY DIFFRACTION,2.2,44.12,"VAPOR DIFFUSION, SITTING DROP",7.5,"20% PEG3350
10% ethylene glycol
0.2M sodium fluoride",277.0,2020-04-01,2020-04-15,1174,1,119,163.0,0,14.65,1,1.23,experimental,12.85,0.167,0.1397,Crystal structure of the CREBBP bromodomain in complex with a benzo-diazepine ligand,SMRKKIFKPEELRQALMPTLEALYRQDPESLPFRQPVDPQLLGIPDYFDIVKNPMDLSTIKRKLDTGQYQEPWQYVDDVWLMFNNAWLYNRKTSRVYKFCSKLAEVFEQEIDPVMQSLG,Protein,119,polypeptide(L),1,14.223,crebbp,2.3.1.48,PDB Primary Data,Homo sapiens,9606,119,1,1,Monomer,A1,OS8,C24 H30 N4 O3,422.52,"(4~{R})-~{N}-[3-(7-methoxy-3,4-dihydro-2~{H}-quinolin-1-yl)propyl]-4-methyl-2-oxidanylidene-1,3,4,5-tetrahydro-1,5-benzodiazepine-6-carboxamide","InChI=1S/C24H30N4O3/c1-16-14-22(29)27-20-8-3-7-19(23(20)26-16)24(30)25-11-5-13-28-12-4-6-17-9-10-18(31-2)15-21(17)28/h3,7-10,15-16,26H,4-6,11-14H2,1-2H3,(H,25,30)(H,27,29)/t16-/m1/s1",
1387,ENTREZ_GENE,crebbp,CBPKAT3ARSTSRSTS1,Homo sapiens,0.5757219281446321,3.49726e-11,BioGRID ORCS,222148,6YIJ,X-RAY DIFFRACTION,2.95,58.37,"VAPOR DIFFUSION, SITTING DROP",8.3,"20% ethylene glycol
21% PEG6K
0.1M tris pH 8.3
0.125M lithium chloride",277.0,2020-04-01,2020-04-15,7177,7,833,224.0,0,102.4,1,2.2,experimental,44.856,0.2693,0.2022,Crystal structure of the CREBBP bromodomain in complex with a benzo-diazepine ligand,SMRKKIFKPEELRQALMPTLEALYRQDPESLPFRQPVDPQLLGIPDYFDIVKNPMDLSTIKRKLDTGQYQEPWQYVDDVWLMFNNAWLYNRKTSRVYKFCSKLAEVFEQEIDPVMQSLG,Protein,119,polypeptide(L),7,14.223,crebbp,2.3.1.48,PDB Primary Data,Homo sapiens,9606,119,1,1,Monomer,A1,OSN,C25 H31 N3 O2,405.533,"(4~{R})-6-[(~{E})-5-(7-methoxy-3,4-dihydro-2~{H}-quinolin-1-yl)pent-1-enyl]-4-methyl-1,3,4,5-tetrahydro-1,5-benzodiazepin-2-one","InChI=1S/C25H31N3O2/c1-18-16-24(29)27-22-11-6-9-20(25(22)26-18)8-4-3-5-14-28-15-7-10-19-12-13-21(30-2)17-23(19)28/h4,6,8-9,11-13,17-18,26H,3,5,7,10,14-16H2,1-2H3,(H,27,29)/b8-4+/t18-/m1/s1",
2534,ENTREZ_GENE,fyn,SLKSYNp59FYN,Homo sapiens,0.60430295449691,3.49726e-11,BioGRID ORCS,224065,6EDF,X-RAY DIFFRACTION,2.0,37.6,"VAPOR DIFFUSION, SITTING DROP",6.982430939226492,"20% PEG3350, 0.2 M magnesium acetate",291.0,2018-08-09,2018-08-29,693,1,79,61.0,0,8.94,1,1.4,experimental,12.097,0.1721,0.1434,Fragment of a tyrosine-protein kinase,GGVTLFVALYDYEARTEDDISVHKGEKVQILNSSEGDWWEVRSLTTGETGYVPSNYVAPVDGSAAMGPVLRLRAFYNGG,Protein,79,polypeptide(L),1,8.591,fyn,2.7.10.2,PDB Primary Data,Homo sapiens,9606,79,1,1,Monomer,A1,GOL,C3 H8 O3,92.094,GLYCEROL,"InChI=1S/C3H8O3/c4-1-3(6)2-5/h3-6H,1-2H2",
4193,ENTREZ_GENE,mdm2,ACTFSHDMXhdm2,Homo sapiens,0.6624177080798752,3.49726e-11,BioGRID ORCS,228019,4UD7,X-RAY DIFFRACTION,2.8,56.0,Desconocido,4.0,0.1 M SODIUM CITRATE PH 4.0 AND 15 % PEG8000,289.6514371309434,2014-12-08,2016-01-13,4008,8,520,262.0,0,58.68,2,1.6,experimental,23.018,0.17838,0.13846,Structure of the stapled peptide YS-02 bound to MDM2,GPLGSSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDAAQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSEN,Protein,114,polypeptide(L),4,12.831,mdm2,6.3.2,PDB Primary Data,Homo sapiens,9606,130,2,2,Hetero 2-mer,"A1, B1",Desconocido,Desconocido,246.2971348233669,Desconocido,Desconocido,
673,ENTREZ_GENE,braf,BRAF1BrafBRAF1NS7RAFB1,Homo sapiens,0.6938568370673808,3.49726e-11,BioGRID ORCS,229816,5VR3,X-RAY DIFFRACTION,2.58,52.44,"VAPOR DIFFUSION, HANGING DROP",6.5,"0.1 M Bis-Tris pH 6.5, 2.0 M ammonium sulphate",293.15,2017-05-10,2018-02-14,510,1,88,13.0,0,9.64,1,2.102,experimental,39.57218347825871,0.2244,0.2095,Crystal structure of the BRS domain of BRAF,GAMDPGGGGSSAADPAIPEEVWNIKQMIKLTQEHIEALLDKFGGEHNPPSIYLEAYEEYTSKLDALQQREQQLLESLGNGTDFSVSSS,Protein,88,polypeptide(L),1,9.544,braf,2.7.11.1,PDB Primary Data,Homo sapiens,9606,88,1,1,Monomer,A1,SO4,O4 S,96.063,SULFATE ION,"InChI=1S/H2O4S/c1-5(2,3)4/h(H2,1,2,3,4)/p-2",
5771,ENTREZ_GENE,ptpn2,PTN2PTPTTCPTPTCELLPTPTCPTP,Homo sapiens,0.7014784440946549,3.49726e-11,BioGRID ORCS,230220,8U0H,X-RAY DIFFRACTION,2.41,49.06,"VAPOR DIFFUSION, HANGING DROP",6.9,"0.49M Sodium phosphate monobasic monohydrate, 0.91M Potassium phosphate dibasic",296.0,2023-08-29,2024-09-04,5135,2,648,385.0,0,78.03,1,1.93,experimental,38.32,0.1917,0.1726,Crystal structure of PTPN2 with a PROTAC,MAMPTTIEREFEELDTQRRWQPLYLEIRNESHDYPHRVAKFPENRNRNRYRDVSPYDHSRVKLQNAENDYINASLVDIEEAQRSYILTQGPLPNTCCHFWLMVWQQKTKAVVMLNRIVEKESVKCAQYWPTDDQEMLFKETGFSVKLLSEDVKSYYTVHLLQLENINSGETRTISHFHYTTWPDFGVPESPASFLNFLFKVRESGSLNPDHGPAVIHCSAGIGRSGTFSLVDTCLVLMEKGDDINIKQVLLNMRKYRMGLIQTPDQLRFSYMAIIEGAKCIKGDSSIQKRWKELSKEDLSPAFDHSPNKIMTEKYNHHHHHHHH,Protein,324,polypeptide(L),2,37.966,ptpn2,3.1.3.48,PDB Primary Data,Homo sapiens,9606,324,1,1,Monomer,A1,UB0,C46 H49 Cl N6 O12 S2,977.497,"(5P)-3-(carboxymethoxy)-4-chloro-5-(3-{[(4S)-1-({3-[2-(4-{3-[(3R)-2,6-dioxopiperidin-3-yl]-2-oxo-2,3-dihydro-1,3-benzoxazol-6-yl}piperidin-1-yl)acetamido]phenyl}methanesulfonyl)-2,2-dimethylpiperidin-4-yl]amino}phenyl)thiophene-2-carboxylic acid","InChI=1S/C46H49ClN6O12S2/c1-46(2)22-32(48-31-8-4-6-29(20-31)41-39(47)40(64-24-38(56)57)42(66-41)44(59)60)15-18-52(46)67(62,63)25-26-5-3-7-30(19-26)49-37(55)23-51-16-13-27(14-17-51)28-9-10-33-35(21-28)65-45(61)53(33)34-11-12-36(54)50-43(34)58/h3-10,19-21,27,32,34,48H,11-18,22-25H2,1-2H3,(H,49,55)(H,56,57)(H,59,60)(H,50,54,58)/t32-,34+/m0/s1",
147111,ENTREZ_GENE,notum,hNOTUM,Homo sapiens,0.7329175730821605,3.49726e-11,BioGRID ORCS,231467,4UZ1,X-RAY DIFFRACTION,1.9,34.0,Desconocido,4.6,"1.5 M AMMONIUM SULPHATE, 0.1 M SODIUM ACETATE PH 4.6",289.6514371309434,2014-09-04,2015-02-25,3212,1,383,287.0,7,44.17,1,1.4,experimental,18.766,0.18045,0.14387,STRUCTURE OF THE WNT DEACYLASE NOTUM - CRYSTAL FORM III - 1.4A,ETGSAQQLNEDLRLHLLLNTSVTCNDGSPAGYYLKESRGSRRWLLFLEGGWYCFNRENCDSRYDTMRRLMSSRDWPRTRTGTGILSSQPEENPYWWNANMVFIPYCSSDVWSGASSKSEKNEYAFMGALIIQEVVRELLGRGLSGAKVLLLAGSSAGGTGVLLNVDRVAEQLEKLGYPAIQVRGLADSGWFLDNKQYRHTDCVDTITCAPTEAIRRGIRYWNGVVPERCRRQFQEGEEWNCFFGYKVYPTLRSPVFVVQWLFDEAQLTVDNVHLTGQPVQEGLRLYIQNLGRELRHTLKDVPASFAPACLSHEIIIRSHWTDVQVKGTSLPRALHCWDRSLHDSHKASKTPLKGCPVHLVDSCPWPHCNPSCPTGTKHHHHHH,Protein,383,polypeptide(L),1,43.567,notum,3.1.1.1,PDB Primary Data,Homo sapiens,9606,383,1,1,Monomer,A1,NAG,C8 H15 N O6,221.208,2-acetamido-2-deoxy-beta-D-glucopyranose,"InChI=1S/C8H15NO6/c1-3(11)9-5-7(13)6(12)4(2-10)15-8(5)14/h4-8,10,12-14H,2H2,1H3,(H,9,11)/t4-,5-,6-,7-,8-/m1/s1",
147111,ENTREZ_GENE,notum,hNOTUM,Homo sapiens,0.7329175730821605,3.49726e-11,BioGRID ORCS,231467,4UZ5,X-RAY DIFFRACTION,2.5,52.0,Desconocido,6.0,"10 %W/V PEG4000, 0.01 M CACL2, 0.05 M NACACOD PH 6.0, 0.20 M KCL, 1 MM HEPARIN HEXAMER",289.6514371309434,2014-09-04,2015-02-25,2901,1,383,84.0,7,43.82,1,2.1,experimental,43.492,0.2371,0.18746,STRUCTURE OF THE WNT DEACYLASE NOTUM - CRYSTAL FORM IV - 2.1A,ETGSAQQLNEDLRLHLLLNTSVTCNDGSPAGYYLKESRGSRRWLLFLEGGWYCFNRENCDSRYDTMRRLMSSRDWPRTRTGTGILSSQPEENPYWWNANMVFIPYCSSDVWSGASSKSEKNEYAFMGALIIQEVVRELLGRGLSGAKVLLLAGSSAGGTGVLLNVDRVAEQLEKLGYPAIQVRGLADSGWFLDNKQYRHTDCVDTITCAPTEAIRRGIRYWNGVVPERCRRQFQEGEEWNCFFGYKVYPTLRSPVFVVQWLFDEAQLTVDNVHLTGQPVQEGLRLYIQNLGRELRHTLKDVPASFAPACLSHEIIIRSHWTDVQVKGTSLPRALHCWDRSLHDSHKASKTPLKGCPVHLVDSCPWPHCNPSCPTGTKHHHHHH,Protein,383,polypeptide(L),1,43.567,notum,3.1.1.1,PDB Primary Data,Homo sapiens,9606,383,1,1,Monomer,A1,NAG,C8 H15 N O6,221.208,2-acetamido-2-deoxy-beta-D-glucopyranose,"InChI=1S/C8H15NO6/c1-3(11)9-5-7(13)6(12)4(2-10)15-8(5)14/h4-8,10,12-14H,2H2,1H3,(H,9,11)/t4-,5-,6-,7-,8-/m1/s1",
42639U,UNKNOWN,obscurin,UNKNOWN,Homo sapiens,0.3770165503023192,0.3580777589016422,NO,248334,5TZM,X-RAY DIFFRACTION,2.38,48.4,"VAPOR DIFFUSION, HANGING DROP",7.5,"17% tacsimate, 0.1M HEPES pH 7.5, 4% PEG3350, 10 mg/mL C-terminal his-tagged Ig59",293.0,2016-11-21,2017-11-08,775,1,100,97.0,1,10.71,1,1.177,experimental,39.57218347825871,0.1852,0.1642,59th Ig domain of human obscurin (OBSCN Ig59),RLEILELLKNAAVRAGAQACFTCTLSEAVPVGEASWYINGAAVQPDDSDWTVTADGSHHALLLRSAQPHHAGEVTFACRDAVASARLTVLGGLEHHHHHH,Protein,100,polypeptide(L),1,10.709,obscurin,2.7.11.1,PDB Primary Data,Homo sapiens,9606,100,1,1,Monomer,A1,Desconocido,Desconocido,246.2971348233669,Desconocido,Desconocido,
42639U,UNKNOWN,obscurin,UNKNOWN,Homo sapiens,0.3770165503023192,0.3580777589016422,NO,248334,4RSV,X-RAY DIFFRACTION,2.22,44.68,Desconocido,7.5,"0.3-0.5M NaCl   
19-23% PEG 3350   
10.52-11.35 mg/ml, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298.0,2014-11-11,2016-02-24,707,1,102,1.0,0,11.42,1,2.41,experimental,39.57218347825871,0.28,0.26,Human Obscurin Ig58 Domain,TAKNTVVRGLENVEALEGGEALFECQLSQPEVAAHTWLLDDEPVRTSENAEVVFFENGLRHLLLLKNLRPQDSCRVTFLAGDMVTSAFLTVRGGLEHHHHHH,Protein,102,polypeptide(L),1,11.424,obscurin,2.7.11.1,PDB Primary Data,Homo sapiens,9606,102,1,1,Monomer,A1,Desconocido,Desconocido,246.2971348233669,Desconocido,Desconocido,
66A,AMBIGUOUS,protease,UNKNOWN,Homo sapiens,0.3813409113400479,0.4358470457804249,NO,248352,5FGY,X-RAY DIFFRACTION,3.71,66.85,"VAPOR DIFFUSION, SITTING DROP",6.4,"Grew over one week at 4 degrees Celsius in 0.1 M sodium citrate pH 6.4, 1.7 M sodium acetate, 1 mM DTT",277.15,2015-12-21,2016-01-13,1871,2,215,164.0,1,24.47,2,2.1,experimental,13.214,0.19691,0.17554,Structure of human adenovirus 2 protease with cofactor pVIC,MGSSEQELKAIVKDLGCGPYFLGTYDKRFPGFVSPHKLACAIVNTAGRETGGVHWMAFAWNPRSKTCYLFEPFGFSDQRLKQVYQFEYESLLRRSAIASSPDRCITLEKSTQSVQGPNSAACGLFCCMFLHAFANWPQTPMDHNPTMNLITGVPNSMLNSPQVQPTLRRNQEQLYSFLERHSPYFRSHSAQIRSATSFCHLKNM,Protein,204,polypeptide(L),1,23.114,protease,3.4.22.39,PDB Primary Data,Human adenovirus 2,10515,215,2,2,Hetero 2-mer,"A1, B1",Desconocido,Desconocido,246.2971348233669,Desconocido,Desconocido,
